e10vq

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QgiB+ELOdL+dbnLgeRiBPe4kQmmgf8X5nRYq9yBeFvq3zByi+M6twaczb5X3oa2y fOmrQbO7mBuLeGQhUZOIZA== 0000950137-07-007003.txt : 20070508 0000950137-07-007003.hdr.sgml : 20070508 20070508165338 ACCESSION NUMBER: 0000950137-07-007003 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20070331 FILED AS OF DATE: 20070508 DATE AS OF CHANGE: 20070508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZIMMER HOLDINGS INC CENTRAL INDEX KEY: 0001136869 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 134151777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-16407 FILM NUMBER: 07828850 BUSINESS ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 BUSINESS PHONE: 5742676131 MAIL ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 10-Q 1 c14902e10vq.htm QUARTERLY REPORT e10vq

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2007

Commission File Number 001-16407

ZIMMER HOLDINGS, INC.

(Exact name of registrant as specified in its charter)


Delaware		13-4151777
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

345 East Main Street, Warsaw, IN 46580
(Address of principal executive offices)
Telephone: (574) 267-6131

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer o Non-accelerated filer o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ

At April 25, 2007, there were 236,776,399 shares outstanding of the registrant’s $.01 par value Common Stock.

ZIMMER HOLDINGS, INC.

INDEX TO FORM 10-Q

March 31, 2007


		Page

Part I — Financial Information
Item 1.	Financial Statements
	Consolidated Statements of Earnings for the Three Months Ended March 31, 2007 and 2006		3
	Consolidated Balance Sheets as of March 31, 2007 and December 31, 2006		4
	Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2007 and 2006		5
	Notes to Interim Consolidated Financial Statements		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		14
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		23
Item 4.	Controls and Procedures		24

Part II — Other Information
	There is no information required to be reported under any items except those indicated below.
Item 1.	Legal Proceedings		24
Item 1A.	Risk Factors		24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		25
Item 5.	Other Information		25
Item 6.	Exhibits		25
Signatures			26

Part I — Financial Information


Item 1.	*Financial Statements*

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS

(In millions, except per share amounts, unaudited)


	Three Months Ended
	March 31,
	2007			2006

Net Sales	$	950.2		$	860.4
Cost of products sold		206.4			189.4

Gross Profit		743.8			671.0

Research and development		52.3			47.4
Selling, general and administrative		361.6			334.9
Acquisition, integration and other expense (income)		2.7			(1.8	)

Operating expenses		416.6			380.5

Operating Profit		327.2			290.5
Interest income (expense)		(0.2	)		0.5

Earnings before income taxes and minority interest		327.0			291.0
Provision for income taxes		93.3			85.1
Minority interest		(0.3	)		(0.3	)

Net Earnings	$	233.4		$	205.6

Earnings Per Common Share
Basic	$	0.99		$	0.83
Diluted	$	0.98		$	0.82
Weighted Average Common Shares Outstanding
Basic		236.9			247.8
Diluted		239.2			250.1

The accompanying notes are an integral part of these consolidated financial statements.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except share amounts)


	March 31,			December 31,
	2007			2006
	(Unaudited)

ASSETS
Current Assets:
Cash and equivalents	$	326.0		$	265.7
Restricted cash		2.4			2.4
Accounts receivable, less allowance for doubtful accounts		692.5			625.5
Inventories, net		658.8			638.3
Prepaid expenses		54.6			55.1
Deferred income taxes		152.3			159.2

Total current assets		1,886.6			1,746.2
Property, plant and equipment, net		820.6			807.1
Goodwill		2,466.2			2,515.6
Intangible assets, net		708.9			712.6
Other assets		215.6			192.9

Total Assets	$	6,097.9		$	5,974.4


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable	$	128.6		$	158.0
Income taxes payable		69.1			106.5
Other current liabilities		401.2			363.7

Total current liabilities		598.9			628.2
Other long-term liabilities		280.0			323.4
Long-term debt		100.0			99.6

Total Liabilities		978.9			1,051.2

Commitments and Contingencies (Note 12)
Minority interest		2.4			2.7
Stockholders’ Equity:
Common stock, $0.01 par value, one billion shares authorized, 250.9 million shares in 2007 (248.9 million in 2006) issued		2.5			2.5
Paid-in capital		2,870.0			2,743.2
Retained earnings		2,997.1			2,768.5
Accumulated other comprehensive income		223.3			209.2
Treasury stock, 14.2 million shares in 2007 (12.1 million in 2006)		(976.3	)		(802.9	)

Total Stockholders’ Equity		5,116.6			4,920.5

Total Liabilities and Stockholders’ Equity	$	6,097.9		$	5,974.4

The accompanying notes are an integral part of these consolidated financial statements.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions, unaudited)


	For the Three Months
	Ended March 31,
	2007			2006

Cash flows provided by (used in) operating activities:
Net earnings	$	233.4		$	205.6
Adjustments to reconcile net earnings to cash provided by operating activities:
Depreciation and amortization		53.4			46.2
Share-based payment expense		20.9			18.2
Income tax benefit from stock option exercises		27.9			2.0
Excess income tax benefit from stock option exercises		(20.0	)		(1.8	)
Changes in operating assets and liabilities:
Income taxes		18.6			26.1
Receivables		(43.2	)		(65.9	)
Inventories		(19.6	)		(13.0	)
Accounts payable and accrued expenses		(17.8	)		(22.2	)
Other assets and liabilities		(40.4	)		7.5

Net cash provided by operating activities		213.2			202.7

Cash flows provided by (used in) investing activities:
Additions to instruments		(34.5	)		(32.4	)
Additions to other property, plant and equipment		(18.7	)		(21.5	)
Proceeds from sale of property, plant and equipment		—			16.2
Investments in other assets		(5.9	)		—

Net cash used in investing activities		(59.1	)		(37.7	)

Cash flows provided by (used in) financing activities:
Proceeds from employee stock compensation plans		58.8			11.1
Excess income tax benefit from stock option exercises		20.0			1.8
Repurchase of common stock		(173.4	)		(7.1	)

Net cash provided by (used in) financing activities		(94.6	)		5.8

Effect of exchange rates on cash and equivalents		0.8			(0.2	)

Increase in cash and equivalents		60.3			170.6
Cash and equivalents, beginning of year		265.7			233.2

Cash and equivalents, end of period	$	326.0		$	403.8

The accompanying notes are an integral part of these consolidated financial statements.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS


1.	Basis of Presentation

The financial data presented herein is unaudited and should be read in conjunction with the consolidated financial statements and accompanying notes included in the 2006 Annual Report on Form 10-K filed by Zimmer Holdings, Inc. In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods presented. The December 31, 2006 condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Results for interim periods should not be considered indicative of results for the full year. Certain amounts in the three month period ended March 31, 2006 have been reclassified to conform to the current year presentation.

The words “we”, “us”, “our” and similar words refer to Zimmer Holdings, Inc. and its subsidiaries. Zimmer Holdings refers to the parent company only.


2.	Comprehensive Income

The reconciliation of net earnings to comprehensive income is as follows:


	Three Months
	Ended
	March 31,
	2007			2006
	(In millions)

Net Earnings	$	233.4		$	205.6
Other Comprehensive Income (Loss):
Foreign currency cumulative translation adjustments		15.9			9.9
Unrealized foreign currency hedge losses, net of tax		(7.5	)		(5.5	)
Reclassification adjustments on foreign currency hedges, net of tax		2.2			2.1
Unrealized gains (losses) on securities, net of tax		—			0.2
Change in defined benefit plans, net of tax		3.5			—
Minimum pension liability, net of tax		—			(2.5	)

Total Other Comprehensive Income		14.1			4.2

Comprehensive Income	$	247.5		$	209.8


3.	Inventories


	March 31,		December 31,
	2007		2006
	(In millions)

Finished goods	$	499.3	$	489.1
Work in progress		53.9		46.4
Raw materials		105.6		102.8

Inventories, net	$	658.8	$	638.3

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

4. Property, Plant and Equipment


	March 31,			December 31,
	2007			2006
	(In millions)

Land	$	17.6		$	17.6
Buildings and equipment		833.5			783.7
Instruments		799.1			768.5
Construction in progress		69.4			105.3

		1,719.6			1,675.1
Accumulated depreciation		(899.0	)		(868.0	)

Property, plant and equipment, net	$	820.6		$	807.1


5.	Income Taxes

In June 2006, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes — an interpretation of FASB Statement No. 109, Accounting for Income Taxes (“FIN 48”). FIN 48 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN 48, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. FIN 48 also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

We adopted the provisions of FIN 48 on January 1, 2007. Prior to the adoption of FIN 48 we had a long term tax liability for expected settlement of various federal, state and foreign income tax liabilities that was reflected net of the corollary tax impact of these expected settlements of $102.1 million, as well as a separate accrued interest liability of $1.7 million. As a result of the adoption of FIN 48, we are required to present the different components of such liability on a gross basis versus the historical net presentation. The adoption resulted in the financial statement liability for unrecognized tax benefits decreasing by $6.4 million as of January 1, 2007. This decrease in the liability resulted in a reduction to retained earnings of $4.7 million, a reduction in goodwill of $61.4 million, the establishment of a tax receivable of $58.2 million, and an increase in an interest/penalty payable of $7.9 million, all as of January 1, 2007. Therefore, after the adoption of FIN 48, the amount of unrecognized tax benefits is $95.7 million as of January 1, 2007, of which $28.6 million would impact our effective tax rate, if recognized. As of March 31, 2007, the amount of unrecognized tax benefits is $99.6 million, of which $29.6 million would impact our effective tax rate, if recognized.

We recognize accrued interest and penalties related to unrecognized tax benefits in income tax expense in the Consolidated Statements of Earnings, which is consistent with the recognition of these items in prior reporting periods. As of January 1, 2007, we recorded a liability of $9.6 million for accrued interest and penalties, of which $7.5 million would impact our effective tax rate, if recognized. As of March 31, 2007, the amount of this liability is $10.4 million, of which $8.0 million would impact our effective tax rate, if recognized.

It is expected that the amount of tax liability for unrecognized tax benefits will change in the next twelve months; however, we do not expect these changes will have a significant impact on our results of operations or financial position.

The U.S. federal statute of limitations remains open for the year 2003 and onward with years 2003 and 2004 currently under examination by the IRS. It is reasonably possible that a resolution with the IRS for the years 2003 through 2004 will be reached within the next twelve months, but we do not anticipate this would result in any

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

material impact on our financial position. In addition, for the 1999 tax year of Centerpulse, which we acquired in October 2003, one issue remains in dispute at the IRS appeals level. The resolution of this issue would not impact our effective tax rate as it would be recorded as an adjustment to goodwill.

State income tax returns are generally subject to examination for a period of 3 to 5 years after filing of the respective return. The state impact of any federal changes remains subject to examination by various states for a period of up to one year after formal notification to the states. We have various state income tax returns in the process of examination, administrative appeals or litigation. It is reasonably possible that such matters will be resolved in the next twelve months, but we do not anticipate that the resolution of these matters would result in any material impact on our results of operations or financial position.

Foreign jurisdictions have statutes of limitations generally ranging from 3 to 5 years. Years still open to examination by foreign tax authorities in major jurisdictions include Australia (2001 onward), Canada (1998 onward), France (2004 onward), Germany (2000 onward), Italy (2003 onward), Japan (2000 onward), Puerto Rico (2005 onward), Singapore (2002 onward), Switzerland (2004 onward), and the United Kingdom (2004 onward). The Company is currently under examination in various foreign jurisdictions, including France, Germany, Italy and Switzerland. It is reasonably possible that such audits will be resolved in the next twelve months, but we do not anticipate that the resolution of these audits would result in any material impact on our results of operations or financial position.


6.	Retirement and Postretirement Benefit Plans

We have defined benefit pension plans covering certain U.S. and Puerto Rico employees who were hired before September 2, 2002. Employees hired after September 2, 2002 are not part of the U.S. and Puerto Rico defined benefit plans, but do receive additional benefits under our defined contribution plans. Plan benefits are primarily based on years of credited service and the participant’s compensation. In addition to the U.S. and Puerto Rico defined benefit pension plans, we sponsor various non-U.S. pension arrangements, including retirement and termination benefit plans required by local law or coordinated with government sponsored plans.

We also provide comprehensive medical and group life insurance benefits to certain U.S. and Puerto Rico retirees who elect to participate in our comprehensive medical and group life plans. The medical plan is contributory, and the life insurance plan is non-contributory. Employees hired after September 2, 2002 are not eligible for retiree medical and life insurance benefits. No similar plans exist for employees outside the U.S. and Puerto Rico.

The components of net pension expense for the three month periods ended March 31, 2007 and 2006, for our U.S. and non-U.S. defined benefit retirement plans are as follows (in millions):


	Three Months
	Ended March 31,
	2007			2006

Service cost	$	6.9		$	6.0
Interest cost		3.6			3.0
Expected return on plan assets		(4.5	)		(3.6	)
Amortization of unrecognized actuarial loss		0.7			1.1

Net periodic benefit cost	$	6.7		$	6.5

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

The components of net periodic benefit expense for the three month periods ended March 31, 2007 and 2006, for our U.S. and Puerto Rico postretirement benefit plans are as follows (in millions):


	Three Months
	Ended March 31,
	2007			2006

Service cost	$	0.4		$	0.5
Interest cost		0.6			0.6
Amortization of unrecognized prior service cost		(0.1	)		—
Amortization of unrecognized actuarial loss		0.2			0.2

Net periodic benefit cost	$	1.1		$	1.3

We contributed $26.5 million during the three month period ended March 31, 2007, to our U.S. and Puerto Rico defined benefit plans and may make contributions of up to a total of $28 million during 2007. We contributed $2.2 million to our foreign-based defined benefit plans in the three month period ended March 31, 2007, and expect to contribute an additional $7.5 million to these foreign-based plans during 2007. Contributions for the U.S. and Puerto Rico postretirement benefit plans are not expected to be significant.


7.	Share-Based Compensation

Share-based compensation expense for the three month period ended March 31, 2007 was $20.9 million, or $14.3 million net of the related tax benefits. Share-based compensation expense for the three month period ended March 31, 2006 was $18.2 million, or $12.9 million net of the related tax benefits.

A summary of stock option activity for the three month period ended March 31, 2007 is as follows (options in thousands):


	Stock			Weighted Average
	Options			Exercise Price

Outstanding at January 1, 2007		14,184		$	59.75
Options granted		2,243			83.61
Options exercised		(1,858	)		40.64
Options cancelled		(123	)		72.67

Outstanding at March 31, 2007		14,446			65.88

The weighted-average fair value of the options granted in the three month period ended March 31, 2007 was $24.66 per option. As of March 31, 2007, there was $177.5 million of unrecognized share-based compensation expense related to nonvested stock options granted under our plans. That expense is expected to be recognized over a weighted average period of 3.3 years.

At March 31, 2007 and December 31, 2006 there were 905,000 nonvested equity share units, with a grant date fair value of $67.86. The unrecognized share-based payment expense as of March 31, 2007 was $17.0 million, and is expected to be recognized over a period of 1.75 years.


8.	Stock Repurchase Program

In the three month period ended March 31, 2007 we purchased 2,083,800 shares of our common stock at an average price of $83.18 per share for a total cash outlay of $173.4 million, including commissions, under a $1 billion stock repurchase plan authorized by our Board of Directors in December 2005. An additional $24.0 million may be purchased under this plan through December 31, 2007. In December 2006, our Board of Directors authorized an additional repurchase program of up to $1 billion through December 31, 2008.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)


9.	Earnings Per Share

The following is a reconciliation of weighted average shares for the basic and diluted shares computations (in millions):


	Three Months
	Ended
	March 31,
	2007		2006

Weighted average shares outstanding for basic net earnings per share		236.9		247.8
Effect of dilutive stock options		2.3		2.3

Weighted average shares outstanding for diluted net earnings per share		239.2		250.1

During the three month periods ended March 31, 2007 and 2006, an average of 1.1 million options and 8.9 million options, respectively, to purchase shares of common stock were not included in the computation of diluted earnings per share as the exercise prices of these options were greater than the average market price of the common stock.


10.	Segment Information

We design, develop, manufacture and market reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products which include surgical supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. We also provide hospital-focused consulting services to help member institutions design, implement and manage successful orthpaedic programs. We manage operations through three major geographic segments — the Americas, which is comprised principally of the United States and includes other North, Central and South American markets; Europe, which is comprised principally of Europe and includes the Middle East and Africa; and Asia Pacific, which is comprised primarily of Japan and includes other Asian and Pacific markets. This structure is the basis for our reportable segment information discussed below. Management evaluates operating segment performance based upon segment operating profit exclusive of operating expenses pertaining to global operations and corporate expenses, share-based payment expense, acquisition, integration and other expenses, inventory step-up, in-process research and development write-offs and intangible asset amortization expense. Global operations include research, development engineering, medical education, brand management, corporate legal, finance, and human resource functions, and U.S. and Puerto Rico based manufacturing operations and logistics. Intercompany transactions have been eliminated from segment operating profit.

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

Net sales and segment operating profit are as follows (in millions):


					Operating Profit
	Net Sales				Three Months
	Three Months Ended				Ended
	March 31,				March 31,
	2007		2006		2007			2006

Americas	$	567.8	$	516.0	$	297.0		$	268.8
Europe		258.8		228.7		112.2			99.3
Asia Pacific		123.6		115.7		58.5			56.0

Total	$	950.2	$	860.4

Share-based payment expense						(20.9	)		(18.2	)
Acquisition and integration						(2.7	)		1.8
Global operations and corporate functions						(116.9	)		(117.2	)

Operating profit					$	327.2		$	290.5

Product category net sales are as follows (in millions):


	Three Months Ended
	March 31,
	2007		2006

Reconstructive implants	$	797.5	$	717.5
Trauma		50.1		46.7
Spine		46.7		43.1
Orthopaedic surgical products		55.9		53.1

Total	$	950.2	$	860.4


11.	Recent Accounting Pronouncements

In September 2006, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accountings Standards (SFAS) No. 157, “Fair Value Measurements,” (SFAS No. 157) which defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. This Statement does not require any new fair value measurements, but provides guidance on how to measure fair value by providing a fair value hierarchy used to classify the source of the information. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after November 15, 2007. The adoption of SFAS No. 157 is not expected to have a material impact on our financial position or results of operations.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115” (SFAS No. 159). SFAS No. 159 creates a “fair value option” under which an entity may elect to record certain financial assets or liabilities at fair value upon their initial recognition. Subsequent changes in fair value would be recognized in earnings as those changes occur. The election of the fair value option would be made on a contract-by-contract basis and would need to be supported by concurrent documentation or a preexisting documented policy. SFAS No. 159 requires an entity to separately disclose the fair value of these items on the balance sheet or in the footnotes to the financial statements and to provide information that would allow the financial statement user to understand the impact on earnings from the changes in the fair value. SFAS No. 159 is effective for fiscal years beginning after November 15, 2007. The

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

adoption of SFAS No. 159 is not expected to have a material impact on our financial position or results of operations.


12.	Commitments and Contingencies

As a result of the Centerpulse acquisition, we acquired the entity involved in Centerpulse’s hip and knee implant litigation matter. The litigation was a result of a voluntary recall of certain hip and knee implants manufactured and sold by Centerpulse. On March 13, 2002, a U.S. Class Action Settlement Agreement (“Settlement Agreement”) was entered into by Centerpulse that resolved U.S. claims related to the affected products and a settlement trust (“Settlement Trust”) was established and funded for the most part by Centerpulse. The court approved the settlement arrangement on May 8, 2002. Under the terms of the Settlement Agreement, we will reimburse the Settlement Trust a specified amount for each revision surgery over 4,000 and revisions on reprocessed shells over 64. As of April 2, 2007, the claims administrator has received 4,133 likely valid claims for hips (cut-off date June 5, 2003) and knees (cut-off date November 17, 2003) and 200 claims for reprocessed shells (cut-off date September 8, 2004). We believe the litigation liability recorded as of March 31, 2007 is adequate to provide for any future claims regarding the hip and knee implant litigation.

On February 15, 2005, Howmedica Osteonics Corp. (“Howmedica”) filed an action against us and an unrelated party in the United States District Court for the District of New Jersey alleging infringement by the defendants of U.S. Patent Nos. 6,174,934; 6,372,814; 6,664,308; and 6,818,020. Howmedica’s complaint seeks unspecified damages and injunctive relief. On April 14, 2005, we filed our answer to the complaint denying Howmedica’s allegations. Discovery is ongoing. We believe that our defenses are valid and meritorious and we intend to defend the Howmedica lawsuit vigorously.

We are also subject to product liability and other claims and lawsuits arising in the ordinary course of business, for which we maintain insurance, subject to self-insured retention limits. We establish accruals for product liability and other claims in conjunction with outside counsel based on current information and historical settlement information for open claims, related fees and for claims incurred but not reported. While it is not possible to predict with certainty the outcome of these cases, it is the opinion of management that, upon ultimate resolution, these cases will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

In July 2003, the Staff of the Securities and Exchange Commission informed Centerpulse that it was conducting an informal investigation of Centerpulse relating to certain accounting issues. We are continuing to fully cooperate with the Securities and Exchange Commission in this matter.

In March 2005, we received a subpoena and we have received supplemental requests since that time from the United States Department of Justice through the United States Attorney’s Office in Newark, New Jersey, requesting that we produce documents and related information for the period beginning January 1998 pertaining to consulting contracts, professional service agreements and other agreements by which we may provide remuneration to orthopaedic surgeons, including research and other grant agreements. We are cooperating fully with federal authorities with regard to this matter. We understand that similar inquiries were directed to at least four other companies in the orthopaedics industry.

In June 2006, we received a subpoena from the United States Department of Justice, Antitrust Division, requesting that we produce documents for the period beginning January 2001 through June 2006, pertaining to an investigation of possible violations of federal criminal law, including possible violations of the antitrust laws, involving the manufacture and sale of orthopaedic implant devices. We are cooperating fully with federal authorities with regard to this matter. We understand that similar inquiries were directed to at least four other companies in the orthopaedics industry.

Following the commencement of the Department of Justice, Antitrust Division’s investigation, we and several other major orthopaedic manufacturers were named as defendants in five putative class action lawsuits as of January 1, 2007. These lawsuits were brought by direct and indirect purchasers of orthopaedic products alleging

ZIMMER HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

violations of Federal and state antitrust laws and certain state consumer protection statutes. In each of these lawsuits, the plaintiffs allege that the defendants engaged in a conspiracy to fix prices of orthopaedic implant devices. The direct purchaser cases, South Central Surgical Center, LLC v. Zimmer Holdings, Inc. et al. and Chaiken DDS, P.C. v. Biomet, Inc. et al., were filed in the United States District Court for the Southern District of Indiana on July 13, 2006 and in the United States District Court for the Northern District of Indiana on July 26, 2006, respectively. The indirect purchaser cases, Thomas v. Biomet, Inc. et al., Kirschner v. Biomet, Inc. et al. and Williams v. Biomet, Inc. et al., were filed in the United States District Court for the Western District of Tennessee on July 18, 2006, July 24, 2006 and July 27, 2006, respectively.

On January 12, 2007, we and the other defendants in the five cases delivered a Motion for Transfer and Consolidation of Pretrial Proceedings under 28 U.S.C. §1407 to the Judicial Panel on Multidistrict Litigation, requesting the court to transfer the cases to the United States District Court for the Southern District of Indiana for coordinated or consolidated pretrial proceedings. The motion was filed by the Panel on January 18, 2007. The plaintiffs did not oppose a stay of proceedings pending resolution of this motion. On January 15, 2007, the plaintiff in Thomas v. Biomet, Inc. et al. filed a Notice of Voluntary Dismissal Without Prejudice in the United States District Court for the Western District of Tennessee. On April 18, 2007, the Judicial Panel on Multidistrict Litigation issued a Transfer Order ordering that the three remaining actions pending outside the Southern District of Indiana be transferred to that district for coordinated or consolidated pretrial proceedings with the action already pending in that district. In each of these four remaining cases, the plaintiffs seek damages of unspecified amounts, in some cases to be trebled under applicable law, attorneys’ fees and injunctive or other unspecified relief. We believe these lawsuits are without merit and we intend to defend them vigorously.


13.	Subsequent Events

In February 2007, we announced that we would acquire Endius, Inc., a privately held Massachusetts company, in a cash transaction. The acquisition was completed in April 2007. The acquisition is not expected to have a material impact on our financial position or results of operations.


Item 2.	*Management’s Discussion and Analysis of Financial Condition and Results of Operations*

Overview

We are a global leader in the design, development, manufacture and marketing of reconstructive orthopaedic implants, including joint and dental, spinal implants, trauma products and related orthopaedic surgical products (sometimes referred to in this report as “OSP”). We also provide hospital-focused consulting services to help member institutions design, implement and manage successful orthopaedic programs, which account for less than one percent of sales. Reconstructive orthopaedic implants restore joint function lost due to disease or trauma in joints such as knees, hips, shoulders and elbows. Dental reconstructive implants restore function and aesthetics in patients that have lost teeth due to trauma or disease. Spinal implants are utilized by orthopaedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities and trauma in all regions of the spine. Trauma products are devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. OSP includes supplies and instruments designed to aid in orthopaedic surgical procedures and post-operation rehabilitation. Through our consulting services, we provide hospitals and other orthopaedic practices resource capabilities in the areas of business development, marketing, in/outpatient rehab practice, clinical pathways, care mapping and space design, community relations, customer service, delivery models, cost accounting, staff utilization and other areas. We have operations in more than 24 countries and market products in more than 100 countries. We manage operations through three reportable geographic segments — the Americas, Europe and Asia Pacific.

Certain percentages presented in Management’s Discussion and Analysis are calculated from the underlying whole-dollar amounts and therefore may not recalculate from the rounded numbers used for disclosure purposes.

We believe the following developments or trends are important in understanding our financial condition, results of operations and cash flows for the three month period ended March 31, 2007.

Demand (Volume and Mix) Trends

Increased volume and changes in the mix of product sales contributed 8 percentage points of sales growth, compared to 7 percentage points in the same 2006 period. We believe the market for orthopaedic procedure volume on a global basis continues to rise at mid to high single digit rates driven by an aging global population, obesity, proven clinical benefits, new material technologies, advances in surgical techniques (such as our Zimmer^® Minimally Invasive Solutions (MIS) Procedures and Technologies), introduction of gender based devices and more active lifestyles, among other factors. In addition, the ongoing shift in demand to premium products, such as Longevity^® and Durasul^® Highly Crosslinked Polyethylenes, Trabecular Metal^tm Technology products, high-flex knees, knee revision products and porous hip stems, continues to positively affect sales growth. For example, during the three month period ended March 31, 2007, sales of products incorporating Trabecular Metal Technology were approximately $51 million, an increase of over 40 percent compared to the same 2006 period.

We believe innovative products will continue to affect the orthopaedics industry. In the second half of 2006, we launched the Zimmer Gender Solutions^tm High-Flex Knee Femoral Implant, which was the result of five years of intensive research based on an analysis of 800 femurs and patella. In the three months ended March 31, 2007, we sold over 14,000 Gender Solutions Knees, representing an increase in unit sales of over 50 percent when compared with the most recent quarter ended December 31, 2006.

Pricing Trends

Selling prices were flat during the three month period ended March 31, 2007 compared with a 1 percentage point increase in average selling prices for the same 2006 period. The Americas experienced a 1 percent increase in selling prices during the three month period ended March 31, 2007 compared with a 2 percent increase for the same 2006 period. In Europe, selling prices for the three month period ended March 31, 2007 decreased 1 percent, which is similar to the same 2006 period. Within Europe, Germany and Italy experienced 4 percent and 3 percent decreases, respectively, in selling prices in the three month period ended March 31, 2007, as a result of reductions in government implant reimbursement rates and group purchasing arrangements. Germany and Italy combined represent approximately 11 percent of our sales. Asia Pacific selling prices decreased 3 percent for the three month

period ended March 31, 2007, compared to a less than 1 percent decrease in the same 2006 period. As anticipated, Japan reported a 6 percent decrease in average selling prices as a result of scheduled reductions in government controlled reimbursement prices. Japan represents approximately 7 percent of our sales. With the effect of governmental healthcare cost containment efforts and pressure from group purchasing organizations, we expect global selling prices will remain flat in 2007.

Foreign Currency Exchange Rates

For the three month period ended March 31, 2007, foreign currency exchange rates had a positive 2 percent effect on sales. The positive effect of foreign currency exchange rates should diminish throughout the year as the weakening of the U.S. Dollar that we experienced in the third and fourth quarters of 2006 is anniversaried. We estimate that an overall weaker U.S. Dollar will have a positive effect of approximately 1 percent on sales for the year ending December 31, 2007. We address currency risk through regular operating and financing activities, and under appropriate circumstances and subject to proper authorization, through the use of forward contracts solely for managing foreign currency volatility and risk. Changes to foreign currency exchange rates affect sales growth, but due to offsetting gains/losses on hedge contracts, which are recorded in cost of products sold, the effect on net earnings in the near term is expected to be minimal.

New Product Sales

New products, which management defines as products or stock keeping units (“SKU’s”) introduced within the prior 36-month period to a particular market, accounted for 24 percent, or $231 million, of our sales during the three month period ended March 31, 2007. Adoption rates for new technologies are a key indicator of industry performance. Our sales have grown with the introduction of new products, such as Trabecular Metal Modular Acetabular Cups, certain SKU’s of the NexGen^® Complete Knee Solution including the Gender Solutions Knee Femoral Implant for the LPS-Flex, and CR-Flex Knees, the Dynesys^®¹ Dynamic Stabilization System, the Zimmer^® M/L Taper Stem and PALACOS^®² Bone Cement.

We believe new products in our current pipeline should continue to favorably affect our operating performance. Products we expect to contribute to new product sales in 2007 include the Gender Solutions Knee Femoral Implant; products incorporating Trabecular Metal Technology, including the Trabecular Metal Primary Hip Prosthesis, Trabecular Metal Acetabular Revision System and Trabecular Metal Spine Components; Durom^® Acetabular Cups with Metasul^® LDH^® Large Diameter Heads; Versys^® Epoch^® Composite Hip Prosthesis; Zimmer^® Reverse Shoulder System, Anatomical Shoulder^tm Inverse/Reverse System; Zimmer MIS Femoral Nailing Solutions; NCB^® Locking Plate System; and CopiOs ^® Bone Void Filler³.

New Accounting Pronouncements

On January 1, 2007, we adopted FIN 48. FIN 48 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN 48, the tax benefits from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. FIN 48 also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

Prior to the adoption of FIN 48, we had a long term tax liability for expected settlement of various federal, state and foreign income tax liabilities that was reflected net of the corollary tax impacts of these expected settlements of $102.1 million, as well as a separate accrued interest liability of $1.7 million. As a result of the adoption of FIN 48, we are required to present the different components of such liability gross versus the historical net presentation. The adoption resulted in the tax liability for unrecognized tax benefits decreasing by $6.4 million as of January 1, 2007.

¹ The Dynesys Dynamic Stabilization Spinal System is indicated for use as an adjunct to fusion in the U.S.

² PALACOS^® is a trademark of Heraeus Kulzer GmbH. Under license from Heraeus Kulzer GmbH, Hanau, Germany.

³ Manufactured by Kensey Nash Corporation.

This decrease in the liability resulted in a reduction to retained earnings of $4.7 million, a reduction in goodwill of $61.4 million, the establishment of a tax receivable of $58.2 million, and the addition of an interest/penalty payable of $7.9 million, all as of January 1, 2007.

First Quarter Results of Operations

Net Sales by Operating Segment

The following table presents net sales by operating segment and the components of the percentage changes (dollars in millions):


	Three Months
	Ended
	March 31,							Volume/						Foreign
	2007		2006		% Inc (Dec)			Mix			Price			Exchange

Americas	$	567.8	$	516.0		10	%		9	%		1	%		—	%
Europe		258.8		228.7		13			6			(1	)		8
Asia Pacific		123.6		115.7		7			9			(3	)		1

	$	950.2	$	860.4		10			8			—			2

“Foreign Exchange” as used in the tables in this report represents the effect of changes in foreign exchange rates on sales growth.

Net Sales by Product Category

The following table presents net sales by product category and the components of the percentage changes (dollars in millions):


	Three Months
	Ended
	March 31,							Volume/						Foreign
	2007		2006		% Inc (Dec)			Mix			Price			Exchange

Reconstructive
Knees	$	407.5	$	366.2		11	%		9	%		—	%		2	%
Hips		316.8		292.9		8			6			(1	)		3
Extremities		24.2		18.4		32			29			1			2
Dental		49.0		40.0		22			17			4			1

Total		797.5		717.5		11			9			—			2

Trauma		50.1		46.7		7			5			1			1
Spine		46.7		43.1		8			6			1			1
OSP and other		55.9		53.1		5			3			1			1

Total	$	950.2	$	860.4		10			8			—			2

The NexGen Complete Knee Solution product line including Gender Solutions Knee Femoral Implants, the NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components, the NexGen CR-Flex Knee, the NexGen Rotating Hinge Knee and the NexGen LCCK Revision Knee led knee sales. In addition, the Zimmer^® Unicompartmental High-Flex Knee and the Innex^® Total Knee System exhibited strong growth.

Growth in porous stems, including the Zimmer M/L Taper Stem, the CLS^® Spotorno^® Stem from the CLS Hip System, and the Alloclassic^® Zweymüller^® Hip Stem led hip stem sales, but were partially offset by weaker sales of cemented stems. Due to the distribution agreement we signed to distribute PALACOS Bone Cement, sales of bone cement improved significantly. Trabecular Metal Acetabular Cups, Durom Hip Resurfacing System products internationally, and Longevity and Durasul Highly Crosslinked Polyethylene Liners also had strong growth.

The Bigliani/Flatow^® Complete Shoulder Solution and the Trabecular Metal Humeral Stem led extremities sales. Orthobiologicals and prosthetic implants, including strong growth of the Tapered Screw-Vent^® Implant System, led dental sales. Zimmer^® Periarticular Locking Plates and Zimmer Plates and Screws led trauma sales. The Dynesys Dynamic Stabilization System, the Optima^tm4 ZS Spinal Fixation System and Spinal Trabecular Metal Spacers led spine sales. OSP sales were negatively affected by the loss of the distribution of the OrthoPAT^®⁵ Autotransfusion System. Haemonetics Corporation ended an exclusive distribution agreement with us to sell the OrthoPAT Autotransfusion System and therefore we were only able to sell this product through February 2006.

Americas Net Sales

The following table presents Americas net sales (dollars in millions):


	Three Months
	Ended
	March 31,
	2007		2006		% Inc

Reconstructive
Knees	$	262.7	$	239.9		10	%
Hips		156.4		141.9		10
Extremities		17.7		12.9		37
Dental		28.2		23.7		19

Total		465.0		418.4		11

Trauma		31.2		28.5		9
Spine		38.3		36.1		6
OSP and other		33.3		33.0		1

Total	$	567.8	$	516.0		10

The NexGen Complete Knee Solution product line, including the Gender Solutions Knee Femoral Implants, NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components, the NexGen LCCK Revision Knee and the NexGen CR-Flex Knee led knee sales. The Zimmer Unicompartmental High-Flex Knee also made a strong contribution.

Growth in porous stems, including growth of the Zimmer M/L Taper Stem and Alloclassic Zweymüller Hip Stem led hip stem sales, but were partially offset by weaker sales of cemented stems. PALACOS Bone Cement and Trabecular Metal Acetabular Cups also exhibited strong growth.

The Bigliani/Flatow Shoulder Solution and the Trabecular Metal Humeral Stem led extremities sales. The Tapered Screw-Vent Implant System led dental sales. Zimmer Periarticular Plates, Zimmer Plates and Screws and the I.T.S.T. Intertrochanteric/Subtrochanteric Fixation System led trauma sales. The Dynesys Dynamic Stabilization System, the Optima ZS Spinal Fixation System and Spinal Trabecular Metal Spacers led spine sales. OSP sales were negatively affected by the loss of the OrthoPAT Autotransfusion System.


	⁴	Trademark of U&I Corporation.
	⁵	Registered Trademark of Haemonetics Corporation.

Europe Net Sales

The following table presents Europe net sales (dollars in millions):


	Three Months
	Ended
	March 31,
	2007		2006		% Inc

Reconstructive
Knees	$	102.0	$	88.4		16	%
Hips		113.4		103.5		10
Extremities		5.1		4.2		23
Dental		13.4		11.3		18

Total		233.9		207.4		13

Trauma		9.0		7.8		15
Spine		6.9		5.5		26
OSP and other		9.0		8.0		12

Total	$	258.8	$	228.7		13

Changes in foreign exchange rates positively affected knee and hip sales by 9 percent and 8 percent, respectively. Excluding these foreign exchange rate effects, these product categories experienced positive sales growth in our Europe region; the NexGen Complete Knee Solution product line, including the NexGen LPS-Flex Knee, NexGen Trabecular Metal Tibial Components and the NexGen CR-Flex Knee, and the Innex Total Knee System. Growth in porous stems, including the CLS Spotorno Stem led hip stem sales, but was offset by weaker sales of cemented and revision stems. Longevity and Durasul Highly Crosslinked Polyethylene Liners, the Durom Hip Resurfacing System, Trabecular Metal Acetabular Cups and the Allofit^tm Hip Acetabular System also contributed to hip sales.

The Anatomical Shoulder System, the Anatomical Shoulder Inverse/Reverse System and the Coonrad/Morrey Total Elbow led extremities sales. The Tapered Screw-Vent Implant System led dental sales. The Cable-Ready Cable Grip System, Zimmer Periarticular Plates and the NCB Plating System led trauma sales, which were offset by weaker sales of our intramedullary fixation systems. The Dynesys Dynamic Stabilization System, the Optima ZS Spinal Fixation System and Trabecular Metal Spacers led spine sales. Wound management products led OSP sales.

Asia Pacific Net Sales

The following table presents Asia Pacific net sales (dollars in millions):


	Three Months
	Ended
	March 31,
	2007		2006		% Inc (Dec)

Reconstructive
Knees	$	42.8	$	37.9		13	%
Hips		47.0		47.5		(1	)
Extremities		1.4		1.3		13
Dental		7.4		5.0		46

Total		98.6		91.7		8

Trauma		9.9		10.4		(5	)
Spine		1.5		1.5		(4	)
OSP and other		13.6		12.1		12

Total	$	123.6	$	115.7		7

Changes in foreign exchange rates positively affected knee sales by 2 percent and had no effect on hip sales. Reported decreases in average selling prices negatively affected knee and hip sales by 1 percent and 5 percent, respectively. The NexGen Complete Knee Solution product line, including NexGen Trabecular Metal Tibial Components, the NexGen CR-Flex Knee and the NexGen LPS-Flex Knee led knee sales. Launch of the Gender Solutions Knee Femoral Implant in Australia also contributed to strong knee sales for the period. The continued conversion to porous stems, including the Fiber Metal Taper Stem from the VerSys^® Hip System, the Alloclassic Zweymüller Hip System and the CLS Spotorno Stem led hip stem sales. Sales of Longevity and Durasul Highly Crosslinked Polyethylene Liners, the Durom Hip Resurfacing System and Trabecular Metal Acetabular Cups also exhibited growth.

Extremities sales increased due to stronger sales of our shoulder and elbow products. The Tapered Screw-Vent Implant System led dental sales. Trauma sales were affected by a reported 5 percent decrease in average selling prices during the three months ended March 31, 2007. A temporary registration issue with the ST360º^® Spinal Fixation System in Japan resulted in a decrease in sales of this device, contributing to the negative growth in Spine sales for the period. Powered surgical instruments led OSP sales.

Gross Profit

Gross profit as a percentage of net sales was 78.3 percent in the three month period ended March 31, 2007, compared to 78.0 percent in the same 2006 period. Primary contributors to the improvement in gross profit margin were reductions in unit manufacturing cost for various products and the effects of changes in foreign exchange rates combined with our hedging program. Under our hedging program, for derivatives which qualify as hedges of future cash flows, the effective portion of changes in fair value is temporarily recorded in other comprehensive income, and then recognized in cost of products sold when the hedged item affects earnings.

Operating Expenses

R&D as a percentage of net sales was 5.5 percent for the three month period ended March 31, 2007, consistent with the same 2006 period. R&D increased to $52.3 million for the three month period ended March 31, 2007, from $47.4 million in the same 2006 period, reflecting increased spending on projects focused on areas of strategic significance, including orthobiologics. We target R&D spending to the high end of what management believes to be an average of 4-6 percent for our industry.

SG&A as a percentage of net sales was 38.1 percent for the three month period ended March 31, 2007, compared to 38.9 percent in the same 2006 period. SG&A increased to $361.6 million for the three month period ended March 31, 2007, from $334.9 million in the same 2006 period. SG&A expenses in 2007 were positively affected by the favorable settlement of a legal claim made against a third party for interference in a contractual relationship with a former distributor of our products.

Acquisition, integration and other expenses for the three month period ended March 31, 2007 were $2.7 million compared to income of $1.8 million in the same 2006 period. The expenses for the period reflect estimated settlements for certain pre-acquisition product liability claims, integration consulting fees and costs for integrating information technology systems. The income in the three month period ended March 31, 2006 was primarily due to a gain on the sale of our Austin, Texas facility and land and a favorable adjustment to acquired Centerpulse reserves related to product liabilities. These were partially offset by an in-process research and development charge from the purchase of intellectual property for an intelligent surgical assist device from MedTech S.A.

Operating Profit, Income Taxes and Net Earnings

Operating profit for the three month period ended March 31, 2007 increased 13 percent to $327.2 million, from $290.5 million in the same 2006 period. Increased sales, improved gross profit margins and controlled operating expenses drove operating profit.

The effective tax rate on earnings before income taxes and minority interest decreased to 28.5 percent for the three month period ended March 31, 2007, from 29.3 percent in the same 2006 period. The decrease in the effective tax rate is primarily due to increased profitability in lower tax jurisdictions.

Net earnings increased 14 percent to $233.4 million for the three month period ended March 31, 2007, compared to $205.6 million in the same 2006 period. The increase was primarily due to higher operating profit and a lower effective tax rate. Basic and diluted earnings per share increased 19 percent and 20 percent, respectively, to $0.99 and $0.98, respectively, from $0.83 and $0.82, respectively, in the same 2006 period. The higher growth rate in earnings per share as compared with net earnings is attributed to the effect of 2006 and 2007 share repurchases.

Operating Profit by Segment

Management evaluates operating segment performance based upon segment operating profit exclusive of operating expenses pertaining to global operations and corporate expenses, share-based payment expense, acquisition, integration and other expenses, inventory step-up, in-process research and development write-offs and intangible asset amortization expense. Global operations include research, development engineering, medical education, brand management, corporate legal, finance, and human resource functions, and U.S. and Puerto Rico based operations and logistics. Intercompany transactions have been eliminated from segment operating profit. For more information regarding our segments, see Note 10 to the consolidated financial statements included elsewhere in this Form 10-Q.

The following table sets forth operating profit as a percentage of sales by segment for the three month periods ended March 31, 2007 and 2006:

Percent of net sales


	Three Months Ended March 31,
	2007			2006

Americas		52.3	%		52.1	%
Europe		43.4			43.4
Asia Pacific		47.3			48.4

In the Americas, operating profit as a percentage of sales increased modestly due to improved gross margins offset by increased spending for direct to patient advertising.

European operating profit as a percentage of net sales is consistent with prior year, reflecting slightly lower gross margins as a result of decreases in average selling prices offset by a reduction in operating expenses as a percent of sales.

Asia Pacific operating profit as a percentage of net sales decreased primarily due to increases in operating expenses as a percent of sales as compared to the prior year. Operating expenses grew at a faster rate than sales in Japan where average selling prices decreased by 6.2 percent as a result of reductions in government controlled reimbursement prices.

Liquidity and Capital Resources

Cash flows provided by operating activities were $213.2 million in 2007, compared to $202.7 million in the same 2006 period. The principal source of cash was net earnings of $233.4 million. We had positive cash flows of $18.6 million from income taxes, primarily related to the utilization of acquired Centerpulse tax attributes. The positive cash flow associated with the tax benefit from stock option exercises was $7.9 million in the three month period ended March 31, 2007. Operating cash flows from working capital changes for the three month period ended March 31, 2007 decreased compared to the same 2006 period primarily due to increased pension funding.

We continue to focus on working capital management. At March 31, 2007, we had 59 days of sales outstanding in trade accounts receivable, which is unfavorable to March 31, 2006, by 2 days. At March 31, 2007, we had 287 days of inventory on hand, unfavorable to March 31, 2006 by 2 days and unfavorable to December 31, 2006 by 10 days. Our inventory levels have increased due to the preparation for new product launches and increased production.

Cash flows used in investing activities were $59.1 million in the three month period ended March 31, 2007, compared to $37.7 million used in investing in the same 2006 period. Additions to instruments during the three month period ended March 31, 2007 were $34.5 million, compared to $32.4 million in the same 2006 period. Additions to other property, plant and equipment during the three month period ended March 31, 2007 were $18.7 million, compared to $21.5 million in the same 2006 period.

Cash flows used in financing activities were $94.6 million for the three month period ended March 31, 2007, compared to $5.8 million provided by financing activities in the same 2006 period. Proceeds from our stock compensation plans have increased in the three month period ended March 31, 2007, compared to the same 2006 period due to an increase in employee stock option exercises. For the three months ended March 31, 2007, we purchased 2.1 million common shares for a total of $173.4 million as part of a $1 billion repurchase program, compared to $7.1 million in the same 2006 period.

We have a five year $1,350 million revolving, multi-currency, senior unsecured credit facility maturing March 31, 2010 (the “Senior Credit Facility”). We had $100.0 million outstanding under the Senior Credit Facility at March 31, 2007, and therefore, our available borrowings were $1,250.0 million. The $100.0 million is owed by our Japan subsidiary and carries a low interest rate, which is why we have not repaid the debt. The Senior Credit Facility contains a provision whereby borrowings may be increased to $1,750 million.

We and certain of our wholly owned foreign and domestic subsidiaries are the borrowers, and our wholly owned domestic subsidiaries are the guarantors, of the Senior Credit Facility. Borrowings under the Senior Credit Facility are used for general corporate purposes and bear interest at a LIBOR-based rate plus an applicable margin determined by reference to our senior unsecured long-term credit rating and the amounts drawn under the Senior Credit Facility, at an alternate base rate, or at a fixed rate determined through a competitive bid process. The Senior Credit Facility contains customary affirmative and negative covenants and events of default for an unsecured financing arrangement, including, among other things, limitations on consolidations, mergers and sales of assets. Financial covenants include a maximum leverage ratio of 3.0 to 1.0 and a minimum interest coverage ratio of 3.5 to 1.0. If we fall below an investment grade credit rating, additional restrictions would result, including restrictions on investments, payment of dividends and stock repurchases. We were in compliance with all covenants under the Senior Credit Facility as of March 31, 2007. Commitments under the Senior Credit Facility are subject to certain fees, including a facility and a utilization fee. The Senior Credit Facility was upgraded to A- in April 2007 by Standard & Poor’s Ratings Services. The Senior Credit Facility is not rated by Moody’s Investors’ Service, Inc.

We also have available uncommitted credit facilities totaling $65.9 million.

In December 2005, our Board of Directors authorized a stock repurchase program of up to $1 billion through December 31, 2007. In December 2006, our Board of Directors authorized an additional stock repurchase program of up to $1 billion through December 31, 2008. As of March 31, 2007, we had purchased shares of common stock with an aggregate purchase price of $976.3 million, including commissions. We may use excess cash to purchase additional common stock under these programs.

Management believes that cash flows from operations, together with available borrowings under the Senior Credit Facility, are sufficient to meet our working capital, capital expenditure and debt service needs. Should investment opportunities arise, we believe that our earnings, balance sheet and cash flows will allow us to obtain additional capital, if necessary.

Contractual Obligations

We have entered into contracts with various third parties in the normal course of business which will require future payments. The following table illustrates our contractual obligations as of March 31, 2007, including the adoption of FIN 48 (in millions):


					2008		2010		2012
					and		and		and
	Total		2007		2009		2011		Thereafter

Long-term debt	$	100.0	$	—	$	—	$	100.0	$	—
Operating leases		98.2		18.1		34.4		20.6		25.1
Purchase obligations		32.7		31.7		1.0		—		—
Other current tax reserves		10.9		10.9		—		—		—
Other long-term liabilities		280.0		—		106.7		41.6		131.7

Total contractual obligations	$	521.8	$	60.7	$	142.1	$	162.2	$	156.8

Recent Accounting Pronouncements

Critical Accounting Estimates

Our financial results are affected by the selection and application of accounting policies and methods. On January 1, 2007 we adopted FIN 48. FIN 48 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under FIN 48, the tax benefits from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. FIN 48 also provides guidance on derecognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. FIN 48 requires significant judgment in determining what constitutes an individual tax position as well as assessing the outcome of each tax position.

There were no other changes in the three month period ended March 31, 2007 to the application of critical accounting estimates as described in our Annual Report on Form 10-K for the year ended December 31, 2006.

Forward Looking Statements

This quarterly report contains certain statements that are forward-looking statements within the meaning of federal securities laws. When used in this report, the words “may,” “will,” “should,” “anticipate,” “estimate,” “expect,” “plan,” “believe,” “predict,” “potential,” “project,” “target,” “forecast,” “intend” and similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include, but are not limited to:


	•	competition;

	•	pricing pressures;

	•	dependence on new product development, technological advances and innovation;

	•	reductions in reimbursement levels by third-party payors and cost containment efforts of health care purchasing organizations;

	•	the outcome of the pending U.S. Department of Justice investigations announced in March 2005 and June 2006;

	•	challenges relating to changes in and compliance with Federal, state and foreign governmental laws and regulations affecting our U.S. and international businesses, including tax obligations and risks;

	•	retention of our independent agents and distributors;

	•	changes in customer demand for our products and services caused by demographic changes or other factors;

	•	changes in general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations;

	•	our ability to protect proprietary technology and other intellectual property and claims for infringement of the intellectual property rights of third parties;

	•	product liability claims;

	•	the possible disruptive effect of additional strategic acquisitions and our ability to successfully integrate acquired companies;

	•	our ability to form strategic alliances with other orthopaedic and biotechnology companies;

	•	changes in prices of raw materials and products and our ability to control costs and expenses;

	•	changes in general industry and market conditions, including domestic and international growth rates;

	•	our dependence on a limited number of suppliers for key raw materials and outsourced activities; and

	•	shifts in our product category sales mix or our regional sales mix away from products or geographic regions that generate higher operating margins.

We discuss these and other important risks and uncertainties that may affect our future operations in Part I, Item 1A — Risk Factors in our most recent Annual Report on Form 10-K and may update that discussion in Part II, Item 1A — Risk Factors in this or another Quarterly Report on Form 10-Q we file hereafter. Readers of this report are cautioned not to place undue reliance on these forward-looking statements. While we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this report.


Item 3.	*Quantitative and Qualitative Disclosures About Market Risk*

There have been no material changes from the information provided in our Annual Report on Form 10-K for the year ended December 31, 2006.


Item 4.	*Controls and Procedures*

We have established disclosure controls and procedures and internal controls over financial reporting to provide reasonable assurance that material information relating to us, including our consolidated subsidiaries, is made known on a timely basis to management and the Board of Directors. However, no control system, no matter how well designed and operated, can provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934) as of March 31, 2007. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report are effective.

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Securities Exchange Act of 1934) that occurred during the quarter ended March 31, 2007, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II — Other Information


Item 1.	*Legal Proceedings*

Information pertaining to legal proceedings can be found in Note 12 to the interim consolidated financial statements included in Part I of this report.


Item 1A.	*Risk Factors*

Other than with respect to the risk factor below, there have been no material changes from the risk factors disclosed in Part I — Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2006. The risk factor below updates the risk factor disclosed in the Form 10-K regarding our search for a new Chief Executive Officer.

Our future success may depend on a successful transition to new executive leadership.

Effective May 1, 2007, David C. Dvorak, our former Group President, Global Businesses and Chief Legal Officer, became our new President and Chief Executive Officer. Our former President and Chief Executive Officer, J. Raymond Elliott, retired from these positions effective as of such date, but will continue to serve as Chairman of the Board of Directors through at least November 2007. Also effective May 1, 2007, James T. Crines, our former Senior Vice President, Finance, Operations, and Corporate Controller and Chief Accounting Officer, became our new Executive Vice President, Finance and Chief Financial Officer. Our former Chief Financial Officer resigned to pursue another business opportunity. We cannot assure you whether these executives will perform as expected in their new offices or what effect, if any, their appointment may have on our business and our ability to retain our other senior executives and key scientific, technical, sales and marketing employees or the relationships we have with the independent distributors who market our products, the orthopaedic surgeons who assist and advise us and key suppliers and other business partners.


Item 2.	*Unregistered Sales of Equity Securities and Use of Proceeds*

The following table summarizes repurchases of common stock settled during the three month period ended March 31, 2007:


					Total Number of		Approximate
					Shares Purchased		Dollar Value of
					as Part of		Shares that May
	Total Number				Publicly		Yet Be Purchased
	of Shares		Average Price		Announced Plans		Under Plans
	Purchased		Paid per Share		or Programs*		or Programs

January 2007		316,600	$	78.87		12,462,400	$	1,172,390,455
February 2007		1,185,000		83.93		13,647,400		1,072,938,155
March 2007		582,200		84.00		14,229,600		1,024,032,907

Total		2,083,800	$	83.18		14,229,600	$	1,024,032,907


*		In December 2005, our Board of Directors authorized the repurchase of up to $1 billion of common stock through December 31, 2007. In December 2006, our Board of Directors authorized the repurchase of an additional $1 billion of common stock through December 31, 2008.


Item 5.	*Other Information*

During the period covered by this report, the Audit Committee of our Board of Directors approved the engagement of PricewaterhouseCoopers LLP, our independent registered public accounting firm, to perform certain tax related services which represent non-audit services. This disclosure is made pursuant to Section 10A(i)(2) of the Securities Exchange Act of 1934, as added by Section 202 of the Sarbanes-Oxley Act of 2002.


Item 6.	*Exhibits*

The following documents are filed as exhibits to this report:


10	.1*	Form of Change in Control Severance Agreement with James T. Crines and Cheryl R. Blanchard
31	.1	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 of the Chief Executive Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31	.2	Certification pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934 of the Chief Financial Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32		Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


*		Indicates management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ZIMMER HOLDINGS, INC.

(Registrant)


	By:	/s/ James T. Crines

James T. Crines

Executive Vice President, Finance and

Chief Financial Officer

Date: May 7, 2007

EX-10.1 2 c14902exv10w1.htm FORM OF CHANGE IN CONTROL SEVERANCE AGREEMENT exv10w1

Exhibit 10.1

CHANGE IN CONTROL SEVERANCE AGREEMENT

THIS AGREEMENT, dated as of , 2007, is made by and between ZIMMER HOLDINGS, INC., a Delaware corporation (the “Company”), and (the “Executive”). The capitalized words and terms used throughout this Agreement are defined in Article XIII.

Recitals

A. The Company considers it essential to the best interests of its shareholders to foster the continuous employment of key management personnel.

B. The Board recognizes that, as is the case with many publicly held corporations, the possibility of a Change in Control exists and that such a possibility, and the uncertainty and questions that it may raise among management, may result in the departure or distraction of management personnel to the detriment of the Company and its shareholders.

C. The Board has determined that appropriate steps should be taken to reinforce and encourage the continued attention and dedication of members of the Company’s management, including the Executive, to their assigned duties without distraction in the face of potentially disturbing circumstances arising from the possibility of a Change in Control.

D. The Company and the Executive previously entered into a change in control severance agreement in the form applicable to Tier III executives of the Company (the “Prior Agreement”), but the Board has since designated the Executive as a Tier II executive, making this Agreement more appropriate. This Agreement replaces and supersedes the Prior Agreement.

E. The parties intend that no amount or benefit will be payable under this Agreement unless a termination of the Executive’s employment with the Company occurs following a Change in Control, or is deemed to have occurred following a Change in Control, as provided in this Agreement.

Agreement

In consideration of the premises and the mutual covenants and agreements set forth below, the Company and the Executive agree as follows:

ARTICLE I

Term of Agreement

This Agreement will commence on the date stated above and will continue in effect through December 31, 2008. Beginning on January 1, 2009, and each subsequent January 1, the term of this Agreement will automatically be extended for one additional year, unless either party gives the other party written notice not to extend this Agreement at least 30 days before the extension would otherwise become effective or unless a Change in Control occurs. If a Change in Control occurs during the term of this Agreement, this Agreement will continue in effect for a period of 24 months from the end of the month in which the Change in Control occurs. Notwithstanding the foregoing provisions of this Article, this Agreement will terminate on the Executive’s Retirement Date.

ARTICLE II

Compensation other than Severance Payments

Section 2.01. Disability Benefits. Following a Change in Control and during the term of this Agreement, during any period that the Executive fails to perform the Executive’s full-time duties with the Company as a result of Disability, the Executive will receive short-term and long-term disability benefits as provided under short-term and

A-1

long-term disability plans having terms no less favorable than the terms of the Company’s short-term and long-term disability plans as in effect immediately prior to the Change in Control, together with all other compensation and benefits payable to the Executive pursuant to the terms of any compensation or benefit plan, program, or arrangement maintained by the Company during the period of Disability.

Section 2.02. Compensation Previously Earned. If the Executive’s employment is terminated for any reason following a Change in Control and during the term of this Agreement, the Company will pay the Executive’s salary accrued through the Date of Termination, at the rate in effect at the time the Notice of Termination is given, together with all other compensation and benefits payable to the Executive through the Date of Termination (including, without limitation, any incentive compensation amounts owed the Executive for a completed calendar year to the extent not yet paid) under the terms of any compensation or benefit plan, program, or arrangement maintained by the Company during that period.

Section 2.03. Normal Post-Termination Compensation and Benefits. Except as provided in Section 3.01, if the Executive’s employment is terminated for any reason following a Change in Control and during the term of this Agreement, the Company will pay the Executive the normal post-termination compensation and benefits payable to the Executive under the terms of the Company’s retirement, insurance, and other compensation or benefit plans, programs, and arrangements, as in effect immediately prior to the Change in Control. This provision does not restrict the Company’s right to amend, modify, or terminate any plan, program, or arrangement prior to a Change in Control.

Section 2.04. No Duplication. Notwithstanding any other provision of this Agreement to the contrary, the Executive will not be entitled to duplicate benefits or compensation under this Agreement and the terms of any other plan, program, or arrangement maintained by the Company or any affiliate.

ARTICLE III

Severance Payments

Section 3.01. Payment Triggers.

(a) In lieu of any other severance compensation or benefits to which the Executive may otherwise be entitled under any plan, program, policy, or arrangement of the Company (and which the Executive hereby expressly waives), the Company will pay the Executive the Severance Payments described in Section 3.02 upon termination of the Executive’s employment following a Change in Control and during the term of this Agreement, in addition to the payments and benefits described in Article II, unless the termination is (1) by the Company for Cause, (2) by reason of the Executive’s death, or (3) by the Executive without Good Reason.

(b) For purposes of this Section 3.01, the Executive’s employment will be deemed to have been terminated following a Change in Control by the Company without Cause or by the Executive with Good Reason if (1) the Executive’s employment is terminated without Cause prior to a Change in Control at the direction of a Person who has entered into an agreement with the Company, the consummation of which will constitute a Change in Control; or (2) the Executive terminates his employment with Good Reason prior to a Change in Control (determined by treating a Potential Change in Control as a Change in Control in applying the definition of Good Reason), if the circumstance or event that constitutes Good Reason occurs at the direction of such a Person.

Section 3.02. Severance Payments. The following are the Severance Payments referenced in Section 3.01:

(a) Lump Sum Severance Payment. In lieu of any further salary payments to the Executive for periods after the Date of Termination, and in lieu of any severance benefits otherwise payable to the Executive, the Company will pay to the Executive, in accordance with Section 3.04, a lump sum severance payment, in cash, equal to two (or, if less, the number of years, including fractions, from the Date of Termination until the Executive reaches his Retirement Date), times the sum of (1) the higher of the Executive’s annual base salary in effect immediately prior to the event or circumstance upon which the Notice of Termination is based or in effect immediately prior to the Change in Control, and (2) the amount of the Executive’s target annual bonus

A-2

entitlement under the Incentive Plan (or any other bonus plan of the Company then in effect) as in effect immediately prior to the event or circumstance giving rise to the Notice of Termination. If the Board determines that it is not workable to determine the amount that the Executive’s target bonus would have been for the year in which the Notice of Termination was given, then, for purposes of this paragraph (a), the Executive’s target annual bonus entitlement will be the amount of the largest aggregate annual bonus paid to the Executive with respect to the three years immediately prior to the year in which the Notice of Termination was given.

(b) Incentive Compensation. Notwithstanding any provision of the Incentive Plan or any other compensation or incentive plans of the Company, the Company will pay to the Executive, in accordance with Section 3.04, a lump sum amount, in cash, equal to the sum of (1) any incentive compensation that has been allocated or awarded to the Executive for a completed calendar year or other measuring period preceding the Date of Termination ( to the extent not payable pursuant to Section 2.02), and (2) a pro rata portion (based on elapsed time) to the Date of Termination of the aggregate value of all contingent incentive compensation awards to the Executive for the current calendar year or other measuring period under the Incentive Plan, the Award Plan, or any other compensation or incentive plans of the Company, calculated as to each such plan using the Executive’s annual target percentage under that plan for that year or other measuring period and as if all conditions for receiving that target award had been met.

(c) Options and Restricted Shares. All outstanding Options will become immediately vested and exercisable (to the extent not yet vested and exercisable as of the Date of Termination). To the extent not otherwise provided under the written agreement evidencing the grant of any restricted Shares to the Executive, all outstanding Shares that have been granted to the Executive subject to restrictions that, as of the Date of Termination, have not yet lapsed will lapse automatically upon the Date of Termination, and the Executive will own those Shares free and clear of all such restrictions. Notwithstanding the foregoing, options and restricted Shares remain subject to any forfeiture or clawback claims under the applicable option plan or award agreement.

(d) Additional Pension Benefit. In addition to the retirement benefits to which the Executive is entitled under the Retirement Plan and BEP, or any successors to those plans, the Company will pay the Executive an additional amount under the BEP (or a successor plan) equal to the excess of (1) over (2), where (1) is the retirement pension (determined as a straight life annuity commencing on the Executive’s Retirement Date) that the Executive would have accrued under the terms of the Retirement Plan and BEP (without regard to any amendment to the Retirement Plan or BEP that is made subsequent to a Change in Control and on or prior to the Date of Termination and that adversely affects in any manner the computation of the Executive’s retirement benefits), determined as if the Executive (a) were fully vested under the Retirement Plan and the BEP, and (b) had accumulated (after the Date of Termination) 24 additional months of age and service credit under the Retirement Plan and the BEP at the higher of (i) the Executive’s highest annual rate of compensation (as compensation is defined for purposes of the BEP) in effect during the three years immediately preceding the Date of Termination, or (ii) the sum of the Executive’s annual salary and target annual bonus in effect immediately prior to the Change in Control (but in no event will the Executive be deemed to have accumulated additional service credit in excess of the maximum permitted pursuant to the Retirement Plan and BEP); and (2) is the retirement pension (determined as a straight life annuity commencing on the Executive’s Retirement Date) that the Executive had then accrued pursuant to the respective provisions of the Retirement Plan and BEP. This additional amount will be paid in the form and at the time or times that retirement benefits are payable to the Executive under the terms of the BEP or any successor plan. The Executive understands and acknowledges that the additional retirement benefit described in this Section 3.02(d) is payable entirely under the BEP, a nonqualified plan, and will not be subject to any special tax treatment applicable to benefits under the Retirement Plan and other tax-qualified plans.

(e) Welfare Benefits. Except as otherwise provided in this Section 3.02(e), for a 24-month period after the Date of Termination, the Company will arrange to provide the Executive with life insurance coverage substantially similar to that which the Executive is receiving immediately prior to the Notice of Termination (without giving effect to any reduction in that coverage subsequent to a Change in Control). Coverage otherwise receivable by the Executive pursuant to this Section 3.02(e) will be reduced to the extent comparable

A-3

coverage is actually received by or made available to the Executive without greater cost to him than as provided by the Company during the 24-month period following the Executive’s termination of employment (and the Executive will report to the Company any such coverage actually received by or made available to the Executive).

If, as of the Date of Termination, the Company reasonably determines that the continued life insurance coverage required by this Section 3.02(e) is not available from the Company’s group insurance carrier, cannot be procured from another carrier, and cannot be provided on a self-insured basis without adverse tax consequences to the Executive or his death beneficiary, then, in lieu of continued life insurance coverage, the Company will pay the Executive, in accordance with Section 3.04, a lump sum payment, in cash, equal to 24 times the full monthly premium payable to the Company’s group insurance carrier for comparable coverage for an executive employee under the Company’s group life insurance plan then in effect.

The Company will offer the Executive and any eligible family members the opportunity to elect to continue medical and dental coverage pursuant to COBRA. The Executive will be responsible for paying the required monthly premium for that coverage, but the Company will pay the Executive, in accordance with Section 3.04, a lump sum cash stipend equal to 24 times the monthly COBRA premium then charged to qualified beneficiaries for the same level of health and dental coverage the Executive had in effect immediately prior to his termination, and the Executive may, but is not required to, choose to use the stipend for the payment of COBRA premiums for any COBRA coverage that the Executive or eligible family members may elect. The Company will pay the stipend to the Executive whether or not the Executive or any eligible family member elects COBRA coverage, whether or not the Executive continues COBRA coverage for the maximum period permitted by law, and whether or not the Executive receives medical or dental coverage from another employer while the Executive is receiving COBRA continuation coverage. Payment of the stipend will not in any way extend or modify the Executive’s continuation coverage rights under COBRA or any similar continuation coverage law.

(f) Matching Contributions. In addition to the vested amounts, if any, to which the Executive is entitled under the Savings Plan as of the Date of Termination, the Company will pay the Executive, in accordance with Section 3.04, a lump sum amount equal to the value of the unvested portion, if any, of the employer matching contributions (and attributable earnings) credited to the Executive under the Savings Plan.

(g) Outplacement Services. To the extent permissible under the Section 409A Standards, the Company will provide the Executive with reasonable outplacement services consistent with past practices of the Company prior to the Change in Control or, if no past practice has been established prior to the Change in Control, consistent with the prevailing practice in the medical device manufacturing industry.

Section 3.03. Gross-Up Payment.

(a) In the event that any Severance Payments paid or payable to the Executive or for his benefit pursuant to the terms of this Agreement or otherwise in connection with a Change in Control (“ Total Payments”) would be subject to any Excise Tax, then the Executive will be entitled to receive an additional payment (a “Gross-Up Payment”) in an amount such that after the Executive’s payment of all taxes (including any interest, penalties, additional tax, or similar items imposed with respect to the Gross-Up Payment and the Excise Tax), including any Excise Tax upon the Gross-Up Payment, the Executive retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Total Payments.

(b) An initial determination as to whether a Gross-Up Payment is required pursuant to this Agreement and the amount of that Gross-Up Payment will be made at the Company’s expense by an Accounting Firm selected by the Executive and reasonably acceptable to the Company. The Accounting Firm will provide its determination, together with detailed supporting calculations and documentation, to the Company and the Executive within 10 business days after the Date of Termination, or such other time as requested by the Company and the Executive. If the Accounting Firm determines that no Excise Tax is payable by the Executive with respect to the Payments, it will furnish the Executive with an opinion reasonably acceptable to the Executive that no Excise Tax will be imposed with respect to the Payments. Within 10 business days after the Accounting Firm delivers its determination to the Executive, the Executive will have the right to dispute the determination. The Gross-Up Payment, if any, as

A-4

determined by the Accounting Firm in accordance with the preceding provisions of this Section, will be paid by the Company to the Executive within 5 business days of the receipt of the Accounting Firm’s determination. The existence of a dispute will not in any way affect the Executive’s right to receive the Gross-Up Payment in accordance with the determination. If there is no dispute, the determination will be final, binding, and conclusive upon the Company and the Executive. If there is a dispute, then the Company and the Executive will together select a second Accounting Firm, which will review the determination and the Executive’s basis for the dispute and then render its own determination, which will be final, binding, and conclusive on the Company and the Executive. The Company will bear all costs associated with that determination, unless the determination is not greater than the initial determination, in which case all such costs will be borne by the Executive.

(c) The value of any non-cash benefits or any deferred payment or benefit paid or payable to the Executive will be determined in accordance with the principles of Code section 280G(d)(3) and (4). For purposes of determining the amount of the Gross-Up Payment, the Executive will be deemed to pay federal income taxes at the highest marginal rate of federal income taxation in the calendar year in which the Gross-Up Payment is to be made and applicable state and local income taxes at the highest marginal rate of taxation in the state and locality of the Executive’s residence on the Date of Termination, net of the maximum reduction in federal income taxes that would be obtained from deduction of those state and local taxes.

(d) Notwithstanding anything contained in this Agreement to the contrary, in the event that, according to the Accounting Firm’s determination, an Excise Tax will be imposed on the Total Payments, the Company will pay to the applicable government taxing authorities as Excise Tax withholding the amount of the Excise Tax that the Company has actually withheld from the Total Payments in accordance with applicable law.

(e) Notwithstanding the preceding provisions of this Section 3.03, the Company will not have any obligation to make the Gross-Up Payment unless the value of the Total Payments exceeds 110% of the maximum amount of parachute payments that could be paid to the Executive without any imposition of golden parachute excise taxes under Code sections 280G and 4999 (the “110% Amount”). In that case, the value of the Total Payments will be reduced to the extent necessary so that, within the meaning of Code section 280G(b)(2)(A)(ii), the aggregate present value of the payments in the nature of compensation to (or for the benefit of) the Executive that are contingent on a Change in Control (with a Change in Control for this purpose being defined in terms of a “change” described in Code section 280G(b)(2)(A)(i) or (ii)), do not exceed 2.999 multiplied by the Base Amount. For this purpose, cash Severance Payments will be reduced first (if necessary, to zero), and all other, non-cash Severance Payments will be reduced next (if necessary, to zero). For purposes of the limitation described in the preceding sentence, the following will not be taken into account: (1) any portion of the Total Payments the receipt or enjoyment of which the Executive effectively waived in writing prior to the Date of Termination, and (2) any portion of the Total Payments that, in the opinion of the Accounting Firm, does not constitute a “parachute payment” within the meaning of Code section 280G(b)(2).

(f) For purposes of this Section 3.03, the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments will be determined by the Accounting Firm in accordance with the principles of Code sections 280G(d)(3) and (4).

(g) Notwithstanding the foregoing, any payment under this Section 3.03 shall be made by March 15 of the year following the Executive’s Date of Termination.

Section 3.04. Time of Payment. Except as otherwise expressly provided in Section 3.02 or Section 3.03, payments provided for in those Sections will be made as follows:

(a) Subject to Section 3.04(d), no later than the fifth business day following the Date of Termination, the Company will pay to the Executive an estimate, as determined by the Company in good faith, of 90% of the minimum amount of the payments under Sections 3.02 and 3.03 to which the Executive is clearly entitled.

(b) Subject to Section 3.04(d), the Company will pay to the Executive the remainder of the payments due him under Sections 3.02 and 3.03 (together with interest at the rate provided in Code section 1274(b)(2)(B)) not later than the 30th business day after the Date of Termination.

A-5

(c) At the time that payment is made under Section 3.04(b), the Company will provide the Executive with a written statement setting forth the manner in which all of the payments to him under this Agreement were calculated and the basis for the calculations including, without limitation, any opinions or other advice the Company received from auditors or consultants (other than legal counsel) with respect to the calculations (and any such opinions or advice that are in writing will be attached to the statement).

(d) Notwithstanding any of the foregoing, the Company shall delay any and all payments under this Agreement by six months, if necessary to comply with the Section 409A Standards.

Section 3.05. Attorneys Fees and Expenses. If the Executive finally prevails with respect to any good faith dispute between the Executive and the Company regarding the interpretation, terms, validity or enforcement of this Agreement (including any dispute as to the amount of any payment due under this Agreement), the Company will pay or reimburse the Executive for all reasonable attorneys fees and expenses incurred by the Executive in connection with that dispute. In addition, the Company will pay the reasonable legal fees and expenses incurred by the Executive in connection with any tax audit or proceeding to the extent attributable to the application of Code section 4999 to any payment or benefit provided under this Agreement and including, but not limited to, auditors’ fees incurred in connection with the audit or proceeding. Payment of fees and expenses due under this Section will be made to the Executive within 15 business days after delivery of the Executive’s written request for payment, accompanied by such evidence of fees and expenses incurred as the Company reasonably may require. With respect to fees and expenses incurred in connection with a good faith dispute, the Executive may not submit a request for payment or reimbursement until the dispute has been finally resolved (either by agreement or by an order or judgment that is not subject to appeal or with respect to which all appeals have been exhausted or waived).

Any payment under this Section 3.05 must be made in the first calendar year in which the first of the following occurs: (1) the Executive and Company enter into a legally binding settlement of such dispute; (2) the Company concedes the amount is payable; or (3) a final and non-appealable judgment or other binding decision is entered.

ARTICLE IV

Termination of Employment

Section 4.01. Notice of Termination. After a Change in Control and during the term of this Agreement, any purported termination of the Executive’s employment (other than by reason of death) will be communicated by a written Notice of Termination from one party to the other party in accordance with Article VIII. The Notice of Termination will indicate the specific termination provision in this Agreement relied upon and will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive’s employment under the cited provision.

Section 4.02. Date of Termination. Except as otherwise provided in Section 4.01, with respect to any purported termination of the Executive’s employment after a Change in Control and during the term of this Agreement, the term “Date of Termination” will have the meaning set forth in this Section. If the Executive’s employment is terminated for Disability, Date of Termination means thirty (30) days after Notice of Termination is given, provided that the Executive does not return to the full-time performance of the Executive’s duties during that 30 day period. If the Executive’s employment is terminated for any other reason, Date of Termination means the date specified in the Notice of Termination, which, in the case of a termination by the Company, cannot be less than 30 days (except in the case of a termination for Cause) and, in the case of a termination by the Executive, cannot be less than 15 days nor more than 60 days from the date on which the Notice of Termination is given.

ARTICLE V

No Mitigation

The Company agrees that, if the Executive’s employment by the Company is terminated during the term of this Agreement, the Executive is not required to seek other employment or to attempt in any way to reduce any amounts payable to the Executive by the Company pursuant to Article III. Further, the amount of any payment or benefit provided for in Article III (other than Section 3.02(e)) will not be reduced by any compensation earned by the

A-6

Executive as the result of employment by another employer, by retirement benefits, by offset against any amount claimed to be owed by the Executive to the Company, or otherwise.

ARTICLE VI

The Executive’s Covenants

Section 6.01. Noncompetition Agreement. In consideration for this Agreement, the Executive will execute, concurrent with the execution of this Agreement, a noncompetition agreement with the Company; provided, however, that if the Executive has an existing noncompetition agreement with the Company, the Company, rather than entering into a new noncompetition agreement with the Executive, may instead, as a condition to entering into this agreement, require that the Executive acknowledge and affirm [his/her] continuing obligations under such existing noncompetition agreement and re-affirm [his/her] agreement to honor the obligations as set forth in that document.

Section 6.02. Potential Change in Control. The Executive agrees that, subject to the terms and conditions of this Agreement, in the event of a Potential Change in Control during the term of this Agreement, the Executive will remain employed by the Company until the earliest of (a) a date that is six months from the date of the Potential Change of Control, (b) the date of a Change in Control, (c) the date on which the Executive terminates employment for Good Reason (determined by treating the Potential Change in Control as a Change in Control in applying the definition of Good Reason) or by reason of death, or (d) the date the Company terminates the Executive’s employment for any reason.

Section 6.03. General Release. The Executive agrees that, notwithstanding any other provision of this Agreement, the Executive will not be eligible for any Severance Payments under this Agreement unless the Executive timely signs, and does not timely revoke, a General Release in substantially the form attached to this Agreement as Exhibit A. The Executive will be given 21 days to consider the terms of the General Release. The General Release will not become effective until seven days following the date the General Release is executed. If the Executive does not return the executed General Release to the Company by the end of the 21 day period, that failure will be deemed a refusal to sign, and the Executive will not be entitled to receive any Severance Payments under this Agreement. In certain circumstances, the 21 day period to consider the General Release may be extended to a 45 day period. The Executive will be advised in writing if the 45 day period is applicable. In the absence of such notice, the 21 day period applies.

ARTICLE VII

Successors; Binding Agreement

Section 7.01. Obligation of Successors.

(a) In addition to any obligations imposed by law upon any successor to the Company, the Company will require any successor (whether direct or indirect, by purchase, merger, consolidation, or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no succession had occurred.

(b) Subject to Section 7.01(c), failure of the Company to obtain such an assumption and agreement under Section 7.01(a) prior to the effectiveness of any such succession will be a breach of this Agreement and will entitle the Executive to compensation from the Company in the same amount as the Executive would be entitled to under this Agreement if the Executive were to terminate employment for Good Reason after a Change in Control, except that, for purposes of implementing the foregoing, the date on which the succession becomes effective will be deemed the Date of Termination.

(c) Payment of benefits under Section 7.01(b) shall be made on the deemed Date of Termination if, and only if, the succession resulted from a transaction that satisfies the definition of change in control under Section 409A of the Code. If the transaction does not satisfy the definition of change in control under Section 409A, payment of benefits due under Section 7.01(b) shall be made within 30 days of the Executive’s actual date of termination of

A-7

employment, subject to the provisions of Section 3.04(d). No interest or earnings shall be paid due to any delay in payment under this Section 7.01(c).

Section 7.02. Enforcement Rights of Others. This Agreement will inure to the benefit of and be enforceable by the Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, and legatees. If the Executive dies while any amount is still payable to the Executive under this Agreement, (other than amounts that, by their terms, terminate upon the Executive’s death), then, unless otherwise provided in this Agreement, all such amounts will be paid in accordance with the terms of this Agreement to the executors, personal representatives, or administrators of the Executive’s estate.

ARTICLE VIII

Notices

For the purpose of this Agreement, notices and all other communications provided for in the Agreement will be in writing and will be deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below, or to such other address as either party may furnish to the other in writing in accordance with this Article VIII, except that notice of change of address will be effective only upon actual receipt:

To the Company:

Zimmer Holdings, Inc.
345 East Main Street
Post Office Box 708
Warsaw, Indiana 46581-0708

To the Executive:

[Name]
[Address]

ARTICLE IX

Miscellaneous

This Agreement will not be construed as creating an express or implied contract of employment and, except as otherwise agreed in writing between the Executive and the Company, the Executive will not have any right to be retained in the employ of the Company. No provision of this Agreement may be modified, waived, or discharged unless the waiver, modification, or discharge is agreed to in writing and signed by the Executive and an officer of the Company specifically designated by the Board. No waiver by either party at any time of any breach by the other party of, or compliance with, any condition or provision of this Agreement to be performed by the other party will be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any other time. Neither party has made any agreements or representations, oral or otherwise, express or implied, with respect to the subject matter of this Agreement that are not expressly set forth in this Agreement. Except as provided in the following two sentences, the validity, interpretation, construction, and performance of this Agreement will be governed by the laws of the State of Indiana, to the extent not preempted by federal law. This Agreement will at all times be effected, construed, interpreted, and applied in a manner consistent with the Section 409A Standards, and in resolving any uncertainty as to the meaning or intention of any provision of this Agreement, the interpretation that will prevail is the interpretation that causes the Agreement to comply with the Section 409A Standards. In addition, to the extent that any terms of this Agreement would subject the Executive to gross income inclusion, interest, or additional tax pursuant to Code Section 409A, those terms are to that extent superseded by the applicable Section 409A Standards. All references to sections of the Exchange Act or the Code will be deemed also to refer to any successor provisions to those sections. Any payments provided for under this Agreement will be paid net of any applicable withholding required under federal, state, or local law and any additional withholding to which the Executive has agreed. The

A-8

obligations of the Company and the Executive under Articles III, IV, and VI will survive the expiration of the term of this Agreement.

ARTICLE X

Validity

The invalidity or unenforceability of any provision or this Agreement will not affect the validity or enforceability of any other provision of this Agreement, which will remain in full force and effect.

ARTICLE XI

Counterparts

This Agreement may be executed in several counterparts, each of which will be deemed to be an original but all of which together will constitute one and the same instrument.

ARTICLE XII

Settlement of Disputes; Arbitration

All claims by the Executive for benefits under this Agreement must be in writing and will be directed to and determined by the Board. Any denial by the Board of a claim for benefits under this Agreement will be delivered to the Executive in writing and will set forth the specific reasons for the denial and the specific provisions of this Agreement relied upon. The Board will afford a reasonable opportunity to the Executive for a review of the decision denying a claim and will further allow the Executive to appeal to the Board a decision of the Board within 60 days after notification by the Board that the Executive’s claim has been denied. Any further dispute or controversy arising under or in connection with this Agreement will be settled exclusively by arbitration in Warsaw, Indiana in accordance with the rules of the American Arbitration Association then in effect. Judgment may be entered on the arbitrator’s award in any court having jurisdiction. Each party will bear its own expenses in the arbitration for attorneys’ fees, for its witnesses, and for other expenses of presenting its case. Other arbitration costs, including arbitrators’ fees, administrative fees, and fees for records or transcripts, will be borne equally by the parties. Notwithstanding anything in this Article to the contrary, if the Executive prevails with respect to any dispute submitted to arbitration under this Article, the Company will reimburse or pay all reasonable legal fees and expenses that the Executive incurred in connection with that dispute as required by Section 3.05.

ARTICLE XIII

Definitions

For purposes of this Agreement, the following terms will have the meanings indicated below:

(a) “Accounting Firm” means an accounting firm that is designated as one of the five largest accounting firms in the United States (which may include the Company’s independent auditors).

(b) “Award Plan” means any of the Zimmer Holdings, Inc. 2006 Stock Incentive Plan, the Zimmer Holdings, Inc. 2001 Stock Incentive Plan or the Zimmer Holdings, Inc. TeamShare Stock Option Plan.

(d) “Beneficial Owner” has the meaning stated in Rule 13d-3 under the Exchange Act.

(e) “BEP” means the Benefit Equalization Plan of Zimmer Holdings, Inc. and Its Subsidiary or Affiliated Corporations Participating in the Zimmer Holdings, Inc. Retirement Income Plan or the Zimmer Puerto Rico Retirement Income Plan.

(f) “Board” means the Board of Directors of the Company.

A-9

(g) “Cause” for termination by the Company of the Executive’s employment, after any Change in Control, means (1) the willful and continued failure by the Executive to substantially perform the Executive’s duties with the Company (other than any such failure resulting from the Executive’s incapacity due to physical or mental illness or any such actual or anticipated failure after the issuance of a Notice of Termination for Good Reason by the Executive pursuant to Section 4.01) for a period of at least 30 consecutive days after a written demand for substantial performance is delivered to the Executive by the Board, which demand specifically identifies the manner in which the Board believes that the Executive has not substantially performed the Executive’s duties; (2) the Executive willfully engages in conduct that is demonstrably and materially injurious to the Company or its subsidiaries, monetarily or otherwise; or (3) the Executive is convicted of, or has entered a plea of no contest to, a felony. For purposes of clauses (1) and (2) of this definition, no act, or failure to act, on the Executive’s part will be deemed “willful” unless it is done, or omitted to be done, by the Executive not in good faith and without reasonable belief that the Executive’s act, or failure to act, was in the best interest of the Company.

(h) A “Change in Control” will be deemed to have occurred if any of the following events occur:

(1) any Person is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company (not including in the securities beneficially owned by that Person any securities acquired directly from the Company or its affiliates) representing 20% or more of the combined voting power of the Company’s then outstanding securities; or

(2) during any period of two consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of the period constitute the Board and any new director (other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in clause (1), (3) or (4) of this paragraph whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously approved), cease for any reason to constitute a majority of the Board; or

(3) the shareholders of the Company approve a merger or consolidation of the Company with any other corporation, other than (A) a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior to the merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity), in combination with the ownership of any trustee or other fiduciary holding securities under an employee benefit plan of the Company, at least 75% of the combined voting power of the voting securities of the Company or the surviving entity outstanding immediately after the merger or consolidation; or (B) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no Person acquires more than 50% of the combined voting power of the Company’s then outstanding securities; or

(4) the shareholders of the Company approve a plan of complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all the Company’s assets.

Notwithstanding the foregoing, a Change in Control will not include any event, circumstance, or transaction occurring during the six-month period following a Potential Change in Control that results from the action of any entity or group that includes, is affiliated with, or is wholly or partly controlled by the Executive; provided, further, that such an action will not be taken into account for this purpose if it occurs within a six-month period following a Potential Change in Control resulting from the action of any entity or group that does not include the Executive.

(i) “COBRA” means the continuation coverage provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.

(j) “Code” means the Internal Revenue Code of 1986, as amended from time to time, and interpretative rules and regulations.

A-10

(k) “Company” means Zimmer Holdings, Inc., a Delaware corporation, and any successor to its business and/or assets that assumes and agrees to perform this Agreement by operation of law, or otherwise (except in determining, under Section XIII(h), whether or not any Change in Control of the Company has occurred in connection with the succession).

(l) “Company Shares” means shares of common stock of the Company or any equity securities into which those shares have been converted.

(m) “Date of Termination” has the meaning stated in Section 4.02.

(n) “Disability” has the meaning stated in the Company’s short-term or long-term disability plan, as applicable, as in effect immediately prior to a Change in Control.

(o) “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and interpretive rules and regulations.

(p) “Excise Tax” means any excise tax imposed under Code Section 4999.

(q) “Executive” means the individual named in the first paragraph of this Agreement.

(r) “General Release” has the meaning stated in Section 6.03.

(s) “Good Reason” for termination by the Executive of the Executive’s employment means the occurrence (without the Executive’s express written consent) of any one of the following acts by the Company, or failures by the Company to act, unless, in the case of any act or failure to act described in paragraph (1), (4), (5), (6), or (7) below, the act or failure to act is corrected prior to the Date of Termination specified in the Executive’s Notice of Termination:

(1) the assignment to the Executive of any duties inconsistent with the Executive’s status as an executive officer of the Company or a substantial adverse alteration in the nature or status of the Executive’s responsibilities from those in effect immediately prior to a Change in Control;

(2) a reduction by the Company in the Executive’s annual base salary as in effect on the date of this Agreement or as the same may be increased from time to time, or the level of the Executive’s entitlement under the Incentive Plan as in effect on the date of this Agreement or as the same may be increased from time to time;

(3) the Company’s requiring the Executive to be based more than 50 miles from the Company’s offices at which the Executive is based immediately prior to a Change in Control (except for required travel on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations immediately prior to the Change in Control), or, in the event the Executive consents to any such relocation of his offices, the Company’s failure to provide the Executive with all of the benefits of the Company’s relocation policy as in operation immediately prior to the Change in Control;

(4) the Company’s failure, without the Executive’s consent, to pay to the Executive any portion of the Executive’s current compensation (which means, for purposes of this paragraph (4), the Executive’s annual base salary as in effect on the date of this Agreement, or as it may be increased from time to time, and the awards earned pursuant to the Incentive Plan) or to pay to the Executive any portion of an installment of deferred compensation under any deferred compensation program of the Company, within seven days of the date the compensation is due;

(5) the Company’s failure to continue in effect any compensation plan in which the Executive participates immediately prior to a Change in Control, which plan is material to the Executive’s total compensation, including, but not limited to, the Incentive Plan and the Award Plan or any substitute plans adopted prior to the Change in Control, unless an equitable arrangement (embodied in an ongoing substitute or alternative plan) has been made with respect to that plan, or the Company’s failure to continue the Executive’s participation in such a plan (or in a substitute or alternative plan) on a basis not materially less favorable, both in terms of the amount of benefits provided and the level of the Executive’s participation relative to other participants, as existed at the time of the Change in Control;

A-11

(6) the Company’s failure to continue to provide the Executive with benefits substantially similar to those enjoyed by the Executive under any of the Company’s pension (including, without limitation, the Company’s Retirement Plan, the BEP, and the Company’s Savings and Investment Program, including the Company’s Benefit Equalization Plan for the Savings and Investment Program), life insurance, medical, health and accident, or disability plans in which the Executive was participating at the time of the Change in Control; the taking of any action by the Company that would directly or indirectly materially reduce any of those benefits or deprive the Executive of any material fringe benefit enjoyed by the Executive at the time of a Change in Control; or the Company’s failure to provide the Executive with the number of paid vacation days to which the Executive is entitled on the basis of years of service with the Company in accordance with the Company’s normal vacation policy in effect at the time of the Change in Control; or

(7) any purported termination of the Executive’s employment that is not effected pursuant to a Notice of Termination satisfying the requirements of Section 4.01; for purposes of this Agreement, no such purported termination will be effective.

The Executive’s right to terminate the Executive’s employment for Good Reason will not be affected by the Executive’s incapacity due to physical or mental illness. The Executive’s continued employment will not constitute consent to, or a waiver of rights with respect to, any act or failure to act that constitutes Good Reason.

Notwithstanding the foregoing, the occurrence of an event that would otherwise constitute Good Reason will cease to be an event constituting Good Reason if the Executive does not timely provide a Notice of Termination to the Company within 120 days of the date on which the Executive first becomes aware (or reasonably should have become aware) of the occurrence of that event.

(t) “Gross-Up Payment” has the meaning stated in Section 3.03.

(u) “Incentive Plan” means the Company’s Executive Performance Incentive Plan.

(v) “Notice of Termination” has the meaning stated in Section 4.01.

(w) “Options” means options for Shares granted to the Executive under the Award Plan.

(x) “Person” has the meaning stated in section 3(a)(9) of the Exchange Act, as modified and used in sections 13(d) and 14(d) of the Exchange Act; however, a Person will not include (1) the Company or any of its subsidiaries, (2) a trustee or other fiduciary holding securities under an employee benefit plan of the Company or any of its subsidiaries, (3) an underwriter temporarily holding securities pursuant to an offering of those securities, or (4) a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.

(y) “Potential Change in Control” will be deemed to have occurred if any one of the following events occur:

(1) the Company enters into an agreement, the consummation of which would result in the occurrence of a Change in Control;

(2) the Company or any Person publicly announces an intention to take or to consider taking actions that, if consummated, would constitute a Change in Control;

(3) any Person who is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing 10% or more of the combined voting power of the Company’s then outstanding securities, increases that Person’s beneficial ownership of those securities by 5% or more over the percentage so owned by that Person on the date of this Agreement; or

(4) the Board adopts a resolution to the effect that, for purposes of this Agreement, a Potential Change in Control has occurred.

(z) “Retirement Date” means the later of (1) the Executive’s normal retirement date under the Retirement Plan and (2) another date for retirement by the Executive that has been approved by the Board at any time prior to a Change in Control.

(aa) “Retirement Plan” means the Zimmer Holdings, Inc. Retirement Income Plan.

A-12

(bb) “Savings Plan” means the Zimmer Holdings, Inc. Savings and Investment Program, which, for purposes of this Agreement, will be deemed to include the Benefit Equalization Plan of Zimmer Holdings, Inc. and Its Subsidiary or Affiliated Corporations Participating in the Zimmer Holdings, Inc. Savings and Investment Program.

(cc) “Section 409A Standards” means the standards for nonqualified deferred compensation plans established by Code Section 409A.

(dd) “Severance Payments” means the payments described in Section 3.02.

(ee) “Shares” means shares of the common stock, $0.01 par value, of the Company.

(ff) “Total Payments” has the meaning stated in Section 3.03(a).


EXECUTIVE		ZIMMER HOLDINGS, INC. By: _ _
[Signature]		[Signature]

		[Title]

A-13

EX-31.1 3 c14902exv31w1.htm 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exv31w1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, David C. Dvorak, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Zimmer Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ David C. Dvorak

David C. Dvorak

President and Chief Executive Officer

Date: May 7, 2007

EX-31.2 4 c14902exv31w2.htm 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER exv31w2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a)/15d-14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002

I, James T. Crines, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Zimmer Holdings, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ James T. Crines

James T. Crines

Executive Vice President, Finance and

Chief Financial Officer

Date: May 7, 2007

EX-32 5 c14902exv32.htm SECTION 906 CERTIFICATIONS exv32

Exhibit 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Zimmer Holdings, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David C. Dvorak

David C. Dvorak

President and Chief Executive Officer

May 7, 2007

/s/ James T. Crines

James T. Crines

Executive Vice President, Finance and

Chief Financial Officer

May 7, 2007

10-Q.PDF 6 c14902e10vqwpdf.pdf QUARTERLY REPORT PDF begin 644 c14902e10vqwpdf.pdf M)5!$1BTQ+C(-)>+CS],-"C$Q.2`P(&]B:B`\/"],:6YE87)I>F5D(#$O3"`R M-C-IB8&!@9F!@ M_=.HV6OLOK3A1//RLM;O_%[\U,H M-&G!*INK1^>OM^5J9+1<^*GXI\;!,UG2:IJ;&!B:[ATS[$F6V!XW?<^R)X;G MJ@\@FR:0<,&FB#.VS47"\(2:1Y+#UQMIAFP\19P3F:\G3L3"X&4^KC!3/'&B M`%#7A`1D$1Q24V^DN/@Y?#RA`A19YB)APM\EY*[DXC>K,F-IF52:H8"=AKO" M3$&KRHQEJ;>`7+#>1ZW"RZ=UI<6VS>P!ZOWY=-',=H69;'P:X8G+DH$.AFBQ M!&D7M`19"E2PJ+4,J)A?IBFI!6C1C"-`&U7+0-;)-*6`?`=B)+662?8X-CO\ M6"C3%`Y4`W*,X`DU5Y"7P8X'F9D"#!06%]>.#E#H=#0`"4$E,(=1`IUDX`"1 MS!8(-H2$RH(ULT:`*28E8V-C"XBA3$I*4!,%15Q#0SO`"L#B&A`%#$Q0AJ"@ MD`9(EA%"<33`C67+@.CB@&J&J`=91G+R``(?!N8K9X&T(A!K@464&'@9&-09 M!>0N<#7,,3W8*](@Y*HCL^%,VQ3;0R;\"R)=UH@9IG!.T6%2/O4^,Z]#PV$) MTP]%!ADFC^RF9K,/*LT>*@^O<5AP-\#3V2P&AN8RD)>`;G8$TJ$,S!]7`6DA M8&A_!M)E#"SLAT%A`L1G``(,`"$+W=`-"F5N9'-T%LP(#`@-C$R M(#%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\+T=3,B`Q,S`@,"!2+T=3,R`Q M-3,@,"!2/CX^/@UE;F1O8FH-,3(T(#`@;V)J/#PO4W5B='EP92]4>7!E,2]& M;VYT1&5S8W)I<'1O7!H M96XO42],+UDO4"]T:')E92]P87)E;FQE9G0O9"]P87)E;G)I9VAT+W-E=F5N M+VPO92]U+V(O7V!A8F-D969G:&EJ:VQM M;F]P<7)S='5V=WAY>GM\?7Y_@(&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F: MFYR=GI^@H:*CI*6FIZBIJJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;' MR,G*R\S-SL_0T=+3U-76U]C9VMOKK[.WN[_#Q\O/T M]?;W^/GZ^_S]_O\"#`"M]G^!"@T*96YD("(B( MB0F)B8H*BHJ+"XN+C`R,C(T-C8V.#HZ.CP^/CY`0D)"1$9&1DA*2DI,3DY.4 M%)24E165E986EI:7%Y>7F!B8F)D9F9F:&IJ:FQN;FYPGI\? MGY^@(*"@H2&AH:(BHJ*C(Z.CI"2DI*4EI:6F)J:FIR>GIZ@HJ*BI*:FIJBJJ MJJLKJZNL+*RLK2VMK:XNKJZO+Z^OL#"PL+$QL;&R,K*RLS.SL[0TM+2U-;6U MMC:VMKX.+BXN3FYN;HZNKJ[.[N[O#R\O+T]O;V^/KZ^OS^_O\!`P,#! M0<'!PD+"PL-#P\/$1,3$Q47%Q<9&QL;'1\?'R$C(R,E)RWM[?7]_?X&#@X.%AX>'B8N+B MXV/CX^1DY.3E9>7EYF;FYN=GY^?H:.CHZ6GIZ>IJZNKK:^OK[&SL[.UM[>WN M;N[N[V_O[_!P\/#QOKZ^WO[^_Q\_/S]??W]_G[^_O]___\"#`#GK#\0"@T*96YDF\T"!HA`@\+$[.[O#.:^' M`.L!$(;UOCJ_Z!4\#I4+(D8+'JV0B&"L$U('0!&#T?"TJ1[>0I2PZ%Y#).VD MLB7F0ZK.ITC8Z:%"(Z24$21]+^L0A#0&P44"R=EI5TE(Z_Q[KF[8JIVG9L)' M6CJA6)]XL`+9F,<@#$M-3S?H1&1]4Z^Z>9KG$Y6QV+C-:<1-L>9S/1NW%TW9 M:U8O%XMYW\^7+;]+EQ6=$9=0>)W62AMA=;#@?"!BTF5B-^P3MY&J?1V^;_>/ MOP[[L\(,V82C)D:B%KE(H!,EK8D%GWK,,SSBG];*:N&M-^"T$DX[+/A33@&1 M'9YV!*,HA*$<7?^3)2HKC#0>;)3"1Q<*RO6*6T-LQAW7>6RIZ3[RD,?TI8S` ML:ZY6G9<>1%8RJ4DC>5JU?4K[C3%C=M4(BU=8[YR86Z' MVYQ3SLA M,Y,+@A'!>S#.$6G(LCBE7K;K"OX(,`#X>NJ?#0IE;F1S=')E86T-96YD;V)J M#3$S,B`P(&]B:CP\+TQE;F=T:"`T,C,O1FEL=&5R+T9L871E1&5C;V1E/CYS M=')E86T-"DB);%1)CN0P#+OG%7F!VI9D+>=Y2@%SZNE+_1\8RDEYIEG((W=.(V->^+%Q*(7? MOO!!,NP26'!M>&Y??YZ8?.Y]?SY^MI)TAZ0T"JSZMTD3BO3)I,)#DIL"&K$- MF&YDF9`4ZJ-/TXV\R1Q@L_T;KCIIZLEH,;7&`L&3&.L.9F8I)HZII.ZY&`ZA M)H6%!K[D8%*4J`HG,F;ZD\%$9*E*[RA0;LQGP._M[X8<9-5K1VMI"+T8-*Y1 M8V-,ZR_"&C*ARAXTD/M@6O0[,YP4'5U,B=26TAX+*1K0H-"Y(U! MUPKO>(-F_1>F<'!.FXE7*9Q#%L86PSN5[_7%E9U)0O?/+A[5CPMQRA6^ZL&] M9MS;0-*^^BH8KM-69WWA.@V6:>-B\!PZ3HF#J2,_9J;D&7_M/#$T')9'W@M: MS+'GG:G[QX'8"O*1:T9-(1OWJ!&XPGZ+>A'EO/,;XR1>A^GDI0&<+29FL87K M4#'+_?8%?@>-;PH7/G8\MOV_``,`?;[3>0T*96YDH2H&@VK M/DA)NYW*QAB'C7O_5`QJ^+P/I0&-EO0+\LR3\\P6IX,#V:YX=Z41KS?XK^0[ M,K9@!ZPQI#%@=QV<[Z(@3D>%08F_Z6"QD9_KKY+KU>9'AX.1G)Z.@+(5<@)3 M>Y*>'&]!HV,J:SU3R0]GZM*!16/BO#BTV'RF)$=4YG9EO+<3WJ6_;$EUKJC MQ:G%N?F9XQ'6_6QE?/YY#!X<-[/$G:((3SW MDZBF.T,,Y&,_]Z\``P"Q?M+D#0IE;F1S=')E86T-96YD;V)J#3$S-"`P(&]B M:CP\+TQE;F=T:"`S.#4O1FEL=&5R+T9L871E1&5C;V1E/CYS=')E86T-"DB) M;%-)DL,P"+S[%7X!Q28$[TG5G#(/R.\'2=$RJ9QT\<0!532Q0HB[\R([\#.:CPJ#@4+`:]^OZ9"1'1HK=D4-B M]UR:1%!:6JM"`-W>HYXXP^#1,9G\_O1Z;J8E:M%[1&P&+J3Y6B9\7#^7"(,B M3^KW$L[1TFXM33C]9!'"%9!U+FW!M;3-S*5MQH'([J98/-9.NJ658VLB"!%\ M;DTR'8R1I_@7IDW29EZJHE"#_JD:$/I143/IH1#D!\[OB^@=DRG`3G=7:)(* M3'18#-P:!+3R4='BU4-@XFTQF0S)QA0RH,9HJ#9.L]B[GD@6LV.P'((.G*'& M&'LRZTPFTW;HH\=D_:@?-]'/)(^R7TX>E)=H=[(8SDG;72`X2W>I7A(S6-&% MVV$H&-:C(G]>[@*8S]=U_PDP`!:OSJP-"F5N9'-T7!E+T9O;G0^/@UE;F1O8FH-,3,V(#`@;V)J/#PO4W5B M='EP92]4>7!E,2]&;VYT1&5S8W)I<'1O"]!+VYI;F4O9F]UB]C;VQO;B]E;61A2].+W!E"]Z97)O*3X^#65N9&]B:@TQ,SD@,"!O8FH\/"],96YG=&@@-38R M+T9I;'1EKG+?>C:.$U=-"D0^]2D!T&1'16V%$@J^OCZ8$"FD8N%0\*"_F M>T`>/MHL."HQ'`$2YR`LO`D2(#%]GLR@#HT9WM]7VZ&CR6'[]\WFSO;G;ON,!&!;F]NX+TV_Y3LOZ@>69_2`*#JY%H"C4B M8'=M`7D>:!_DHKW_E1<]`)L@Z/Y>1`X%DDRIY&`E)MJGAU(T.##D:56_*4_XS;UDLAF`-:T*S8L_1>_\_']#H\1@5 M@0DT^[#K\SZ^WB!+;-ITI>,^9-,_EVU4[OBEWW^T5?=4%7W5Q(>Q*=QZ&!A7 M+%2[(%;LLG9>[#>,6M5%T[XT;=ZG['Z0X]A@PH*!W8VG*&A1H* M)):(CW)[OQL]=?+Z_')J?K.\28`G_E.]$;!]*NN>-U+DDV0^-I1W#40*\5>` M`0"_#_!D#0IE;F1S=')E86T-96YD;V)J#3$T,"`P(&]B:CP\+U-U8G1Y<&4O M5'EP93$O1F]N=$1E7!E+T9O;G0^ M/@UE;F1O8FH-,30Q(#`@;V)J/#PO3&5N9W1H(#8W-B]&:6QT97(O1FQA=&5$ M96-O9&4^/G-T=7^$@/C:9O6[L56`=TP'9I@!WF M'AQ;J;TEMB$-)"]]RXZ`.<_V<&X/E-ZG/P7W.X2M]"/S0UI0\?]R1,IF4E23&+,+64"K% MI!,JD](P([5.NBJX;=N0*P+U\TRTDI4P'BCB3,,4^J'II_I("4=5+[XYQ_ZW MQX3FS&+M(1>:*>@;/U?Y*N1_%F&;DD)F4BAFN%FE[/)2X8S^Z*=N'/P'(J3Q M*C"%1MQ%F@5IBZT52JP\*O%L!?JCN,ZV@A6NP-S'S7;AP[!!]/NA[9LZHFK) M%>Q?\ZTH-:(WG6]^XH>S.,&I#A27-.=SYV/G`ST)I,4XO5@(_BDO4&D_QU`/ MD2HD[K4"02I%66)W5\\4ETFF( M(^4-YO?^THLV&]S("N?H(-[F>/!-[,?A(E>HR\,8$H,!82IHUP5M)7HC!-DE MN2C)+IZ,HM53O5Y'1AY)Z.?0Q][/Y!^IN'MINGIX6OSD*/.VB6EV>X4@G-(I M*Z!%@.$IS:*NL:?@&]\N;PE*2'JBXSN-0^SFU%.BP6F6$N-#"O&F83XW76HH M8.[04K].7,#D0S\F1Q?..B8.>\V?UBG_KI/LV;W[]WJ>:9UZ4?>V)\T=2YO2 M'&U<%DVQQ6P2I1>N==%5?D,9C5[4`[8K5V)A!9*NAO(J78UR],^P]WZ@=($K MG,_['Y[\)49[Q7C-@NR+AQK74UQ4GOQ`%Z8%*5T\(]8BC8^5,"U_1H1FP/&$ MI:"M7V>6/V9_!!@`$I$[$0T*96YDNKU7+9N5[?B?<@+3]*)0WZWOEX] M?V4R%&U76J*ZRA0W*"X5O_+U1^3+E$>+\2;EQIYT[YH9%6V&D(6>8 M3JV8PQ4XO!XV7=O,8&+(2RONO^.D*NE%NP_M)_QH)TOQT$SQ;%'R=1_F?9CX ME_"+<\J48@J[W$D2W6&>FF'F<(GQN@.?E-2BB4VB;Z:M!2M>GYT$L/<\"GPP3B?@1W;!$$G'E,"*A&! MU[CEM((T/RY0&29-BH**)1HXKC6Z(-,NI!]_R890&OM^:6%KV,MI^C];WX+*8V#C0?OQZRZ0X3FORK^:?@EZ@[>_ M8$P7MKF@K-P3P$5I(8ZJGEHGJAU$X'4BZV&=XSI1K<_KA&5$XKQ.Y.QIG3AC M_UPGJDLT\SJ1K<&[X4J%T&$?^CXA&-&.#Y^;@2]V6GP0S;&F[$@9(!?=1#UT(S>U M(1`23=S/O[8Y@2NUS7F"-C3E29PE.(ZR./:[_:4P?L:0`GAIM*9A91- M,XP\K&\VBL#(W9#ZNDW?RF;S;$+$XZ]`8Y9:>:S[##SW?"IC.7*]/V6;:'G8 M37UL;P<[VLG.=K&KW>QN M#WO:R][VL:_][.\`!SK(P0YQJ,,<[@A'.LK1CG&LXQSO!"ZRM6N<:WK7.\&-[K)S6YQJ]O<[@YW MNLO=[G&O^]SO`0]ZR,,>\:C'/.X)3WK*TY[QK.<\[P4O>LG+7O&JU[SN#6]Z MR]O>\:[WO.\#'_K(QS[QJ<]\[@M?^LK7OO&M[WSO!S_ZR<]^\:O?_.X/?_K+ MWW\$&`"]PG\""@T*96YD7!E+U1Y<&4Q0R],96YG=&@@-C0T,2]&:6QT97(O1FQA=&5$96-O9&4^/G-T M&HG+`G*:AH000K"A445!00$!"K%BI$ MB!AN@80[2%$P@`E(!96+%-1`1!$*Z`(J7O!"O51!+:CKA:[KE.T6M]/.^)[T MR[9[Z,S.[(_]L?-]\_YX9IYOWN>9YYD/XUAP.1B&B2-"0M8&![A&*],4FB5K M5:F),Z@S(\$8>PO&T68.\D7IOQ;]NHKOJ,)L(7\6'+$;=G2T%7.X&%;;O$Z5 MD:]6)NW)DBU*6"SS]/'VPZ!_+R)0:F5R6I98G*M+DZA29:K1Q; M$<=)R'&;Q5DKY(2*.)4<3A"KGV/!$7#N8];8:BR3*^-NX:9P]5PCU\SSXE7R MWEFLM*BP^(%OS_\2M\%#\#:!NZ!2,"6,$5ZS7&'99OG**M;*8#W;.L7ZJHV' M39_M$ML>D84H171EUN99+V<'SM;:6=GMMNL2.XHUXA&BC@#[8/OK]N](/0ES MULSIGBN>FSQW8I[#O/QYXP[1#F\H!95G]A2Q%][N'83&P;PKH.RIO2B&V8## M)YUC8`G1G<1$"=%?8I)]3_:,P)9G0XPL)[ M$/1Z3'GUH\5(A`2(IED:;&7&2`5>=J"T3"LMTVZ.]9)$9SF*M?5TO;9I7QH5L`FYKTK);SU+B]`K8.`-\@(O\7,(W?B0B"!: M?P2&M.%I\J0L'?F: M?L8&@<^#VZ80,EJ-Y&@V&J!\C"@9BI`=;11\>'O'(S!0<.M>_ZL;]'\HL);E MM"-?JE"I)1$=C1*L&/$4/KD8%"MS;%>6^A15#+!"%-[N\FIT%X]FA=1QW57-"IC#X6O=F; M+JWF'_BNO_H*U5C6*U=EY:BV]FL/>M%E%?Q>K[8G:R3%J26[_9X.3L5*#Y9% MQ:4;XPL<$HMTZL^IE(["X[>*1X8GZ<-:_A+%D6@JYYBRZUQS6UO?GKK2*?IP M35=^545?I$-ZRZGRHY+V$ZWM$Q_%?SP@9;-Q`+PP6/J0=Q,%D?^GC[`&A%@_ ME/.@#_I(5(Z$4(ZS3Q6#'W8>_'CG'[$:8[MW7[K8TWUI4-$;&Y.4L),6F`1J,G@_9NT.72N MMB1IMV1;P3UPED*^X)4.Q`\NM48B5QI=1-8D^FP:S0=[D'T'/A`$9<@&A$X+ MD=@9U=`BW2F36RX&X;"(QX2?(A?M;W\@91X4"%`-POB9@OISYXXU2'IU<6JI MF12$520BH9[6,-8"D0X6H$"I%G, M0X>E3:^4I*1E)8<^2O\+*]`61"`;CW_L>UI*3/:W]QJ>4E/K+K@BJ]6>H>FL M8JA%/.`Q@;GB+\^#`IR)/,8#:DDF<)5@*;)A]_%;AIR$B`]Z`3'`.K=`0.3! M_+O`$Z!=%C1'=C167M#KZ>/'3VN;Y*,-JU!\Z6B MUARF&_Z$'6?B>4RFR9LT+\?CD)IOP"=/#.G:))"`HUAS-_\'-FQG3?:GQ4:P M15P@V=Q(D0-8$U/$$_!EQLGSG7V7OVU^+A<2DP%Y7@G(HQ"W)\B@0/.WS\#NZE-8UY7:.)OP\TONB3_>A\K4>2P+2?OF,2VJS8&6@ MQ.4SQ22P/72":`BAV$1+;WJB(`5:O94F7B!_L%",-C?JJQMIXG)C54--8^UV M%(DLM[OD"L&%J2:?Z^Y^?:(]+)[(MO>VS@#^O0S;WSJ3+\\4:"!C*@O/ M[7R/-,S)>2HZBFIO/&QS1DXPTI9P,RJ.3\ M@V%:6@U/!>8**"'_#N4_H7*^Z)#.H#X+]SJ@K4-M$/\"R\$#?!`-_D0Z'(=_ MD!TXD7V_XDT1;$G" M.$ZD0=*AL>G7%.!.0RL;Z"H!T76A'OC_YKK:HZ(XKS@*#QZ" MCPH:FX`IHO68HQC!QS'5JJ&V=]:[.?8;(#F>_#OGF^_>W^_>W^_>KP*\>)B& M:W,B!/Q*8D^8&RU+>+>!A&TR11@I1D.;:V2=YTD(4OQE+]<$^(-FZNSYD9R0N*?3KZEQ6@"5\O MHXBCW/]D?5;2ACCW0L`I,I!R[A%W4PW8:C[^8D`)W#()`[ M!:(,]R0V;4[J(AQE]^8>#46AZJ\,_=TAH9P&Z61]@!CJP"8KI,ZW`8+@#$R+ MECG%95+GS@.)[3;56D+XU\G:E+CIN-0(]AZ8?XPJ:8+`/1TND/C+`NE0H+;\ M9PR$$1@$#I%3^D%;5=\F`D=ZRQU?[:)#G%!L9UNA1O;\+T5F!'\OEU761.Z* MR;G`*P;2U>)H<@@RWI=(L_D$!8KKT0CKR<43]F;U^UV)-)J:+,$J`1]NRHK, MI`36:.WI=E32_"\XN,'=XR-DKDLJG(N)4W9&0D)`@8A_$,?$KZZNWM.?3R>^KEQW\6PG+C<+:# M:&$5J90A&/5,L2%_^S8^Y3-SF(4>N$.&>L[E(?L^!7\NP>4+>DT\BTQ4Q&R< MK'T_*;]-5'3D=HWMDDK)#Q)I&0S"-:AAXLP1F0*7("E7*8KZ(11/&Y4J^*/7 MLRFR9LGN),=U7@DC?;7V#C7'7$+=6X=K%!V#>1+;DU62MI)W;R9+MZ7.4]G= M)I/9N9^57^*5C78"#GZC3)72Q[;EE5W>34-ODL@-8^&GX3QV6`@^ M5@(8_$1BBXK-BSM$KL4=3Y9LS@S/%`9;U>57Y^FD??H_"/)2QKHF:F!<`R[" MB3.,N!T#,,`(V_MA8@,L@G%BW0A<@3/Q-8S':)B$$^AJN0XFP02(AGBZY+Z& M*\1!C=4XH<-)-?:8=N*[U!,?TIS[97;Q;H/]!@]A!/QLIVV=A[VOMQ3T.*D[ M8?"^.0*=U-P-B?PMJ\8\BW>'D8BT;=LSA,PL2_9'.[VYAY"M?*LY9"LJJM?V M'MZ(+([Z2SR^;!-(C3%9;TS4@/='P&\C]E.XPF!4=?PTDP<[5`-XS`'EAE+=!VG=I=<4G$QZYC/Q$B-K)^*8E4GX:K:H MA.`5S?946TF:B%%PA#F[?Z`&7N&Y&S`78_*#*!,2>\Y48YFITO"NWOS>3MH) M]V0RU&*PJI+`>KS(P#K69QPM(%_CZZS6@R<5_4L??L'=40S*9@W$Q1%#5E;J MUO@U=7.TW#5N6]_EM6;_'7ZL#GUL*S!.]&(_6 M:K8X)[?D8$U+[+^T$-H)+]\&SX#SL?M%?.,*PUV9U6@X=);O:O_B#/SJ`I*@ M$D$5E?*\UO.YQ[@='L\]M#L\8`6E8'F5ET+EO2!WB_T6KY23;M-`U@&AFTF7]8VE_)$RZ]>JLN](I"ESG[DB'':['_A1U1J4[PYU M%)6V[QI+GZUYR:ZILF_ILTBZLS+<+:[[6:QZ=;#$UEN/)"L MC%)A!GBY%JFY."2VV5R5K>,3K%:JI+>%-^%-9GN).:^(KSY@_5+%^(@&L.R7 M#NK@(VSVPX68^$E4;%9L%EV5'#*)<43E./G2@K*;X"4<.?T$_9D]*06)Z7S" M9LM*LSHB9++9GF*/[,5@..Q''TE2:>6]?&\UFT'WKU'=/WRXK*WF!LL&/F'3 M\LP=*B\?T"=1*K.S.$7>QU<5YG73;&Y+Y+2Y?&UN!H3@+3]\@\S>8EFLFNAC M.J-W)=EO\A!*(`(Z#]16YY12U#E6IS+@]*Q2!KQ[6L;H_5"O-RW;X_,GXIRC7Z^.D,Z5%&U_K*,!$Y M&`O>('`;N#HEKE.3GLZ8S>9LDS;)6IHGPE[R_=M--.U1H6&A[YVU%I[9=Z1$ M.!J7?_#_=%=[4%/I%9>EY#)V!S7QLG"S>Z_:4:FNJ[:NZ`CBJ]*ENX*"(*@! M1(V\!`E!"`$"!!*X"83W0X0DEQ`,(*PHCP)U$:QL1459[4JW3K4Z/FI5NCMS MKOV8V7X7MC/M[.P?F3N3[W%^YW?.=\[O4&>L39UWZXX?H'<0DE2T+`I)8GY! M^7V9,,#=-HV/TTEE%=&WI7U=7+N=06&C9&96:G*L5*[N=#QZU6HU,6Y+LMKX MYL-*YX>T2LE/;J#M$S7Q;0TR-N,CZ!W(<4MA\"T^4$GAOQQM$ M[)8?RU`Q4(-""0A%$Z2ELKZK7_JH#%%!:/V)`X$AV7^P8V6=E'63]W0X-<-2 M$,-"9SQT.9')BE,G]TE]]WP#2_K*8<']>EM>XGXV8J3B&GM]TKMKUQJT;`^6 M(0L>+H7%4S>ZQ_L%C"-**S]_!*/$7'EAE(QD4*+F'3WD/F-1:PO%3Z)X!7%% M9RX.I=#O")LBMC-0NL9K$]J!-Z(53[T?W+/;/^^D`PB)^LN&2@,LK'?%"Q%/ M2ZP=)VO35&6 MT16);)@AP?5;M)Y,33\1&23]4#G]-ST#)M&P/AN+U1U21*Q;@[R0W_3V-W\9 M;7LV)HP9+,=_T`L''4YW@!D%-V>LZK:VG)_8YMB#/BE&GJOH?9&CZ*$H-%4?J\-0C[2!V_?S3@LU M,50SSPX)7^0YQ/:_^^#&XP$_PXI/>GQ*\F*;Y%\:/HU?1GZ!W`G)"\V9F-@R MN11]X.^S9>?`_KO)3!$A>;XM*F?[T4^IL'9U7R:-_WBY+;A0GAA#!=\]`0MA M$7BTX(\S(JHB#+1D6A-@<-EN.&7HH,YU-36^9-G*5GK2VGYYC+J6V)I;1>/C M6V="R(SN:(?*VA+I=!H6"V.88'+&<][=;&TNYRUUE/WKIR3C>QU5D/X8W-TY8)(^OA/'W<@ZN%E87\_"VAB%H=`82M\LE.Z"VOS9*/TH^GC_3\8_ MR\'["J]Z):S'A0ZV008)(M.KNV,-0>@C),G?N'L+^RW,H]%*=^3^"/=6!MY_ M#._@TLRL^0Z]AY@-B$`DCCJ*-H/?%7[^*(9]#^_:"%ZS6BP.7I%U%T;ZOC(A M)^]@/5JT.40YQM+W43=YR)A0.47!4B*NPYX\(IU^\@0VPT:O">\MB;(XE4#R M-S<$S_H+*M3'J)DBXDAN[F'!,QLAV.-@RS"_O,VI`U9@:SCH+_Y)&E5[0Z6? M)-T"]P7EZR0#%/U43OL$N;?*CS6%2M&HK6H3F([_' M.UZW#E;W76000_PF0Q^2BSM<$QZVDE@.1F'YQP^Q2P]P%&IA@"/WE.34CU&2 M5MA+?-5KJ:E0W47;9QZV#]`%IB0)D"OG4)[%<0Y'5<8+@0E7*F+ M%_*C41CBLCKX3>WBYN;4UT#_(\HB>0S/8(J$Y4HB7Z_+R4@_8CF$M>/:WP;] MFD$?05[96BHQ31XN"$9GQ7LQ,2K5+FD:5<%(:8[AXAH'AYYCIK/$$*T]SXO'_)B,>?3IZ M2)E!<_8"!3/HL(+HP+(FA,(ROI-(3T]).28-*>ZQ,_`4!2F(B]J*G!@*SV6[ M.G9/W^R_V-PJ-)WTT<8Z`RRH=74K3^/#.+&9/XI6PVI!N/$90LE8K1`U%Y]C MXZELG5JKHG>B`!^(=,FSLB6EE+7)T%Y"0#]/]L/O)^-^-+B; M*;/%:#/B2[,5!*>O9BO33#EEIZMB_9&?1SA0L7\V4S;.6"?L2%$0MD*3UA8` M7C/S/3@1N,&(BTGT&HVX6$6PEE_>T%MG;"SU=,/Y8TF#S9RXAD^8B0-?W/)] M)&_X=([,+LTOR:M%7I#N(7GY!L1GK5R-O=230SZXC.MKBM.H+);=_B&M;@R^ MWX`532DWYVZ+KB*OX10L1N$>^/'YZ8LC"UT5X,L1*D,]"C_5TY\YG^H3OT_JM6%V04JVA^%[(3/7/(L M&EL5Q;489EGY,=4#'AFA+DIM2F"L-*>PQL24EI@JJ;.:=EE@P8&L^);#X\_- MH^`Y1,,O^:6-0PU&2XD@T_\#2`"W__=)Y0&+^GP#]Z,$,?I\Y0<.>)[Y.)K[ M>I<&]Z"2_'6.!WV9^%:5]UZ9"/MNC/ASD_<0BPD>H$-Y%_\,"?Z+U1JQT7-FM5%CU$9!4M$154 M5(($"!("200LBPAA,RR*(HM*0?8JBR"BQ8$RC*6R*$HY(+96U"(S4AWK<-Y+ M/WN%F!&'*_W9XI=C>8>-G:S[@AC_0X0,ZV(DE(:I@N=COF$8K5VK$7E&'5>IHE5JF ME8?8B,62R$CQS@\*&O%.N4:NCC5<_W`C5FC$,K%6+0N1*V7J(V)5J-A'$:72 M'HN6BR4>8EE4B*U*+588>)JCP1I%B$*F5L@U-G]-@G$,#\-YF)DYMM02<^1@ M6Q9BH1BFP#`MAL5A6#:&20T]8%P,QPHXVXW,C:1&649=W$AN/?<6]TW0`^!=BV1D2.T'#2 MP.Q,'XDM1T8FR,N&_+PUZ/(W5,7IN]/GZ48T31+3?2&=1[92RQT3(])I`1NM MKX>BAO.7(;RJLE[XW2BHJP9&(::::$^97O=$+-NF[[GR[9N\)MF9/`S&<)3'@F6;Q#Y'RLI3F"(]RDE M"4G%!T3(=!5:_,F*X?`;0(Z![5O&H%^>59A90J>7%F6VB+IK2XLO,;G9Z,WO M1G@'S\#;"\_)$&W9/QX_A#6#9G?\()II!TY^#D,D)Y[#E9HXK;](XOVP))7I>Z+7 M-P]4W[2J_7M]?M,I$Z+SW0@Z2C[[_N:-.KK-J6OM;3<3J?L^G5:T5=H_Q@@T MK!MD(@PPX3@P(2V$+U$^P[J1<['ZPA\''U"/I<5:=41BT.&F$]4%IW)R\NB< M_+R<7%%!049J?,)!+YE!879C'*=C@@L=LQM)9&MKBU8A%PK15UQON=)7_0;= M;D<6G;="FX&C!]4;"@I>/ASYEOZ3!OLGN%>1&PFV+UX8AG6A@(X8WC=,RWN\ M[DN_.IY@!9L11X]4RRE4L'J3Q)<6P$76]AT5^^0]YL?N?(]Y+O%\C^V:#'T2 M)QR"]\BOC/B"T`VQA"%`RIG8ZDNG3C=?H:MJ]?K.AAR=U=G/PW9'4NJ+21>J M2BZ5T?6JXE=4`;\@"X^Y63]5JSES/#3& M(]2;UF7BU?RNFHX:JCBM.D:GU(?0AZJ2':ED?N>:G.Z#HNCT:)UTHN)>$'-. MAV^0.E[QH03B=,`VQ@K!KH4(>HR6D$3Y_V^5"/IKK["GC],")[DM4$CZP,D^ MOD"<`ES.?>!R87Z*(6%YXX7FKV*JE4JU^HB\(:&<$3@7Q,ZZQW%2X1876@US M>/+0L=_=\7L\05+UK+":4_D2BE]R(6^6)L$B%^5[.&7R1JT,?$,N_V\B6AV=)L6J`?92^-<&!R@LNJ8#&9 M?`KW"8G/"A6A-!XXPU:\_>N?)FI]7ZT6DF79^#=%?6CDR(PK;(- M<`FR7V?#('EAWCH M[CLIO@T:^,0-Y#3&)^+!Z0T?>?:32,>#5)C"Y\+7NPC$@)X MY\[JS^8Q5Y^G%N")*:DI,2(DYR$..H'KLO+23XL`RP2W0+2.0@*)GS>]._K. M-M%A?=2)L*\UX[`6C&9@X?.4NJ`NQG?8^H)3B8D@J98UO@FZ\YR&*?>PLK"0J:RJNE,@TA0',M.C7"^9"5<=O?L*O(=CY=P M*.CC"VEXUY6+=0,B4/+0OG=3^``/PF>7X@8WLX):8<^HVPBHAG:-$E,0#@,D M\1SX#FU*">46*/-Q/#`P1A-3DQTMEZMI9(<N^Q_;U1H4Q96%&=ONJY6* M1GL'I"?5;31B5BT?&(/(@B\22XTKHN(#4\9'5%"$A6'H`881D(%A&%XJ.#R: MIR+R$&1P?*&F6%T7S+H2WQJ-;FHUJ^LZZGIZ;OWUSK_\<;W!!)!YE'Y($-JL8'L/,Q M=2Y1#<7EX`?AL(6#H/%`XZ'8.PA[8=_`8W@0<%UG*MLU#^^"KP6O"",J(S*$/*"&WP:*_1S>A:=O M$B-;C?'`-XJTWQ7@F2>`\3`;]U+QA@/-I3G):G*7/,H5X2D7IMO*-EZ&5OE"R.2&+S1;137 M;INCC??5B\GFE-Q!(JR6D&Z-I;,DWU:X5S@&@VDH8^SCZ2+#WN@4;E-T[B9> MA%W(G49L"!`TP"#<0`^!'HLDMD%G!Y2VB=)PH)U@M88_T/1?Q6\IC MCA4FY"H%&1SRLPX5J8]R>#A^ZSYA[/N.WL/M@KWS;%67!H9^'32JWG.O M8IO\K8+UN5-F0,5N*_>&-@;.W825X`M:/!54>*>`:QFV0D37LTK2^R_@8V/* MS&R>W0;AR,-)8W$(F6S%)T0Z==MC= M3K(\<4)%;?-/7CX[O-@D^7L(5L!A&OQ;2YY=@#P$$\UW8GE5[E(!;!&//5W+KTD@!?&#NBIA-:. MX4W`R",?;]S'RJY5\%*-=^F9BZ:JW.D<_@AM_D0[#T\:#33,AR(8V_,/GGT! M(T]_,'>_4,MDPF8ZD8G-BC9E;OVLV4^#MV!O'$0:[=,8=F:)$-('5,P3#2O# M`/`]:Q/@,]2WS^HHX#U".>F`-DGUT@G=3DKRAH,2$UR8+GW%P7KHQBO0K.S$ M`*7^@Q+RO)?#4%_IWFM%O(0/BNA*EHWT&$?@;HCX]7N"WW-^2()%<@V45("< M5*4W=$G,;&O"GAM*L%OUQ9?SR:$N$=WYF6(^(O.RR=`N_T0.A3HI."AWJ:_8 M2FX4DD\[1'3;5&H(Y=P;T(I40P+_1?W=>9KMR3&BH2BE7"\82^K3.C7[X;U\ MB/#0MC_W.TY*GD*$>=(LF>.XJ.UQ6(?7\K`._2]NFX@NFFIV!K_J6[""NY7@ M+C"67^)@,=I7_>]1=$O4H_>W<8G)N1&*IL]**-R\I7W!U]@`^2.(P8;U7:K. M_U.AKX3+D(?.A^6G"IG8.#A.Q@=N%1D/.=BVU_2+$^56=`+FT/$,]@E?F(W' M::;K\SH$.0;=K"^^J/3JP"L4*H=+S)7LZDQ2 M_#B$O72I,TVD/*.$YN3K:IYQ\F@K`JO["&UCH%C^BK:ZES.!:1Z(A)H+"[2[ MKRO=N%E7U%/H84:&SC6*F!K)-]7!'G6M4!(:1<+)ADR,.'S?C-RLG$CCF2+3 M46Y:91??G/(17Y\Y)#@*'@1X.: M<-L/?"`*DG$`,=CIY`G`@W`RC@(_[`/SA4,#,37F.X@#$:C;3B=0,["(X\;X M8TKP2+>F`[H4=_J7$U*(.SUF;Y>3?E_>66(,57HZUZ(-R/(`#K$FEUWF8`$R MUTFY=9H7O97V(T)%N<-^@V,?`XO?.8-Y'E550@X$\DF'#@YS!<2_!4]21K>..:MF1;Q.F,BD'@M1H!F,] M0<5/?!C/'U]&^]\`[VC@-'NK+'DV`3]TG57W@].3I9^`ZP<="WH%M-`_=,!^ M"%H5H.02TA2@KK&2>KTUH3)Q/UX/12-.[0'O.N`XF(@#J_UY?(!A;XOHTLZR MC%>:U,U0FM0HH:""=.DO'*Q"W5;(P.=IF,:PC]V1\CWU@=W%9^S@DX-]">YQ MYH!4O)2LESKF!UFDS8V?GG+8LV4R4LQ\T'OV@<1`HR= M5AX5SBW?$!Z$-2O!^[C(:YE&O(6N8CKFE@],5'WPJP#M^O@G'< MGT\=['K1.R6P@J]G^H4C_[-3554-44Z(JO[-='FEI`[(-TH7.7G7EP@&-.CQ M@&JACLF"$-I]GLG"(70=F4@U^R48H/G2GRQ>%4D;F479<\DL.U:$9Z=%HBOV9[^-9@#9YC`:%7@,N*F]U4W(Q,BVLF MVP[BX*IER+E/#K1*;=W)JS MGM,EKS-G\7BLF\+CX>^T]I3>7L8U2=9NQ?,D$1TW5QKMDR'7?6Q$&0/Q\MG& M:S;;B7PR&>YZ8A;^,)7Z8;H2DRB\):R.GRXS)U/%X&'Z`1\#W=.IA8TT% M=^C8?]FNTJ"HKBP\C--]R9A@PIL7H)_S'A.=4:-FE$I%3502(0I&"6[L(BJR M+T&AN^EN&IJEZ:9I:&1K'CL*S;XI+H@BN*'.*"Z`HVB[CI-4G,2H.:_J,E5S M&R?FSU2]/Z_JG/M]]Y[M.\96O<';%G7BN\+9(:\ZIJI`T MUA8=,Q(+O1R=U58DM"WOF?<"=Y_"B^T)\$?"9T>PW5T?AVUW(&84 M?"IZ*RL&BNU_[:%72>O98B.3*!>W]NCCTK+3LS,XDB%2/!_VBC+-635E$LO! M_.,VI'8Y.I;+ZY[C#\$);W7&:Y"[+GF!K6V>KT%+\]55-R1D:L!\D(Z^:B_L M*G2QQ;U'N-=C5R+B?BI!B3#[J)&\15S^=]A M#@-)XBGOJ555,Y6M^0-]G(.F39AY"9;S1V6.HU:0/:(FR8XV3I\MO%S=QORS:^Y'WDHL MPFBOI[F36Z:D(UY^W)S]O!H3? MB?*+2@U%S%&#-)XCM[TAB)KM#MZ:(7P`2^B`Z(@P#V;9V@FB4><];>T^;4J- M+^:*4HI2JI(:C2XMQLJ:!DFUNC6^CJW<&\I',F0%L+=U)+>?U]^9_-L1$`\1 MVH.&2N'WEM?$FQZ`S$IUPK^>TY%9X?MV,MX>9V`!S+XZ<*9_(';=?HY*@(6X MB?;2&FH/2X3+R,;UE(UKX#37XC=<\1+4'!-?$<;@WRW""#OA,)@CZQWK[FXB M2MA'7*@340FG:XY7GJBR)]<:A80V0%UV!T=G"(M@.1V1'+;.C?'^]#!\F<[! M93$X97@.+F8^P^_ZX(WX@XD59!N9>PYFMY9R^`XLHA]5]C8-,[=+O8+W+4BTUO'JL#,H[\:\QI')'`%')`#3C@+?YG8*86%!R&FUV1QM%Q+N+?R M`@3<:K)08Z[4$==G2^F6ZKK6;I;\]FOJ#=_J[,?T`_I0B=^Z'?@MEEA@<>2A M5HX:"QL2/.DKO0U=#RJQ)#%%^\6Z54F/;[/475>X?ISN78V4J<9B*3%TY7>G M%$ MQ_NF%7RLU*2@Y.G`$HV)C,A@="@/9N)97P?%!D:]3L>"_Z5CZ'2("]Z$>"H6 MK=%D;\LFCQ;'HR"3W'1+`CGHQ.%>OID9K@_WXG`06BW7!FF)111R6$F`9Y4- MR^!/SQW_\?P3*_62K!,:7KRV4%M%!"B@W`)_>8#<7^&B0D:SV5C!5-;D^7)8 MA58I# M72B]PK`YD(W47`ACY%)53_0AW^$MSAA.](6^,O\4_V5+DIDY-]@4("I7E&1F2]1J M718K5T$"+_[&&+X_X#)>#'[.S4TB<`3&8CC-\#@L#?459V5D9F6HTKC=T;Y; M(^/T1F?A8Y1+*DKP4_BE!;VNJ))\,]-;I`SEIJ1H6Y;>*X.=?LB?;4R>6:GN MNOE#K&!1_'(OR"MLET"':B[I[6VA3E?'>G#X3W(/4D;8;,( M)\E8F,[W2R`5P2S/INV^>Z*V![&WI^%NV>!"I^$*R][`:2R"F\6N^0E4/)D! M>B&,QI(5V`[/PLR3N4##HFO`_1O^O/@A=N*JIGQH_'8R;!A[,3QXZ>DI8O8N MGN.U)X!SP/'5L*E-L.2C+B-A8BF+; M+1F'&."N@ROIW2[N=]U6;P]*E')ZH^@FRB$TOP^6!RN"5;80EI0:2IC.`L5N MCIJTZNB>HC.6+@8<3/B39+QFJ3QF:\B1!AMV%6P>$=ZSY,H<#SP`I97HVBEA M%5T?GFP.8/!["_!O,8L7CGL^'KG6UU+%F;"/.#`M^7,=(991@4)+4PM/2$@G M(!E4F*T3K<'WZ+Q8@])?;I^=JM"K&+?P[YYRY,QWAFY.?I?OF6C;\7CXX9EW M>>8EQPDK-3)AI;.2B@SI*"VHRN:@V2!J4%*C0IJDW286-#9DRQU,7?3F>58FH/7F)&5%/)?RFOVI^FSBC>!F\O MF$PWYQ*=RWS)XL:,&LDRT,4I0_$%1.1-2Y&NR"VTM87>]I:6EA;N+872@E`% MQ(H5Q3=PB,.X#:,D,YMD?ECR#R8.]>5&&B"+%3>Q`E[6OD^P)Q<;/C>@6=\F39KHB+3BI MG)9YQ"OSR!*91KP.MX4^L)VM+MJ?7%U=;:TG;4Z;TTY?16.JMX8UE\]?Z(]' MZ#H_5F>LJ2ZCXRK31/U@O2:D')[%C;)+2U?2567TG(X+GR*A$=H MY5%\FG/I"DEB!-7CI1:3^1A=K:DP5%!9YF\$!NZA)08\RIWD@ M%27+Z,70@MF\5K&5[.YJBCAI$>6R>*>]TRI6G-KP"+&1SY+W!IR-+92G)7S< MST`JW(U<]P0&$B)5Z='!51U\)"I#:>ALK"+KK1JCEGX/:3^$ M4EFC6OU!LJ^[J=\MX^]A\>$&OV4(82O0SO1\2-T"Q"#9&W:%$]DWLW@WYZWK MW`D4^BV]1'";/%2SV]\K/WH>6'Y!1JQ8<%J\E-?EBP48H.%/< M$Q#5R52F;)<*DF#\3IJKH;6>)77FQO+$(LL7\:.\AB^:0*F0FWX?%GC;HM$X MGR&BE2S>;@_;=:31:LY^G];W%=P(DJ%N9U`NJ)#%^_E6QW#VK^C-=*1":\OR M#9S&EL'"8AE/YPARC%\(-;?0]^!53!8(LZN?2*-BBB#M(X:DPXDOIUC523Y@ MTI/FNC*3AEZ'M`B'9LSFL03:R..#?)B7TQ08\#:NIZ%5"RID3Q?*1Y>S9&TA MHG?0A*:N/*BA\KDB*T,,58;++LV^*,J>W.3/4#QQ1B8PJGRM6 M&17/%0N-BB1I%5!I-2YL7:VU?!&%:!5T24LQ$?V%V]!\+*@:\[@&[E!`JU#' MLZ6RA'Y%5C=OA\`=`E,(7*&4Z:OZ)\MD)?''KFOU5P@ITI>S>PE.F'H^;YYMHWM7$.RF/I\&LK]V=M8\A M;OX"_>NYUR+^H=#QEDZ!I7MY3]B*N-@AS[PA(YX,JAPI$[S.6QPV"M-T' MNX5D=(B7JKRPT/%2[_S9ER5;*LRE_2?``#M^#"4*#0IE;F1S=')E86T-96YD M;V)J#3$T-R`P(&]B:CP\+U-U8G1Y<&4O5'EP93%#+TQE;F=T:"`U.3`T+T9I M;'1EQBZ>U08E*9! M>DA/JUG$,UJN!QY9!94(XH$H+HB<@PXW,\`X#(.'A(>$A2)U1XP:DI%P/\26_,320ZV!J:DZM5*??LS>>"4F9Q"X.7+9[K MBDO?Q&!7#%[`K4G-259PV[3J?$66FMN0G9*CRLU1)>4K4N=SW)K,3"[*E4'- M12G4"E6AL/O&%*=4(?W+/<7^)[ M\.?$0N(:Z4T>D7A*XB4/)R1/^/?$Y1-K)]&3=D[ZQF.S1Z/G'SW-THG2:UY; MO2Y,7C+YXA1BRB7O8.\22D)E4@]\EOI!E^O$N,]0$`6?`G:7:+D/`E>N7!R548DDCCL+1)ZO0`A3, M1)A0X$NTC!42+-2((/>^^`3ZC(8@F`3NL!RV,N";"SZA,('=9\`[H]N#.&:1 M#GDD(RF[&_EMW900+Y%RB(8BT=?#8ANBZ9O'1X?N,N=4)Y05288D-N%"K9)) MBT[3E`@2$#TD&@"]&'K@((UR"/U&''()*5<*8M$Q$(O_44I[8&T]37TG\SJS MLE2J#,5I79M.B4T_@ M]A,QB&$!_?P!+X=98Z8_9*'0Q6@4,1G1+2!A>5]HIU_DPESDC^1H.4I&[3-N M?OQ?6`D!L!]B66EE/__JK#<\_B;W!^I[6,\/T]3]UL:>2T.R_@'U9PA#\H29 M>OD!'4Y]_[SNQS3$,QXRWX6>71.U.F&S2M#IY`.:BKJR>D'M\.YZ""U/J1Z^R1E"HUO[ M4"2RHF0&+7NYXUOX]%M8]0M+M<#TP+-A+-6C*ZZI+I93=XN->H.^LMH\M6,0 MI+`*UK9+J![4BAKHAV?C@A=N1ZL1,.L3O8 MNY,)BEJ)IK'4:'9Z7;^<>@K3^2:ZT6HY?$/V][X]8<)XSS#.L0CX0]H+_*M> MT0BX\[N:Q4Z.5]!]$(<7$F6&JOW9^9LZ0F5(B]:A/+0=[8+`=2"!P*>_GN^3 M%QW!=\6M6XMP&9H4_1WXP9.KB?WK#.@9BZC[5![[. M*?25ZDZ#DM%49!I+WP?1@9V$2[`8(F&W7!B,2%B,BEATDH"(+?01J[7QI@S6 MG49>@9O2T5?HWBZUO=MQ^'Q]]YL&=L/E;FCH=DD]::.>.:7.:?1XE5!6'>F2 MV\N45J08RSZ0XZWD'5BB.X@'K4U4H.VRO$3+R09K\S#HY+#48#+%,CJCKKJ8 M;37<@V*MM:R@?%^YWK\@LZH<+:Z14,]&0(^WVLWV!S+88BF<72%OJ\'?SM*= MWG=6_M5,/7+ZNZP8=,35ZL]KTAAM95:U_HT/;41)S MY.DE,I2.MJ$_(VWB"90!3:,_'STS+!^`S4W#QZS7K/X.U*(CKQLZC-F,;@\* MR9^YDCMH;Z4^QMR#E8"R2*Q1L*.^-43$%AS?8JX;TX[B"WV,L.Y`R@$/AB M*ER#PCI;3V>W3;`39^KE7[B@AL7\3)>=3AWQ>S7C[>0M"-/8<12X8;D1>XF=O[DRKB#0V+@>-Q+1O!Y'&P38.FN'K84%DE^!6XG;X]UX$\%+^$'< M0B!J/%D?DU\4\:Y/43:-N8]IM;78V][UH,%\[?]LEWE44V<:QD&\%ZPU6J[Q MX+W3>^M2EW&KUO6(5MO:T6KQN)5-45`!+8,2`@D)DI"$A)@0R((L(80@@D`` M1Q%Q1U"ICNNHB(Q2ZU+7,YY:>MZ/^3(R-V#GK_G[GO.][_-^S_/[WFL;F'-F M:N\G]D!)KX(ZU/N#MY-(OK:N.',;+=-(^:!,\'S(=X5CD)K`<^3DR>PR>4DL M'NJ9$Q2+1RDSUZL#^EM*S(DQ':&M.0[+`9;'V&R^)6HW2#V-A(.$\N7W;>]#2'K_>U6BA$(+QX`[\(?X+EN)$'G)K@5[_$,00!AK8 MQ'IJL%8(H]Y`!T2\;%CV&19,P8_Q9CS*`./*V8&\'ST$=?V4V_O6FS68P$/N MJ/8@3^L]F5LU/*T_\"SZ7]KU7E/+<^KH$H.AX!C;`AL(K:LH^R8#&\^#X`Y' M/8*%Q,XN-)'R]1EB0:[97,S"H.GHI7H!'&[[,4.28)`.O5I_O7*5/G\]8 MI0\4]S<@Z:$ZT=_MP@TY\OJ,^NF@#X)QE>=N=M$P'B\QQ/%G\N](UG[]-EJA MBG^/WS3>J6%>IV;SD;+LX9UJ->06-+-ML/V*%H;C3@(FD=1S7(">"1V6W/QF MYOPE\9PEL8OP^-UJ8VXR)TBK1QYW8(G#[KCT&#YZ5.J@[E/=*![%"X_P[XB8 M3%.HU&)&HC!;I)PY+=DJVVMRS9AX%67+_-HU)Z\3#'WI* M@DI)-`1A(M]<6EW#\+GK/R_P'[UW^][-]MYOAOUGOT=W+RF*Z,?R$D MLCB=FJ5NX%6XC_?^5C0FZ\F\(<9?LF""_&K_C/NNIMR#_K M8F7N&6]UI=S_LMI@L.-1ESQ%?'40H0@BCSSMB2"<)+2A?U:>+;`U['L/E7L- MOEF\-/36.RD9N0E/*-42-^IH3;ATZ>P&X8J#- M"Z)>AV:&:<*S`@2/E`V(*_.M_AE$C_S@[>_"K7$;8U8S(7]M[GQU`Y;!*(=3 MF\[)TK.2:''QGHH*EZ.J1G1Z'IZ$65[R&#RZ6W2EYT)';04KR&@).XD^*A\0 M4/P(OKNK*:928-XA88CA?,DO+R$!!I\P;!;C$9/QVJD<50\M=X21T1*QA,E4 M6XKM,`PM;H(O.6T>0:6$*<,T8=H`F7_K@$:-2+V+W8(_U^L)ET[C7L?O:+QE M5N(IH64KNCDJ]71;"0RZU3_R)G6\3BRF4ZVBP^XK)ZXUL;S(9C2RW+?F$4BO M^L%4R!,^.72]\QQ3D2]-56MY6,9$?,*^.J<@F8 M6_[B?A=]+&%_&*]V%@[&XU;5+NIY\\LS^SY6$(RWEJ&N6I"Z?/'$NVAVEU\] M^D3XE/S<,Y_8JD["@I6,0F.U^ITI:^GU+>O`%SZ^]^-#EJ?8 M#GD+7>BJ+&(+BW2%#/6?QR\?W'%F.[-*N=,DU8TG>B*%X1%1,].Q3^[S+$[>Q`M4) M62JBS_3YM'N),5SIXY($0F.7Z1XEHIK0=A@BC-R>G"!AU&I+`4?)RNZ#K9Z^ MLLF2,O-3/#T\@=7GP`=HI=0C[U" M`M3O@:]$`Y/.(^B/B"%[.%BZ6B<6&,2FG,YPH*#65TF:18$JN+UT4TI[N?7.B` MV8WL;VC&^PYFRF.\'=09B;KL/(V,-BFT*1EA`=1(^!0N_]_JCY1G):GH,SO$ MV_EY%Z%UE)@ZA6:!KS`\,3,MA4F2'H.G/A2%>Z\Z>>_:<$[/*FX$#DWX2CZWBL?BV*$1U+HU?Y2/1N'?M09"QVHV2RK=P0\F+Y*$/*-?BS!I_=F#EZPFF MS5JK(M$FVXW]$EIMS)M438U$S]U_DAQN.K#1LH#_FXTR&^N:4%,N:L MVNQD4?;Y/X(Q0$^6][S[:AQF]V82;I]`3HC;\11-RG^XS;5J5-(#N*H04P1_ M`K;:`]/+?)2],++XU0SC/J>6L\CW_EYL**.+S.+IN>'I3R^1=O%P+WO"O+>A M[W8XW.1^*\#;28KOQ,^_&DS^.ZF,;9`$FY<*O\!\MDXJF.DZE?8T\2SFG1"/ M?`@_N@L9\`0;A;.<\+:;HP-&6?1#!SCOD([:#$L"'+D#)^.HTE);WX5QV-K[ MB?!ZW^^F+S+73(JVO'3T8@>T"&8ZGVGFV*N]1P^TL2V\SJ!I=2\6KVN1B&6N4XRSZAW%1*3OPZ1+R71(F7&T43E M-U-UH02:A7_XPT:A+1QFN3V"7;S^A^:6L]:ZL[%:<[VV7E^J#?I^#=Y^W`_5:^L3%;1XOZ:SBL7ILA_4=5,%93F9P^W-D0:E<%K'?J;SBO$I&TV!K7_73%P?2]?&1)RS_XB].,U."Q6]B[\'U(M>$3U2>T9#RH(R;DO9; M;\!KEU$0<1[N><'-9K.R?0>_];`=_V8?V4E55F='YXTE(0H.#L,+\-8W]&A9 MGTBF5*N$*9.V;/K$+AQYY)"PL*`.MNF^$$-,K$??T%##Z-/5FC?)9EZT2+\/ MZPO%[";-#[IE'H*W:9E[>0:YT$8[P>LT!;X7!6SV3'7Z^F>?#RY329%3;&)O=/3/.(M?T',1!VI]IG]*;6Z25*X2B M@/X,G?;ZB_$X3(@&"P!3Y@9C4QVC,]3K#2P^BN?)/$2NCAK8)G\@G*LQF'6, M-EE9>X0E:3Q_;!WF/SNZD#L:+>&*D)7;#N$"L426*V5D=;WM]:RN-Q^V=M#& MZ[#))T2]74M9>^7@0)O-[1(. MC4[.S2R=QS^.2;4[U3ZFVV<$W@W"$K\W?^Q+KL?>(XOFMHPC.PHZN6<%EK9F MDY/YT'[ZEU[6E3*)]^70DJSTTB+A^_E56B6#CLNK^L6,5*&0LLB>%3"T0"0, MPL)T,!`]D;OD_YU'RCD?/N+#>#M7-//!8'ISGK5MV[9MV_H6L[9MV[9MV[:-_^&\'!$1!Q0XH<(% M-ZE!A\5RB MYD4^MZCY40`%40B%401%40S%40(E-5%+H33*:.(JBW(HCPJHB$JHC"JHJHNK M&JJC!FJB%FJC#NKJXJZ'^FC@$7=#-$)C-$%3-$-SM$!+M$)K0]QMT-80K1W: MHP,ZHA,ZHPNZHILI6G?T0$_T0F_T05_T,T7OCP$8:(D^"(,1@R$8BF$8CA$8 MB5$8[15]#,9BG%<\XS$!$S$)DS$%4S'-%L]TS,!,S,)LS,%T#,'=B)7=B- M/=B+?=@?$.L`#N)0A%B'<01'<0S'<0(G<0JG<09G@V*=PWE<"(KW(B[A,J[@ M*J[A.FZ$Q'L3MW`;=W`7]W`?#_`P)/8C/(X4^PF>XAF>XP5>XA5>XPW>XEU8 M[/?X@(]A\7W"9WS!5WS#=_S`3_R*$M]O_,%?_,-_`08`?<&2#PH-"F5N9'-T M?'NSV,\_?^>+.7^6>*V,^`OT#(_E-NK^B?-S^`D`VBYOX>QO5[?SP` MJLD0^^GXU^6O(_M/_@.B?V[\N/7C!IN#@^BL9/;?57\D6[HTOYNP!E6S?1?_ MG<^ZB8VO<>H/N^W?5_7V'6.36R`V96+P?Q[.^5R+N0$"#``6X6\O"@T*96YD M%LM-"`M,S(X(#$U,#(@.#$S72]!7!E+T9O;G1$97-C65N M+VXI/CX-96YD;V)J#3$U,2`P(&]B:CP\+TQE;F=T:"`R,C@O1FEL=&5R+T9L M871E1&5C;V1E/CYS=')E86T-"DB)5)!-3\,P#(;O^14^#G%(6[&=JDAH`ZD' M/D0']RQQ2R3J1&YZZ+\GR:HA#K'BC\=^;7GL3AVY"/*=O>DQPN#(,LY^88-P MP=$1U`U89^+F%6LF'4`FN%_GB%-'@X>V%?(C)>?(*^R>'^ZK.Y!O;)$=C;`[ MUY]?*=`O(?S@A!2A`J7`XB#D\46'5STAR(S]Q65N72]4>7!E+T5N8V]D M:6YG/CX-96YD;V)J#3$U,R`P(&]B:CP\+T)'(#$R."`P(%(O5%(O261E;G1I M='DO2%0O1&5F875L="]/4"!F86QS92]50U(@,3(Y(#`@4B]4>7!E+T5X=$=3 M=&%T92]302!T'0@,34X(#`@4B]$97-T*$,Q-#DP,C`R-3`P,#`P,#$R*2]0'0@,38P(#`@4B]$97-T*$,Q-#DP,C`R-#`P,#`P,#$P M*2]0'0@,38S(#`@4B]$97-T*$,Q-#DP,C`R,S`P,#`P M,#'0@,38T M(#`@4B]$97-T*$,Q-#DP,C`Q-#`P,#`P,#8I+U!R978@,38V(#`@4B]4:71L M92A)=&5M(#(N($UA;F%G96UE;G207-I M'0@,38U(#`@4B]$97-T*$,Q-#DP,C`P-C`P,#`P,#4I+U!R978@,38W(#`@ M4B]4:71L92A.3U1%4R!43R!)3E1%4DE-($-/3E-/3$E$051%1"!&24Y!3D-) M04P@4U1!5$5-14Y44RD^/@UE;F1O8FH-,38W(#`@;V)J/#PO4&%R96YT(#$U M-"`P(%(O3F5X="`Q-C8@,"!2+T1E'0@,38W(#`@4B]$97-T*$,Q-#DP,C`P-#`P,#`P,#,I+U!R978@,38Y M(#`@4B]4:71L92A#3TY33TQ)1$%4140@0D%,04Y#12!32$5%5%,I/CX-96YD M;V)J#3$V.2`P(&]B:CP\+U!A'0@,38X(#`@4B]$ M97-T*$,Q-#DP,C`P,S`P,#`P,#(I+U!R978@,32DM,S(R*&ET96US*2TS,C&-E<'0I+3,R-BXT*'1H M;W-E*2TS,C8N-2AI;F1I8V%T960I751*"C`@+3$N,#DY."!41`I;*&)E;&\I M,3`N,2AW*37!E+U!A9V4^/@UE;F1O8FH--2`P(&]B:CP\+T-O;&]R4W!A8V4\ M/"]#'1=+T5X=$=3=&%T93P\+T=3 M,B`Q,S`@,"!2+T=3-"`W.2`P(%(^/CX^#65N9&]B:@TV(#`@;V)J/#PO3&5N M9W1H(#4S,3,^/G-T2DM,S(W*&EN=&5R97-T*5U42@HW M+C`Y-S4@,"!41`HP+C(Y.3D@5&,*6R@N+BXN+BXN+BXN+BDM-2XW*"XN+BXN M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BE=5$H* M,S(N-C'!E;G-E&5S*5U42@HY+C,T,C0@,"!41`HP+C(Y.3D@5&,* M*"XN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN M*51J"C(V+C0V,C8@,"!41`HP(%1C"ELH,34R+C,I+3,V-S,N.2@Q-3DN,BE= M5$H*+3,T+C@P-S,@+3$N-S`P-R!41`I;*%0I-C8N."AO=&%L*2TS,S$H8W5R M&5S*2TS,C`N,BAP87EA8FQE*5U42@HY M+C,T,C0@,"!41`HP+C(Y.3D@5&,**"XN+BXN+BXN+BXN+BXN+BXN+BXN+BXN M+BXN+BXN+BXN+BXN+BXN+BXN+BXN*51J"C(V+CDV,34@,"!41`HP(%1C"ELH M-CDN,2DM,S8W-2XQ*#$P-BXU*5U42@HM,S8N,S`S.2`M,2XT,#`R(%1$"ELH M3W1H97(I+3,R-"XY*&-U'1=+T5X=$=3=&%T93P\+T=3,B`Q,S`@,"!2+T=3-"`W.2`P(%(^ M/CX^#65N9&]B:@TQ,B`P(&]B:CP\+TQE;F=T:"`W-C0V/CYS=')E86T-"B]# MF%T:6]N*5U42@HQ,BXT-C8@,"!41`HP+C(Y M.3D@5&,*6R@N+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN M*2TU+C"DM,S(U+C&5R*36%B;&4I+3,S-BXV*&%N9"DM,S(T+C8H86-C M2DM,S$U+C@H7"AU&-E2DM,S(P+CDH7"AU2DM,S$V+C,H:&5D9V4I+3,S,RAL;W-S97,L*2TS,30N-"AN M970I+3,R-2XV*&]F*2TS,C,N-"AT87@I751*"C(Q+C8Q-3<@,"!41`HP+C(Y M.3D@5&,**"XN+BXN+BXN+BXN+BXN+BE4:@HQ,"XV-S0V(#`@5$0*,"!48PI; M*%PH-RXU7"DI+3,X-#DN,BA<*#4N-5PI*5U42@HM,S(N,CDP,R`M,2XT,#`R M(%1$"BTP+C`P,#$@5&,*6RA296-L87-S:69I8V%T:6]N*2TS,SDN,BAA9&IU M"E= M5$H*,C`N-3$U.2`P(%1$"C`N,CDY.2!48PI;*"XN+BXN+BXN+BXN+BXN+BXN M*2TS,#$P+C(HERDM-#(Q-B@P*3(Y.2XY*"XI,CDY+CDH,BE=5$H*+3(P+C4Q M-3D@+3$N-#`P,B!41`HP(%1C"ELH0VAA;F=E*2TS,C,N-2AI;BDM,S(W+C0H M9&5F*3%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,3<@,"!O8FH\/"]#;VQO'1=+T5X=$=3=&%T93P\+T=3,B`Q,S`@ M,"!2+T=3-"`W.2`P(%(^/CX^#65N9&]B:@TQ."`P(&]B:CP\+TQE;F=T:"`Q M,#(Y-CX^&5S*5U42@I4*@HM,"XP M,#`Q(%1C"ELH7"B31DE.*2TR,C4N-"@T.)1<*2XI+3(R.2XR*$9)3BDM,C(P M+C$H-#@I+3(R-"XV*&%D9')E"DM,S(U+CF5D*2TT,C4N-RAI;BDM-#$R+C4H=&AE*2TT,3`N-BAF:6YA M;F-I86PI751*"C`@+3$N,3DV,2!41`I;*'-T871E;65N=',I+3(R-RXY*&9R M;VTI+3(Q-2XX*'-U8V@I+3(Q,RXT*&$I+3(Q,RXV*'!OF5D*2TS-S2DM,C8P+CDH9F]R*2TR,SDN M."AE*32DM,S4X+C$H M=&%X*2TS-#@N,RAI;7!A8W0I+3,V,2XX*&]F*2TS-#8N,2AT:&5S92DM,S0X M+C4H92DW+C4H>'!E8W1E9"DM,S4Y+C(H2E=5$H*,"`M,2XR M,#$X(%1$"ELH"DM,C@U+CDH2DM,S$S+C,H<&%Y86)L92DM,CDV M+CDH;V8I+3(W."XQ*"0W+CDI+3(W.2XT*&UI;&QI;VXL*5U42@HP("TQ+C$Y M-C$@5$0*6RAA;&PI+3,W,2XX*&%S*2TS-32DM,S4Y+C(H,2PI+3,U-2XT*#(P,#2DM,C`P+C4H,2PI+3$Y-BXW*#(P,#"DM,C`V+C4HF5D+BDM,C(Q*$%S*2TQ.3(N."AO9BE=5$H*5"H* M6RA-87)C:"DM,C`Q+CF5D*2TR,3,N M-BAT87@I+3(P-BXU*&)E;F5F:71S*2TR,#`N,2AI"DM,S(U+C8HF5D+BE=5$H*,BXP,#$Q("TQ+C@X-S@@5$0*+3`N M,#`P,2!48PI;*%F4I+3(U,2XR*&%C M8W)U960I+3(U,BXV*&EN=&5R97-T*2TR-#'!E;G-E*2TR,S@N M."AI;BDM,C,V+C@H=&AE*5U42@HM,BXP,#$Q("TQ+C(P,3@@5$0*,"!48PI; M*$-O;G-O;&ED871E9"DM,S4Q*%-T871E;65N=',I+3,U-2XW*&]F*2TS-#`N M-"A%87)N:6YG2DM,C,X M+C(H:7,I751*"E0J"ELH)#$P+C0I+3,R,RXV*&UI;&QI;VXL*2TS,S0N.2AO M9BDM,S$W+C@H=VAI8V@I+3,R."@D."XP*2TS,3DN,2AM:6QL:6]N*2TS,S4N M-2AW;W5L9"DM,S$W+C,H:6UP86-T*2TS,SDN,2AO=7(I+3,R,BXS*&5F*3$W M+C0H9F5C=&DI."XT*'9E*2TS,30N-2AT87@I+3,R-2XV*')A=&4L*2TS,S$N M-"AI9BDM,S(T+C0H"DM,S0R+C'0I+3,S."XY*'1W96QV92E=5$H*+3(N,#`Q,2`M M,2XR,#$X(%1$"C`@5&,*6RAM;VYT:',[*2TS,C4N-BAH;RDQ.2XS*'=E*3(P M+CDH=F5R*3,U+C8H+"DM,S$V+CDH=RDP*&4I+3,R-"XY*&0I,"AO*2TS,34N M,BAN;W0I+3,R-BXS*&4I-RXU*'AP96-T*2TS,C@N,BAT:&5S92DM,S,Q+C4H M8VAA;F=E65A&%M:6YA=&EO;BDM,C2DM,C4Y+C8H<&]S'0I+3,S-2XW M*'1W96QV92DM,S,X+C0H;6]N=&AS+"DM,S0R+C(H8G5T*2TS,S$N.2AW92DM M,S0Q+CDH9&\I+3,S-RXX*&YO="DM,S0S+C,H86YT:6-I<&%T92DM,S8S+C4H M=&AI'1'4W1A=&4\/"]'4S(@,3,P(#`@4B]'4S0@ M-SD@,"!2/CX^/@UE;F1O8FH-,C$@,"!O8FH\/"],96YG=&@@.3$U,#X^2DM,S(P+CDH65A2DM,CDR+C4H=BDR M,RXX*&%R:6]U65A'0I+3(R,BXT*'1W96QV*34N-BAE*2TR,C0N.2AM;VYT:',L*2TR M,C,N,BAB=70I+3(Q."XU*'=E*2TR,C(N."AD;RDM,C$X+C@H;F]T*2TR,C0N M,BAA;G1I8VEP871E*2TR-3`N,2AT:&%T*2TR,S0N-BAT:&4I+3(R.2XR*')E M2DM-#`U+C@H2DM-#`U+CDH9F]R96EG;BDM-#$V+C@H=&%X*2TT,38N,RAA=71H M;W)I=&EE2DM M,C`X+C2DM,C(R+C$H=6YD97(I M+3(Q,2XV*&4I-RXT*'AA;6EN871I;VXI+3(R,BXQ*&EN*2TQ.#`N,2AV*3(S M+C2DV-"XV*"PI+3(P,RXV*$ET86QY*2TR,3,N-2AA;F0I751*"C`@+3$N,C8T M,B!41`HP(%1C"ELH4W=I='IE2DU."XY M*"XI+3,U-BXV*$5M<&QO>65E65E'1'4W1A=&4\/"]' M4S(@,3,P(#`@4B]'4S0@-SD@,"!2/CX^/@UE;F1O8FH-,C0@,"!O8FH\/"], M96YG=&@@.#@U,SX^F%T:6]N*2TS-#$N,RAO9BDM,S(S+C0H=6YR96-O9VYI>F5D M*2TS,S@N,RAP"DM,C8X+CDH8F5N M969I=',N*2TR-C$N.2A3:&%R92UB87-E9"DM,C'!E;G-E*2TR-C$N-"AF;W(I+3(V,BXU*'1H92DM,C8S M+C(H=&AR964I+3(W-"XR*&UO;G1H*2TR-C$N,RAP97)I;V0I+3(V."AE;F1E M9"E=5$H*,"`M,2XR,#$X(%1$"BTP+C`P,#$@5&,*6RA-87)C:"DM,S(V+C4H M,S$L*2TS,C`N,R@R,#`V*2TS,3@N-BAW87,I+3,R,2XT*"0Q."XR*2TS,3@H M;6EL;&EO;BPI+3,S-2AO"DM,S(U+C2DM,C,T+C'!E;G-E*2TR,30N,BAR96QA M=&5D*2TR,C8N-RAT;RDM,C$T*&YO;BDS,2XX*'9E'!E;G-E*2TR,38N,2AI'!E8W1E9"DM M,C(X+CDH=&\I+3(Q-"AB92DM,C$X+C$H6UE;G0I+3(T,"XV*&5X<&5N'!E8W1E9"DM,S(Y*'1O M*2TS,C65A2DM,3DR+C8H;V8I+3$X,2XW*"0Q-S,N-"DM,3@P+C'1'4W1A=&4\/"]'4S(@,3,P(#`@4B]' M4S0@-SD@,"!2/CX^/@UE;F1O8FH-,C<@,"!O8FH\/"],96YG=&@@-C(S-#X^ M'!E;G-E2DM,C0U+C,H'1'4W1A=&4\/"]'4S(@,3,P(#`@4B]'4S0@-SD@,"!2/CX^/@UE;F1O8FH- M,S`@,"!O8FH\/"],96YG=&@@.3$U,SX^6UE;G0I+3,S-RAE M*32DM,S(S+C,H;F5T*2TS,C4N-2AS86QE M2DM,S4V*&XI,"AE*3$T+C,H=RDM,S4U+C$H9F%I2DM,C,S+C0H,C`P-RPI+3(R,2XU*'1H92DM,C,T+CDH1BDW-"XQ*$%30BDM M,C$T+C@H:7-S=65D*2TR,C8N-BA31BDX,"XS*$%3*2TR,3@N-BA.;RXI+3(R M,BXY*#$U.2PI+3(R."XT*)-4:&4I+3(T,"XQ*$8I,32DV,BXU*"XI M+3,Y,"XV*%,I,"A&*3@U+CDH02DP*%,I+3,X,RA.;RXI+3,X,2XW*#$U.2DM M,S@W+C65A'1'4W1A=&4\/"]'4S(@,3,P(#`@4CX^/CX- M96YD;V)J#3,S(#`@;V)J/#PO3&5N9W1H(#$P-S4Q/CYS=')E86T-"B]'4S(@ M9W,*0E0*+T8S(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`V."XY.34R(#8V M-RXW.#4V(%1M"B]#2DM,S4T+C@H0V5N=&5R<'5L2DM,C`W+C4H M0V5N=&5R<'5L2DM,S,W+C@H M0V5N=&5R<'5L2DM,C,X+CDH=BDQ."XQ*&%L:60I+3(S-"XV*&-L86EM2DM,C,R+C4H2DM,C8Y+C(H:6XI+3(V-2XQ*'1H92DM,C8X+CDH M56YI=&5D*2TR-C4N-"A3=&%T97,I+3(V.2XV*$1I2DU-"XY*"XI M751*"C(N,#`Q,2`M,2XX-3,W(%1$"ELH5RDV-2XS*&4I+3$Y-BXV*&%R92DM M,C`W+C4H86QS;RDM,3DW+C,H2DM,C`U+CDH8V]U2E=5$H*5"H*6RAA;F0I+30S."AO=&AE&-H M86YG92DM,S,Q+C(H0V]M;6ES2DW,BXX*"PI+3(P,RXU*')E<75E2DM M-#4T+C@H<')O*3$R+C(H=FED92DM-#4T+C@H2DM-#4R+C(H=VET:"DM-#0T+C$H9F5D M97)A;"E=5$H*,"`M,2XR,#$X(%1$"ELH875T:&]R:71I97,I+3,X-BXV*'=I M=&@I+3,W,"XU*')E9RDW+C(H87)D*2TS-C8N.2AT;RDM,S%LP(#`@-C$R(#'1'4W1A=&4\/"]'4S(@,3,P(#`@4CX^/CX-96YD M;V)J#3,V(#`@;V)J/#PO3&5N9W1H(#8U-C0^/G-T2DM-#$S+C0H,3,L*2TT,#4N,R@R,#`V*2TT,#DN,BAA;F0I+30Q-2XT M*&EN*2TT,3(N-2AT:&4I+30Q-BXS*%5N:71E9"DM-#$R+C@H4W1A=&5S*2TT M,32DM,S$W+C(H,C2DU-"XQ*"XI751*"C(N,#`Q,2`M,2XW M.3<@5$0*,"!48PI;*$]N*2TS-S8N-BA*86YU87)Y*2TS.#$N.2@Q,BPI+3,W M-BXY*#(P,#2DM M,S0Y+C(H=&AE*2TS-#@N,BA086YE;"DM,S0U+CDH;VXI+3,T,RXU*$IA;G5A M2DM,CDS+C@H<&5N9&EN9RDM,C@V+CDH:6XI751*"C`@+3$N,C`Q."!4 M1`HM,"XP,#`Q(%1C"ELH=&AA="DM,S$Y+C@H9&ES=')I8W0N*2TS,C(N,RA) M;BDM,S$R+C(H96%C:"DM,S(R+C(H;V8I+3,P-BXU*'1H97-E*2TS,C`N,RAF M;W5R*2TS,#8N."AR96UA:6YI;F2DV,"XW*"PI751*"BTR+C`P,3$@+3$N,C`Q."!41`I; M*&EN*2TS-C%LP(#`@-C$R(#'1=+T5X=$=3=&%T93P\+T=3,B`Q M,S`@,"!2+T=3-"`W.2`P(%(^/CX^#65N9&]B:@TS.2`P(&]B:CP\+TQE;F=T M:"`Q,38S-#X^F5D*2TS M-34N.2AB>2DM,S,W+C@H;W)T:&]P865D:6,I+3,U,BXT*'-U2DM,C@P+C$H M=&\I+3(V-2XQ*')E871T86-H*2TR.#$N-BAO7,L*2TR-3@N-2AC87)E*2TR-C@H;6%P<&EN M9RDM,C8T*&%N9"DM,C4V+C8H2DM,C8X*')E;&%T:6]N2DU-"XW*"PI751*"C`@+3$N,3DV,2!41`I;*'!R;W8I,3DH96XI+30Y M,"XR*&-L:6YI8V%L*2TU,#@N,BAB96YE9FET65T:'EL96YE"E=5$H*+3,R+CDS-C4@+3$N,C`Q."!4 M1`I;*&MN965S+"DM,3DY+C8H:VYE92DM,3DX+C$H2DM,3@X+C0H868I,3$N-RAF96-T*2TR M,#$N-BAS86QE2DM,C0Y+CDH=V5R92E=5$H* M+3,X+C8W.3$@+3$N,3DV,2!41`I;*&%P<')O>&EM871E;'DI+3,T-2XQ*"0U M,2DM,S$Y+C'!E'1=+T5X=$=3=&%T93P\+T=3,B`Q M,S`@,"!2+T=3-"`W.2`P(%(^/CX^#65N9&]B:@TT,B`P(&]B:CP\+TQE;F=T M:"`Q,C,P.3X^2DM-#DR M+C4H-RDM-#8Y+C0H<&5R8V5N="DM-#@V+C4H;V8I+30W,"XX*&]UF%T:6]N'!E8W0I751*"C`@+3$N,C`Q."!41`I;*&=L;V)A M;"DM,S,T+C,H2DM,S$W+C$H17AC:&%N9V4I+3,R,BXV*%)A=&5S*5U42@HO1C,@,2!4 M9@HP+CDY-S<@+3$N.#0X,2!41`I;*$9O2DM,C&-H86YG92DM,C@T+C8H'!E2DM,C,W*&4I-RXU*'AC:&%N9V4I M+3(U,"XV*')A=&5S*2TR-#,N-"AA9BDQ-RXT*&9E8W0I+3(U,BXV*'-A;&5S M*2TR,S@N-"AG7,I5&H*+T8V(#$@5&8*,RXS,S,S(#`@5$0**+LI5&H*+T8S(#$@ M5&8*-RXU,#`U(#`@,"`V+C8V-C(@,S0S+C(W-34@-#(S+C@Y,C@@5&T**#$I M5&H*,3`N,#`P-B`P(#`@,3`N,#`P-B`S-#@N.30T."`T,3DN-#7-T96TL*5U42@HO1C(@,2!49@HQ,"XU.34R(#`@ M5$0*6RA!;F%T;VUI8V%L*2TR,#7-T96T[*5U42@HO1C(@,2!49@HQ,"XP,#4W(#`@5$0**%II M;6UE7-T96T[*2TS,C4N-BAA M;F0I751*"B]&,B`Q(%1F"C$Q+C,Q-3(@,"!41`HH0V]P:4]S*51J"B]&-B`Q M(%1F"C,N,S8W,R`P(%1$"BB[*51J"B]&,R`Q(%1F"C`N.#4V(#`@5$0*6RA" M;VYE*2TS,C`N.2A6*3$R-BXX*&]I9"DM,S(P+C8H1FEL;&5R*5U42@HW+C4P M,#4@,"`P(#8N-C8V,B`S-C0N,C4Q.2`S,C$N,SDR(%1M"B@S*51J"C$P+C`P M,#8@,"`P(#$P+C`P,#8@,S8W+CDY,S8@,S$V+CDW(%1M"B@N*51J"D54"B]' M4S0@9W,*-SDN,#,@,C@Y+C`R(#$T,BXU,C8@,"XT-3,U-2!R90IF"B]'4S(@ M9W,*0E0*+T8U(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`W.2XP,CDY(#(Y M,2XY-C@T(%1M"ELH3F5W*2TS,C$N,2A!8V-O=6YT:6YG*2TS,C(N."A02DM,3@Y+C(H,2PI+3$X-2XS*#(P,#"DM,C`P+CDHF5D*2TS M-#`N-RAO;FQY*2TS,C4N,2AI9BDM,S$S*&ET*2TS,C@N,RAI"DM,S(U+C8H<&]S:71I;VXI M+3,R-2XV*'=I;&PI+3,R-BAB92E=5$H*5"H*6RAS=7-T86EN960I+3,Q.2XX M*'5P;VXI+3,P-RXR*&4I-RXU*'AA;6EN871I;VXI+3,S-2XT*&)Y*2TS,#DN M-2AT:&4I+3,Q-"XR*'1A>&EN9RDM,S$W+C,H875T:&]R:71I97,L*2TS,CDN M,RAB87-E9"DM,S$S+C8H;VXI+3,P.2XU*'1H92DM,S$Y+CDH=&5C:&YI8V%L M*2TS,CDN-RAM97)I=',I+3,R,RAO9BDM,S$R+C$H=&AE*2TS,30N,BAP;W-I M=&EO;BXI+3,Q,RXW*$9)3BDM,S`U*#0X*2TS,#DN-2AA;'-O*5U42@HP("TQ M+C$Y-C$@5$0*6RAP"DM,C`P+CDH;&EA8FEL:71Y*2TR,#DN."AF;W(I M+3$Y-"XU*&4I-RXU*'AP96-T960I+3(P-BXR*'-E='1L96UE;G0I+3(Q-"XR M*&]F*2TQ.3,H=BDQ."XQ*&%R:6]U2DM,C,R+C4H9F]R*2TR,3"DM,C$W+CDH8F5N969I=',I+3(Q."XR*&1E8W)E87-I;F7,I5&H*+T8S(#$@5&8*,RXV,S,X M(#`@5$0*6RA$>6YA;6EC*2TS,3,N-"A3=&%B:6QI>F%T:6]N*2TS,CDN,BA3 M<&EN86PI+3,Q,BXS*%-YF5R*2TS,3,N."A' M;6)(+BDM,CDX+C@H56YD97(I+3,P,2XS*&QI8V5N2DV M-"XW*"XI751*"C2DM,S$S+C8H3F%S:"DM,S(P+C(H0V]R<&]R871I;VXN*5U42@I%5`H-"F5N M9'-T"DM,C$W+CDH2DM,C,Y+C8H<&%Y86)L92E=5$H*5"H*6RAO9BDM,S(S M+C0H)#2DM,S(U+C@H3W!E"DM M,C&-H86YG990I+3,P-BXV*&%S M*2TR.#DN-"AU2E=5$H*+T8S(#$@5&8*,"XY.3$=E;BE4 M:@HO1C,@,2!49@HS+C4Q-#<@,"!41`I;*$-O;7!L971E*2TS,3"DM M,CDS+C$=E;BE4:@HO1C,@,2!49@HS+C8U-C4@,"!41`I;*$Q#0TLI+30S,RXX*%)E M*3$V+CDH=FES:6]N*2TT,S0N-RA+;F5E*2TT-#`N.2AL960I+30T-"XV*&MN M964I+30T,2XX*'-A;&5S+BDM-#,V+C,H26XI+30S-BXX*&%D9&ET:6]N+"DM M-#4Q+C0H=&AE*5U42@HO1C(@,2!49@HR,RXQ-C,S(#`@5$0**%II;6UE&AI8FET960I M+3,S,BXY*'-T7-T96TI5&H*+T8R(#$@5&8*,BXY-#6UU M*5U42@HR+C@Y-C@@,"XP,C(W(%1$"BBH*51J"C`N-#$Y-2`M,"XP,C(W(%1$ M"BAL;&5R*51J"B]&-B`Q(%1F"C$N,SDT-B`P(%1$"BB[*51J"B]&,R`Q(%1F M"C`N-S0X,R`P(%1$"ELH2&EP*2TR,3(H4W1E;2DM,C(R+C@H;&5D*2TR,C,N M-2AH:7`I+3(Q,BXY*'-T96TI+3(R-2XT*'-A;&5S+"DM,C$U+C(H8G5T*2TR M,#2DR."XS*"PI M+3,R,BXV*&%N9"E=5$H*+T8R(#$@5&8*."XQ-#`V(#`@5$0**$QO;F=E=FET M>2E4:@HO1C,@,2!49@HT+C(V.#<@,"!41`HH86YD*51J"B]&,B`Q(%1F"C$N M-S8X-R`P(%1$"ELH1'5R82DQ.2XS*'-U;"E=5$H*+T8S(#$@5&8*,RXU.#(X M(#`@5$0*6RA(:6=H;'DI+3,R,BXX*$-R;W-S;&EN:V5D*2TS,C,N."A0;VQY M971H>6QE;F4I+3,S,RXS*$QI;F5R7-T96TL M*2TR,#`N-2AL960I+3(P,"XY*&1E;G1A;"DM,C`X+CDH6YE$=E;BE4:@HO1C,@,2!49@HS+C0S-30@,"!41`I; M*$Q#0TLI+3(Q."XT*%)E*3$V+CDH=FES:6]N*2TR,C4H2VYE92DM,C$Y+C@H M86YD*2TR,C(N-BAT:&4I751*"B]&,B`Q(%1F"BTS,RXW,C0U("TQ+C(P,3@@ M5$0**$YE>$=E;BE4:@HO1C,@,2!49@HS+C8W,S4@,"!41`I;*$-2+49L92DX M+C8H>"DM-#4X*$MN964I+30U-RXY*&QE9"DM-#4V*&MN964I+30V-"XU*'-A M;&5S+BDM-#4S+C,H5&AE*5U42@HO1C(@,2!49@HQ-2XQ-3@W(#`@5$0**%II M;6UE"DM-#0V+C8H2VYE92DM-#4W+CDH86QS;RDM M-#4X+C$H;6%D92DM-#8T+C,H82DM-#4W+C0H7-T96TI+3$X-"XQ*&QE9"DM,3@Y+C4H9&5N M=&%L*2TQ.37-T M96TL*2TS,3,N.2AT:&4I751*"B]&,B`Q(%1F"C4N,#0U-"`P(%1$"BA/<'1I M;6$I5&H*+T8S(#$@5&8*,RXS,3`W(#`@5$0*6RA:4RDM,S`V+CDH4W!I;F%L M*2TS,3(N,RA&:7AA=&EO;BDM,S$V+C8H4WES=&5M*2TS,30N-2AA;F0I+3,Q M,RXS*%-P:6YA;"E=5$H*+T8R(#$@5&8*,34N.#2DM M,S$U+C(H=&AE*2TS,S$N,BAL;W-S*2TS,30N-RAO9BDM,S$W+C@H=&AE*5U4 M2@HO1C(@,2!49@HQ-RXW,C$Q(#`@5$0*6RA/%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--3`@,"!O8FH\/"]#;VQO M'1=+T5X=$=3=&%T93P\+T=3,B`Q,S`@,"!2+T=3-"`W.2`P(%(^/CX^#65N M9&]B:@TU,2`P(&]B:CP\+TQE;F=T:"`Y-#$X/CYS=')E86T-"B]#2DM-#8X+C(H.2DM-#8Y+C0H<&5R8V5N M="DM-#@P+CDH86YD*2TT-C8N-"@X*2TT-CDN-"AP97)C96YT+"E=5$H*+3(N M,#`Q,2`M,2XQ.38Q(%1$"ELH$=E;BE4:@HO1C,@,2!4 M9@HS+C0Y-S<@,"!41`HH3%!3+49L97@I5&H*+30Q+C"E=5$H* M+T8S(#$@5&8*,BXU-3$@,"!41`I;*%0I-C8N."AO=&%L*2TS-#@H2VYE92E= M5$H*+30Q+C`Y-#$@+3$N,3DV,2!41`I;*%-Y2DM,S`W+C@H9FDI M,3`N,2AX871I;VXI+3(X.2AS>7-T96US+BDM,C6YE'1=+T5X=$=3=&%T M93P\+T=3,B`Q,S`@,"!2/CX^/@UE;F1O8FH--30@,"!O8FH\/"],96YG=&@@ M,3$R,#D^/G-T2DM,C4X+C4H,BDM,C4Y+C8H<&5R8V5N="DM M,C$=E;BE4:@HO1C,@,2!4 M9@HS+C4S,3<@,"!41`I;*$Q04RU&;&5X*2TS,#DN."A+;F5E*2TS,38N,BAL M960I+3,R-2XV*&MN964I+3,R,BXX*'-A;&5S+BDM,S(R+CDH3&%U;F-H*2TS M,C(N."AO9BDM,S$W+C@H=&AE*5U42@HO1C(@,2!49@HQ."XX-C8R(#`@5$0* M*$=E;F1E7,I751*"B]&-B`Q(%1F"C(N-C2E4:@HM-#(N.#$W-2`M M,2XR,#$X(%1$"ELH0W)O7-T96TI+3(T-BXU M*&%N9"E=5$H*+T8R(#$@5&8*,3$N-S$R(#`@5$0*6RA4*34W+C$H&AI8FET960I+3,S,2XQ M*&=R;RDR,RXU*'=T:"XI751*"C(N,#`Q,2`M,2XX.#2DM,S4Q+C(H2DM,CDT+C$HF5D*2TS-#`N-RAI;BDM,S(Q M+C@H8V]S="DM,S(R*&]F*2TS,32E=5$H* M5"H*6RAA9BDQ,2XW*&9E8W1E9"DM,S(Y*&)Y*2TS,34N,BAT:&4I+3,Q.2XY M*&9A=BDQ,BXY*&]R86)L92DM,S(T*'-E='1L96UE;G0I+3,S."XY*&]F*2TS M,32DM,S(P+C(H9F]R*2TS,3DN,BAI;G1E'!E;G-E2DM,C0Y+C4H M8VQA:6US+"DM,C0U+C0H:6YT96=R871I;VXI+3(T-2XQ*&-O;G-U;'1I;F2DM,C(S+C0H9'5E*2TR,3$N,RAT;RE=5$H* M,"`M,2XR,#$X(%1$"ELH82DM,C`W+CDH9V%I;BDM,C`U+C0H;VXI+3(P,2XX M*'1H92DM,C`V+C4H&5S*2TS,C$N,2AA;F0I+3,Q-"XW*$YE="DM,S(T+C8H M16%R;FEN9W,I751*"B]&,R`Q(%1F"C`N.3DW-R`M,2XX.#(Q(%1$"ELH3W!E M2DM,C4V+C8H:6YT97)E%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--38@,"!O8FH\/"]# M;VQO'1' M4W1A=&4\/"]'4S(@,3,P(#`@4CX^/CX-96YD;V)J#34W(#`@;V)J/#PO3&5N M9W1H(#DQ-3D^/G-T2DU-"XQ*"PI+3(S,BAF'!E;G-E'!E;G-E'!E;G-E+BDM-#,P+CDH1VQO8F%L*2TT M,S4N-2AO<&5R871I;VYS*2TT-#(N-BAI;F-L=61E*2TT-#`N,BAR97-E87)C M:"PI+30T,RXW*&1E*3(P*'8I,3(N-2AE;&]P;65N="DM-#4P+C$H96YG:6YE M97)I;F2DM,C,P+C$H2DM,S(V+C4H82DM,S(W*')E9'5C=&EO;BDM,S,X+C4H:6XI+3,R-RXT*&]P M97)A=&EN9RDM,S,X+C4H92DW+C4H>'!E;G-EF%T:6]N*2TS-#(N.2AO9BDM,S(S+C0H86-Q=6ER M960I+3,S."A#96YT97)P=6QS92DM,S,P+C4H=&%X*2TS,S$N,BAA='1R:6)U M=&5S+BDM,S(R+C8H5&AE*5U42@I4*@HM,"XP,#`Q(%1C"ELH<&]S:71I*3$R M+C$H=BDQ,BXT*&4I+3(V-"XW*&-A2E=5$H*,"`M,2XQ.38Q(%1$"BTP+C`P,#$@ M5&,*6R@Q,"DM-#$Q+C8H9&%Y'1=+T5X M=$=3=&%T93P\+T=3,B`Q,S`@,"!2/CX^/@UE;F1O8FH--C`@,"!O8FH\/"], M96YG=&@@.3,T,CX^2DU-"XX*"PI+3,Y-BXS*'!L86YT*2TT,#DN,BAA;F0I+3,Y."XS M*&5Q=6EP;65N="DM-#$U*&1U65E*2TS-3"DQ M-"XS*&5R8VES97,N*2TS-#4N,BA&*3$W+C0H;RDP*'(I+3,T,"XT*'1H92DM M,S0R+C8H=&AR964I+3,T-RXY*&UO;G1H65A91<*2XI+3(T,BXR*%2E=5$H*5"H*6RAA="DM,C8T+C0H M36%R8V@I+3(U."XT*#,Q+"DM,C4R+C(H,C`P-RPI+3(U-2XV*&%N9"DM,C8R M+C,H=&AE2DM,C2DM,S(T+C0H M8F4I+3,R-2XX*&EN8W)E87-E9"DM,S,S+C@H=&\I+3,R-RXT*"0Q+#2DM,S0U+C0H;RDQ."XQ*'=N960I+3,T-2XR*&9O M2DM-#$S+C@H8V]N=&%I;G,I+30P."XT*&-U2DM-#`S*&%F M*3$W+C,H9FER;6%T:2DW+CDH=BDQ,BXT*&4I+30P,"XX*&%N9"DM,SDX+C0H M;F4I."XV*&=A=&DI.2AV*3$R+C0H92DM-#`P+C@H8V\I."XV*'8I,3(N-"AE M;F%N=',I+30P-"XR*&%N9"DM,SDX+C0H92DQ."XW*'8I,3(N-"AE;G1S*2TT M,#$N-2AO9BDM,SDQ+C8H9&5F875L="DM-#`X+CDH9F]R*2TS.3,H86XI+3,Y M.2XV*'5N2E=5$H*,"`M,2XR,#$X(%1$"ELH4W1A;F1A2DM,S(R+C4H:7,I+3,P."AN;W0I+3,Q M-"XY*')A=&5D*2TS,C4N,BAB>2DM,S`Y+C4H36]O9'F2*34X+CDHF5D*2TR-#`N,BAA;BDM,C(Y+C0H861D:71I;VYA M;"DM,C0P+C$H2DM,C'!E;F1I M='5R92DM,SDT*&%N9"DM,S@W*&1E8G0I+3,X-BXX*'-E2DU-2@N*5U42@HR,BXS,#$V("TQ-BXQ,S,X(%1$"B@R,2E4:@I% M5`H-"F5N9'-T'1'4W1A=&4\/"]'4S(@,3,P(#`@4B]'4S0@-SD@ M,"!2/CX^/@UE;F1O8FH--C,@,"!O8FH\/"],96YG=&@@,3`Q-#D^/G-T2DM,3DP+C0H<')O=FDI-RXY*&1I;F2DM,C`T M+C4H=&AE*2TQ.34N,BAS;W5R8V4I+3(P,2XW*&]F*5U42@HP("TQ+C(P,3@@ M5$0*6RAT:&4I+30Y-2XV*&EN9F]R;6%T:6]N+BDM-#DX+C(H4T8I.#`N,RA! M4RDM-#2DM,C,S+C(H;6%Y*2TR,C@H96QE8W0I+3(S M-RXX*'1O*2TR,C4N-"AR96-OF5D*2TR-S@N,RAI;BDM,C4S+C2E=5$H*,"`M,2XR,#$X(%1$"ELH8V]N8W5R&ES=&EN9RDM,S@Y+C$H9&]C=6UE;G1E9"DM-#`V+C4H<&]L:6-Y*38R+C4H M+BDM,SDP+C8H4RDP*$8I.#4N.2A!*3`H4RDM,S@S*$YO+BDM,S@Q+C2DM,SDW M+C8H=&\I+3,X.2XX*'-E<&%R871E;'DI751*"E0J"ELH9&ES8VQO'!E8W1E M9"E=5$H*5"H*6RAT;RDM,C(U+C0H8F4I+3(R,RXX*&-L86EM960I+3(T,"XY M*&]N*2TR,3@N."AA*2TR,3DN,RAT87@I+3(R.2XR*')E='5R;BDM,C(U+C,H M2DM,3@Y*&EF*2TQ-S&%M:6YA=&EO;BDM,C0X+C4H8GDI M+3(S,"XQ*'1H92DM,C0P+C4H=&%X:6YG*2TR,S@H875T:&]R:71I97,L*2TR M-3`H8F%S960I+3(S-"XR*&]N*2TR,S`N,2AT:&4I+3(T,"XU*'1E8VAN:6-A M;"DM,C4V*&UE65A'1=+T5X=$=3=&%T93P\+T=3,B`Q,S`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`M,2XQ.38Q(%1$"ELH86-Q M=6ER960I+3,S,BXS*&-O;7!A;FEE2DM,S,U*'1O*2TS,C$N."AF M;W)M*2TS,C,N-2AS=')A=&5G:6,I+3,S,2XR*&%L;&EA;F-E2DM,S(Q+C8H86YD*2TS,C0N M-RAM87)K970I+3,S-2XQ*&-O;F1I=&EO;G,L*2TS,C2DM,C(T+C"DM,C(T*&]R*2TR,C$N-"AO=7(I M+3(R-2XY*')E*3$Q+C2DM,C0Y+C4H4F5P;W)T M*2TR-#(N."AO;BDM,C,U+CDH1BDQ-RXS*&]R;2DM,C0R+C@H,3`M42DM,C(Y M+C8H=V4I+3(S-"XS*&9I;&4I+3(T,BAH97)E869T97(I,S(N-R@N*2TR,S2DM-#4U+C65A'1=+T5X=$=3=&%T93P\+T=3,B`Q M,S`@,"!2/CX^/@UE;F1O8FH--CD@,"!O8FH\/"],96YG=&@@.#$S-#X^2DM,C8W*&)A7-T96TL*2TR-3DN."AN;RDM,C4R+C@H;6%T=&5R*5U42@HP("TQ+C(P,3@@ M5$0*6RAH;RDQ.2XS*'7-T96TI+3(V,"XT*&%R92DM,C4X+C4H;65T+"E=5$H*5"H*6RAA;F0I M+3(W.2XS*&YO*2TR-S4N-2AE*3$S+C(H=BDR,RXX*&%L=6%T:6]N*2TR.3(N M-BAO9BDM,C&5C=71I*3$P+CDH=BDQ,BXU*&4I+3(Q.2XS*$]F*3(S+C,H9FDI,3`N M,2AC97(I+3(R-"XU*&%N9"DM,C(R+C8H0VAI968I+3(R,2XR*$9I;F%N8VEA M;"DM,C(Y*$]F*3(S+C,H9FEC97(I,CDN-"@L*2TR,30N.2AE*3$S+C(H=BDR M,RXX*&%L=6%T960I751*"BTR+C`P,3$@+3$N,3DV,2!41`I;*'1H92DM,C`P M+CDH968I,32E=5$H*,"`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`S+C@H;6%Y*2TQ.30H:&$I."XW*'8I,3(N M-2AE*2TQ.3`N.2AO;BDM,3@T+C@H;W5R*2TQ.#`N-2AB=7-I;F5S2DM,C`X+C8H65E'1=+T5X=$=3=&%T93P\+T=3,B`Q,S`@,"!2+T=3-"`W M.2`P(%(^/CX^#65N9&]B:@TW,B`P(&]B:CP\+TQE;F=T:"`V-3$P/CYS=')E M86T-"B]#&EM M871E*5U42@HM,"XT.#@Y("TQ+C`P-C(@5$0*6RA$;VQL87(I+3,R-2XR*%8I M.#0N,BAA;'5E*2TS,3DN-BAO9BE=5$H*+3`N,C@S-"`M,"XY.3DR(%1$"ELH M4VAA2DM,S(T+C$H,C`P-RE=5$H*-BXR,C0U M(#`@5$0*,"XR.3DY(%1C"B@N+BXN+BXN+BXN+BXN+BE4:@HX+C@R-C4@,"!4 M1`HP(%1C"ELH,2PQ.#4L,#`P*2TS-C8T+C(H.#,N.3,I+3,U-C`N-B@Q,RPV M-#F5D*2TR,#8N,BAT:&4I+3(P,"XY*')E M<'5R8VAAF5D*2TT,#0N-BAT:&4I+3,Y,RXV*')E<'5R8VAA2DM-#$Q+C4H M=&AI2DM,S(P M+C@H4V5C=&EO;BDM,S(W+C4H,C`R*2TS,3DN-RAO9BDM,S(S+C0H=&AE*2TS M,C4N-BA387)B86YE&QE>2DM,S(R*$%C="DM,S(T+C8H;V8I+3,Q-RXX M*#(P,#(N*5U42@HO1C$@,2!49@HP("TR+C,Y."!41`I;*$ET96TI+3,R-2XR M*#8N*5U42@HO1C4@,2!49@HT+C`W,#,@,"!41`HH17AH:6)I=',I5&H*+T8S M(#$@5&8*+3(N,#8Y,B`M,2XX,#(W(%1$"BTP+C`P,#$@5&,*6RA4:&4I+3,R M-RXQ*&9O;&QO*3$R+C8H=VEN9RDM,S$X+C8H9&]C=6UE;G1S*2TS,S(N-"AA M&AI8FET M&5C=71I*3$W+C(H=BDP*&4I+3,Q-"XU*$\I,"AF*3(S+C,H M9FEC97(I,CDN-"@L*2TS,38N.2AA*3`H&QE>2DM M,S(R*$%C="DM,S(T+C8H;V8I+3,Q-RXX*#(P,#(I751*"BTS+C(U-"`M,2XT M,#`R(%1$"ELH,S$N,BDM,34P,RXY*$-E%LP M(#`@-C$R(#7!E+U!A9V4^/@UE;F1O M8FH--S0@,"!O8FH\/"]#;VQO2DM,S(U+C$H875T:&]R:7IE M9"XI751*"C(R+C@P,#4@+3,N-3DY."!41`I;*%I)34U%4BDM,S$Y+C4H2$], M1$E.1U,L*2TS,#,H24Y#+BE=5$H*,"`M,2XQ.38Q(%1$"ELH7"A296=I*34N M-BAS=')A;G1<*2E=5$H*,"`M-BXP,#,T(%1$"ELH0GDZ*2TR-34N-B@O&5C=71I=F4I+3,T-RXU*%8I-C8N."AI8V4I M+3,S,"XV*%!R*3,V+C,H97-I9&5N="PI+3,S-2XR*$8I,S@N-"AI;F%N8V4I M+3,R-RXQ*&%N9"E=5$H*5"H*6RA#:&EE9BDM,S(W+C(H1BDS."XT*&EN86YC M:6%L*2TS,S(N.2A/9F8I,3,N.2AI8V5R*5U42@HO1C,@,2!49@HM,C0N-3`Q M,2`M,BXS.3@@5$0*6RA$871E.BDM,S,S+CDH36%Y*2TS,C$N,2@W*3$N,2@L M*2TS,C(N-B@R,#`W*5U42@HR,BXS,#$V("TT-2XR,S(T(%1$"B@R-BE4:@I% M5`H-"F5N9'-T7!E+U1Y<&4Q M+T9O;G1$97-C7!E+T9O;G1$97-C7!E+U1Y<&4Q0R],96YG=&@@-#DR-"]&:6QT97(O1FQA=&5$96-O9&4^/G-T MGQ`F01>B)H:%B4[B42^*X&Y14''L^^F??[8^;]OM_OY_IR,'[HQ,SR]T0Z4\ZKPE3\^0SW)"ZJG`#WMTHSISX68 M&X=3?V2U.E=/J=+2\V0+4A?*EH0$![WK.I=-G"&N,R10%JI0IRAE\7IMGC); M*XO,2553N6I*GJ=4+);)0K.R9'&N"EI9G%*KI`K8KQ-3R51:F5R61\D5RFPY ME2E3[Y+%J'+4>?IN MEGO:7>C>CO/Q3?@7/!7O!7\7?]ACAD>FQ]-),9-:)L^?7#[YAY^<]XSV'/9Z MUTLO\!-T"9Y-T4SY9FKXU+ZI,*UPVFUAD@@3%3F7"-@7/6!P&#?KA-]"=WXW<>=GND&=$-8^ M%27GH@@QA,-D\(0`2"1@T7H@@O].BNQYQ?BU1?5^2PDT2X&F56K('6A.3%QT MK`<[+(J"<K,)?<\V/&?2B> MT\/YU:X->H-ZKR\%6VE^X4[S8'M#NZU1>ODE#IF\%IG9K".VJZH3C20%%_G. M-5`CA@5@'$)&7CS'+=:`:Y/3#8B:@A^L(82G(YA655Y;D:^-[@B3(B)8C M+:)0),S^)7B#]Q\_OSLJS>[``\*B-2LE>Y"W&2)@+4R"9@AZ?&K=HK)]I:8R M:7\5+KALIJD!YD6?D!F$^:)GFP;;Z M3FN;U(]I$5^M:#)E$*(AG2X&X`8'V[90`0YL(*`#Q#O M6[2>1"=Y+#_]<+D?#O=3M)!9?`06=HF>,0]@LYBRXD@8CMQ3D*FFWX0LXJK8D+R]6H_EUOE=`BW?7U[>>D,`&\\I0 M:9?A),3ASB&>Z#[%OUK99,HDBBLS3)4DFN+ M3]',9(G5%GQ94FD^FBUQU>YO:&H^)H%(\]*(-[5[?[0VG*'YF^OTC?V$O:G7 MTDJ>AYTX<(]J(MZ,S_*L'X:AH_#YKSEV"&16LB)NA@=B-*+A?6(X9$HGTK:A M9<:]9-Z>Y)(D20::W@CO0QIX03F\!]S^%?.D/<91T.!9O')#A4ZMRN]%;A)T M$+V'BMG%M!9F^$/(G>_L]'EI]X$S$-D^7M\P9O$5H"XSS?R3YF0R45QHH\5; M:POV#Q!M32?VTR3PF."V3[LLPU9?&HU2_&L5#?LRB9+R9/,$MJ*X@HKD*A;; M6;Y@"VN2?H:AA?D,(\IE'K.Z:5G=IK&ZR5G=HLSV!JNYWGI("F*&:OUM3\.% M.K;FS?^J*1KZCZJL59AS?`$4F.FB`L=<6ICS*EPTY+C+C(O;KAZQC-@\:)3. M1U><&MS$V\1H<*2A>&.F0Z8LPFC6EZ61B..R(J30_P99I&2,Z M#IZSMI//&0ROY8ERKSM'\6X>PV<^K37A$_T3BF+5%?%&]LIG-/_?9+3;#EO: M2%<."@L<\VEAKJ-5-`27'4O$:`O;T]!4=2@)>3H#?%*1M,RTK=2#`@7-5];) MK6-$9_,9FYW\#AB<34ZC\Q3;#>8P=<>`;*P=.\!2H*3XP]4G#)N)O-*$J@)R M!1IQ.6'`,66`TP5S&4^8RV5^Y9"*_U8SIP!Y^#M)%!Z;./#\3X\9?XB1.G_N MC!4ONH6FPPJH9>-KA\T0AGQO(`Y2HR2T!YE(ES3PFT$8GK!T&LP3?0./F"=B MN\76>4SRE7E504Y9:$:*-'^W-F^5I*2LIF:/5'07!<))\5O-?/H--?MM?2PU MYR$!-PZU[#LN`0)$-V"ZE.TAE/7-(M$(3W`9*9Z\&'`(W@)HI@O0AV\`P<8? M(L3)*:GIH9(,:G\])94?P",/AU37$]:^GI:#)!AVPS;H!`7Q/SB#S\X'/(ML M-)K-%D-UE=E<5(("D;?/02W>>7'`:O_#B1W`EX#LUM=7/I).Q)Q=-ET3G&2! MWVM..JS[.SZ47.M-7[]>$QRJE1KWI%5NE[!L+(4!\5O=[TIV(4M&LZVGOIO\ M!#;A/;SOT4,<$FE>@E5?F_]9,.SS@9_:KSR\0["=WD%KS.S.Z^$)9*S0@D&C M3CC<,\@F>2IXB>[7ZL6]O,Y&:S/=?2G]M@0"[MT#GYM)%Q,_D@9\'7W@+M%4 M\Y>7P#N`W.)M9)<1%YT=87=)-KM]-*5JLS%[0V^!"!/,%]R_>@/`ZS03I"7H?"$9`VUYW[%]/5'M;4>8>E-"%3 MFU9.L]9S])SIIDZMV@?JB@Y%19$R!)P@4*J`B`0(D`02KH$8+B&$('<(R"48 M0H`@D()<5"ZV#BV*%EQ77FLM3Z]/+_C\[$]^U+7;?^<_[[?]7W?WWLJ M5_+/%,E?;C+:W7B)4X7:4OE+N8/JN@(1*0EW3Y/0R`\-8RD(8M?FC!IT8_^1 MK#%-J;8);;Z[6/)N.Y==_?*UDO+:ABX<3C%U8`K^U9N;["B'-^&8@1`19UD/ M(`314G%4"J56%>H[&V[H!YDI4"+['`XA2O/'X8UJY05?"O'11O0QVA!3L>GY MHZ%'?IE9L/:9A!;%P]^6O!1V%9FUT)-JRF!U/)H]&_`US^CWP MA%VS(19^,.!9-:W0<@GT"=SC$PCZ%3_;>;!ZHT3>"/W@A">+DB;5MA6/P M](,LWV*7!V_#1EAN#U.P1G`XXE3L<2H^].SAZ?%^FI\Y?6`2_MD+'YG, MMHF]1?2P;O".0)47X2VG3FO*BVL&87=%)T-\G\\_22'H^(]K2R2OS MUG,TT8.>%PDFYR!COJOP6&[\061Y+T(S6OR_UHJQD7'[VAXF8:W@E#0J((!* M_J3H?KVNZDP=`P&MXS]>(:@MX1,C.U0[#V.H7](`IO8V=[06RV0[M>L$[?V<,#-D"PC5LWQ?FTP@QV MPU19>;Z2R4W/2"'C#?+F&8X")&@I M#ZV*4QP-H91Y)25,<6U-(]EYJCHS79@J\NU/'(:]?1#%KGM,?\7EH]`.\):# M.(#='O@5\4Q)+"I9*8M]K3V7>*JL3XS2AV"FNJW;'6". M&$IAO(4QJ[J'9BS%1?=D M&>V,.;-*+B-]W%3':)R_E-TNL)AATYW.BBA)B!"M/A"J':BC^;]1W8J4L^3T M*VAGLF5(`2""LKQFM*2H_P3:'RLDHJ&2*UXA]0;B7O']')@OT2T/J- MM*;P)W8KAY#LR3B2O3N')W:PZ%JU0C)+G:Y6T&CKXC@'WN`:GYR'I3W7>1=: MAN[W4O5G,K(9PBIQ1E&[R!A#PH6'_=/C/31_4:":A.>FEF18`J0CY@!%](,( M4R`N.3HXDT7X,H*_R6(=B#Z5M4$?DXG[FPM2`V:1[7$P!`O8!W;P"%NNV8$9__1-M!6G44K^@2M7?3W)17: MH[?F^FY/]-%\<+`M#B[)@3OC;W*$KV#II[`\%@>6$_$=[&9!3:%5%T_&'$?, MGU$DC;=`R-@E"V!O+*5*J_)2$F*<=R,=`\NYE\%%W]\USC/7CLSW4K5ERBR& MN)#HC*+WD5XCVK-S`[,C;;2LFB-)BPU.H7*5154,(;/^'<)NDGV)Y_UW^'VX M,X@NT''*F_0=5G+"1YOGY+7!Z3"=KQL#'PX1[Y$NU:Q1\5XAS5:PP[2MX'IX M(P:6$U*L2[%`"2(D25')E%)=7LX04O,\"&^0]P)UB1\$N*QQ_R543*KK[U4R M2NQ@,FDETB"T(P@=86R=26'AR8O+1JJZZC0NOD?FC!+VDUZCVMK9P7NC[5@+ MS>QVLUT^+(,3L,P>3.P!0;-!$;SG,&K;'*B]W#!^&3IA"5-A%B`G)$![T-;- MLTI28FVN;&A"T%E05R`E98=0FC?*IP^ER[31E!AT)@=AG*[= M8/ZVS,*DMU7G&BE\0DEL![=A,_9U4(=OF+_8-9#.+^KXGD/)9(Q#LWF[8@/TTMA@*VPULS\OI M_!.%-74MBD`K8K3HM1]G^J\.M#`ZC2\*2SLLUP3FKQ1#@P/2P`/!7Q^`Y&%+ MF3C)WPN5;3VAM1JQ@)L:Y7`7F/4O8)'F$<,P]^U4,0U?67D>:JMQ31P,T"K_L@/+?>-8_)TGX$'AZCV3!-I MUF%H(%-F*_N^Q6[P:<\W]MC7A0OBN6FG\]49,5F&8,K+(\K)I^7$L"_3?NI< MA(24IL1%JMRUL#*#%A?)T$Z.B7NVN*'H3),QN8\:_[+K&?,]6OWD"[)8>VGD M+XT>P66TS?B\DI=>.R7P[:$#7PAWKA76<83<@VO<1",(AAU#D%((VG2!S MM+[3LY=FKW;1,CU'GGG23XH96E35,0KN%N`SC[@V+!^<_C<`N0)&_??LIIIW MK'<2FO<+]QCW"Q-.$Y;X:_<9%7V"94]S&X:!C9RKWO>AG]$?^PH&;"!T/%XZ M"!-.Q'^GWR'V*(70RAQD3;G`'K8FABG%10/M*1AIT MBU38U[7%]=<>C8H%@6U_:6`:4[^+FM_#ZJV>'@[[;Y-V^#BFIW<2Y/<%W?<) M$[@3^)OX*Q6OEXM4EA^;.HHEBEV'^QP8I083N/<^]S+W#/!:1IO=6`C^P@>A_=.AL]UVP@3^$]\8X94@P@.CY-V]\-V]QZFIW<2 MZO-/1B)-@43UJ8&Q.&AKMOW M(I2>&8T&CUV<^V>-<@BF!K6W]WKWA?<1&KEFGG-J=&MP'F.T>&@:8C M:_?@!7`&$]I2,%TQ6#`(B0:)]Q*`TW?5"!/Z7H)=@4N""`Y^V#[I+?<']U1V MUO<&+>E:I!)=^)<3.1.5^"3W#Q5G;WIT=AMPA:FBAA]K]S`%GYFTUJX;$SFC MDG>G&ZRAI:6,'Z.,=+%J&U=H:B)!'WO9@JMWIP@34_L[>C68?:(UW:G,:>Y1?P+RGHMR\'I>?EIV3 MF`C["I^K9KH;S<3?L:4?#OMO^V';._<'^(FFHW<2]]S+$U@3N)GX+Q6RE8O[ M+*T?DV>P^TA:&E-+3'!^=I>1A!X36)&";I9^&V-^9GEPH6JP[N/K]SWQ'Y2: M]Q7W9/<)&JQMJ&IKB09_TWS>:_+H9$WAF@56" M488(#GF=^3&;^X"8]X&1!O>=E/QUC0=]F?A6E?=>F0C[;HSX1?_#`GW#0N,#`[XB!3Y*Q4"#`#%Z4&."@T*96YD``#(*K(``0"``$`!``'`$(!!_B(#O?R#OB(^$&[]RZR`?7HH586AI86!IK+6VKJVWM*UI81X. M^*;WF:/W4IS@H\NC`=6KVL[1N_.K`_B.^'`5]PDJZ_L,^PHJ*_L*^PKL*_<+ M]POLZ_<+'FR*%24X."4E.=WQ\M[?\?'=."0>4"$5E@=QDH.1;ZYKM!B$E`6T MFYF;JAJP:J)7'H5[BG(;4X$&IHB.AVX:BOL=!7>+B8>''H6$A8E^B0B`!XR@ MFHN5&Y>=BXJC'Y8'UG0??(@6,F9*+DQN2EHN*FA\M]SP5;71\ M8!Z'WP:/E(^,DQNHGWEQ'PZ!E?@>D/?)L[20!AZ@)?\,":(*S@L*#0IE;F1S M=')E86T-96YD;V)J#3@S(#`@;V)J/#PO3&5N9W1H(#(R."]&:6QT97(O1FQA M=&5$96-O9&4^/G-TH#9+V$X)\ M$@KD,"A`;__7F+@1PVB^-;%;IVB%4*P"LFE.)\4RMW>4">6LNQBS$F6=]?8J MIPAQ'N_OB2&6O<78KP`#`$@P:XX*#0IE;F1S=')E86T-96YD;V)J#3@T(#`@ M;V)J/#PO1&EF9F5R96YC97-;,30V+W1R861E;6%R:R`Q.#7!E+UA- M3"],96YG=&@@,S0P-2]4>7!E+TUE=&%D871A/CYS=')E86T-"CP_>'!A8VME M="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY48WIK8SED(C\^ M"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L] M(C,N,2TW,#$B/@H@("`\"UN&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@ M("`@("`@/'AA<#I#&%P.D-R96%T;W)4;V]L M/C-",B!4;W1A;"!0=6)L:7-H:6YG(%-Y&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT"UD969A=6QT(CYU;G1I=&QE9#PO&%P34TZ26YS=&%N8V5) M1#YU=6ED.C`R8SDT8V$S+35E,#,M-#(X-RUA-F(U+34Y965A.#`V-S,Y,CPO M>&%P34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@ M(#POF4@,3$Y/CX-"G-T87)T>')E9@T*,3$V#0HE &)45/1@T* ` end EX-10.1 7 c14902exv10w1wpdf.pdf PDF FOR FORM OF CHANGE IN CONTROL SEVERANCE AGREEMENT begin 644 c14902exv10w1wpdf.pdf M)5!$1BTQ+C(-)>+CS],-"C4R(#`@;V)J(#P\+TQI;F5A-IB8&!@!J+;#*P,##PI#/P,",#/P`(496'@ MV``36>@PE-TD_8&"X"!=L?%I'`XB"D\S& MQD"2-3042#(*"J+),C"X8%4/9N/T$1*0A&(&!E,&7N8/HH?R9!&KVL3GR'[ZU>3UD2SKX!J-F9@ZOX/I!F!^#1`@`$` M7=E@,`T*96YD%LP(#`@-C$R M(#%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--34@,"!O8FH\/"]#;VQO'1'4W1A=&4\/"]'4S(@-C(@,"!2 M+T=3,R`V,R`P(%(^/CX^#65N9&]B:@TU-B`P(&]B:CP\+U-U8G1Y<&4O5'EP M93$O1F]N=$1E7!E+T9O;G0^/@UE;F1O8FH--3<@,"!O8FH\/"]3=6)T>7!E M+U1Y<&4Q+T9O;G1$97-C"]U+W8O>B]G+U@O:R]"+W$O<75O=&5R:6=H="]0 M+V-O;&]N+W1H'EZ>WQ]?G^` M@8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRM MKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P(,`*WV?X$* M#0IE;F1S=')E86T-96YD;V)J#38Q(#`@;V)J/#PO3&5N9W1H(#4R-R]&=6YC M=&EO;E1Y<&4@,"]&:6QT97(O1FQA=&5$96-O9&4O16YC;V1E6S`@,C4U72]" M:71S4&5R4V%M<&QE(#$V+T1O;6%I;ELP(#%=+U-I>F5;,C4V72]286YG95LM M,2`Q72]$96-O9&5;+3$@,5T^/G-T'B`B(B(D)B8F*"HJ*BPN+BXP,C(R-#8V- MC@Z.CH\/CX^0$)"0D1&1D9(2DI*3$Y.3E!24E)45E966%I:6EQ>7EY@8F)B9 M&9F9FAJ:FIL;FYN<')RGIZ?'Y^?H""@H*$AH:&B(J*BHR.CHZ0D MI*2E):6EIB:FIJH**BHJ2FIJ:HJJJJK*ZNKK"RLK*TMK:VN+JZNKR^O MK[`PL+"Q,;&QLC*RLK,SL[.T-+2TM36UM;8VMK:W-[>WN#BXN+DYN;FZ.KJZ MNSN[N[P\O+R]/;V]OCZ^OK\_O[_`0,#`P4'!P<)"PL+#0\/#Q$3$Q,5%Q<7& M1L;&QT?'Q\A(R,C)29FYN;G9^?G MZ&CHZ.EIZ>GJ:NKJZVOKZ^QL[.SM;>WM[F[N[N]O[^_P?GY^GKZ^OM[^_O\?/S\_7W]_?Y^ M_O[_?___`@P`YZP_$`H-"F5N9'-T'1'4W1A=&4O4T$@9F%L2](5"]$969A=6QT M+T]0(&9A;'-E+U5#4B`V,2`P(%(O5'EP92]%>'1'4W1A=&4O4T$@9F%LK43\&*(/ M>32^X#&/\TW$&66,Z9C!<_I61E"MK(D-1!2'CWP?C:?!QF6`JE#6$8OS$G^. MT2W)OF^KAZI+1I);*@C4\.0^_QAET&:VDMB1&T6-5;$VFAHE8Z$45="4IIR) M-&Y]M,'CSBU(E5Q M?@[=\LOY*AD)T$=`M=24OU4;X$W.<)?3E*R+SJ]A804T*L)0I$BS249*:#4,+M<[QXYZ&(Z7]99,0&WE M-,C0ZZVD`D*O9XBN1(N531VJM6_#$!`$[[62#,\K!!"K*G88@%:D:X8D/9RT M`IX*C!FZ$UA5PS'!&L'@KMC!_5SUL'T0_F=(V(+PVV;WVK5'>8/>-`%`<(76 M>=<()NVJ^M`<0G(?_Q)@`!9`,?L-"F5N9'-T'CH7U8;Q860Z_K\2Z'U8'!I=Y\M<+N%1M=-WPAODWC&3+ M=^P#JAUOV17/2K&+<>8,]TS-%9LA1.\<3+QZ[5]6?S%VJJD)X\">>;5IA,#D M?H1JHU3#GKT))PQES;C<6?($OQ#YP.SCCA2.WOO4O`3 M'3OL":H607[9F*@Y@7^8<41.-#/[!J%/[`%V='@ M2A7\>5=+;!%H<0.$9*PKW>A'L!\+Q"Q#*2Z_H-M4&&L4-NLJ63"V2-_1E"[> MG4N/[8--GK(D@L3`YG8DQD:@/D(6Z^5BM="($"`N4Z*3PA(DF.Z*!D`A@9Q@ M-B$M`2BKQ3[1MK:C\IVW+?T3Q].US]G>\ M%.SMFU3(L91LOV;M_67.9B.^-^%UIS"T.%3JO_]65HW%T008_71">%[U[X_[ M@F,K7MG_?U_4EHUE'VAQD!Z$BW5`3[6XSTMUS,QS\'.P)E$!O64QP1R+Y26R M\$M>`$F&/$*)<-[F`\BGF@9.@BC9H58!K'OS8]>9:U$6+0L'1*HM)!OMN+=QHM8&:2Z45:%9.ED*,8,]A?%L_.6"T=%2 M42^20,EZT$5*-!(S3>[H;<]_[=[N=M\@M@>2!0_9"M#[[=(IS`FI;H#:NRE% MTRUR9=OBDZ-(UW`E,Y*:/AY,EV.-SR1;:HGH'+*/9A@^^4:)&FP)<([[K(N. M:M:YV,WCE(SOB(82BIGHIK6C88<81HJV1?5UXCE`R=X-+GT2,[+V-M@L%.'V MR?BCS6(%W;%L&[G<,J*6C<"GP1.=3CU7/!-U3:X ML!U142T9O%XI4JV`EY=%P MLEEP'[T^V6@S6HLVYU-82A4I5-F2;E&(EBU.D"KZ#EL7550@J,ERI4`[;TO% M;"2[%V`LQ3':O'NP1&Q!]@9#"LB7+^_DYN$A1%R-PLJUS)S/`Q[&?B#4JL6H M3!;+7;,=5\"TD7KIQ;R^OEY+EI.(ZSYO0>:2MT!6ZR8I1;H6(Q7!WMQ6M(3O M:ZTDO__^B"ZL8[;L\2KKWSM_(%85X/>+`3/'O=)#R;WRZX#OP43R7-$;/IDI MAPP+F0TKZ_P3H%=D$KVC^_\"#``B@"35#0IE;F1S=')E86T-96YD;V)J#38W M(#`@;V)J/#PO3&5N9W1H(#4Y,B]&:6QT97(O1FQA=&5$96-O9&4^/G-TB`VL9E*H$'825ZC M3]Q=L.),;@O++M]^_!@>-ZS:CAH=[*OH>NC'S%(@5')_/7^2.N6FB13F[!)AV<_G:,UD[6)TAR1:80;2D2Q,QS#'-T M)EF*V1:$#==2#?>FCGT>QMGD'3EAA_J/\,CYOA"UBPG&<;%WO`M!2B6"(E M6$5^1A=@.LDUJ'[O27.MH(QQCI9JWG=HZ9;!%N/%V!WH4@R''K"?:#J0-9N8 M'-XCE(2.SB<+2F"EP,AT,@EC#J;X@"4 MBE_<.&+<0O&3+9&"^][,TXA+A8:>_<'F!NA[<1J;-1_M$JJ%C;,?[9+3$A\? M`S#&QLEYDUSPL-'V,%!XSEYL;V:L?*UH<43E`UJZ0-`@6@R$_ZM!34N60@XG M=IK'\+8^70^J7UPZ%4;;CSWOPS0;_U;84R3L]^>X%#XT>0[C&/">%LH+71+- M+)@UY/YD_-$6'#IXAQ6_^^!3#&.&$^$.L6#?DQM;![3JD*DC*:R5)U,C61>[ M@G7]8%E7Q/-2-C==W5570=V[*BD*'7D7U;ZKD@+_F5G*F8;`+\!N@ES< M(=\A-&KUY:1>OY/`X3_QNQLV=S]^R>JX;$0'O60EI::LK8!4WNJ*T49)):IH M-]5_`08`":D;;@T*96YD9XE.+7T61%=P?'7V:3//GV0W=XA8Z*RRJQSU]:FSAHFI8_5KW M!*0S0/348O#DQGKT2^0L+V_6ASGV3TE-L(OSD3SG[33[8SQHOG/]A`/SE]0( M?A6;T)?,=]/P7(^O1&+/[9$F&\"Y99`"A+0DA8@BA+MYCG&^_9%*B8RN67V7 M$O>)2:3LF#8 M4BZ`B:R0`@HVNZ2]7("_^TX04#*P`C%*??;]2XK*65X]W'W>4EN8Y`]_\).Z M&A@49295SA"B$.K,#__''R$D`PV(<5Z[*D4W%'?S@-Q@PJI$06[>K(RR2[QM ME`HKB%Z1[GC[V)&``A#B5ST"6)*QZWM*YBA_,PV8:EP@07/#;I86K8JN"5JK M?>V#2X2V>#SLWS+U;CJEV('FH5@A8E@Z9'ZG*6GW?3>N9Z=SWHVQV'+7ICB3 MXJUK?*C%K#_.TWHXTM%@'_>N<S&`\7HH83Y9(Y6/M;C6L^TQMA!P>553!C"*,-!8'U\0GBUY*YNZ)$` M[<&R[A;W?0VB$IG^-UQ\.1@LN0]N`M#DX>E+PO+!J]CRA5<`]BPAH&NHZ^JG M`?\]FKKO7],G]E.``0`C+3.8#0IE;F1S=')E86T-96YD;V)J#38Y(#`@;V)J M/#PO3&5N9W1H(#4T."]&:6QT97(O1FQA=&5$96-O9&4^/G-TA=< ML>!3:,U;U@V#BR[X;L*-*?%XM=U<*,$K]AU73+2$I"5` MO[HY7G.%FAU<(37R?A>27%L(EI/@("FS:UA8`>"8.T!R+K.+($UXU(8/T?64 MIBLPA4=Q5#4&LA1UFIK,7H4B;BE^[3\V^V_0X^4P6WNR'FFJ-:RCLZD0-MEN M29-!L&'L`LTH]N6E^P2SM-`C@#-U-W% M+923*'[:/IR25T%=.Q:R!8?1]M$522UZJUM$TH!4([F\"TZ0#>LR\8:]'CM_ M2&1('I<(U`A_#3[.84JMIZ60II%Y*4+?G^>%(U(0\/M8[*01!(F8)TAI]`HI MC02K&R3<1"W!I"0VG&?G#V2O8U5"0)MHYQ/9"F4"E='M;20(+:'3?2!8+"7% M_UX)I"99W31EWB7K0.71==&MJZ[B')XY]\V=D%VAFC:%XC M+9@`:56115_@A&K'Y;;6XQQ.9-=\W852TZ?(>Z>?$9Y>$P35D*CA?%YBR2Y' MUQ]O&_T4?AM#KI+C#72_CX$RS&.:I=9`^Q'B!=]QB9T?TDA*(]:_1GUO_PHP M`/\_&ID-"F5N9'-T7!E+U1Y M<&4Q+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O8FH--S$@,"!O8FH\/"]3=&5M M5B`W-B]&;VYT3F%M92]02DM'3T\K5&EM97,M271A;&EC+T9O;G1&:6QE,R`W M-B`P(%(O1FQA9W,@.3@O1&5S8V5N="`M,C`U+T9O;G1"0F]X6RTQ-CD@+3(Q M-R`Q,#$P(#@X,UTO07-C96YT(#8Y.2]#87!(96EG:'0@-C4S+UA(96EG:'0@ M-#0Q+U1Y<&4O1F]N=$1E7!H96XO5"]C+V"]Q=6]T961B;&QE9G0O<75O=&5D8FQR M:6=H="]W+V9O=7(O>F5R;R]N:6YE*3X^#65N9&]B:@TW,B`P(&]B:CP\+TQE M;F=T:"`V.#DO1FEL=&5R+T9L871E1&5C;V1E/CYS=')E86T-"DB)C%1-3]M` M$+W[5_BXKLBRGU[[""%4J:JV`M\0!Q?682O'1K9#X6_T%_?-.DF+2B640V9V M=]Z\>3/CZD-RPYI^\)L^=)MLH67!)7L<^J>0.5ZR,?3=2,<[.ABG6._0QM2Y;C&(&G? MT86(Z'2H+`!6S_YN-X5,"I!YRJ1"`I\)]BLS!!>I:5Q=^2D,ATPF9Q<`YMEM M]2E95&Y<*;J50*AU\TM!;16_/JP0YA1!Y M*O`[V#-$4:32P$!0M86`9U>9S4&\6B\_KZA4@7K6ZW_R"\4=TJ-(9?(4,-P< M\]OWY8\0P@)$:$L4EXD[#JK?B2.2)E(<&^6 MF(!<._`UO"RM)GILM:S67[]0P%LE2:5X"0%>QR@N)*>0O_23%B^%Q$.)AS)U M2&;E?_4[O=2I3*OF[:P12[QF>L,NPEA_#VV87K*%/%.G MEVI&AF)"%H"%)#?LLF_;/L/-G8,5"-Y\[=*^; MAKXEEWI5=_=DTO[<[X8]$/4F[H5"U?/VD&VIT0U9"EV;5P]9_RS>R;Z%Z$\) MIFBA+',Y\SV@RX+&`0-"25[(IQ(>_1!Z,)'HJ:8!F@XO(P]96A2Q>LYH.MB\ MI9:FBNY0H&%-'=J18@J*Z2E$XABX^.!L9S??@P'7OF/9I:./4K-KV\44MJ2& MD%&F*?AQYD3:3P\$J:,B1W3:D;J+Y4$$5D=J<=;GBC4;_+AKJIK\% M&`![C4*M#0IE;F1S=')E86T-96YD;V)J#3D>\ID+L,X\P.&+QTN.BM!T<%5DC8PM7)%^4CK-4[<7OER7Y:)4RO\/]#NS&_D7!E(#`O1FEL=&5R+T9L871E1&5C;V1E M+T5N8V]D95LP(#(U-%TO0FETF5;,C4U72]286YG95LP(#$@,"`Q(#`@,2`P(#%=+T1E8V]D95LP(#$@,"`Q M(#`@,2`P(#%=/CYS=')E86T-"DB)',,#D!`(``#`RZ[/QG^V[?ILV[:-R;9M MV[9MV[9=.^W,!@3\%C& M,*:QC&T]K&O_>SO``ZRYQK_O<[P$/>LC#'O&HQSSN"4]ZRM.>\:SG/.\%+WK)RU[QJM>\[@UO M>LO;WO&N][SO`Q_ZR,<^\:G/?.X+7_K*U[[QK>]\[P<_^LG/?O&KW_SN#W_Z MR]]_!!@`O<)_`@H-"F5N9'-T7!E+U1Y<&4Q0R],96YG=&@@-C@W-"]&:6QT97(O1FQA=&5$96-O9&4^/G-T MU?=7.2*:$VD2AZKD*Y.B--ID MC5:9HHJ>(Y\VZ.1!*IU*J[=TWU\C5^OD2GF*5AFM2E1JX^6:&+F_ M.DF3DI:LDBM\Y-5JZVX'1;(W7J:+52JU;IYOR1"89;'D;BF(B'6=M@ M4\9@3GQLO@#SP+$E&+;4`5-C6"J&^5NDP`B,Q$KQU?AN_!K^EN?.6\U+XA7R M[A`B(I2X1+SEA_,O\G\DMY#W!)1`(^@7JH771;-$#6.D8RJL"*M%5AE6WXQ= M.+9B[`_C-H[[UMK+NL3Z7^)EXELV2IM:FRZ;U^,SQC^9L&#">8E0$D+-H`Y3 M9MLPVR%Z!MUEYVZ793%[15UJOV%U`"B%G9:D!?S M>O4UB"="*^?0G[9%G+S,'-E[8_@`VXR&:6JX,_IB_')FFOOVN#Q6S"6;&J"\ MZQ]HCW7WP98ZZER6V9$3TH@W%=E.]FGP'0+K`9@%Q*NEI9ME M%?%T6\/F#9]X(YFKG^GJX?8K$#PL4\+W=+0@,3Y2M5"Z+JVRPBBC_I-5:4RO MV"1%5K/01S.FWXT]#W0_.+^66?;7%)855+)Y5>4%K=(K]5451V7%16CD+8_L M$%APZ^$Y'9U2_;=']V%V3W6&T=@IVVLHR=K&(+X'LO)@Q3K.&PH0!IAD`&31 MK50`5?.&\Z;'80UE#WON,(\"*U*T<=LCHEIVU)7NV;6KA-VUNV17L;2T-#_; M8/S+2J5,K#,O2L4[GA#085Y$(V=G9S0+>3&(;5SVY3+V='"/]]<)Y0?LT1+` M3:`98:#TY?W>:^QO,-CXA#B-O&EP?O'"(HL7`VS^>#SXA@'^W)LN\YTV(L=$MB:?O'*DH6]0 M"E;'G$.](N:ZSI$A'Q1(9G*,4)S>P@U>E\"=`=5=ZA8XP2/Z5O&Q_!:#J"NN M7*%EO"(]Y[`!JJN;I,:47,VZI_FU,!?&/8,I8/])L_*0C/I'S]GC9Z\P9Y)_ M0/2*>0EH8A1;54#65[7?'Y3VMJP-=?;:Z))D(0M&ORXN,%52W@:Y]RD#EP!& M>AH7&"Y`-T8#23]H$E+GD4>_D#*`QX@0K>BB4:X`LF&(++:(?HK[:@`'[C8! M*[D'-(0*]G]F^JQ$=OIY=BFY/2L[:XL4J00(1SO(W,*2O+U2P`K`.PRY,DBL M"%[%KDG^QD\:94K:L?D+W0#,`]X;<'B>=2+BDBS@KM-!CTJ1.+V>XU^`W`-X MTQ#L_I[@@LQ>-,K/04O0*A3.H)B1V6`%/BTP_QXPB_LF!^LSXT+8:A#_!%+P MJ1>A2-1*OVF8\3$B-ZWS]UK1"Y[7RVK+RF2UQUKV-4G%%7INJ!<_S"D(;HUY M%CTJ$!C#(SX^F$->:CQTHEL*B0*T872([!9`K'D*:;G&+*Z77.WS[@7-K9`^ M:@ABH9NFGH/0K3U1P7B'*?W=-W7WL]308$?KR3H6N2!W>G&/&XQG+4/NC<"_ M=$/_-6)>RJC^*R<>M+]@^E;W('+!]#73W=O4CQ46X#S?R`17ANI_P$VC.TY> M_K:_>4W(_.`8E9;=?'3>5_<9<;4>@"F0Q#$,N#A M""2R078>"$,.;A>0")B_7CYTZAQ;7)2G#;%\^OPH![@&9CJM,#-C![M-KTR+ MDT[>"F/Z'AX=>@P.)K0NP.(RBPUA%Q"2[X"@(F`2_/PA,U(U"/$_:-+WJ0"O M?EN0V4HE__M=-IQH+!_HOLT\#BC79VTL#(EIR#CY/]D0^WLV4"ZGN;@/!@"' MFZIA_1EN02I>9?8ES&NKZ?"2]/WQ]U`QUVV?*D#1HYF&\(2E*5J'-,.V(N-. MD0$V5`OU8:;V_265>RID%V`,"56",X[DWO2*.",3$[!N6G#-42($<@?\0=A%3S0?-$^F%!9::"&0T0+L_QC8T[]X=+@>DA5;!L_O?W8$"`:\Y1<5BQW$M(.)*%]=:6\2ER[@,%,I6".&QAD4"20B;+";` M8TE0V4'`6`1%4<:!L2JCXL*X]K2GUK%-I?U>>N-T[A-/.^=TSOOOG7M_O^]^ MW^_[W>_NQ)\KOF[29K2P\OA3R;WA?C2F\0N9Z]Y.+&AG!-,4L]%4S92:\FJ4 M\F,C3S@\3?QTT>PK>C&@5)OP7:>$Q"=U3!*"%9D0+U-3X5GA!FW\^N9%2KR* M3$(O8!4VPNIYL!0VWH/IQCPVL4H6&;$V$+^HQ#/PM/M$L;-LPT<[V*[N<]5] M2GCQG_XO62?RRK4+=\6S/K$+%$CD$16NT$[!X$W8#AZ@PHM!@O>SN(Z25W+H M>G99QK,$O*9)7IG#R"-@JS"LJ#;P/3!C(.8O)YA+FRS+?&ALPWK#AEV:XA;& M!8H)10=T=T%)!V%Y;(?*NN:?)KFE3Y(G"%]!@"*:FO/ACD@\78E?-N1UL9"' M8+[NMMZ<6N[O40 MQJ$AK25[N1C;"E7F!A);`B>T(Q?8191S_A?R`W7=$^2/A3CB>00?K0GR9E50XI?C./`O,3RJ_1$(U@MNZ:WI)1YN-! M:C??5RP;$#?E#@`XG416VUWI?&KZ+0UU5OX#][@@S6 M01%X#3UDY.,P\]3;YRCQ1]@5^Y-"NS5LZ7^; M73$"TLC'2KD`D\'CG(F%]]%(O=%6P$PT2J\-VGG)#W88L$MY5VCDJ8#"#/X" M#7M@``>C53GQ/F+\C3R:^"]L02/E!T>+&!XW,<47@+(+JURA3Z>6FV,*[TA@MVR%E_))YOZ.'3[?SKF57)?-J5V"#^1 M38%V*30*?8JKIK(;A61I)X?&M.6I@;1S+PI.28UC_FJ]\X8R*BF22RU*KDAD M-676M&[E(?AC/FQC)S1U5/A6K*@\!GJ(A^-6CIJHD+S]%PW$<$(K.@%K9+$4 M=MNZ(0=[*WT3\SI9(1+=M!9?%!-VY/DQ)#:ARBYU/!&Q=E'X$Z<1)PM&&=[) M45=S:K(":*1@1&YS&9B8)BX8+,Z`RB_-)2 M`I[K8T.!JN2ZF)*;EJ*APHGR9*H=+Q%G(7R+;?+CCF"14,,181S.PHC&]W7( M*1?B97@E1W56:'=TL%IJH((;`ZX01@D81_BNZ0L<<85Q5_".^!(O>3I>!J M`9J&^=BO9A&#CU#R,0Y=WF_.?*Y0]3(Q6PT\\B_(X#^C80<:,$(F/B^#I93\ MD7.7<$]QI*2XOPO<J/E=O!M8=C5%0#_DA62U645M8P M#;UAHTKPO/CU719VX_O5X$W__61CW_CP0K]*QDH]4[#P[VY)=0V$V2&LYO>^ MPG9>X9.OX2_2PH'3""8?3L23:U@+E0TK9,[S5#9>(;,0?ZX]Q,-DY6EG+K4Z M5[5`E-EQ)%;=)CAXR1,[/+5)'>),@U,XZG*.)6DFC>O0LHSPM'CFO:BM'PN-7#W![2?QGZ82XOF"_S$L^1<.:?7T,%.#$'0+ MPB_!9M/1"E/O@:G/&E.T@5+'>JECHQA,)@E&WZ:/H+FD!%44@V68V3TH>_-A M8G,UW6#).Y5'F,YPZ)RV1F?'WN227.*.%^*@Y=[I:>_F>'"0RJ-]QI#\)IIO M/%I3S\`TF/L0SY15J%J#$NF(&,..7%*[/AX%%R:8]IW![\(A=]*FZR_?K\_O M+_`0!=(AW.Z0E`AWI<((!"K6Q'/KL9L2EU)"H/"]S.RL0PEXI:R>^NQ@^07P M5,(GE'.=\WM9BG`>6#$&I=BG8:.LM9 MQQ)D,C0<9WY>!P&CTA;LIHB%4,<@#HV]AWH->S7LTR4HU1#Y`>-R/^,L:-6P MW#*C_<'KMV'N&+FO.N%%162N)B*%T69&I,4K0Z(:>\@0U%(V`//Z&#("?:#( M3$_+4"NC#$>.L!",_F;X!K_,R!_AJ>\%[DTNCVZLYVMKV!*MV4PW=E0U-_2D MKV4V(_DX]MFP),R+?O-4R.DS_9W-[^_OVV?O??9W9G[:#0%Z=V/XKIP26@='^1H#CW@IE$7G"Y4^ M4:VOH$[K)2(&9_L5QVOW:KOGS7T(5PDBTY(3-E._WS*)I>+2)YV]P^8\ MD86I$%>(&[*.&19T&.J;6LA&9:>HF:X_&L>F4%B)^WANVL"?MCV8^M,`Y(]@ MVD/Z>NZ7SE?$'=,PUTV<@']](4@I3LS>3X5LO@27P86WSE\:/)^QM9(A,N%R MY!`$:_2V/I*[`3Q<+WJX1LURM;SFBE:!]G21-8%";ZY``,U'"7!1KFN\M]>! M!6DHWZ3E$9G#36?KSS7XX+1NP\PN"'J\VFY[L0<%Z]$7>YBU M&0_13?X&65&(EE;`.A;\QE!V[!H);T)?X(LR_PB73.Z7P.5M,-UE=OHYQS*_ M67<51MYS.(GQ`&(@X-EJ04=CO45C"\1/ M.=7)$.,)(UR0X*:KI6>Z'I&'Q9K/MZ[/>GR?)AX&P#MG!:X-0)YGL$BP80![ M4&Q)I38N%Z*W=W7'7LEBB+O-@>OT2AEY^%B!0TD3$P&1*3$',,9$_(L9^,DE MR'/FCP>8:6+J6R2HX(G*A<86TG:JSV:@*WHTM=2E'USPC0M%3:H6QAI\:']HA%D2;I>9[)"P!Y_I<;#LU:D\,9E`TV"#51&NP12KP78>!Y]2, MYL(/7OA]_>)C-_%/K.I5+'^+2=.`=2`$I<8(::0T0K9``0QU=08K5=]4%L8@ M!5@O*]FAI0G_Z]R_\4M,:LWHZ;#;VYWB%E&J(@-OYW4HLYN;J!V9#?UD-C3T MBA.LU>^.HE-45Q,HJ421DWQ6.@@%?<_A6PP7"S3&B-R(O`CY`CDPL*^Q"'\9 MO/A_(3#W-2S<;,6']M!-W*N1[DJY'',2PG85ZP++J1G#_(G#Y-G;J*W M>1XL9/F[C#++99+[;M;]N<<]?-:]]F?W++`W3QF&-3*W%OO/KU,/^4V[X7;/ M-WP#-?J*`M2R],-YTEX`IC/CMP>:D@,H9$(;,O1QGE&)(<% M!\H/&2=):`;=]FX\>5^5AT4R*`7\0:Z+*L$6AUF09>#%5Y9WV+'`!^/Y/RY: M%[HS6T+W%Q[JWT;M.Y`1%\9,`#4F.Q4KBU'$*'UDP&"I?E6'[;,].K].->KW MP`V#W,29!S.",(4RQ@.>RH((8W[]<1)V@]Z3G;8.ZDIC2BB#DL#&+$VRQR(1 M-Z.I@!TD81Z`N+A9.%/-:SB5DPMT>K7/0.N,-]1Q M"0)$KD5>:`ZB9CZ"`KAB##)_AXM7/D+SF8:7H0+T3@[8.#,!W]X*-#P,WQ$8?EC`Z`^\N*,$T_R:4"F5"A:>$5=7Z*NJ$47:0 M(:;<6L')BDO.'@KZFM''.6C3:FGZWIB!%@]V`]Q]C7O?69KKUSH-Y6ZL;%]R MZP7VQ)RZ2`J]OPS]`M%H^430XVMC_1T-C!F%\J/R02:WE;4+?",HR]/((J8\Z3Z934(&)3Y\P..:[(W>GGI8''?8\M5CXCVN7:O"A=`S8)(0YKI-DG403'H.GVAE2:NM5:GGJ!:K4UM MQW.;TY+2(5\HJ-4JU$7R0[9XJE?)X3L^7PT^7HJ0S@NI_.Z M\FS9&>3N&'G:,NFCX0):SB>2T*HZ0#BJ*DS&6JK<.2`]0]V8ZG]T-=49W<$0 M'>B-&[QD>TF[C3S6[!H]?4:RV(XG337$O=/E-8;WB`7OD25XC5CT9C6='*X0 M)R7ZB,7BD@)2:]`:RNAA-,)?VG?DXMG!XP.MM+*&IRS,$V=0D?HKG0QT/0>^ MJLL%5FZ>U>^.&V[!+8W?2=D7!#MUNI8>$GZ/`F5@3&>2'"2),Z@`I*M51<6T M^(@H7T2%%%VW,O`^6I(/.G1=NITD,H,/OL[N:SQG&F#0\0CI8,-) MZXC5Q[=2PNUCO9JX.&\NR[/[&`6_KE$.F!*%5:*5IW^"34&TJKJ,JJ%D<-`^?"\=8KE?7='G7L52F! MPQ*X@?5J_M?OO+E;.+X"M&ILI=ED0*DWX3JOZ!"7HK5H+90%E.UZS^:+?]=[ON[61LF3%TP27(6.["8^+ZR#%B5 M,<[YD<3\_=`5T?ZVZ?4U4F5-[3F@@BQV%GM53T%/ZM'?(M\C).Y]YYD\8^7* M;3V2LWX;U;#/Z5K452;5T-KD9RQ7L2+IQ%RI!4MZYP(=E%S#OJ9G>O<6OY>_ M521^L_VVS(ZM[2SHD*SYK@HTKZQ[;J?\M)D+)DZ1N_6=GQ780+AO_O''[EE" M,W\D"F_XD0\*>$/A MHNR]U[:?_2ZU3P[88="9!:S39_1*\CWJ7OE#:B7C?P:S!H;_#`(-#,P_S+Y+ MBU;VL]I6M^8H2O^68_N^\(WMWN="V32G?Y5^`".$MPA[?]8']3!Z&W$9+3QX$S2HJR:A*2US_KZ=7>M*DMJ:*ZCC/1'GACN^M%22HYZN=^5-KYN^RJ=^+N]F^SYK\IZ:' MO7;FC["IW^-FU03=Q:> M$&82!8(P#IH)3J(HXK-Z=K%2M:>H++4^L(@+BZB\@D3>222&,;P3$F(>((H0 M`@B%%N7E82M:==4NJT7J\>U:M^NI:WM*>VK=AWONQ%^Z[H3V[&G/GIES__C- M;^[WW7N_^PDP?S],(!#,W/[.YOB$A"5)J@*E9MDF;4:^*LMWOHB3";A9_LR3 MU+V!?EQX8!A:API>FEZ*\/"B@""H"8;3(>?"J6]#,3^!X$C'AJ)BO5JU+U>K MB,I:I%@9LSIZJ2^^/A5C?#%FA2(VNRA3J=BAUVB5!1K%IL*L(G5QD3I#J\Q> MKE#$YN1[@_EC(DR!Q6+UV"W!:L$)OV@_ MN]^_A17"5_XZ_XNX!#]*B(EDXI8H5?14O%)\=)IB6O?T6=.SIO\0D!QP/]`: M%!Y4&W1'8@SV#]X4?'?&ZAF=(7A(76!<4H`W1Z!ZB\Y+:0D`M)2"(B\=@(_Z M>@K''Y`7NLHHN#+$XQA@#PU1:^[/1]-0,)J!YC#DYRC@QMM?C(ZV]XPP#DME M.@I'OT/OY$N!YEZC)L_#`L"_MR(LNYA=H,YFTHMVE.7+%M:]."67)%M=D#/$ M+=8)4C@DY#YQ4>\ZC<CJKQ)A^:?_LS%^Q MXKZ#W;DI=%3B6C27(>\5[F\\+2>_A'E<&]7JL!__6/9@>%\\6H$BS$OLUX&F[XC8B7(8"DA[#+%CX#S!!&D0T(;K()I=>K$5HE$9@TX2L'D[U>)P MM([)(&X`!4=NVX\^03?3-`W]KN.C3?V^X?7#^7YH[O HD)ST2SUS*:^1[ MRHI\:+ET94V6N>H7:)Q#-`ZKV"-XU,9T)=HI*TFWGVQVN">`E\^20^MK"^H,4S3TF\LM*35\T4Z72&7+L(W0 MQ^S-#2>8<=#@]>TCE@NRMG[SWE*3UFR0MYG^#.5ZY^Z5%BM::Y;^B-W5>,Q^ M70910^5;#!9#O6$*_ZI^&(9=<&.@3A=Z"?PXC9N!93Y'>''+BARJ#+ M+MDZL$J&]J,=_'+HTS]`>=!V[YL3(Q/R"Y#0-M'KN.R0NE`[*[IBZC87TNP^ MM+Y0RV@+U94I,O1F'LSX#%8_`ROLOO-\/YK5)'>;<=YOK"Z/P"6HX<*%O)K- M+B+=J;:?HKN='0T=#`1S"6W77;8+37QB*RLZ8^HUY])ZD\:H^_E()`KK$/?, MEV1"R"WD^X9Z6.)B72\OEO^[RW(-HC]!O*X!1Y&;WC"C(%EBDO7<,7G3:1^8 M^\9YYZ!=*H$W?Z2E?QDL]/S@R[B&0$^\!MQ,)'$&'&UBB8_KV\M*Z>K*_,HL M9JY7O!^)=;5[:OFYI+I$>;9LYPC=Z.AVMC,@XM;POG7-VX^W$9R8NXC;"41Z M,PW)VK+-1OY^CTN4Z-39AND.9WM#YT\U-]LN-TDE#JNKJM2C<(7J/!7DL"?/ M1V07#UW76I5-E]4>Y"41Z0WD2:%,K@9'T2QQWMS)MN6@`&_T[!P45EF55".> M8E1HR[2/T$=L[L8>AM_67_.,>&\]Z/T][B9@/F<=@"!GRZ!&X-!6N1_P,4B.+1053(KW(BT$E?@!92H!9V,]Z3R$1!V'-X`*G? M#L6M0)(EZ"G:B\*L$-'%3.GZPV$8F-KE^G_Z1`61_"I_:/J`=R1#558M[TC3 MO>O^IVJ+2Y32^G)R$)6C-X;T,.DS` MQG>I9D>#JT\&?GT9L2@&2:WKRRML=MV4+[\2K*K$7F'S*C%HG<+7O2`?-'2P?7`Z6V1#1>^7V(QKFH[>L^_B4O%4:NRW9=$5U[D\>H]]284GQ>8S9 M)=K9:+"=IH]8'?M#V]PN]_A3"/E;NYO\G'S,Y7*YU`COE5I"_U^:RSRJJ3N+ MXR*^$-MC='B-1][3]VKK4NO"<9F*'=NIG:-3*M)Q915E*XA1((0D$#"!!$(( M6T@$D@"!R":K0H@!`1&JN*%,44"JN&_5,]6.SGWVQ]1YT>F_[_?.N?=[[^_[ MN?*2(E<5RBE=4D)NA!RQ?IO/OVV0`$46DSC-QJCCPDV$P'1ZY:OW#Y^ M7Y]3D*.G)+D8/KD/);#=*\DOM-0V]40-D>#QSW\_&12W>CZBU]R6'^DD+O[?560DF,CC/DF?2T%-).)]7&NV<4?R>C2M\2P,;^975X\<'VM M^_^]/)[5J-Y#)'FA+J6`6A0;R,Y7BMS\5^#12DW`\1:8E5]TT>BT89[X]<=F]Q]?C[[Y M?8VSF4&**?CMWRAGP"TRS@EU!46JT9S3X_:9Q3S@$A M$X@5<+HG`S$+!_J9GVI.%1M:BCQXBJZ@'H97Z5YZ"_RO9I;B-ES*1,!4_IX0 MB3"%5&;H"NL?P9.\8EJ5A^$V7U565MH>3,.IS8JIWDNRJ\YR]!U:?#!OU2\T M[ACH/0J\"3I7@^%2F6]FHHA(UL:WVYM:K@U0N&WR?0/_P0.(@^EUM=*@)4N0 M8'Y<3%DOQ5-8F5E=$%):)G&WWH&&V_@S9@X,\-*>`G7YPGW\FNS!31*2F"U6Q%)H[J<'4;HEC@EY8#G^!#;#J:N#)C2M]5OC% M4)H<#+_1!%@'^%;>S"R8@S_S2_-7!61P>2A6T<+0%2Y'[X#PKBO\^HH?'A4< M]AWI>\`Q]G0(-L+L,DMF"IVH5[_D\R?K.\4F.["EE&5"4^$M]+.WQ-9Q9@>**_PE_EG\E-=NM[)U(E5,92 M>]%JC0:K5*L:M[.+!=OPS6BI7X7W!(V+N_M+8>KPVYK;E=%JD8@0ZX6MC9L528"FHH&OS,?C,^N3&.'%"<,2?E;L*K4)M)N4JOIXL,VE*B*KXD-9N* MTF@CLXC=.MNA>A*F][.+#:^6'H:K&+AP=`T8FL+I,1R%C3?)DL-J):U(TR82 M"EU<@[7,8K'('']#[@%HW6?QE">'A\(JX5X%[&HU5KKK^QJOP]*!F'%\`O^= M$3!+^+X<5;K!D$SC$X8DH2&,7(>X6]&T3?:$%AF]3[3WH("0FN3%Z=3:'3&) MVX@=O=O!!>9=/W>;8L&T3]9+E%36&*D2H[J$Q/][[^>;URQ9EHQRNIN#3Z#% MDT'\@,"0E2EH2OYCJ[;&UDSEY375Z$C]L^_3R^CR]);D$`*_6$J&??%>Z7P97YE:= M@S5FZP_)B139-D4HA>:P;ACA-(*[J<]QA5MKN058-VDN26.K83^T#K7%$W$E MTH9!^_E3+8J">"OW+M&[,_P+A`"A[\U[*!$3J:K](7%Q6WY1OH> MC&0YP1RA\I)%:MBH??I,,1V['N4$$TG:/9W])_K.ME+X!W6,BGU"528WQB2( MI-'1UN2J1G.]Y6T<._/2S,JUC>%#((69?)]`<:R03-$:=47ZFEP#C3^'I=.-]Z/4\%F=_C/V*W1W'$\ M!F]^O9&M7W!D_'XI*<_**Z7Q&.,-J&@BVD0U4=Z?KT;);!M@$N'M-6 M,_K<01I*M''232@[_E/VL`ZPT@LG1[E=]W] MW?T]+51!(?9'YYT9MXUDW\"C\3IFKS/?[X7[):0F-==$XQ%'?P*MG6@7'=GM MY8GH#<%L;AYG3ZL2!%_@PX)$,;&M\'<$GO'$!>/Z&^Y<.:6U!]RQ6N,5OX:!'+L3^C MQ5X.WU>!-\P<%-Q$7%HEYI^LW./WX7H4CC@!!UI^@/<>0A!,HWDHU`1_ M+V<(NU;B_JL13`]83,^$03YZ?R7R13RAL*BZM0WF5EVDKE2?Z>@D+^5LC:/1 MZ`.^-0>SYI3+DPCQPDEN')I&[5=FQ.TB91!J8P5Y:MSLTCV.>N9R.[6-15B>/S\VTL1Q>X. MQA4_!S-FV\##Z#@^S,7K3/H!<*TG\7-'4J+L9%&+]E23T"3R^2N:[AU#*R6: MW"X(45D?8$L]7]\5UM0$V<4+N,DID-A6OZFA5W= MK3,=G9;6UJ&7`=2B3%L<&48Q@ES*Q=J4<`D(DB57DI`L,9=-3$*RY"Y)(!:0 M3&D@%EI+]`EK509J=7J_:!_ZX/3E7[J=VDU?^N;+>3K_^?XY<[[O.T=OE.C$ M>!F;SH)P77MIH@#FK%^Z'?>#!W-PIY!@2WA^ON>PSFX#^R M^;^N(LO3[O,88+Z,'JUUX'Y^&.(\-7^$-.H4/42@!=VA+N_FIGP_S"T^A'0J MFXZ5*>\O&O[CQC+\:SHG";U;X#)3(2SG3_UIT4OUR&RHS16@*OP%..J&SB]&?Q^+W5K!-1,J:4CG&* MMVT-[OT;Z=D#W/B M67G-TSXV040XN+R;S.XE$`#?^CFXL'7!YC!Z*XK<(O?K5)6]I%!MZ:1]S@BL M^`-+WXVF@M,"&S_!WN0IK1:U!_70H:5Y'`0NKS$VX1]O018AE*&&+^4=P8D\!M0<1R`^8E M,!`[[U1$T>A8*(@#=W30.U3?7%-:CVDSO%_D*LL@VG5H0-^'`ZM=Q7--CU-N M=-*N[G;C5G*6+=(C[+-[3DL4*!#)Y:%!='!8KN2J#/B'9C[R>D(!;#:96EFZ M?H%]HK".]JD3Z$3"`OEKV6^R)S.B[YDH'24*F&?F`0W2/N9Y(>5U6GWH5;KM MU4D\<#S%5GZ`]+4W]DNQ]R4:O1(%)^2:J1Y4IE#(<$"W+YA<,!?.,&*8.T?$ MQ:>U,C7VWHKG)%*WET7;WL8(*-!\?02^JS$7R?R`8A`!+[&5'$/KTZMKWZ%+/0G)"/M9#O6FC9+$+%(3&@P8()2Q2,S M\N7!S1T!EJ3AL),/(]3?9^Q;U>-,W1AL&1>P4BLSX()/6AZ_G5`49Q;O9IC^\!ITVE;I,=,C"L%"C1@%3&01(BJB("I@(JB$RXDS M#/2``PIX!)C!X11W41$/:(4,-Z)R9+64I-@$O,"D8J*)&I,RJYLUZN;U^$W* M[3'^L;7U=;T_7M7W>^]W=#=)N+H0)$DJUZZ*6+$FTG>#5I]BG!MJT"4[NS-% M%2E.=A6GCY^"E^#T%WDOWI5/-Y`3(-<=;),N3Y_@JR1<2+*Z[CU#1BZO3=N6 MI?%)FJWQ6QRX:(ZS!KRJBYUU\7Q-2++APQ3-^EQC5HK>J`E/3S+P&08^,2LE M>9Y&$Z+3:=8Y$8R:=2G&%'Z'U'VUC$9KU"1JLOC$Y!1](K]=8TC5K-:F&[)R M,U(T(2LTB>G);QEXC5:Z9\S^T*A-UB;RVA3CO/\A0I#2(=P)8A))>!+$+(+P M)@@?%V*NC'C;A0@@B%`78CE!K'0AUK@0ZUV(]PEBAB0*X4H@PH,WYMK8=\96 MC?UC7/"X:WB_XM53`$%D-P3)ND>8\41\>VI_7V=[?V]*5_RFM*3-:D5%0:/= MHY%L@`4P'1;(8`1X)GQ?1/$.M:EX3UJJ*F[G$,SD(!=];P7EU?X3T=A7C?OP M.`8G_`O/@LF@N0>+8244XO'@YNF-E3-QI81J;;#/,9$0"3XR,;*!\=EW^BHG M7MV)<"4FY9GH4&MKS6%5EW4+SSD8M,:2C-U*U49Q'%)8!5C:)7Y@(@_:E\CL M80*SJ617Z^;?L5&LGV:@,._HT2_-U\9\[,'#%@%IRS:5=[*UM=V-HVK(I@YO M;P[)8#_*W;^F6,W#-\AA@3W,+V!^@LUR14Z_?4P+^2F$B?Z"S.X%`/U`QZSL$TM0$$&Q>_=MR,C\R^?^JEP*IZ% MY^,M.`J4.!#R8?*M+[^_R2D@V"KP-KC0"LVMO*!\!O[@?PHH@3;1[;5VCNFU MG"T)9QTY:(W.LJY(39MX\0XZ`\ERB9#O:J_,V:I5.37G.2A&OU[0XTDUW"GX M.9/*PQ,W9OJ6ND$>.E=7<1E4(SSVK)=V2G!\12F@+:<%2@41M2@[(`PNPOQ4 M@1;M9CC#X$<\==W<7!+!>J*MN_1OX^@B*!N!I6=@#GBIZ>>OV7'_STZ'U=@? MOX]#P16'03E'B_=!U=C:SP&-[C24?W%`+4V5_+G4!S:!_(_$L@C\97:KP,0> MV%8QR(HY:+BG_%RY6L`/>73>TBN1QDFX")+0E=ZR\\[^3SPZ:SY7LLHIQMKM MQ;&%DDT_"2BV*K7B'RSLA"*\$T6FFF.+I/Y#I-!8!3LED""7YHB4P&RH2"H? M51KZ7OM;C)YABG[4_1:T/LA*!\#OYTAET))B:=PO*$]8'8 M5[4RN[J?$W7H1UOI#>=2O_&HQ](M@=`=$DRDWK*^4$UG\.+72"%N^'.#YV?% M1GA+]F*NP(0?S"[_CA4CT;WFLH$*Z7HEPO$.'8X7=7)(]JK^J?O2@-'D[CVX7U7P4 MQ>*!$H3_+0;+<1I/':JU+!_@Z!Y'.@HW%$85JE]EQ3ZMA6R3@O([A,E$#[LW M`YH.O`Q[+RS"NW$P#BZ"W??!NP.6@89K<<4Q>!%^`Z?C5)B-O2!1.K/!"U(A M'2^"-W`,YWQ/NYOA[\Z\`R5%(0*"Z=OT8V@2'S.VRK*_759]U[W5&T^)R\93 M]W-B!+[)[,XKK#%W=;M\6-=G7,D6%/O@\6KZ(::C0?[$ MQ*5C:Q-56U%9=\+6H_VG"E8/P80?@0S^7'N4PV_>E-,W`\[FG+S$#E_^Y"*, M'<0HK$[]*E_BRV;R):'90[PD5'L(B)$TV-`H$_\J,"&5QK*[K-B`KIN?%A_' M"]V:J!)(D#L>4Q:<(&^BCL/"IY4W*MP<#2C`6!+JM-^.%.5.\\E:>XC,'FT/ M9+!64L329$YF37LR]V6I,8WOX*EP7;Y7,)T]QG;66[]TAN\!C\X5'K&Z:Q3=^FK3["U]`O=/T--RJ'A]6&JNK$&ZJ>CH:61@['?<;LRL_*T*K2\MIM M]W]MJJ_D%(/YS:+7)5C10(X"!P'PINRH7<.T%QXSQ[..9S7HVP'YYM[^W385 M++XF_4UHF!KZ!*/E:2FY.SFHP;$(8O%UYN3!(QV]JOM5F%V+_;9MC-I0<*&1 M4\3E7Q4];*0`,T`)$V7B?""9#&-F^CI54.1MT/0<`/=;1T[MT\=8/QBH'K0. MC09T+)N+/2.E;YS[O1DP^=LK9X9[G3"C$-4!"YU('+#@+H-`:&-`W7JRH^T0 MGUVEKM9;XTIU;L^P'Y.5LVW+6M6<[-_N6OY+9_7'M%&&813'Q^+28(]S>-6[ M9,G,8IQ@S(1%<#"68);%P4`J999N(!568.-H9:5`UQ9:N(/""N/'$"C'CZX% M4=D*>]_W>9[W^Y[[ M&-@2,>>H@4?1404"<0?1`71D*V7SYP7?6H"1.=%9'Y3MA'TN[9!L<]@(U-VV M>.4COR7B`Q0#7\!FK"A<(=:3B3_-HD'<1]Y&+P-BW7PUOZA5JT"OI26^EWKK MH^7S3`,@GB9K:E,*3E#*4=-4%8U?;"1GUFM+\JG,Y<]@%'P)Q@SC)1R!=A5/ M$UOFX_RN%/X"/T9=^ZJO=X/CVCSTPX'1V0"U6.*YU$[C]/>WL\G9$9/V&))S M^<9]37?=;9U#_0SN/P!WR.];[@=^X`ZI3SE23Z3;%I=HV2(GB/)[TAB7L$8T M9,)%KT"J.'\/`WD`GT_T9BDU^LQ<&HZA+!9\8^URX/E>!BJC76NC65@G@$]: M')X!"O:!-O_TQ!R?54:C>E!8;2QVX'@MD*%2W.-MX2<8*U^$L>AUR!!KT"60 M!4ZKVTN)45+=KVW=-C6%O@6Y1H?6@O.L@(A#2C&([S8:7]%-_]CHI+_H2XVZ M6'N&#E4,1@K/W<-P0Y4N>3V,N(I.L6"ZZ;29P?A8LS8_5$8&GX0H:@7Y@V<, MI2?Z56(Z."^0.3SG':2@$V#'DKAFJ,O2U;3/5#X?IXC/.\E6,PT1Q/1#E,D" MCWW(H90@JO3UQ76XMDT`!4X;IH!S^X!K8L8_SWU\3B)?P>ER)?(U`OBTV>+V M2>*X;LS#O_W<.2DZ`"W#_H5]QMU]PITYX2R`_;*[M#E"$!V:` M'R?=W301\#6FWU',=%T?$DQS:^W%RK/NT]BU8S](?X=!;T%+ M:RQ58M#F2%8=SOXU7,>4H<.#$7WMK:XK;?=+9Q1K=[];9S"/!%13L45Y1X;& M:6)UX:;F6#\C0_&U#^#?DY+EA,,[XAGR($PJCTA[0YV7K8X\/XL>`0/OC(=A MBB?C2_Y^IOS*+H/9J"M5Y//7KS)P[BF0+K#0;8"'!7F'J-LNADG881*)3;%2 M(&NI$V]F8][L'\Z M!5I`S2P8MKLL/1=@-,J)07O1$4=C7GTD"Y,$8.2+N4&J+_"X=X#VJGH,;:;( MCLK6JCJJJL*N;Y3&!F25O<&$;F3LB(#]E[?US:"Z2\QNA^JN2%3*BZP+1G&[ MZ?[4BWMW]NR&S(O\'EFP,%JTD?\(,`!$V&MT"@T*96YD7!E+U!A9V4^/@UE;F1O8FH-,B`P(&]B:CP\+T-O;&]R4W!A8V4\/"]# M2DM,C$Q+C$H<&QA;G,I+3(P-RXU M*&AA*3@N-RAV:6YG*2TR,#`N-"AT97)M9(I-3`N-RAS*2TQ.30N.2AS:&]R="UT97)M*2TR,3`N,BAA;F0I M+3$Y.2XY*&QO;F2DM,C@T+C2DM,S`P+C(H<')I;W(I+3(W M,BXU*'1O*2TR-S`N-RAT:&4I+3(W-"XV*$-H86YG92DM,C2DM-#@V M+C4H8V]M<&5N2DM,S$W+C$H9'5R M:6YG*2TS,C4N-"AT:&4I+3,R-2XV*'!E2DM-#$X+CDH16%R M;F5D+BE=5$H*+T8R(#$@5&8*,34N,#4Q(#`@5$0*,"!48PI;*$EF*2TT,3$N M,2AT:&4I+30R,2XY*$5X96-U=&DI,32E=5$H*+3(S+C4X,C@@+3$N,3DV,2!41`HM M,"XP,#`Q(%1C"ELH2DM,C4S+C8H M86-C&5C=71I*3$W+C(H=BDP*&4I+30P-2XR*'1H2DM,C4Y+C8H:6YC96YT:2DV+C65T*2TS-#@N M,RAP86ED7"DI+3,T."XV*'5N9&5R*2TS-#&5C=71I*3$P M+C@H=BDQ,BXT*&4I+3(P,BXT*'1H92DM,C`V+C8H;F]R;6%L*2TR,#4N-2AP M;W-T+71E2DV,"XR*"PI+3(P.2XS*&\I M+3`N,2AR*2TR,3`N,BAT97)M:6YA=&4I+3(S-BXU*&%N*3@N-2AY*2TR,#@N M-RAP;&%N+"DM,C$V+C(H<')O9W)A;2PI+3(Q-BXX*&]R*2TR,3`N,BAA2DU-2XU*"PI+3(S-RXU*'1H M92E=5$H*+3$U+C6UE;G1S*5U42@HM,38N-C0Y-R`M,2XX M.3,T(%1$"BA3*51J"C&5C=71I*3$P+CDH M=BDQ,BXU*&4I+3(T,2XY*&UA>2DM,C0U+C$H;W1H97)W:7-E*2TR-#0N-"AB M92DM,C0P+C@H96YT:71L960I751*"BTR+C`P,3$@+3$N,3DV,2!41`HM,"XP M,#`Q(%1C"ELH=6YD97(I+3,Y,RXQ*&%N>2DM,S@Q+C0H<&QA;BPI+3,Y-RXV M*'!R;V=R86TL*2TS.3@N,BAP;VQI8WDI-C(N-"@L*2TS.#4H;RDM,"XQ*'(I M+3,Y,2XV*&%R2DM,SDP+C$H7"AA;F0I+3,X."XV*'=H:6-H*2TS.38N,2AT:&4I M+3,Y,RXW*$5X96-U=&DI,3`N.2AV*3$R+C0H92DM,SDU+C$H:&5R96)Y*2TS M.3$N,BAE>'!R97-S;'DI751*"C`@+3$N,C`Q."!41`HP(%1C"ELH=V%I*3$U M+C4H=F5S7"DI,3`N."@L*2TR-#@N.2AT:&4I+3(U,2XY*$-O;7!A;GDI+3(T M,RXU*'=I;&PI+3(U,BXS*'!A>2DM,C4Q*'1H92DM,C4W+C4H17@I,3$N,RAE M8W5T:2DU+C,H=F4I+3(T,"XX*'1H92DM,C4Q+CDH4V4I,3DN,RAV97(I-RXR M*&%N8V4I+3(U.2XX*%!A>6UE;G1S*2TR-#,N-"AD97-C&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C2DM,C&5C=71I*3$W+C(H=F62*34X+C(H6UE;G0I+3,Q,2XU*'=I;&PI+3(Y,BAB92DM,CDQ+C@H9&5E;65D*2TS M,#(N-2AT;RDM,CDS+C0H:&$I."XW*'9E*2TR.#8N,2AB965N*2TR.30N-2AT M97)M:6YA=&5D*5U42@HM,BXP,#$Q("TQ+C(P,3@@5$0*+3`N,#`P,2!48PI; M*&9O;&QO*3$R+C8H=VEN9RDM,S`W+C,H82DM,S`T+C0H0VAA;F=E*2TS,3(N M,RAI;BDM,S`T+CDH0V]N=')O;"DM,S$Q+C,H8GDI+3,P,RXY*'1H92DM,S`X M+C2DM,S`U+C$H=VET:&]U="DM,S$Q+C,H0V%U2DM,CDX+C(H=&AE*2TS,30N,RA%>&5C=71I*3$W+C$H M=BDM,"XQ*&4I+3(X,"XV*'=I=&@I+3,P,BXU*$=O;V0I+3,P,"XW*%)E87-O M;BDM,S`Y+CDH:68I+3,P-RXU*%PH,5PI*2TS,#(N,RAT:&4I751*"E0J"C`@ M5&,*6RA%>&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C2DV,RXT*"PI+3(S-RXV*'1H M92DM,C0P+C8H8V]N6UE;G1S*2TU M+C$H+BE=5$H*+T8R(#$@5&8*.2XS.3,T(#`@5$0*6RA4:&4I+3(R-2AF;VQL M;RDQ,BXW*'=I;F2DM,C4Y+C,H M<&%Y;65N=',I+3(U.2XX*'1O*2TR-3,N-RAT:&4I+3(U-RXU*$5X96-U=&DI M,3`N.2AV*3$R+C4H92DM,C4X+CDH9F]R*2TR-3$N,BAP97)I;V1S*5U42@HM M,32DM M,C(X+C0H=&\I+3(R-2XU*'1H92DM,C(Y+C,H17@I,3$N,BAE8W5T:2DU+C(H M=BDQ,BXT*&4I+3`N,2@L*2TR,S`N,2AI*2TP+C$H;BDM,C$Y+C@H86-C;W)D M86YC92DM,C(U+C$H=VET:"DM,C(X+C@H4V5C=&EO;BDM,C,Q+C(H,RXP-"PI M+3(R,BXR*&$I+3(R-2AL=6UP*2TR,C(N.2AS=6TI+3(R-BXU*'-E*3(R+C,H M=BDQ,BXT*&5R86YC92DM,C,V+C@H<&%Y;65N="PI+3(T,"XQ*&EN*2TR,3DN M."AC87-H+"E=5$H*,"`M,2XR,#$X(%1$"C`@5&,*6RAE<75A;"DM,S65A"DQ,2XS*&5C=71I*34N M,RAV*3$R+C4H92DP*)(I-#4N-RAS*2TQ-S2DM,3DQ+C,H:6XI751*"C`@+3$N,3DV,2!41`I; M*&5F*3$W+C0H9F5C="DM,S,R*&EM;65D:6%T96QY*2TS-#4N-2AP&5C M=71I*3$W+C(H=F62*34X+C(H'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S(#8S(#`@ M4CX^/CX-96YD;V)J#38@,"!O8FH\/"],96YG=&@@,3,R,#`^/G-T2DM,S4P+C0H;W1H97(I+3,V,"AB;VYU2DM,S4V+C$H M=&AE;BDM,S4X+C4H:6XI+3,U-2XY*&5F*3$W+C,H9F5C=%PI*2TS-C$N.2AA M2DM-#DR+CDH<')I;W(I+30U.2XU*'1O M*2TT-3&5C=71I M*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C65A&5C=71I*3$P+C@H=BDQ,BXT M*&4I+3`N,2B2*30U+C8H&5C=71I*3$P+CDH=BDQ M,BXU*&4I+3(P-RXY*'=I=&@I+3(R."XW*')E2DM M,S`R+C$H;W1H97(I+3,Q-"XV*&-O;2TI751*"BTQ-"XV.3,Y("TQ+C$Y-C$@ M5$0*6RAP96YS871I;VXI+3,V,2XY*&]R*2TS-#8N,BAI;F-E;G1I=BDQ,BXT M*&4I+3,U-2XT*'!L86YS*2TS-34H;V8I+3,T-BXR*'1H92DM,S4Y+C2DV,RXT*"PI+3,U,2AT:&4I+3,U-"A#;VUP86YY*2TS-3`N-"AW:6QL M*2TS-30N-2AP87DI+3,U,RXQ*'1O*2TS-34N.2AT:&4I+3,U-"A%>&5C=71I M*3$P+C@H=BDQ,BXT*&4I+3`N,2@L*2TS-30N."AI*2TP+C$H;BDM,S4P+C(H M86-C;W)D86YC92DM,S0Y+C@H=VET:"E=5$H*,"`M,2XR,#$X(%1$"C`@5&,* M6RA396-T:6]N*2TR-S8N-2@S+C`T+"DM,C8W+C4H82DM,C"DQ,2XR*&5C=71I*34N,BAV*3$R+C0H92DM,C4Y*&9O65A M2DM,S`U+C$H;W1H97(I+3,Q-"XV*&-O;7!E;G-A=&EO;BDM M,S$W+C@H;W(I+3,P-BXU*&EN8V5N=&EV*3$R+C0H92DM,S$P+C$H<&QA;G,I M+3,P.2XV*&]F*2TS,#`N.2AT:&4I+3,Q-"XS*$-O;7!A;GDI-C,N-"@L*2TS M,#4N-RAC86QC=6QA=&5D*2TS,S,N-BAA2DM-#&5C=71I*3$P+CDH=BDQ,BXU*&4I+3$W M,RXY*'=I;&PI751*"C`@+3$N,C`Q."!41`I;*&\I,3@N,2AW*3`H;BDM,C,T M+CDH=&AO2DM,C0R+C2DM,C0U+C0H=&AE*2TR-3(H17@I,3$N,BAE M8W5T:2DU+C(H=F4I+3(T,"XY*&%N*5U42@HP("TQ+C(P,3@@5$0*,"!48PI; M*&%D9&ET:6]N86PI+3,S-BXU*&%M;W5N="DM,S(Q+C@H=6YD97(I+3,Q,RXV M*'1H92DM,S$Y+CDH0D50*2TS,#@N."A<*&]R*2TS,3,N-2AA*2TS,34N-BAS M=6-C97-S;W(I+3,Q,2XX*'!L86Y<*2DM,S(P+C(H97%U86PI+3,R,BXV*'1O M*2TS,38N,2AT:&4I+3,Q-"XR*&5X8V5S&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C2DM,C,R+C(H<')I;W(I M+3(P-"XT*'1O*2TR,#(N-RAT:&4I+3(P-BXU*$-H86YG92DM,C`T+C4H:6XI M+3(P,BXW*$-O;G1R;VPI+3(P,RXU*%PH8BDQ,2AU="DM,C`R+C&5C=71I*3$P+CDH=BDQ,BXU*&4I+3(P,BXS*&)E*2TR M,#8N."AD965M960I+3(Q,2XX*'1O*2TR,#(N-RAH82DX+C6%B;&4I M+3,P."XR*'1O*2TR.3DN,2AT:&4I+3,P,BXY*$5X*3$Q+C,H96-U=&DI-2XS M*'8I,3(N-2AE*2TR.3@N-BAU;F1E"DM,C4R*'1R M96%T;65N="DM,C"UQ=6%L:68I+38N,RAI960I+3,S,2XR M*'!L86YS+BE=5$H*,BXP,#$Q("TQ+CDS,S$@5$0**%PH95PI*51J"D54"B]' M4S,@9W,*,3(U+C$W."`Q,C8N,#(X(#8U+C,Q(#`N-3$P,C(@&5C=71I*3$W+C$H=BDM M,"XQ*&4I+3,R,"XR*'=I=&@I+3,U,RXU*&QI9F4I+3,U-BXT*&EN2DM,C@S+CDH&5C=71I*3$P+CDH M=BDQ,BXU*&4I+3(W,"XS*&ES*2TR-C@N-"AR96-E:2DQ,"AV:6YG*2TR-S0N M,2AI;6UE9&EA=&5L>2DM,CDT+C4H<')I;W(I+3(W,BXU*'1O*2TR-C4N,2AT M:&4I+3(W-"XV*$YO=&EC92DM,C'1E;G0I+3$Y.2XT*&-O;7!A'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S M(#8S(#`@4CX^/CX-96YD;V)J#3D@,"!O8FH\/"],96YG=&@@,3(U,#,^/G-T M&5C=71I*3$V+C8H=F4I+3$U-2XW*'=I=&AO=70I M+3$X-BXU*&=R96%T97(I+3$Y-"XT*&-O2DM,C@Q+C(H=&AE*2TR M.3$N-RA#;VUP86YY*2TR-S8N-RAD=7)I;F&5C M=71I*3$P+C@H=BDQ,BXT*&4I+30P-BXT*'=I;&PI+30R,BXU*')E<&]R="DM M-#(Y+C0H=&\I+30R,RXY*'1H92DM-#(W+C2DM-#$X+C4H86YY M*2TT,34N-2AS=6-H*2TT,C,N,RAC;RDX+C8H=BDQ,BXT*&5R86=E*2TT,S$N M-"AA8W1U86QL>2DM-#0U+C$H&5C=71I*3$P+CDH=BDQ,BXU*&5<*2XI751* M"C(N,#`Q,2`M,2XY-C$T(%1$"BTP+C`P,#$@5&,*6RA)9BPI+3(X,"XR*&%S M*2TR-S(N-2AO9BDM,C2DM,C$X+CDH=&AI9(I-3`N-BAS*2TR,36%B;&4I+3(P-BXS*'1O*2TQ.32DM,SDP+C$H M=VEL;"DM,SDY+C@H;V8I,C(N,RAF97(I+3,Y."AT:&4I+3,Y,RXW*$5X96-U M=&DI,3`N."AV*3$R+C0H92DM,SDU+C$H86YD*2TS.3@N-"AA;BDX+C8H>2DM M,SDP+C$H96QI9VEB;&4I+30Q,BXV*&9A;6EL>2DM-#`T+C@H;65M8F5R2DM-#`P+CDH=&\I+3,Y-2XV M*&5L96-T*2TT,#&5C=71I*3$P+CDH=BDQ,BXU*&4I+3$Y,"XY M*&AA9"DM,3@X+C8H:6XI+3$Y,2XT*&5F*3$W+C0H9F5C="DM,3DU+CDH:6UM M961I871E;'DI751*"C`@+3$N,C`Q."!41`I;*'!R:6]R*2TQ.3,N,2AT;RDM M,3DQ+C0H:&ES*2TQ.#&5C=71I*3$P+CDH=BDQ,BXU*&4I+3$Y,"XY*&UA M>2DU-2XT*"PI+3$Y,BXR*&(I,3(N-2AU="DM,3DQ+C0H:7,I+3$X.2AN;W0I M+3$Y,"XR*')E<75I2DM,C(S M+C,H;65M8F5R2DM,3DP+C0H;&%W*38V+C4H+"DM,3@V+C4H86YD M*2TQ.30N,RAW:&5T:&5R*2TQ.32DM,C"DQ,2XS*&5C=71I*34N,RAV92DM,3DU+C0H:7,I+3(P M,"XS*&5N=&ET;&5D*5U42@HM,30N,S,V-R`M,2XR,#$X(%1$"ELH=6YD97(I M+3(Q,2XU*'1H92DM,C$R+C(H4V%V:6YG2DM,C`S+C@H=VEL;"DM,C$R+C8H<&%Y*2TR,3$N,RAT:&4I+3(Q M,BXR*$5X96-U=&DI,3$H=BDQ,BXU*&4I,"@L*2TR,3,H:2DP*&XI+3(P."XT M*&%C8V]R9&%N8V4I+3(Q,RXV*'=I=&@I751*"C`@+3$N,3DV,2!41`I;*%-E M8W1I;VXI+3(T."XR*#,N,#0L*2TR,SDN,2AA*2TR-#$N.2AL=6UP*2TR-#4N M-2AS=6TI+3(S,BAA;6]U;G0I+3(T."XQ*&5Q=6%L*2TR-#@N.2AT;RDM,C0R M+C0H=&AE*2TR,C,N-2AV*3$X+C$H86QU92DM,C0T+C0H;V8I+3(S."XT*'1H M92DM,C0V+C(H=6XI,S`N-BAV*3$R+C4H97-T960I+3(T-BXU*'!O'1E;G0I+3(R,BXQ M*'!E"DQ M,2XS*&5C=71I*34N,RAV92DM-#,Y+C(H=VET:"DM-#8V+C@H6UE;G0I+3@N-R@N*5U42@HO1C(@,2!49@HM-BXT,SDY("TQ M+CDV,34@5$0*6RA<*&%<*2DM-3`U+C8H26XI+3$Y."XW*'1H92DM,C`V+C4H M92DQ."XX*'8I,3(N-2AE;G0I+3(P-BXU*'1H870I+3(Q,2XY*&%N*3@N-RAY M*2TQ.3&-I"PI+3(T,"XR M*'1H96XI+3(T-2AT:&4I+3(T,"XU*$5X96-U=&DI,3`N.2AV*3$R+C4H92DM M,C$Y+C,H=VEL;"DM,C0V+C8H8F4I+3(T,"XX*&5N=&ET;&5D*2TR-3DN-2AT M;RDM,C,V+C6UE;G0I+3(U,BA<*&$I+3(T,RXT*)-'&5C=71I*3$P M+CDH=BDQ,BXU*&4I,"B2*30U+C&5S*2TR-3(N,BA<*&EN8VQU9&EN9RDM M,C8U+C(H86XI."XW*'DI+3(U-"AI;G1E"PI+3(V,BXV*&]R*5U4 M2@HP("TQ+C(P,3@@5$0*6RAS:6UI;&%R*2TR-S6UE;G0I+3(U M."XS*&%N9"DM,C8R+C,H=&AE*2TR-C@N.2A%>&-I%PI+"DM,C8T+C,H:6YC;'5D:6YG*2TR-CDN-"AA;GDI+3(U-BXV*$5X M8VES92DM,C6UE;G0L*2TR M,S4N-2AT:&4I+3(R,RXU*$5X96-U=&DI,3`N.2AV*3$R+C4H92DM,C(T+CDH M6UE M;G1S+BE=5$H*,BXP,#$Q("TQ+CDV,30@5$0*6RA<*&)<*2DM-3`P+C8H06XI M+3(P-BXU*&EN:71I86PI+3(R,BXV*&1E=&5R;6EN871I;VXI+3(S."XS*&%S M*2TR,#0N-"AT;RDM,3DQ+C0H=VAE=&AE6UE;G0I+3(P-RXS*&ES*2TR,#8H6UE;G0I+3(T-RAW:6QL*2TR-3(N,RAB M92DM,C0V+C0H;6%D92DM,C4T+C4H870I+3(U,RAT:&4I+3(U,2XY*$-O;7!A M;GF2*34U+C8H'!E;G-E*2TR-3`N,2AB>2DM,C0Q M+C4H86XI+3(U,BXQ*$%C8V]U;G1I;F2DM,C0W+C$H=&AE*5U42@HP("TQ+C(P,3@@5$0* M+3`N,#`P,2!48PI;*$5X96-U=&DI,3`N."AV*3$R+C0H92DM,3DQ*&%N9"DM M,3DT+C0H2DM,3DW+C0H86-C97!T86)L92DM,C$X+C8H=&\I M+3$X-2XX*'1H92DM,3DU+C,H0V]M<&%N>2DU-RXW*"XI+3$X-BXV*%1H92DM M,3DQ+C$H06-C;W5N=&EN9RDM,3DW+C@H1FER;2DM,3DR+C(H=VEL;"DM,3DU M+C&5C=71I*3$P+CDH=BDQ,BXT M*&4I+3`N,2@N*2TS-30N."A)*2TP+C$H9BDM,S4T+C4H=&AE*5U42@HP("TQ M+C(P,3@@5$0*,"!48PI;*$%C8V]U;G1I;F2DM,C@Q+C$H=&AE*2TR.#4N.2A%>&5C=71I*3$W+C(H M=BDP*&4I+3(U,BXQ*'=I=&@I+3(W.2XW*')E6UE;G1S+"DM,C2DM,C@X*&%C8V5P=&%B;&4I+3(Y-RXY*'1O*2TR M-S8N-"AT:&4I+3(X,"XR*$5X*3$Q+C,H96-U=&DI-2XS*'9E*2TR-CDN,2AT M:&%T*2TR.#`H;F\I+3(V.2XX*$5X8VES92DM,C@Q+C6UE;G0L*2TT,38N-2AI9BDM-#$U+C$H86XI."XW*'DI-3%LP(#`@-C$R(#7!E+U!A M9V4^/@UE;F1O8FH-,3$@,"!O8FH\/"]#;VQO'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S(#8S(#`@4CX^/CX- M96YD;V)J#3$R(#`@;V)J/#PO3&5N9W1H(#$R,#,S/CYS=')E86T-"B]'4S(@ M9W,*0E0*+T8R(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`V."XY.34R(#2DM,S8X+C(H M=&\I+3,W,BXX*'1H92DM,S&5C=71I*3$P+C@H=BDQ,BXT*&4I+3`N,2@N*2TR,3,N,2A)*2TP M+C$H9BDM,C$R+C@H=&AE2DM M,C`X+C2DM,C,Q+C0H86YD*2TR,S0H=&AE*2TR-#`N-BA%>"DQ,2XR*&5C=71I M*34N,BAV*3$R+C0H92DM,"XQ*"XI+3(S-2XX*%1H92E=5$H*,"`M,2XR,#$X M(%1$"C`@5&,*6RA#;VUP86YY*2TS,C(N."AW:6QL*2TS,C8H8F5A&5C=71I*3$P+C@H=BDQ,BXT*&4I+3$V M."XT*'=I;&PI751*"BTR+C`P,3$@+3$N,C`Q."!41`HP(%1C"ELH8F4I+3(U M-RXX*&1E=&5R;6EN960I+3(W.2XW*&EN*2TR-3,N-RAA8V-O6UE;G0L M*2TS-#@N.2AT:&4I+3,S-BXY*$5X96-U=&DI,38N-BAV92DM,S`X+C@H=VEL M;"DM,S,W+C,H8F4I+3,S,2XU*&1E96UE9"DM,S0W+CDH=&\I+3,S,RXQ*'!A M>2DM,S,V*&9E9&5R86PI+3,T-RXT*&EN8V]M92DM,S0S+C@H=&%X97,I+3,S M,2XU*&%T*2TS,S@N,2AT:&4I+3,S-BXY*&AI9VAE&%T:6]N*2TS,34N,RAI;BDM M,S`T+C65A&5S+BE=5$H*,BXP,#$Q("TR+C$V M-34@5$0*6RA<*&1<*2DM-3`P+C8H3F]T=VET:'-T86YD:6YG*2TR-C`N,2AA M;BDX+C71H:6YG*2TR-34N-RAC;VYT86EN960I+3(V-RXQ*&EN*2TR-3,N M-RAT:&ES*2TR-#DN.2A!9W)E96UE;G0I+3(V-RXV*'1O*2TR-#@N,2AT:&4I M+3(U-RXU*&-O;G1R87)Y*30Y+CDH+"DM,C0X+CDH:2DP*&XI+3(U,RXW*'1H M92DM,C4Q+CDH92DQ,RXR*'8I,3(N-2AE;G0I+3(U-RXU*'1H870L*2TR-38N M-RAA8V-O6UE;G1S+"DM,C,Y+C@H M=&AE*2TR-3(H0V]M<&%N>2DM,C0R+C6UE;G0I+3(W-2XX*'5N M;&5S&5C=71I*3$P+CDH=BDQ,BXU M*&4I+3(W-BAW:71H;W5T*2TR.30N,BAA;GDI+3(X-2AI;7!OF5R;UPI+"DM,C`W+C(H86YD*2TQ.3DN.2AA;&PI+3(P-RXT*&]T M:&5R*3(U+C8H+"DM,3DW+C@H;F]N+6-A2DM,C(R+C0H=V%I*3$U+C4H=BDQ,BXU*&4I M,"AD*2TR,CDN-"AI*3`H;BDM,C(U+C0H=W)I=&EN9RDM,C,T+C0H<')I;W(I M+3(R-RXQ*'1O*2TR,C4N-"AT:&4I+3(S-"XY*$1A=&4I+3(S,BXQ*&]F*2TR M,C$N-"A4*38Q+C$H97)M:6YA=&EO;BPI+3(T-BXW*&%N9"DM,C(X+C,H7"@R M7"DI+3(R,BXX*&%N>2DM,C(R+C8H<&]R=&EO;BDM,C(X+C@H;V8I+3(R,2XT M*'1H92DM,C,T+CDH5"DW,BXT*&]T86PI+3(S-"XV*%!A>6UE;G1S*5U42@I4 M*@I;*'1H870L*2TR,C@N-"AI;BDM,C$Y+C6UE;G1S*2TS,32DM,3&5C=71I*3$W+C(H=F62*34X+C(H'!R97-S;'DI M+3(Y-"XY*'!R;RDQ,BXR*'9I9&5D*2TS,#`N-BAI;BDM,CDY+C$H4V5C=&EO M;BDM,S`T+C@H,RXP,BDM,CDV+C0H;W(I+3(Y-2XQ*%-E8W1I;VXI+3,P-"XX M*#,N,#,L*5U42@HM,38N-#(R.2`M,2XR,#$X(%1$"ELH<&%Y;65N=',I+3,S M,RXU*'!R;RDQ,BXR*'9I9&5D*2TS,C@N.2AF;W(I+3,Q.2XR*&EN*2TS,C$N M."AT:&]S92DM,S(V+C4H4V5C=&EO;G,I+3,R-"AW:6QL*2TS,S$N-RAB92DM M,S(P+C$H;6%D92DM,S,S+CDH87,I+3,Q-RXX*&9O;&QO*3$R+C6UE;G0I+3(P,2AI2DM,3@V*'=I;&PI M+3$Y-2XW*'!R;RDQ,BXQ*'9I9&4I+3$Y-"XQ*'1H92DM,3DU+C,H17AE8W5T M:2DQ,"XY*'8I,3(N-"AE*2TQ-S0H=VET:"E=5$H*+3(N,#`Q,2`M,2XR,#$X M(%1$"C`@5&,*6RAA*2TR-S`N,RAW6UE;G1S*2TR.#@N,2AT;RDM M,C2DM,S$V+C,H;W!I;FEO;G,I+3,Q.2AO2DM,S8X*&%N*3@N-BAY*2TS-38N,2AA;F0I+3,U."XX*&%L;"DM,S8V M+C,H<&%Y;65N=',I+3,V,2XY*'5N9&5R*2TS-3DH=&AI"DQ,2XR*&5C=71I*34N M,BAV*3$R+C0H92DM,C$Y+C0H86YD*2TR,32DM M,C$T+C0H2DM,C0X+C0H<&%Y;65N="DM,C8S+C0H9'5E*2TR-3$H=6YD97(I M+3(U,2XS*'1H:7,I+3(U,"A!9W)E96UE;G1<*2PI+3(V,BXY*'1H92DM,C4R M*$-O;7!A;GDI+3(T."XT*'=I;&PI751*"E0J"C`@5&,*6RAP87DI+30T,RXW M*&]R*2TT,S8N."AR96EM8G5R2DM,C(U+C&5C=71I*3$P M+CDH=BDQ,BXU*&4I+3(X,2XV*&EN*2TR.#(N,2AC;VYN96-T:6]N*2TR.30N M,RAW:71H*2TR-SDN-RAA;GDI+3(W,RXV*'1A>"DM,C@P+C(H875D:70I+3(Y M,"XQ*&]R*2TR-S@N,2AP2DM,C0U+C,H<&%Y;65N="DM,C8S+C,H;W(I+3(T M.2XW*&)E;F5F:70I+3(U-"XV*'!R;W9I9&5D*2TR-#@N-RAU;F1E6UE;G0I M+3(S,"AO9BDM,C$P+C$H9F5E'!E M;G-E7,I+3,P.2XX*&%F=&5R*2TS,C"DQ,2XS*&5C=71I*34N,RAV99(I-3@N,BAS*2TS,#@N,RAW M6UE M;G0L*5U42@I4*@HM,"XP,#`Q(%1C"ELH86-C;VUP86YI960I+3(R,BXW*&)Y M*2TR,#$N.2AS=6-H*2TQ.38N-2AE*3$X+C2DM,3DW+C0H2DM,C`X+C"DQ,2XS*&5C=71I*34N,RAV*3$R+C4H92DM,C8T+C8H;6%Y*2TR M-C2DM,SDS+C0H2DM,S@S+C(H86=R965M96YT*2TT,#DN-BAO&5C=71I*3$P+CDH=BDQ,BXU*&4I+3(Y,RAA;F0I+3(Y,"XV*$-O;7!A M;GDI+3(X."XX*&5N=&5R*2TS,#(N-2AI;G1O*2TR.3(H82DM,CDS*&QE9V%L M;'DI+3(Y.2XT*&)I;F1I;F2E=5$H*,"`M,2XQ.38Q(%1$"ELH8V]N M8V5D97,I+3(Y-RXT*'1H92DM,C@U+CDH86UO=6YT*2TR.3,N-2AI6UE;G0I751*"BTQ-2XP,3<@+3$N.#0R-"!41`HH M4RE4:@HW+C`P,#0@,"`P(#2E=5$H*+3$X+C(R M-38@+3$N,C`Q."!41`I;*'!U2DM,C6UE;G0I+3,T-2XU*'5N9&5R*2TS,3DN,RAT:&4I+3,S,2XR*&-I=&5D M*2TS,S0N."AP6UE;G0I+30T,2XY*&%F=&5R*2TT,CDN."AA*2TT,C,N,RA#:&%N M9V4I+30S,2XR*&EN*2TT,C,N."A#;VYT2DM M,C,P+CDH7"@S,%PI*2TR,38H9&%Y2DM,CDP+C8H<&5R:6]D+BDM,CDP+C$H268I+3(X-BXT*'1H92DM,CDQ+C8H M17AE8W5T:2DQ,"XY*'8I,3(N-2AE*3`HDBDT-2XW*',I+3(W.2XY*&5M<&QO M>6UE;G0I+3,P-2XX*&ES*2TR.#4N-"AT97)M:6YA=&5D*2TS,#@N.2AF;W(I M+3(X-2XR*&%N>2DM,C2DV,RXT*"PI M+3(P.2XS*&-A;FYO="DM,C$S+C@H8F4I+3(Q,BXU*&QE"DW M+C(H8V5P="DM,C(W+C,H:6XI+3(Q.2XW*'1H92DM,C(S+C4H8V%S92DM,C(Y M*&]F*2TR,34N-RAA*2TR,3DN,RAT97)M:6YA=&EO;BDM,C0Q+C0H9F]R*2TR M,32DM,C$X+C@H=&AE*2TR,C,N-2A%>&5C=71I*3$W+C(H M=F4L*2TR,3$N."AC86YN;W0I+3(S,"XW*&)E*5U42@HP("TQ+C$Y-C$@5$0* M6RAL97-S*2TS,C4N,RAT:&%N*2TS,C0N-"@Q-2DM,S(P+C@H9&%Y&5C=71I*3$P+C@H M=BDQ,BXT*&4I+3`N,2B2*30U+C8H&5C=71I*3$W+C(H=BDP*&4I+3(P,2XQ*&DI,"AS*2TR,#8H;F]T*2TR M,3(N.2AR97%U:7)E9"DM,C$V+C8H=&\I+3(P."XT*'-E96LI+3(Q,BXW*&]T M:&5R*2TR,3(N-2AE;7!L;WEM96YT*2TR,S(N,2AO2DM,C`X+C8H M=V%Y*2TR,3`N,RAT;RDM,C`X+C0H2DM M,C`X+C8H86UO=6YT6UE M;G0I+3,Q-"XT*&]R*2TR.34N,BAB96YE9FET*5U42@HP("TQ+C(P,3@@5$0* M,"!48PI;*'!R;W9I9&5D*2TS,SDN-"AF;W(I+3,S-BXR*&EN*2TS-#0N-"A! M'1'4W1A=&4\/"]'4S(@-C(@,"!2+T=3 M,R`V,R`P(%(^/CX^#65N9&]B:@TQ."`P(&]B:CP\+TQE;F=T:"`Q,S,U.#X^ M6UE M;G0I+3(Y-"XV*&)Y*2TR-CDN.2AA;F]T:&5R*2TR.#,N,RAE;7!L;WEE2DM,C8Y+CDH;V8I,C(N,RAF2DV,RXT*"PI+3,R,BXW*&]R*2TS,3"DR."XS*&4I-RXU*&-U*3$T+C,H=&DI,S0N-2AV*3$X+C$H92DM,C4S+C,H M=VDI,3DN,RAL;"DM,C"DQ."XQ*&4I-RXU*&,I-RXU*'4I,"AT*3$X+C0H:2DP*&\I,3(N-RAN M*2TQ.3$N-BAO9BDM,3@W+C0H="DQ,2XV*&@I,"AI*3$R+C"DQ,BXU M*&DI,"AS*3(P+C@H="DP*&DI,3$N."AN*3$R+C4H9RDM,C$T+C,H;BDQ,BXU M*&]N*3$Y+C,H8V\I,30N,RAM<"DQ,RXY*&4I-RXU*'0I,"AI*3$W+C4H="DP M*&DI,3$N."AO*3`H;BDM,C`Q+C@H82DW+C4H9W(I,38N-RAE*3"DQ."XQ M*&4I-RXU*&,I-RXU*'4I,"AT*3$R+C&5C=71I M*3$W+C(H=BDP*&4I751*"E0J"BTP+C`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`Q+C@H=&AE*2TR,#8N-2AE M;F0I+3$Y.2XY*&]F*2TQ.3@N-RAT:&4I+3(P-BXU*#(Q*2TR,#$N."AD87DI M+3(P-2XV*'!E"DQ,2XS*&5C=71I*34N M,RAV92DM,38W+C$H=VEL;"DM,3DU+C8H;F]T*2TQ.34N.2AB92DM,3DU+C0H M96YT:71L960I+3(Q-"XQ*'1O*2TQ.3$N-"AR96-E:79E*2TQ.#0N,2AA;GDI M+3$X."XV*%-E*3$Y+C,H=BDQ,BXU*&5R86YC92DM,C`X+C,H4"DQ-RXT*&%Y M;65N=',I+3(P-"XR*'5N9&5R*2TQ.30N-2AT:&ES*5U42@HP("TQ+C(P,3@@ M5$0*6RA!9W)E96UE;G0N*2TQ.3DH26XI+3$X,2XW*&-E'1E;F1E9"DM,3DU+C4H=&\I+3$X M-2XW*&$I+3$X-2XS*#0I,"@U*2TQ-SDN,2AD87DI751*"E0J"ELH<&5R:6]D M+BDM,C$P+C&5C=71I*3$W+C(H=BDP*&4I+3$W."XT M*'=I;&PI+3(P-RAB92DM,C`V+C@H861V:7-E9"DM,C$P+C(H:6XI+3(P."XT M*'=R:71I;F2DM,S(T M+C@H;V)L:6=A=&EO;G,I+3,U,"XX*&EM<&]S960I+3,S-2XT*&)Y*2TS,S(N M,RAL872DM,S,S+C0H=VEL;"E=5$H*+3(N M,#`Q,2`M,2XR,#$X(%1$"C`@5&,*6RAR97%U:7)E*2TT,S,N,BAA;BDX+C2DM-#$X+C0H2DM,SDQ+C0H87-S=6UE*2TS.34H86YD*2TS.3@N-"AA9W)E92DM-#`S M*'1O*2TS.34N-BAP97)F;W)M*2TS.34N-RAT:&ES*5U42@HP("TQ+C(P,3@@ M5$0*,"!48PI;*$%G2DM,S(W+C@H="DM,"XQ*&\I+3,R-RXU*&]B=&%I;BDM,S,T+C0H2DM,C(U+C8H2DM,C,W+C@H:6XI M+3(T."XQ*'1H92DM,C0V+C(H"DQ,2XS*&5C=71I*34N,RAV92DM,C$R M+C0H=V]U;&0I+3(T,RXV*&)E*2TR-#8N-"AE;G1I=&QE9"DM,C4Y+C4H=&\I M+3(T,BXT*'5N9&5R*5U42@I4*@I;*'1H:7,I+3(S."XV*$%G&-E<'0I751* M"C`@+3$N,3DV,2!41`I;*'1H870L*2TS.#6UE;G0I M+3(Q,BXS*&]F*2TQ.3@N-RAB96YE9FET6UE M;G0L*2TR-S$N,BAS=6)J96-T*2TR-38N-"AT;RDM,C4S+C2DM,C8P+C(H:6XI751*"C`@+3$N,C`Q."!41`I; M*'!A>6UE;G0I+3,S-RAU;F1E2DM,C4R+C@H=&AE M*2TR-3&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C&5C=71I*3$P+CDH=BDQ M,BXU*&4I+30V."XW*&1I97,I+30V,RXX*'=H:6QE*2TT-S`N-BAA;BDX+C2DM-#8S+C6%B;&4I+30W."XS*'1O*2TT-CDN,BAT:&4I+30V-RXS*$5X96-U=&DI M,3"DQ,2XS*&5C=71I*34N,RAV99(I M-3@N,BAS*2TR,C@N.2AD96%T:%PI+"DM,C0T*'1H96XL*2TR,S@N."AU;FQE M2DM,C(S+C@H;6%Y*2TR,C@H9G5R;FES:"DM,C(R+C0H=&\I+3(R-2XT M*'1H92DM,C(S+C4H;W1H97(I+3(R.2XU*&EN*2TR,C4N-"AW3HI751* M"C`@+3$N.3"DM M,S$W+C$H-S`X*5U42@I4*@I;*%6UE;G0I+3(R-BXU*&%N9"PI+3(Q,"XW*&4I-RXU*'AC M97!T*2TR,C`N-2AA2DV M,RXU*"PI+3(X,BXY*'1H92DM,CDQ+C8H17AE8W5T:2DQ-RXR*'8I,"AE*2TR M-32DM,3@T+C@H=&AE M*2TQ.34N,BA%>&5C=71I*3$P+CDH=BDQ,BXU*&4I+3$Y,"XY*&%N9"DM,3DT M+C,H86XI+3$X.2XX*&]F*3(R+C0H9FEC97(I+3$Y,2XW*&]F*2TQ.#2DM,C@S+C$H2DM,C@Q+C$H=&AE*2TR.32DM,3@Y+C@H;V8L*2TQ.#$N,2AO2DM,32DM,C$T+C,H;W1H97(I+3(Q."XQ*'1I M;64N*2TR,C(N-2A.96ET:&5R*2TR,C`N."AP87)T>2DM,C(S+C@H:&%S*5U4 M2@I4*@I;*&UA9&4I+3(S,2XY*&%N*3@N-RAY*2TR,30N,RAA9W)E96UE;G1S M*2TR,S8H;W(I+3(Q-2XW*')E<')E'!R97-S M*2TR,3$N,RAO'!R97-S;'DI+3$W-"XQ*'-E="DM,3@W+C$H9F]R M=&@I+3$X,2XX*&EN*2TQ.#4N-RAT:&ES*2TQ.#$N.2A!9W)E96UE;G0N*2TQ M.3,N-"A%>&-E<'0I+3$Y.2AA2DT-"XX*"PI+3(X."XU*&EN=&5R<')E=&%T M:6]N+"DM,S(U+C0H8V]N2DM,CDR+C4H=&AE*2TS,#(N.2AL87=S*2TR.#$N-"AO M9BDM,CDU+C$H=&AE*5U42@I4*@I;*%-T871E*2TR,38N-2AO9BDM,3DX+C2DM,C`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`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,C,@,"!O8FH\/"]#;VQO'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S(#8S(#`@ M4CX^/CX-96YD;V)J#3(T(#`@;V)J/#PO3&5N9W1H(#DS,C8^/G-T2DM,3@P+C0H86YD*2TQ.#@N-RAT:&4I+3$X.2XV*$5X96-U=&DI,38N M-2AV92DM,32E=5$H* M+3$Y+C(P-C,@+3$N.#@R,2!41`I;*%1H92DM,C@W+C,H:6XI,C0H=BDR,RXX M*&%L:61I='DI+3(Y-2XT*&]R*2TR.#,N."AU;F5N9F]R8V5A8FEL:71Y*2TS M,3`N-RAO9BDM,C2DM,C$S+C(H=&AE*2TR,3@H0F]A&5C=71I*3$V+C8H=F4I+3,R-2XX*&EN*2TS,C2DM,C`X*'1O*2TQ.3"DQ,2XS M*&5C=71I*34N,RAV*3$R+C4H92DM,C`R+C,H9F]R*2TQ.#@N."AA*2TR,#(N M,RAR*3`H92DQ-RXT*'9I92DQ-"XV*'&5C=71I M*3$P+CDH=BDQ,BXU*&4I+3(T,2XY*'1O*2TR-#(N-"AA<'!E86PI+3(T-RAT M;RDM,C0R+C0H=&AE*2TR-#8N,BA";V%R9"DM,C,W+C,H82DM,C0Q+CDH9&5C M:7-I;VXI+3(T,RXY*&]F*2TR,S@N-"AT:&4I+3(T-BXR*$)O87)D*2TR,S2DM,C4P+C2DM-#$Q+CDH8GDI+30P,"XR*'1H92DM M,SDY+C,H<&%R=&EE'!E;G-E9(I-34N-2AS*2TS,3DN-RAI;F1E<&5N9&5N="DM,S,X+C8H875D M:71OF%T:6]N*2TU,32DM-#@Y+C,H;W(I751*"BTW+C`U,C(@+3$N,C`Q."!41`HM,"XP,#`Q M(%1C"ELH068I,C,N,BAF:6QI871E9"DM,S,T+CDH0V]R<&]R871I;VYS*2TS M,C(H4"DQ-RXT*&%R=&EC:7!A=&EN9RDM,S0R+C@H:6XI+3,R,2XY*'1H92DM M,S(U+C2DV,RXT*"XI751*"C$R+C8S,#0@+3(N,SDX(%1$"C`@5&,* M*$$M.2E4:@I%5`H-"F5N9'-T%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,C8@,"!O8FH\/"]#;VQO'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S M(#8S(#`@4CX^/CX-96YD;V)J#3(W(#`@;V)J/#PO3&5N9W1H(#$Q.#,S/CYS M=')E86T-"B]'4S(@9W,*0E0*+T8R(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P M-B`Q,#DN,#(P-"`W,3`N-#$X-R!4;0HO0W,X(&-S(#$@6UE;G0L*2TT,S`H869T M97(I+30Q."XU*&%N>2DM-#`T*$-H86YG92DM-#$T+C(H:6XI751*"BTW+C8X M,30@+3$N,C`Q."!41`I;*$-O;G1R;VPL*2TR,S8N.2AM96%N2DM,C0Y+CDH<&5R9F]R;2DM,C0R+C8H=&AE*2TR M,S0N.2A%>&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C2DM,C`S*%PH;W1H97(I+3(Q-"AT:&%N*2TR,#4N-2AA;GDI M+3(P,"AS=6-H*2TR,#(N,BAF86EL=7)E*2TR,3@N."AR97-U;'1I;F2DM,C(V+C8H9'5E*2TR,#4N M-RAT;RDM,C`X+C4H<&AY&5C=71I*3$P+CDH M=BDQ,BXU*&4I+3,Q-2XV*&)Y*2TS,#DN-2AT:&4I+3,Q-"XR*$)O87)D+"DM M,S$V+C$H=VAI8V@I+3,Q-BXW*&1E;6%N9"DM,S(P+C(H&5C=71I*3$W+C(H=BDP*&4I M+3,W,2XR*&AA2DM,SDW M+C(H<&5R9F]R;65D*2TS.#8N.2AT:&4I751*"C`@+3$N,C`Q."!41`I;*$5X M96-U=&DI,3`N.2AV*3$R+C4H92DP*)(I-#4N-RAS*2TQ-S2DV-BXU*"XI+3$Y,BXR*$8I,32DM,C0W+C$H=&AE*2TR-3$N M.2A%>&5C=71I*3$P+CDH=BDQ,BXU*&4I+3(U,RXS*&YO="DM,C0V+CDH:6XI M751*"E0J"ELH9V]O9"DM,3DY+C4H9F%I=&@I+3(Q,RXT*&%N9"DM,3DY+CDH M=VET:&]U="DM,C`S+C4H2DM-#$X+C0H4&5R2DM-#,Q+C(H;W(I+30Q.2XX*&EN9&ER96-T;'DI-#`N-R@L M*2TT,3,N,RAO*3`H9BDM-#$Y+C@H2DM,C@T*&9R;VTI+3(W,BXV*'1H92DM,C2DM,C65A2DM,C8X*'!E2DM,3DW+C0H;BDM,"XQ*&4I,3DN.2AW*2TQ M.3`N."AD:7)E8W1O9(I-3`N-BAS*2TQ.#,N-RAS=&]C:VAO;&1E M2DM-#(V+C2DM,C2E= M5$H*,"`M,2XQ.38Q(%1$"C`@5&,*6RAR96UA:6YI;F2DM M,C8P+C4H:&]L9&EN9RDM,C4T+C4H2E= M5$H*,"`M,2XQ.38Q(%1$"C`@5&,*6RAO2DM,S4R+C,H;W5T2DM,C4Y M+C"UM;VYT:"DM,S`X+CDH M<&5R:6]D*2TS,3,N-"AF;VQL;RDQ."XS*'=I;F2DM,C,X+CDH;W(I+3(Q-2XW M*&=R;W5P*2TR,C,N-BAT:&%T*2TR-#`N,RAI;F-L=61E2E=5$H*5"H* M6RAT:&4I+3(X-2XY*$5X96-U=&DI,38N-BAV93LI751*"D54"B]'4S,@9W,* M,38Y+C0U-2`Q-C8N,S,W(#,U+C4T-B`P+C4Q,#(R(')E"F8*+T=3,B!G2DM,S,U+C,H;W(I+3,P-BXT*&=R;W5P*2TS,C`H=&AA="DM,S,Q*&1O M97,I+3,R,2XQ*&YO="DM,S(V+C,H:6YC;'5D92DM,S,R+C4H=&AE*2TS,C4N M-BA%>&5C=71I*3$P+CDH=BDQ,BXU*&4I,"@N*5U42@HP("TR+C`Q.#$@5$0* M*%PH:5PI*51J"B]&,R`Q(%1F"C$N-#0U-B`P(%1$"BB3*51J"D54"B]'4S,@ M9W,*,3(Y+C`S,R`Q,C(N,3%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,CD@,"!O8FH\/"]#;VQO'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S(#8S(#`@ M4CX^/CX-96YD;V)J#3,P(#`@;V)J/#PO3&5N9W1H(#$Q.#2DM,C0W+C$H;W!E"DW+C(H8V5P="DM,C8Q+C0H:6XI751*"E0J"BTP+C`P,#$@5&,* M6RAD971E2DM,S4P+C4H4VAA2DM,S4P+C,H97%U:71Y*2TS-C(N-RAS96-U2DM,39(I-3`N-BAS*2TS,S8N-RAS:&]R="UT97)M*2TS-3(H;W(I+3,T,"XU*&QO M;F&-H86YG92DM,S,Q+C(H06-T*2TQ,"XU*)0I751* M"B]&,B`Q(%1F"C8N-#DP.2`P(%1$"ELH;65A;G,I+3,S,"XT*'1H92DM,S(U M+C8H4V5C=7)I=&EE&-I)0I751*"B]&,B`Q(%1F"C4N,C,X,2`P(%1$"C`@5&,*6RAM96%N&5C=71I M*3$P+CDH=BDQ,BXU*&4I+34R-2XT*&]F*2TU,C$N."AT:&4I+34R-"A%>&5C M=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C6UE;G0I M+34S."XS*&UE86YS*2TU,C@N."AT:&4I751*"BTQ,"XX-C'!R97-S*2TQ.30N-"AW&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2 M*30U+C2DM,S8Q+C&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U+C2DM M,S4Q+C(H<')I;W(I+3,R,RXU*'1O*2TS,C$N."AA*2TS,C$N,RA#:&%N9V4I M+3,R.2XR*&EN*2TS,C$N."A#;VYT2DM,C$X+C@H=&AE*2TR,CDN,BA#;VUP86YY*2TR,C`N."AI;BDM,C(U+C0H M=&AE*2TR,CDN,BA%>&5C=71I*3$W+C(H=F62*34X+C(H2DM,C(X*&)E*2TR,3@N M,2AI;F-R96%S960I+3(S-RXT*&9R;VTI+3(R,2XU*'1I;64I+3(R."XW*'1O M*2TR,3DN-RAT:6UE+"DM,C,S+C@H;W(I+3(Q-2XW*'1H92DM,C(Y+C(H;&4I M,3DN,2AV96PI+3(Q-RXY*&]F*2TR,34N-RAT:&4I+3(R.2XR*$5X*3$Q+C,H M96-U=&DI-2XS*'8I,3(N-2AE*3`HDBDT-2XW*',I+3(Q,2XY*&5N=&ET;&5M M96YT*5U42@HP("TQ+C(P,3@@5$0*+3`N,#`P,2!48PI;*'5N9&5R*2TR-#`H M=&AE*2TR-#`N-BA);F-E;G1I=BDQ,BXT*&4I+3(T,BA0;&%N*2TR,S0N-2AA M2DM,C,Y+C4H8F4I+3(T,"XY*&EN8W)E M87-E9"DM,C0X+CDH9G)O;2E=5$H*5"H*,"!48PI;*'1I;64I+3,S-BXT*'1O M*2TS,C$N."AT:6UE.RE=5$H*,BXP,#$Q("TQ+C@X-S@@5$0*+3`N,#`P,2!4 M8PI;*%PH,UPI*2TU,#`N-RAT:&4I+3,S,2XS*$-O;7!A;GF2*34P+C8H"DQ,2XR*&5C=71I M*34N,BAV92DM,S(P+C(H=&\I+3,R-RXU*&)E*2TS,S$N-BAB87-E9"DM,S,P M+C9(I-3`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`@+3$N,C`Q."!41`I;*$-O;7!A;GF2*34P+C8H2DM,S(S+C$H87,I+3,Q-RXY M*&EN*2TS,C$N.2AO<&5R871I;VXI+3,S."XV*&EM;65D:6%T96QY*2TS-3$N M,RAP&5C=71I*3$W+C$H=BDM,"XQ*&4I+3(U-RXY*&$I+3`N,2AN*3@N M-BAY*2TR-3DN-RAP;W)T:6]N*2TR-C@N-BAO9BE=5$H*+3(N,#`Q,2`M,2XR M,#$X(%1$"C`@5&,*6RAT:&4I+3(V."XY*$5X96-U=&DI,3`N.2AV*3$R+C4H M92DP*)(I-#4N-RAS*2TR-3&5C=71I*3$W+C(H=BDP*&4I+3,X,BXU*&$I,"AN*3@N-RAY*2TS.3`H<&]R M=&EO;BDM,SDS+C(H;V8I+3,X-2XX*&%N*5U42@I4*@HM,"XP,#`Q(%1C"ELH M:6YS=&%L;&UE;G0I+3(T,RXQ*&]F*2TR,C$N-2AD969E2DM,C$W*&1E9F5R M7,I+3,R,2XQ*&]F*2TS,C,N-"AT:&4I+3,R-2XV*&1A=&4I+3,R M.2XT*'1H92DM,S,Q+C(H8V]M<&5N2DM,SDP+C$H8V]M<&5N M2DM,3DY+CDH9(I-3`N-BAS*2TS M.3,N-"AF86EL=7)E*2TT,3$N-2AT;RE=5$H*5"H*,"!48PI;*&-O;G1I;G5E M*2TR-3(H=&AE*2TR-#8N,BA%>&5C=71I*3$P+CDH=BDQ,BXU*&4I,"B2*30U M+C%LP(#`@-C$R(#7!E+U!A9V4^ M/@UE;F1O8FH-,S(@,"!O8FH\/"]#;VQO'1=+T5X=$=3=&%T93P\+T=3,B`V,B`P(%(O1U,S(#8S(#`@4CX^/CX-96YD M;V)J#3,S(#`@;V)J/#PO3&5N9W1H(#$Q-#DY/CYS=')E86T-"B]'4S(@9W,* M0E0*+T8R(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`Q,CDN,#,S(#9(I-3`N-BAS*2TR,#`N-RAF86EL M=7)E*2TR,3@N."AT;RDM,C`X+C4H8V]N=&EN=64I+3(R,RXW*'1O*2TR,#@N M-2AP2DM,C(Q+C8H65D*2TR.#8N,RAB M>2DM,C8Y+CDH=&AE*2TR.#`N,RA%>&5C=71I*3$P+C@H=BDQ,BXT*&4I+3(W M-BXQ*'5N9&5R*2TR-SDN-RAA;BDX+C8H>2DM,C9(I-3`N-BAS*2TR-C@N-RAP96YS:6]N M*2TR-SDH7"AI;F-L=61I;F9(I-3`N-BAS*2TR-#`N-"A"96YE9FET*2TR-#DN,RA%<75A M;&EZ871I;VXI+3(V."A0;&%N*2TR-#4N."AF;W(I+3(T-2XV*'1H92DM,C0V M+C,H4V%V:6YG2DM,C(R+C0H<&QA;G,I+3(P-RXU*&EN*2TR,#@N M-"AW:&EC:"DM,C`S+C,H=&AE*2TR,3(N,BA%>&5C=71I*3$P+CDH=BDQ,BXU M*&4I+3$Y,"XY*'=A2DM,C@Y+C8H;W(I+3(W,BXU*&EN9&ER96-T;'DI+3(Y M,RXY*&UA=&5R:6%L;'DI+3,P-"XS*')E9'5C92E=5$H*,"`M,2XQ.38Q(%1$ M"ELH86XI."XV*'DI+3(T."XT*&\I+3`N,2AF*2TR-#0N,BAT:&]S92DM,C0W M+C,H8F5N969I=',I+3(U,2XR*&]R*2TR-#0N,BAD97!R:2DQ-"XR*'9E*2TR M-#`N.2AT:&4I+3(U,BA%>"DQ,2XR*&5C=71I*34N,BAV92DM,C0P+CDH;V8I M+3(T-"XR*&%N*3@N-BAY*2TR-#@N-"AM871E2DM,C(V+C2DM,S6UE;G0I+3,Y-BXU*'1H870I M+3,X,BAI6EN9RDM,S`U+C@H=&AE*2TS,#@N-BAR M97%U:7)E;65N=',I+3,R,BXY*&]F*2TS,#`N."A396-T:6]N*2TS,38N,B@T M+C`Q.RDM,S`Q+C@H9F]R*2TS,#(N,BAP=7)P;W-E&5C=71I*3$W+C(H=F62*34X+C(H6UE;G0I+3,P,"XR*&9O2DM,C4U+C&5C=71I*3$P+C@H=BDQ M,BXT*&4I+3(V-"XW*&9I*3$P*')S="DM,C4X+C8H8F5C;VUE&5C=71I*3$W+C(H M=BDP*&4I+3,Q-"XU*'5N9&5R*2TS,C0N.2AT:&4I+3,R-2XV*$$I.#&-H86YG92DM-#4U+CDH06-T+"DM-#0X M+C@H87,I+30T,BXU*&UO9&EF:65D*2TT-#0N.2AA;F0I+30T.2XT*'5S960I M+30T,"XR*&EN*5U42@HM-RXY-S8R("TQ+C(P,3@@5$0*+3`N,#`P,2!48PI; M*'-E8W1I;VYS*2TS,#0H,3-<*&1<*2DM,S`P*&%N9"DM,S`R+C$H,31<*&1< M*2DM,CDT+C,H;V8I+3(Y-2XR*'1H92DM,S`X+C2DM,C(X+C,H;V8I+3(R,2XT*&ET2DT-BXR*"PI+3,Q,2XS*&(I+3`N,2AY*2TS,34N M,RAT:&4I+3,R,"AS=&]C:VAO;&1E2DM,S$V+C0H:2DM,"XQ*&XI+3,Q,"XU*'-U8G-T86YT:6%L M;'DI+3,R.2XS*'1H92DM,S(P*'-A;64I751*"E0J"C`@5&,*6RAP2DV,BXW*"XI751*"C(N,#`Q,2`M,2XX-S`W M(%1$"BA<*'E<*2E4:@HO1C,@,2!49@HQ+C8V-C<@,"!41`HHDRE4:@I%5`HO M1U,S(&=S"C$Q,2XR,S$@,C@V+C4X,R`Q,3(N.#$Y(#`N-#4S-34@2DM-#$R+C2DT,"XW*"PI+30P-RXV*&\I,"AF*2TT,#@N-2AS96-U9(I M-3`N-BAS*2TT,C$N."AT:&5N*2TT,S(N,BAO=71S=&%N9&EN9RE=5$H*5"H* M,"!48PI;*'-E8W5R:71I97,L*2TR-3(N."AI;F-R96%S97,I+3(U,BAT:&%T M*2TR-#8H4&5R2DM,C0Q+C4H-24I+3(S-RXS*&]R*2TR M,S@N-"AM;W)E*2TR-#`N."AO=BDQ.2XS*&5R*2TR-#,N-"AT:&4I+3(T-BXR M*'!EEPI*51J"B]&,R`Q(%1F"C$N-C$U-B`P(%1$ M"BB3*51J"D54"B]'4S,@9W,*,3$P+C8V-2`Q,C`N-S4V(#8V+C0T-"`P+C4Q M,#(R(')E"F8*+T=3,B!G2DM M,C$S+C$H=&AE*2TR,C,N-2A";V%R9"DM,C(P+C,H870I+3(R-"XW*&%N*3@N M-RAY*2TR,30N,RAT:6UE*2TR,C@N-RAP2DM,S(P+C@H0V]D92DM,S(V+C4H4V5C=&EO;BDM M,S(W+C4H-#`Y02XI751*"C(N,#`Q,2`M,2XW.3<@5$0**%PH9&1<*2E4:@HO M1C,@,2!49@HR+C$V-34@,"!41`HHDRE4:@I%5`HO1U,S(&=S"C$Q-BXR,B`V M,S4N-#$T(#@R+C0X."`P+C0U,S0Y(')E"F8*+T=3,B!G6UE;G1S*2TS,S,N-2AD97-C2DV,RXT*"XI751*"BTV M+C$W,S4@+3$N-SDW,2!41`HP(%1C"ELH7"AF*3$Y+C@H9EPI*5U42@HO1C,@ M,2!49@HQ+C@Q-#$@,"!41`HHDRE4:@I%5`HO1U,S(&=S"C$Q,BXV-#D@-3DY M+C0Q-"`V,2XW.34@,"XT-3,T.2!R90IF"B]'4S(@9W,*0E0*,3`N,#`P-B`P M(#`@,3`N,#`P-B`Q,3(N-C0X."`V,#(N-#$X."!4;0I;*%0I.#4N-2AO=&%L M*2TS,C8H4"DV-BXX*&%Y;65N=',I+34N,2B4*5U42@HO1C(@,2!49@HW+C`T M-C4@,"!41`I;*&AA3HI5&H*150*,S$Y+C`Q,2`U-38N.#DT(#(P-BXP,C(@,"XU,3`R-2!R90IF M"D)4"C$P+C`P,#8@,"`P(#$P+C`P,#8@-C@N.3DU,B`U-#8N-#`V,B!4;0I; M*%M3:6=N871U7!E+UA-3"],96YG=&@@,S0P-2]4 M>7!E+TUE=&%D871A/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I M9#TB5S5-,$UP0V5H:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\ M"UN&UL;G,Z>&%P/2)H='1P M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AA<#I#&%P.D-R96%T;W)4;V]L/C-",B!4;W1A;"!0=6)L M:7-H:6YG(%-Y&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A M=6QT(CYU;G1I=&QE9#PO&%P34TZ26YS=&%N8V5)1#YU=6ED.C8S9C!C-F9C M+6-F,S,M-&(P9"TX.61F+30R8F4S8F,R-61B9CPO>&%P34TZ26YS=&%N8V5) M1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO')E9@T*,"`U,@T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#(V M-S8P(#`P,#`P(&X-"C`P,#`P,C8X.#8@,#`P,#`@;@T*,#`P,#`R-S`Q-2`P M,#`P,"!N#0HP,#`P,#,Y-3,X(#`P,#`P(&X-"C`P,#`P,SDV-C0@,#`P,#`@ M;@T*,#`P,#`S.3')E9@T*,3$V#0HE)45/1@T* ` end EX-31.1 8 c14902exv31w1wpdf.pdf PDF OF 302 CERTIFICATION begin 644 c14902exv31w1wpdf.pdf M)5!$1BTQ+C(-)>+CS],-"C$T(#`@;V)J(#P\+TQI;F5A%LP(#`@-C$R(#7!E+U!A M9V4^/@UE;F1O8FH-,3<@,"!O8FH\/"]#;VQO'1'4W1A=&4\/"]'4S(@,SD@,"!2/CX^/@UE M;F1O8FH-,3@@,"!O8FH\/"]3=6)T>7!E+U1Y<&4Q+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O8FH-,3D@,"!O8FH\/"]3 M=6)T>7!E+U1Y<&4Q+T9O;G1$97-C[(QKJFB.#582MOD@#!.4`RT0!SEWW>&M2.UE\B2-;LS\[V6V==,VH^#M9'R[0!OM`@#.V^L63R$=CG@UE"V%K?SDOY> MK5^0W*W319H[KA*2^:`$$\Y#_LURE<<4]X7M:J:4CRA+G(Z3K:-\IB!/5VD\ M=P37S,/#YL8`:+C=;;.=XTLF87XSP7I8YAO35[!UI&8![*X3NHFP)U3A"GT/ MQ;TS$][^4E,[Q(7-"BL9HK9\?=Z)($OBW3;-TR2;Q'(FI`YL5S#)16BD)G?Q M>G[S-3$20I@[7HC$L<.!9'$?-EB^@XM(Z2N:#1!^GE&EJ5IN;O-D:8[AA^Y0 MUSD,Q%=<&KW!?R9(LA#X7$K_JSF;;Q<./0&B)YF[H:P#N+M.?CBNY!'&^X$+ MR9&3X&=>5)R*C4LBQ,^(>+5>[H0Z#!F)O@0EJ>N+YZG M3#@F45;]6!_>\*@"W!B?BO'S1"71B!"$+[6.#(%`%(]+1$D-7`1/J+-P2/P) MJ\HDZD$_'3!U#:<:"XTN7JM)CIIHZL'4/OQY*?JQZH^3!@\7^NIWUX_4#C#[ MKJ6*(^>*\#SH^H9N),8IN/O=="5T!_/,(?RLFZ;JC:,(UMUQ7[>/PY7A$Y"V M)?LR6!G)*!HIP#?S&0$+^W8OU1T\A!Q M&(NQ:JJ6MJ6'<^141+11&&41-#C2U\611GSD/13E:-1%F-=EO&OJ\ZV&L3-L M@<%W'NR_`@P`8^$120T*96YD2[9N:-CI]O M>\6%D'*WEUP)V>V./]]^,5/M57/@#3N;U49G%MP[Q7LVF6'%N:VY9MX.-B43 M[Y3<<9YC0]+F&BMC7:;EH-+@[7,QIZ@"!T$O&K'VVD#`7HM]D-6QC%"H?U6V))OS4XAP ME,N`VA;FMTO;0/5:Y=7M@;1PC>2$R]JI]C3YQ9R!.LI4J]1!IS'S] M?\R0X_,#<"&DW-7`02FS.SX]?&>*5[46P%MV'%U5-T+QALWN5!TX,)^6V8;E M=]6T7+%4U6`DNN,RNIEB6TSKW+SXX9SL-N?LTCF&Y%^G?-2P(^ZA;L3?KPX*_ MXH,&5?4^=5-,*U;_<7Q^J#=TR4'(MJ!W,2QSG!"KT8J;2STE4?IYCIWK,3L[ M@;TPFXK/L-X-/K@0ZX"4W]8IEU)[Y)2- MK:5^8>ZE*GZ]M:90J?O-6_RW>\M^1'5SL!-UH=0+1=:)X/&]D@;#\,X)7!"R M-'M9D%&Y#9W/V0W-^1QQ>OG:&H$(%TZL`'><0(4S)TBT[CB;/7X73E"H<^/$ M&9@KYY`YX#8R##U<.8<+9\[/$R_ME[R.H/-B?%A'ZDM;6HI)PT:+T#0+]RE# M*QPV-!_W',FHC194\,DE?\IL@#LL65J[D6Q`^VYS:I#-[893^8;2%W*AVYX\ MDE?3XZ"=%;0/G5U3Z6&0=^MQ0/M##SQI_Z_'OU=YB54M\6TJ]NK(TFCU5TAI MJ.D:>GJ(LFUQ-G&=2X9!86CP\X.SS$*H5?XM@F6Y8+\'\`[D3FV9)*^'NVCYM:'[II[4NVH!R_ M(/_NCP`#`*1H2?\-"F5N9'-TX%!G#H`]LF+177>TNET*`;&O"28PD[.3?YZTPOIM)ETZS[+Y][^TNI[>7 MT[>7'VSP+OK)CCJ9L2B%$%7#XM)'.UH=K(E[!.NNXLQ&>M659!]Z-'AS577L ME_.%J%%S=T7)NZ82+'E*;"O%ED@Q61U9_X=BO&J93U<3XIK1L;M-5^L(C(#3 MU4>S)1J7;'H0R*QF'9(=EDF'B=!$@P[C$JR[4,DAUYOUB603K"=!G.,#6OP\ MO;W4NY)7O#OPW>D5TN]7.UR+4HH6E21/\I8%,_N0*'JD0HJ*AO4FMY%"(C@C M1PEJ$13'U;D=]:_%T79P*X#>S717EQV%YHYW*6NHA9DJDLF M.#T1T0:B,8T4_+3RYLS?"MZAHPE40$:>K=-NL&N%>K`%M_WJ(?S-J0K>#'J) M:]<.A?_=M0/4N4!>PYZ]27>Y"?]JZ9,/F4E;0\L@04S!0GHIP(Q/0R0_@-KB M1FHEN81;?J%GW:!_7##%FXW6N_U6^XDW!U]PF,YN=LS0+:""T=$[W4\4$31Z M'>,20-MLC(*Y%$>4Z3`^>$J@Y=6A%@()D]6]G6S"FDG9D:GGS_W!=K:KV"^S M4*K.W9_JE9*HTPXBE11;`R6[Q_;H!%64UJSPI<)N-/]"QH3#_,`M1(IT[$SS M5>*`VS&_MRDJQ=F\A!G70VF"ID]7I60#P7H8?!A7"Y0@"^CJLJ#\![@89X*> MIJSV2*R'P#I` M$B`"$\'EC+=Z".(93^H>FMR%JD80GY=DPO*'2H0C1BGH.?ILYYC7A`#-FH'8 M&)84YUSCCI@P8JT!B%Y3M&Z$NR4I&WF?=-F%PI]K[.$#ICJ@O4P^T^?CX^ZP M:<$;KGM>M4CN&M,"4P\<",4UP5%QH`Q,[+QF'T/&K(2:YA17O%JXERG%P.`J M"H2#%X'NM<%:51NAQ*9-1=T.C]V[F^$Q%G4^H>3=\-_>V>2MZ)?E705KT.D^ MCU(P%`$6/501KB[Y"->E9'#)1EBR>E]RZHK5K2O6MX@+`%P7+=??/`2"/_L_C&Q#U&O."&&2>G(77@\`6=#F#KDB- M:Y">_%I-@CDQV6_42H>>3*:\17PYK_#S2##0C.IRC>Z]>15N1-LRC69-VW_" M%S!N*SF38S"G`@9I-9G]BZL1VFB)]'G_5X`!`#^&29,-"F5N9'-T5-O)&DCD M0E$"[&_TBSLDG6POL4B1PQF2RN'GB]TUSKBA<[O#]Y=?ZI+J7)9T/G_J)K2# MZ50Z:M>;5AWGL;["&1R,^C'CZ"/NRWQ:KK6D7/_JEAQ7W+A@!K5D8.5T)B1K MHAK77,M*9K#&J54[#^]]+I00D7!< M^&@[(MU88UV_.XR@'XUNVIY8')BALZKH%IFS[E'KI*%5+5<]P+5QCA%GXFP] MTE:.J!^Z,WO%S&P/]SB#R/&3O8LF*OE$=U&M1^T=;'0IHH)7ID&TGYS?'KX-W9Y M^]ZXSI/5!6TR`6K)>]4!^97*.AJH-&R<\],U:[='X%W[P&P=?L^W5!?=1&R# MP&01UVWF43=^Z("T]6O;!5+3^-8X;-Q_FR=#C#)%+`H@`E&R^)25+6R%]X[+ M82%[;A@F-:@!"3)1]9*`)Z+A>9Y.R"MK@30@C9O-AT=@Y)T MCX"3)F7/18\M?%<*],"CA@1UFY:Z%G+:#K>HRY,+QO=.!BY(<' M>8^]Z:@``Z8RB7@98I0*/:(F-I>"/P&Y*0+\IM]W_P08`$`\#`T-"F5N9'-T M7!E+U1Y<&4Q+T9O;G1$97-C M]LQM9@XF.&!-8B,G`V*?L2_>:CLP M:`\HIKO=U55=WOU>;83FM=MWIC[\R\%\6F+FN^93^' MH=A4E>":3>[H75^(DM?,=<;/2*@ME^Q@^Z+!UW7.>OPF).J2&7^@JULVFME& M9X841J.K-9_>3E,JE)H+YCQ55CC-)YLNH>Q@"3&C"Q;BO3B<;32S"Y12B@(] M3J+A+?H`R2>D-%D7_!S#4'SLP%CRLA1BO1%B@AN6+1GD.G+=BXZA@_(OI"6A3E_C:*+[DT37Q"DK@:B"># MK@^09(.&%/S?;4)O12:?7Y`K:HRP/*"*SK"H33KGAP`.[?(09)V,=7RL75&` MUBYHZF>_T[.\^QU]:5?*S_"3``49L;@`T*96YD M@!,)\O3=O7G]0C.!#<+I@J-`UNN_4JRFOI2T( ML08R75PLR9`93[9P3-":'4A$K43=\CG%W*[-NWWK#VK?*PX>D"I-6$$(M69N M)0]:A@B9]934H!YZ)2A$;#3*N\4;EG1P@,Z1[C]$SC\)'JJ_$BS5TISB*J%\ M=%J`@T)=$#!2NQ[U,EF'T)AT'4_I,@M>4C+QDDDI",/N/*8AUQF"V7^GX]<\ M+DD*E9<#GX?!REACQF.:MDV\;BJ8H16[LHLN;/NZ.*?[S.:$[2G^K.Z1\3;_ M=SEE86-$?[-._PHP`.\A6KD-"F5N9'-TSF,*>YS&T>\YK/_!:PH/];R,(6L:C%+&X)2UK*TI:QK.4L;P4K6LG*5K&J MU:QN#6M:R]K6L:[UK&\#&]K(QC:QJ]K+WO:QK_WL[P`'.LC!#G&HPQSN"$ZR,4N<:G+7.X*5[K*U:YQK>M<[P8WNLG-;G&KV]SN M#G>ZR]WN<:_[W.\!#WK(PQ[QJ,<\[@E/>LK3GO&LYSSO!2]ZR\:K7O.X- M;WK+V][QKO>\[P,?^LC'/O&ISWSN"U_ZRM>^\:WO?.\'/_K)SW[QJ]_\[@]_ M^LO??P08`+W"?P(*#0IE;F1S=')E86T-96YD;V)J#3,Q(#`@;V)J/#PO4W5B M='EP92]4>7!E,4,O3&5N9W1H(#,Q-3,O1FEL=&5R+T9L871E1&5C;V1E/CYS M=')E86T-"DB)7%1Y4!1W%NYFF/X-'A.=MEWI<7LF@%=0!#4H$0U@4$!`!,\0 MCQ$&'&%FH(=C$'05@0$9#B6[*JB)T$A40,6#`=1XQ@,/`O'*>L2D3+EE='?5 MY/7DQVYM#\EN65O=]?YX5>]][_N^]WXDX>Y&D"2IBHN*GA\:X;O(8-1;)H69 MTY-=66]138HCW,710T;B8&SZM>#7F?+19G(HY+T#=HN>SY&R`\-H#1:M3IO%ZY+U1AV?IC6G:*,- M)G-67H9>&SI/JS,E3S;S6H-49\E>8S$D&W2\06_Q>XL(04H?X4$20ST(EB"\ M%,0D@ICL1DR5$4$D$480X03A(ZE`N!.(^(`P$I\3#N(^\8:,)`O).VXSW8K< M;LOFR/:ZCW,O='\B7R3OH/RHW=1M]$=D1=V*8,5)CYD>E1X_#]HRZ/E@\^!' M_6N5KI_!P#C7A-[[:GDO""QXTQ]A@<67YJ^:D2"5K"V& M]TF8?$MV$4"\SA/CD<$I7Y]'#71WZMD\2 M4Y-62EC1%3G.CW-)"WPK@_/.>4P`A3?]ZV/Y4TJYLE8/J9M?G"[$OASOQ8`:O>(%]8`1HGT`0 M1$`1'@(*K[%8Y8VK.65Y@W-B+@FQ,%XFQC8PXPOWW]2(-]2;:V=*R M8Y>ZK7P5K^EG4$QI,E;8.8LX&"G+P5.,`8J$LS!:)O*0REBH>>;"S>^JL2\% M@>`G!PK(\KM?L#`1O],:@]^-P^/B<[DFZO&1J]OJU:_JQIGQ(#P4C\*!.%23 M)4Y#R@VGQ5L/5'`8QH8`1?=<$C]C&FI;+_>HZ>^^:5X5YQ_$)Q9HUB.ZYVXF M#-=A3S9@J2F1BS&^F*Y.,V:MB^XU_54B.!24H+VSNB_X"PW]7?O^-N$>^VS. M"5\\:'9`M$EB##58!C(Q/%>U]SCHP9NVBOY0PXCA,]%D/$2:9]84[*7`@J2H%->02FW7!&+@"9%C_LRF"!V,'"0.@FT'-^A MWL,O^DKNEMPT>I[-.K<\E@V*S#9PT?'?SU6OMJ:9XV^DWX.HU^`&?W@1=VVE MH(DX&K/-OUJAK,F!SQR9C?#O_:I&F`@9B`([0 MX]F+.?H!#@%W?<^>6GME+4>?JJW855U;LPPOQ![+QN4J8)Q8R7Q;?NW*U=H8 MO#RK>%EI/K=E:T9)OGIN_EWPT2BKR@4(:1.E7?O4&2QSA@M,8EE^R\I?L$6L M'V6F,-_O,(9L,"S>XLG#*@$9*A(KC[)U=<>;^CC(IG:E'0K-8-?E;8TIX7BX MA_I+81/S-[#]`]ODRF7E`G$N@]`XP%>4+V&:>`/09B#$-H$N^$Y;`O+GQ,M@ZS&FSO]V#@#D4;(;7J MZQ>/6:"\3D_?Q54@NO7$3I`W@HP%?[RZ*H'#5WFJH_1$623;;T6Q:;:$8DY9 M9>UR>C23IR!<#!1DSC$PD?&;$6*`1M@Q/UKC[X9D(]O%5^W2`1_ MDM;]SQ!&I^\:"3T45-<`(1&.9L'/'$P,XV+AGF.:`0D/PID6.-0R(&$@!#8")="Y M].$ZIX;Y']&8]-+X8H[.Y<6'Z!@DRR7C?*/'9$Y01UEWM&N@!+T\8\3#=V@: MX<=,J@`/6Y;I:U=``3JYI^H\J'MY[%4O,5[1?YM2:J6%N/@6X"0!4`/]DG[D M`NPL/?XV(`_]`@JO3*JXP<(&!*JZL*"_:`3XD:EO&QM!KL@HF;5$0B'+\$_1:!%I\WU1#[GJ1[;H;+YK!=:G6^< MBA<60T4OA!R33F$,1[_YW1_-__N3CCGI!5F.P\`=AT.EAA:_!W532Y<&:/2P MH?+J=DYY66)VKA,."N3/$J]B")0YRP5FR?:U59=9T8JN.RI/5G("?L:C]M(. MB29.PL60A&YT5+2[\D]Y=,)VLBS*13\NK61)D43_J8"6;$NINL+">BC&ZU%L MBFV)2Y9G2(D?E@M.2B!!+@&)E,`LJDJJ['8!W>JR=U9(#5_QJ*.T\W<]DVV+ M72?T"OWFN9,05&\@D,YPJB"7,5%8OB)A!O951V37=&G$=/3#0?O7KJ'^R2/' M@"?T$=>^&TL3BC@Z@Q?O(-=J9N/E;TD4[' M*B[L;Y,WB4^HKFWU?9]*W=)X]*!XQ[H%++Y0AO#?Q0_E.)6G=M:5SKV@H1W] M)A1I+EI0Q+GLZLB(UZK>#OO M)=M$-/&+`V&RI!FB;):AHH`AJX&I2,.K+0PV0$"D]!6*O+^6EP*U,`J+`G&* MXT6-`19!9K:`Q*'#N3`U?#FW.23LN6R?G^?)^3_G_,[_'-]^#$._@!(L0#G* M2Z!@"?SZ(0Q\N=[W,!H#<3>F82+LPSUDU";`/M@#B9"&@;`;H[D-[!Q],-Y' ML'M+RG.8V,0*D;QD$Q^KRC$O,!!)@8]IQ#3IE,P/U\SVD8;%XPTA+#%:>D%- M_:QUZ(*8M4CJ=/Z5@JOL-:W>$%^:\B&+T/I>&6\W_ M&=_-'K@K<`["J%*`G%X@#^S\BM1A,=>,R>9OQOOACM@LW&G@>`7.20OR3,WY M'"IA0#3:M.J`]QEZ`3[#I,JC1(9:/%'JT`<*&@YGZ\*+2367;=2755EE\PR< M[:+@/$Z+($'LA8=(^AC'MCY[-K@3#K>#KDX3KE"I9BAEK\1VFM M*I)L491"CP<((A\;@9U@84E@>%I@>%E-C9=TZH,87*+0K3-I\"(;-?6Z9$CV M<*EE]"YW:[C^Y0,&GE#3[35CE>Q&X:S?\MXV]T:7W,,5)H0I4XN'=-V&%";# M:"0U/LCNA_VB@F9=11UCMQH?E),H;TC[ZIO4K2D0AT,^>`0O7U*JM"HMF6ME M-BJI3%G>Q[34M"^"!SLP\@X/B:IS:RX7,1GI^EB=T-$V*MV<:XYYAL?!Z4.V M+W5+UW*E1%"ST>4.P4Y._/_EV[I^_04F(_G,M4(6/?`KLFOEB8H;*EBC/R8XREMBJ->SS(L,1%!P&B:M/?;REK)= M7OF3BEE^>\\V&_@A#;M``BQ]@>[E4R>E144BG4YG*)5E&5LJ.*BG7A\<)%&] M(R(CPD>-M?<:!IK9'U,K6YG&=JOSU_K$LVPH16?BA_%(G_^(D3]*^:ECQC(U MQ:975";,R(;[.WJ[.8R=D.;F9V:H9)?RG(ZE-_9V"T?`S1_/:N#1)R$/=*6IAX4AEBA!WW5^K_G!UOBS2P7CDMKN`& M_+Y6#*W7U[+*J/QZ/J8:SM5+,,W$:RK!V[B);3WRWO&Z[:YO MI/\*,``Y^(0]"@T*96YD7!H96XO9F]UF5R M;R]T=V\O62D^/@UE;F1O8FH-,S,@,"!O8FH\/"]3=6)T>7!E+U1Y<&4Q0R], M96YG=&@@-3`Q-2]&:6QT97(O1FQA=&5$96-O9&4^/G-T@K2BXW;8=KRTMQ MWL^=GSW-%X6AS)]R?_(E9VLP+S!Y0ZO/T&Q)KAASP_%#]G!-5HXV]8-=>OG; M.^?+EX0$KUCDBD$O8X@KA@3*EIT>W?H4I-35=I4M<[_U4DP7#B8AQOF-06;A6%2')M#8O-Q MS!_#EN+8"@P+Q;#5'EB,-Q8LJ($1&(E%8OG8`/8,)_&W<`5>B?_1;;J;P6V` MF$FL)4J)^^[KW>^1(603):4L%$\OIH]ZB#TL'O>FO#&EPW.J9Z+G@ZE+IN9/ MBYOVN==NP`1^Z3\"0(UB"`@("T`*D8!'7&7XAG.O=.!+Q:;KM MZ"RT"G`S:"98L#ZY._H9-UD&"?>)7A0A@8#OOX<%H&"!2[NU[1:G'HZZ$7>Z MP#0+5B'_D3`M_Y\HD_0J58B_C/=! M)=$'1R0Q4'F9%LD+@]HS,K3:W>HN4XM,%&;-=JPU MX,5P@8"SPH3K*)3SS[7D-4J4U^X0M^.M3Z#^"0'5#DX",RRH)C*L`I6@&6A& M!11_=O,!3!084(Q.9&QWS!3%2!1$] M?:&CD5(8ZH9D_-_H_1:T+I#,HX\/F\TV:9=Y3[;,N956IE3$57`B\VW^Q"@. MC^X3O`;>D.37DC')Q@,I4K2?@C!80PZ>_^;1"Q;;0%;%$E+EOO+T%H41Q;P+"W*Z^8?_5D,-\?4MYCKL!C&)=A\56,K>PN'"/%*DIA*,BLN1`=>E!*6#E$+$= M+6>12+EQ/; MS*M/,[$I:94IG!$.T`Z[W'Z%#RYME%N'B1W7?'0>" MA0`4WK"<0YT4;$,/)4\^+"OJDC%[+YDNI(6PB$5>Q5%Q.34]'-_@WFAI.,8= M::AJD3+G;CXWHJFN4Z&1+:IT$9S$@/7X.\I4B,ICZ`7?#FX)6^7EG_ MP*?'+DK!^U;HG+9)78T]_+>N69]/\!3@3/I17^BAX+,QV`)^H$?+`$#@K:8B[_MO6=X-8-(@JS=$) M!=8N3@16H44O#/3#X5ZAR],):#K1^6]L9B'&&/@?8*5$0[V5N#4#^4C1?'-5 MOPRJ:/"O&*]LS+.%^IV`7#VUIK!()\SI#UJJRV9NX4!*`=%N6MHH:Z,.P%S2 M>9)BNHWTY;+6TC`7MU7ZXFB!F\'(]]`B2!"<\Y=?FA\Z,3#9_"FO$[95P*<5 M13F&$"F:)^"?LM:T<3#[U_CC_\6/H$,*-]&AI@R`SBD?#$/_KO$!ALEZD,]L=[G8 M0J)M1FJTO&7_2M:Y@$98=NY[90+3`CN]NCK[^#.6GVNAP>(\1S908.5'2(MS M$Q62G[OR9T6B:_2'[[@8C+4>O%PK=,/16CLLZN#_U8UW`<6O`HIPQ*%ED@#+ MAE/;>_8UQ%\J;O(`K![\GT,6"_M0D+")P<()0E-0#DH%SO^QECO_'Z*K-"J* M*PL'F>['C!-(J)1HE5/%1!W'J!GE9.(2@U&(@HD$-V0349%]"0ITTPTMW4+3 MT#0TFS0%-)MTLR@@BT9$V5Q09W")@%&T165,]^]]WOWN_=G2*7;V!.)%"TH5*;4\KB;W^Y1$Z"[5K!)FZ1"[;%MHN>0APD M@^W8)#O=Q]#1`LU69D].@D)@]O-?%AO)_;K#%8DFO!_RYUXHACFU0%'P/EY3 MY<+@>C$Q)D6WTCG5KW>8,1?92G-`Y1X(<&=*#"@R+XNYAX/A7`CY/U M106]'>"DP?/P`OQ>UJKL&<+S+SIM*JL@8A(BJMY9S?L:R56Y1XPW*+ZP#\$L M5<76BC/`530U*,[`KJ):H?6J34:81?=-:<0;-`DKK/?Y%;*>=HI_>,JF MB']DR]\&=W)CHG0+=J)QL9AWYW\6<5,U2(+7B^K$0X:2?\("&N+%4YY3/XM2 M^$%4*VBG_6/E15`GP;I:Q]8GFQ["7\>(E]`.#F2,YDAT"J-612L2Z=#8QBYA M>)T\-@!+SS/"Z`HB56D*91(=JZVO9V$WNJ+]`2]AB.?8+M#]@+PDKK'.6%W% M%JDYCFH\57&BH2O-C?%"Q$N\ZK,/(A93'CVA??V][2=:&3=]9W8%7=:8T]W) MVBN;^-G78#5W1N)XTP*2)\28(,XCY,6\ZQ5-]+]:%K[O*<+4=$'YSO<^VA`PF"_K%:IV(F`J0^:<&*.SD*">_6)M/G]$F MQ;!"ME_SHGJ;XW=M^7=A!>D;$1KL1J_:-"J,^,7/&EM[]7R= M;EZ#KLQ80U4H&F.JF+)#05P8C=_`=E;VN;S:(5J#XRIC28QK];AA%VPL&P0-(VW-IJ$H3$2YRG$1&QO<:S M9>?*[82T;D)L$Z`6F^,W;?EEL)H,30C>[$)[KNV`3X^P<%T,3FGN/23LC93/WVOV".@0'@^:CE^<1/L,]O\:+&% MJ[P/B1W`3MRJ[^EGNO2?=-*5-8;ZDWM-.["'%G^Z@UT3]0`/B5UE*D\-DP(& M#OU-EUTW2,$0V"-[''L1_C*Z+PF6'H?(-KW9T7PK]N&Z*^![UV0FAIV)T\XO M5I(-%56-K8SPVZ6LUGZGL1O.ZLX*HGPV[\6_9P0++`YK;V2)X>`^WIT<:JMI M&2_#5%RB>L/FC^.?WF.(!\YP^RS9YHKDR;K"),'0F3N06!A.KU\:@&=O.[GG MX78HSLG9R`M0,@,J<..^L98NP1)O-% M,3D!N35497M'I8[);U&7T`,_ML$;YU5&98WU&^+O%4%-JH3-^5+EQ:-(?\]5+] M70HRT+F.-JZ>[J\.\6"Q/W*5JOW5@D4XLE\G!'8XUB^!/T\Z?C/YH85X*:BQ MDA-ORE.7"^(!*#-WM]17NELV+P7I#`9=*5UFS/9F<0KZ6):Q5<,0 M4-+2J):&ZNIZ]UO!Q\YM:;1.`(M%G;2W,X.!5U M%AY-4QU-2TEE#T1X[PR+SM+-Y3]`F0+=>1^93ZK_#-V+<@QT6[X\B)U*0KN. M9GFD,=-9OK(B>6$A6JOF0!HGWI8K*[Q$\=]-N__'ZNXS[5[R?_=XM#-9X2VH M'K]&\'_P1Z1&3=2!;N,A#'`K/B=1U4]",]&?[;O:4 MAW@R.`9M2=`$6?F;P*'].=&YHQ3HTA6I!L-)SZTX)U7E\<3F(ZTZ([M]"[]D<%>;,C*%T`.[9'%I@2J+"3 M(5UA\4Q!IO<@`:&RW_&^!=PMQ%?W)TCO%$6@-7@XAW;GII:=H(3MH/548V4# M?;DBS(O%!]'Z>'6HU2)$8$K>$:Z+@F0$#NZF/=X'P_?X,_>FP]VUA@N:#I=W M['4XI9EW,=O43T#IA"UD\<$DIM8(FX,#IB<6`@G+;@'[;UBT_#%V8LNGO$C\ M1V%U&_ZIO^?:LPN"V5MX@<=!7]8>QU3`MB;>CE-=<1RQ0.(X,3:"G: M$E&`)96BH**D_/.44*;"@S*2]>(-N*'9':45KY;:I>>+,M*H5U"OG_&"F>^ MV7=G[/L<]SCKXXF#'UYXEJBN.8Y:B,%1"[E#KMFI%`J0SB%?743>38HP0")J M.G.^EB$&:XO#F^G:4N/Q$Y*JB(,1$O=`-NOIM!#5^TO\DOWE0JZZHF._M:1] MD[):G\1OK5%)'"]<]3)`Q*T``U$'-V"()(HSX4^B-#'1D*E1IZMDT95[Z?>" M/7=LZ`^]&LX2IDN1HJ;DRL-1U/9`><02Z>/>(XQ<3!S$*PR(,!7EY^66T#GF MT_^CN.Q_FZK".-YFW'LFXB1T(]VYR6E('`8UB!A18_`G8O0'P5_$13+4S?&V M3[=;NW*WV%K6[`;,9X67@9"2@AA&"01&)_@/?YSQ/GO/Y/M^!"]+M/\X]^OG`U)=5EZ/*;+>%?45U.H]/%FK7 MSU^0VXK\IX6NTC4S]GL<\@:'_$;.>".>BI!]NQ5O][>-7J]7#>!H(IJ(D6ML M27QUWGWEXJ79A3+Q9P1_\*BW1VJ/W_S1!;5_45/H1L"DZ\UUOR[#1WRE>=SU M7&[9I6FELQB>LJW'T#TM*7=AGG@#Z%`D%/Z!>-U]OC[ID_`MTP4/V48?JFHS MVB[,4FC#[Y[YW&*R5B,+"$[**$)CH%+DS^92SRUIF7ZN64_0?M?K.[GC*E/*GC5]G M$T.C4GJT="KC@F;XK7PSG3T]7#_-TS):>!WN7Z"BH/YH<\.*"Z M@_WD+=;_`1P2E)J:R>'IRO!LBNM_I:#YP4QDC@E;V!YG!S1_!HXS>*J4+-6K M?ZR@BF;X\WM`8D^'>NL@Z[#0,=VM=]]@S=#N_!/6 M&!/5ZH+>:K&M"IJ,E6(R#JKAG6^3@>G.7W*X4$GD^(.Z%#2KC\?G=SYFKSB9 MR-[OZ?!I[FBK`FU<3X[G-%?&+(R,DH?PLL#=>_G=_^BBM$W&0[ZV<(1H1H.I*=P*?.Z"6=E^GTH0GMY.!X/X@LYC1[%]]4 M\/$N1KX@#K>_-^>6.K1NU>68.U+JN?S@_!W`5PALIF]8W'`G$JU-C^)5BJOV MY[9M0=MSV]J@K8%N`ZGE:%+8?ESMW2`Q(D*1;A(L]@^*LM5"3EQ*)T_?EX"( M[,2S3?R^?0DU^2]H+V-O;&]N+V]N92]W+W,O<2]U+VPO<"]N+T8O M;2]Z97)O+VAY<&AE;B]1+UHO2"]G+W-E;6EC;VQO;B]T=V\O0B]B+W1H1$20L)37@$#",-3814!$1&UN[96:W=55-;5:GW5 MW1E=Q\ZY^F/J)L[L'SN_F?/'F3F_[_E\SSDLS-\/8[%8\W9MC]JQ9?O2O9)L ML7QYI$*4)4GSY9-9\M`EEO[.^"\"#I3-G@WD.M,T] M$SPCA8?YL5C5GJW2W`*9Y%"&0K@X;8GPD[!U:Y;Y8NB'&.:+8:N$X>G25+%P M3X%<(H#R`!#8(B0*^3"E8(1YF4_ZQKX,TG-[+=" M1LP?@$1/F6HAGK_EOEW`GR[F$'>T M`>,E'=8,TF!.LQD%:,YTM.9+G6V?*4C+E`=\"VNUU?CB;2EB%$OEI;AZZLJ; MOP,M#:%6AV,?J;5I2W0"C_4ZZ`K*C?DFM4D?E)]5;$)K[('$\VN@QSV5SLH; M%.QR*?]@IEOL.)=A%?0QO_:Q+K]APM^PW^YD-O!A(_*?1+/0%TB-V[>;7E5>ZNRGPZQ:%HS`4 MY-A26.1TJ6BN82QQG.&V\IH>0/Q-:Q,Q2*B9=/#C)Q]0R724N;BRJN<9_.RJ MHRTNG!B,MMALQF3G.G')$I2U(#>S>4+`?63H9^@6 M5O=#D#UBP^M?^&F'DE)W4M'9(W?^]0-$P/QFCU5':W3%>:2B4=_>WMK`_ZDA6H-\L03'+:.($3-SB)XI4"A5E-%03J:VQ8!A7\QP/7[UR@ MVH^HE6:K=V]2133(%_-3$T226$H4UW;=4^&I:*$[RW%8V_;SO2ER..M8O)?V M4[01+8SJW?3FY=-G[EH!=R-*:V&F>D'=RD*+;C.?3;%/,$+^$\[JZ75XFCD/ M<7=019;J:KJVQM%$MN?5ZTL%A^P.L8W<7SE8V$/!C$NP!KB=]`VXB0.+4]F+ M(XPS7M,-$?^DZH^4F&F#T9%/&BIS>]N:/1Z/=F0KXB6@L+5Y@I4FN.)`;4!'&=Y76EU81.JT,0:1`/UVVHY/ M8M#EQ8CK=LDXKMGM%+U9; ME;1T(RI+(@LY M>7!JLO0>D4%T,2E>VJ2#LL,JRJYW-M)$>O<_P#%$GE8.&'3*/Z'"+(33DYQ!"*X?.O-#()%^J?_*P[/4T4I]`4UT MI84CFYS,<6:?N7#BS/?G!-S>%B4\?[7]:GH=;X1A$]_`[/F#$-0P\N<;@417 M8_5E8/=0Q#?'=(>&J-I^Q_GCLD9%U.=H1F0F;5;9G6.0Z&NB_H!E5V&\Q;O? MSMI:5RW54Z'5FXHEQH/T>C2"$F7O5#"%^%5N-N3FUE M^9&&KE/J;NK2\W9@T3\B[N,KY%AO3:N`8*X>VQU30;LY'J!Q/<=L+39JLE5- M!Z@%^@U9-/%J,\Q<&DEF:A/WK-<^&[;X!C8&[WI9`U#'AC'FC_P-G,[7SFI[ MC<4>9'*6F$JLTHS$`YD:C4EJ*3;9K`YK67'@+&9E67BG?Z+FRZ2[B( MKQB1=U[)&=(,-64HK:UHK!^N]-!35;669!I9._L+ M4E`>;&N$]QV%W6WW&!F@AHJ*@1N&6GV`0A\.XH#"5-CWPM13PV:P$G#X;A.4 M^";W`Q5M<'=F=AMWA*2;AQ^%I&GW')T:B\_W#:@>$Z2ADGJC&Z.5GIT?$Y2C M=9=X5UQ..5<>@,(%XWE\BW4;:TES@G`?$XR/?`63JYF.E!NFCWULE!^,AJW[ M&8(:^Q7F>=1MU?WE['Q.4@COQTCP=]F?A6E?=>F0C[;HSX MGIA"@T*96YD'EZ>WQ]?G^`@8*#A(6& MAXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*S MM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X^?K[_/W^_P(,`*WV?X$*#0IE;F1S M=')E86T-96YD;V)J#3,X(#`@;V)J/#PO3&5N9W1H(#4R-R]&=6YC=&EO;E1Y M<&4@,"]&:6QT97(O1FQA=&5$96-O9&4O16YC;V1E6S`@,C4U72]":71S4&5R M4V%M<&QE(#$V+T1O;6%I;ELP(#%=+U-I>F5;,C4V72]286YG95LM,2`Q72]$ M96-O9&5;+3$@,5T^/G-T'B`B(B(D)B8F*"HJ*BPN+BXP,C(R-#8V-C@Z.CH\/ MCX^0$)"0D1&1D9(2DI*3$Y.3E!24E)45E966%I:6EQ>7EY@8F)B9&9F9FAJ: MFIL;FYN<')RGIZ?'Y^?H""@H*$AH:&B(J*BHR.CHZ0DI*2E):6E MIB:FIJH**BHJ2FIJ:HJJJJK*ZNKK"RLK*TMK:VN+JZNKR^OK[`PL+"Q M,;&QLC*RLK,SL[.T-+2TM36UM;8VMK:W-[>WN#BXN+DYN;FZ.KJZNSN[N[P\ MO+R]/;V]OCZ^OK\_O[_`0,#`P4'!P<)"PL+#0\/#Q$3$Q,5%Q<7&1L;&QT?' MQ\A(R,C)29FYN;G9^?GZ&CHZ.EI MZ>GJ:NKJZVOKZ^QL[.SM;>WM[F[N[N]O[^_P?GY^GKZ^OM[^_O\?/S\_7W]_?Y^_O[_?___ M`@P`YZP_$`H-"F5N9'-T'1'4W1A=&4O4T$@9F%L7!E+U!A9V5S+TMI9'-;,38@,"!273X^#65N9&]B M:@TR(#`@;V)J/#PO4W5B='EP92]834PO3&5N9W1H(#,T,#4O5'EP92]-971A M9&%T83X^G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D M;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2(S+C$M-S`Q(CX*("`@/')D9CI21$8@ M>&UL;G,Z&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI07-T96T@."XQ,G4O5R!"151!/"]X87`Z0W)E871O&UL.FQA;F<](G@M9&5F875L="(^=6YT M:71L960\+W)D9CIL:3X*("`@("`@("`@("`@/"]R9&8Z06QT/@H@("`@("`@ M("`\+V1C.G1I=&QE/@H@("`@("`\+W)D9CI$97-C&UL M;G,Z>&%P34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@ M("`@("`@("`\>&%P34TZ1&]C=6UE;G1)1#YU=6ED.C$V-3AF,69A+3DU-C$M M-#DU9"UB.3`S+34X.#AB9F0Y8SDX93PO>&%P34TZ1&]C=6UE;G1)1#X*("`@ M("`@("`@/'AA<$U-.DEN#IX;7!M971A M/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0](G EX-31.2 9 c14902exv31w2wpdf.pdf PDF OF 302 CERTIFICATION begin 644 c14902exv31w2wpdf.pdf M)5!$1BTQ+C(-)>+CS],-"C$T(#`@;V)J(#P\+TQI;F5AF4@,S0O4')E=B`R.#@FL2?W."E_D/, MU*FY1%^IAG$&1#DO`T/>.R#-",2G`0(,`)ZO"_`-"F5N9'-T2DM,S,R+C$H=&AA=#HI751*"C(N,#`Q,2`M,BXP-S0X(%1$"ELH,2XI M+34P,BXX*$DI+3,Q."XY*&@I,"AA*3@N-RAV*3`H92DM,S$T+C4H2DM,S,U+C0H2DM,C`W+C(H:VYO*3(V+C$H=VQE9&=E+"DM M,C$R+C(H=&AI2DM,C(P+C4H<')E2DM,S,Y+C@H M;V8I751*"E0J"ELH9FEN86YC:6%L*2TT-#`N-RAR97!O2DM,CDV+C,H8VAA;F=E M*2TS,30N,2AI;BDM,S$P+C0H=&AE*2TS,#@N-BAR962DM,C`R+CDH M;&EK96QY*2TR,#0N.2AT;RE=5$H*5"H*6RAM871E6EN9RDM,C`T+C@H;V8I,38N-RAF:2DQ,"XQ*&-E2DM-#`W*&QI:V5L>2DM-#$T+C8H=&\I M+30P-BXX*&%D=BDY+C@H97)S96QY*2TT,3(N,RAA9BDQ-RXT*&9E8W0I+30Q M,2XT*'1H92DM-#`T+CDH2DM,SDX+C$H9G)A=60L*2TT,3(H=VAE=&AE65E&5C=71I=F4I+3,T-RXU*%8I-C8N."AI8V4I+3,S,"XV*%!R*3,P M+C8H97-I9&5N="PI+3,R.2XU*$8I,S@N-"AI;F%N8V4I+3,S,BXW*&%N9"E= M5$H*,"`M,2XR,#$X(%1$"ELH0VAI968I+3,S,BXY*$8I,S@N-"AI;F%N8VEA M;"DM,S,R+CDH3V8I,3,N-BAF:6-E2DM,S(Q+C$H-RDQ+C$H+"DM M,S(R+C8H,C`P-RE=5$H*150*#0IE;F1S=')E86T-96YD;V)J#3(R(#`@;V)J M/#PO4W5B='EP92]4>7!E,2]&;VYT1&5S8W)I<'1O7!E(#`O1FEL=&5R+T9L871E1&5C;V1E+T5N8V]D M95LP(#(U-%TO0FETF5;,C4U M72]286YG95LP(#$@,"`Q(#`@,2`P(#%=+T1E8V]D95LP(#$@,"`Q(#`@,2`P M(#%=/CYS=')E86T-"DB)',,#D!`(``#`RZ[/QG^V[?ILV[:-R;9MV[9MV[9= M.^W,!@3\%C&,*:QC&T< MXQK/^";P7_\SH8E,;!*3FLSDIC"EJ4QM&M.:SO1F,*.9S&P6LYK-[.8PI[G, M;1[SFL_\%K"@_UO(PA:QJ,4L;@E+6LK2EK&LY2QO!2M:R M]K&O_>SO``ZRYQ MK_O<[P$/>LC#'O&HQSSN"4]ZRM.>\:SG/.\%+WK)RU[QJM>\[@UO>LO;WO&N M][SO`Q_ZR,<^\:G/?.X+7_K*U[[QK>]\[P<_^LG/?O&KW_SN#W_ZR]]_!!@` MO<)_`@H-"F5N9'-T7!E+U1Y M<&4Q0R],96YG=&@@,S$U,B]&:6QT97(O1FQA=&5$96-O9&4^/G-T$YVV7>EQ>R:`5U`$-2@1#6!0P0$1/$,\1AAPA)F! M'DY!5[EFD%/)K@IJ(C02%5#Q8``UGO'`@T"\LAXQ*5-N&=U=-7D]^;%;VT.R M6]96=[T_7M5[W_N^[[T?2;B[$21)JF(BHW01.M_%1I/!.BG,DIKHRGJ+:E(< MX2Z.'C(2!V/SK_F_SI2/MI!#(?<=J!M^?O30`!7A1I(U>^98TG)Y8_*Z#.WX MA`G:@*`9[T]TQ>D#,<@5@_RUH8F6M09M7*XUPV"R:B/,"18^S<+K,PR)?EIM M:&JJ-M;5P:J--5@-?):4'1A&:[1J]=H,7I]H,.GY%*TE2:LSFBT9N6D&;>@\ MK=Z<.-G":XU2G35SK=68:-3S1H/5[RTB!"E]A`=)#/4@6(+P4A"3"&*R&S%5 M1@211!A!A!.$CZ0"X4X@X@/"1'Q..(C[Q!LR@BP@[[C-="MRNRV;(]OK/LZ] MP/V)?+&\@_*C=E.WT1]1#NI6!"M.>LSTJ/3X>5#AH.>#+8,?]:]3NGX&!SM? MD1T@E\%7SDAF,8_U>!AVL$%->#WDX^%<$WKOJQ6](+!PJ;O]T07NOR40)M7L MQ\',>0'T,`P<[$,+K,?Y,)RSH)]B3G^$!19?6K!Z1IQ4LJX8WB=A\BW913R? M.7L`Y-=!Q7YIOAJV,MFT3->1U\3MJ*ZH5N_[NHPM'T2GYRP2L+2560Y M/\XFK?"M#,X[YS$!%-[\KX_E3RGEIB:G9Q/9`%-@-$R102_P3$3!@I(L+KMD MMF&;O#60"YZ5`:JFUV?+\*^'.[$@QF\\@7V@1&@?0)!,!^*\!!0>(W% M*F]4T_ M@Z+LB5A1SEG%P4A9!IYB%%`DG(71,I&'9,9*S;,4;'E7C7TI"`0_.5!`EMW] M@H6)^)W6*/QN#!X7F\TU48^/7-U6KWY5-\Z"!^&A>!0.Q*&:#'$:4FX\+=YZ MH(+#,#8$*+KGDO@9TU#;>KE'37_W3?/J&/\@/CY?LP'1/7?38;@>>[(!R\SQ M7)3IQ71UBBECO:[7_%>)X%!0@O;.FK[@+S3T=^W[VX1[[+,Y)WSQH-D!.K/$ M&&JP#&1B>+9J[W$P@#>=(_I##2.&ST23\1!IGEE3L)<"RZ$.U(;*`@`3KE%92R\(I8!#0I>MR7P02Q@X&#U$F@Y?@.]1Y^T5=RM^2F MR?-LQKD5T6Q01*:1T\5^/U>])B?%$GLC]1Y$O@8W^,.+F&NK!,W\HU';_*L5 MRIHL^,R1W@C_WJ]JA(G`00!]ZN`F!J2-\X+%$,E*WFDN!N#Y!CQ["4<_P"'@ M;NC94UM>65@O(6!%?>92MJSO>U,=!)K4KY5!H&KL^=VM4"7"?PAZ#X`C0=X0?4:IH$_!&$.0F@S[(;GS`&*SKQN_R$?>[/1FZ9@ M-WUNG8,3R]WKR\L;SZCIK`?[8L+'9.HQJ\'E_1X,W*%H$R17??WB,0N4U^GI MN[@*1+>>V`GR1I"QX(_75,5Q^"I/==A/E$:P_3DH.L465\PIJW*ZG![-Y"D( M%P,%F7,,3&3\9H289JE3@VO[])JD[N+GEUF8U0:38"Q0C[''M%9.@$UI%+^E M("LM??:I`#5.PC[8'Z_&"T&%9\!&&''_VJ-O!N3C6\77+1+!GZ1U_S.$T:F[ M1D(/!=4U0$B$=2SX^4,8;N;P)8K>S:,V6WMI--N_!25EFW4,+]AS3#$AX$,ZTP*&6`0D#(;`1*('.I@_7.37,_XA& MI=ICBSDZFQ,\]6-29^@CLS9T:Z!$O3RC`D/WZ%IA!_3J7P\;'FZ M;[D"\M')/57G0=W+8Z]ZB?'*_MN44BLMQ,6W`"<)@!KHE_0C%V"G_?C;@#ST M"RB\,J'B!@L;$:CJPH+^HA'@1Y[:.#/_(SRL0D&__`WE'(3LUWGOXQHDD&Y* M>3FG&28 M=`IC./K-[_YH_M^?5,Q)+\@*'`;N.!PJ-;3X/:B;6KHT0*.'#957MW/*RQ*S MOJ[K,BCGHNJ/R9"4GX&<\:K=W2#1Q`BZ&!'2C MHZ+=E7_*HQ.VDZ61+OHQ*25+BR3Z3P6T=%M2U146-D`QWH"BDVQ+7;(\0TK\ ML$QP4@()<@E(I`1F<55"9;<+Z%97>6>%U/`5CSKLG;_KF6A;XCJA5^@WSYV$ MH'H#@72:4P79C)G"\I5Q,["O>GYF39=&3$4_'"S_VC74/WGD&/"$/N+:=Y,] MKHBCTWCQ#G*M9F:6,T!RL5VH9K)5\NX7")>)GLZQ#/R'Q;*-:>J,XCB$M;2E0"Z.P*!"G.%[4&&`19&8+ M2!PZG`M3PY=SFT/"GLOV^7F>G/]SSN_\S_'MQS#T"RC!`I2CO`0*EL"O'\+` ME^M]#Z,Q$'=C&B;"/MQ#1FT"[(,]D`AI&`B[,9K;P,[1!^-]!+NWI#R'B4VL M$,E+-O&QJASS`@.1%/B81DR33LG\<,UL'VE8/-X0PA*CI1?4U,]:ARZ(68ND M3N=?*;C*7M/J#7'%$GH%#/SOTC937=T/LF?.BRA&[W-IN-7\G_'=[(&[`N<@ MC"H%R.D%\L#.KT@=%G/-F&S^9KP?[HC-PIT&CE?@G+0@S]2)^A%^`S3*H\2F2HQ1.E#GV@H.%PMBZ\F%1SV49]6955-L_`V2X*SN.T"!+$ M7GB(I(]Q;.NS9X,[X7#+R1OT2SZ'3Y=":BJ5H]7F9:9]W1LBHW_#J!3\(%)I M#`3YI]POR:*IE-N:+Y@K6G_T9.F_D#X%HG?97!H:[>+&M0*;*+K1"P:IDI MEZQU4$$:?:A`O(L`EW/'Y6YS_P<^@:=#'JY3KF`I9JC%?Y36JB+)%D4I]'B` M(/*Q$=@)%I8$AJ<%AI?5U'A)ISZ(P24*W3J3!B^R45.O2X9D#Y=:1N]RMX;K M7SY@X`DUW5XS5LEN%,[Z+>]M+`#(^_PD*@ZM^9R$9.1KH_5"1UMH]+-N>:89W@/G526E0DTNETAE)9EK&E@H-ZZO7!01+5.R(R(GS46'NO M8:"9_3&ULI5I;+F-OMW`$W/SQK'9^\SB$=Q`A_A`$''V'SN,= M@](HL][>Q?!/,%E#C96V&F(85%"=&I7SA.R`?S"&DHOH]RIH\6EW]X"3/4[1 M>8^:JDS@W2`A!W&OI(6))Y4A1MAQ?Z7^S]GQMD@#ZY73X@INP.]KQ=!Z?2VK MC,JOYV.JX5R]!--,O*82O(V;V-8CW^U<]]P$W!:3IQ>OV^[Z1OJO``,`]/&$ M2PH-"F5N9'-T?_XS?M[ M?L_S[/.^BV/N;AB.XTSTVG51:]?-_3@U0ZF9MUZ5D9CI*L_D)#CG[\Y-F^B' M0E'FJ]Q7?N0T%>8-!A]H]NV?)KHDQ-QP?+]]I2HK1YWZZ7:M[+VDV;+YP4L6 MO>_:%[_9@UU[<)!,D:S:II1MR-%HE1D:V9K,))4Z2Z5.U"J3`V0R17JZ;+T+ M02-;K]0HU=E\]0T;6:I&EBC3JA.3E1F)ZATR58HL*C53IK'G.(F_B\OQ"OPO;I/<=&Z]Q!1B%5%" MC+JO=;]'!I,-E(0R4QP]C];0HQZ;/08]IWLF>3[SBO%JG?#>!-V$2Q-MWC[> MJ=XO!0L%=WPB?,R3/"<9)@W[QON>%#+"3.%KIHAY-7FY3"`3:+AP*$,88,)A MD"9W,]%,TTLN7#01.W'PVVNWQ",QM5IU6FY"TNG"5FMU9:6%K:RR5)HE5FMI MD=[PIS6)4H'&L42']X\2T.]8(D*!@8%H#I*+$=N^\OQ*MFO#M?`OTVV'IJ)E M@)M`-28&Z].[0U^QXVT0-TITH7`1!/[P`\P!N1C8M,&M@ZQR8,W-F#:C82HL M0[@)J6:)D77N4D4T*Y"5`+8D6PA!W4S"")HN8IK^/U$FX==4(?8RW@T51#<< M%$5!Q65:("L``K\)!`&^!;SJIE,-G6T[6S,RU.H=R@Y#DU00:LUVK-+A17"> M@#.\PM44ROG/*O(Z):G4/N4`(N#%<%D,ZJ*""U'Q6@RFEP.1?>O MFZ$*)DM;W5%4(M(A+^3=B[00!5&]H`5O\$H$'8J2"DSUCMF\&:F\B5Y^<+R> MDNMJ^J74LP+3;>[H$`Z/1PE. M!7\0Y5>34"4`@C^\X]>/Q2#.[SKP=],"\.S_>Q9.AT[.9`>5Q0)B\6#)%7N!B=T'8&BN\R>BX= M#*)97$P\A?[AC"$CH8-F/D3 M@#7TPS#`G!["?Z/"HXG7)1&#\YK"*GS$-1F;&]\?A5"610:*OS"7F5@NV.&:0@E`\05`(AO`\$ MDP#3X%]OBQ'3A)#[6^/U)L_P?!S`V,UD_>1*]?%VV_#5F^('T;;L@KB]'Z>< MR#_YFU1O_R753%`7E_;6Z'*XR0Y;>KA%.KS>$4$X8NVB>$M>S8ZOD9F[.E5' MH62G41^?OD*K]L_1[RXW5'CH8:N=SO[$U%MCJ:NNE?X9/$FHIWKFDOOR:M,, MXI2TBA16#_MI9SY_@8"&8^"!CI$"N&RRZSNA]PS8.O5V(9!C4#KV$=#,J0;' M%-&W975&A=@938<9=R\NY_L?TDP'J`\#V_7OD/Z%C5(S?_#SFN^/`"&&0+2R M;B&+VBG8BAZ)GIXL+>R0,KLN&LZG!8N1&'D7K8G)J>IDN3KW>G/=8?9@7663 MA#E[ZX4>37"M-%/IKK7M"R1( MSO]8O)$6F4$Q%Q9!U"CXFBNE.8UD1OK*,.0C04(TX2%LAW?ZKG1W27MZOSQ\ M00(^@R$S6L9]U7=RW[FTOACC*,"9]$-^T$G!5\.P&?Q!BSX`'!5+T5&*:=#3 M=TIJ"M\8$&XT+"]CF718SUT1'3;9SX%P("NAG[VQKOFCQ6+4ARI,D7%&:P^!`%S_EV1@T'&U_C4TIP!@=]R,L%:FH=^.W9"!?"9IMJNR10B4- M`>4C%?5YMA#_HY"KI<(*"C6\S@!04QTV4Q,+$@J(5L.">FD+M1=FDLYC%'-: M3U\N;2X)=7%;IBV*Y+GI]%PG+8`X/CE_^V7X_J.]X\.?<1K^MO+XM+PP1Q?^1_^.%TL#%77L9__'8['6;1V;X1@XJ&6>7?5#07UBSV M'\_J^3[HM.,_C<'`&&'W@S8[M;2ZT'Y-#-M@`&VBY66[%KL@VNST>)V+IF_9 M:F_O8^VH34\/E=3Q-J-8-`"QOZ_S%,;[!1J3W>%NQX$>(QK]X(*=4I@U!^^Z MP.ZU6+^V\$T7]/3(KT+[(?_8GLSKXE[S36%C!+1Q%T1#=35WJ_FC9_3T_5); M7IC8F41ORLW3L,J6!Q&2S-T9^KQ]AD,Y4F--2WZOY#.8;H%8/CG'?YZ-]W&- M8X3C!?_`H#@*[72:D8$SDVBKGAHJ:]JS5.R<0R,L.W=Y*:_7:*=76+*//!=S M,\TTF)UGR3H*K-PUTNS<2`7GYR[]V=?(*NV!.RX=P\W[+E>SO*?_);I*HZ*X MLK#(=#\R3C"A4J)5GBHFZCB.2Y3)!#6*B1(%$PENR":B(HL(B`(-W=#2+;0- M34.S25-`LPG=@`@B:,0%`1?4&5PB:!1MB3J:')T,T7C+\Y@Y\QH2YU3]J7/N MK>^[[R[??7BE">98Q/\VVS6!5'0'J?V;M?BO]$?Z=?5!+?(2WTYUF0.,,\*\ ME[";`3EV(_V\D#QN^!VQ0>+Z'4S:"0QKK-!EE_#XV9L+]##8 M+R8VL3-'^=%I`&W-<,36'\/#H"3]\?S-3!.]3;^W/*$. M;X.\R6>+8%(-,`S,PXLJ73ELD5*#2>A&NJ#^-5.)BVV1UYO0I[DJ4Q\#_JA' M#VK<*X&_2:GG(X'B$&TIS#_7!LY:/`5/PW_)=,L::QOQ1;M=125$#D-DY0<+ M13\3[9:SSW2-$0NZ$(PW)^/QE7R--`/<)2.]T@SL+JDA#5Q59X+Q;->(5OJY M-GZ^[3R_0;:_'14?'+4K%!_:BS?!@UZ>D+0:.[.X2"IZB+](A)%J),/+)+72 M/F/Q/V`:"W'2$:^17R0I8B^J(0KL^+WJ/&@284F-4\NCE0_@SX/4*S@&$^EH M[;Y=*9Q&O4N9P(;%-'20$=ATL`=FG^'(``RFU6E*52(;H[-8>-B$+NE^PK,X MZCEV"/+8KBB.;:@U557RA1I!8!J.EA^N[TA;P7DCZA5V^_+CR)F,9V=85_>Y M8X=;N!6&]JQRMK0A^W0[[ZAJ%"=<@87""9G3=2O('E.('Z/.Y5\L;V7\V M3Y_GI<`2C/9X&(_P;@HZ[-7N,[#F(K@^>;T.$'YWF>_:^`PN$[JE&KV$&@F4 M!Z0&*AT4*#NO2)?'GM`E1O,DVF]%B<7NT!U[\4.83_M%AH6L8-U6WB9",?-I M0\LY0W)T`9^7D)=0%E>KGU*O+S55,^7*ANA*KG1/L!#.XG'8P59]KJ]7WQO\ M^W&0=A':G;I2\??F,>)U0R"S4D?@V3`=OC]T[U;6:T4/S(*IUT[W=)R.6I7/ M4S$P&]?1GAI=11LC7D4VKF=M7/U'N1:\Y8KG(\O.Z)(0%O]N#D;8&8?`-%EK M?TM+'9$C;VFN5D+%G#.=+#U5YD#"N@XQC8":[0Y=MQ?GP$(Z+#YDE2OKM;@- MOMC'PU4I.*=Y=,YE/\7O>>,U^,/;B\A*,/T"3&THXO$]F$,_*FVMZV;O%GD& MYI,E5">(,QMAJ]GN9ZL]7!9]:3P1'*0MALYNKL/P63M;46VT-&VI6X\]=?B+ M]?RBJ/NX3^HN5WMIN10P"N@C?59M+P-]X(@<<Z@_I$CWHOM;JYJ%2S,0F:#Y?M33N\5V.NN\"-T_2K>Y(D:PO2"2& M+L+VA(((=MGL0#QA;=/FBW$\=:O2=8E.*6=B:_?5*3EJP,4O/&@;P1C8,OP$ M%O>`Q)S:[V+@J,&'F,Z31&<'YE0S% MB4++5>D;T\FA[1)0@"')<(>!#'2JK56PL-U5H9X\#D#N29H`#;&(0(Y+"/#$ M@]TR^..PTW?#GUBI5T3358)T9:ZFC$@0H`,YFY+\DC;)IZ0@O=&H+V%+35D^ M/$Y!2^49:[0<-?FR^!^RAR651#775U59S`G5T1$I44F<+:*%`JPH(1'=MU)W M\B>!4I#*LB4[]0D%;0QXD:'.X:\DQ?)"=3JC5&KW\'^-/7^M)14?GNDSX;P79GZR>+'Z``I=]%7[IL: M,%;NA=E&MC5/$Y M1T`1V3OUIQDX@@PGNZYWEH5Z<3@:K8[7!MOJ-UY`V[)WY=QFP(":JII(6WR; M[>/'XW#TI2+3/X-8Q`HH3B_9DI]=7T6$'_6GOIRVQ/OKO8E<>]JN]M7LQFU1 MP3[\`$HG9``=:%J<)LUF$DDK)W2=T,)",8*)'W6:? M'1&;`[B[HW!W;'#!HW"Y!]_"J._-E(]XT_@.Y`/:_[.Z\\O0L,7L/3_/>!28'RP!1;"@N+=(7LD1SY=IX:M&KIHWD]YF86'`WX MDWB\?$'2S@U!QZMMV&6PKE=\WWQ`YE0S!`HK]1Q&Q*5T56B\T8_%[\_"XS&' M9P]X/.Z]T5Y?QANPM]0_-?XS+2&65H*"BY)S3S&D34D%Y:9K)VU9ZO4*[ M0442D"X@/WUD[G6&,D(":CQQIH:C>FN*(HZP-26F0X=EE9$[(F4>07SFXU$A ML@3(_),#%"16?>'!WUK2L5%594@4UU2K94YG+WL;(?)&H)&JA6O01U-%!^!_ M%);_:QMU&,<3ZMVGSEG'KI7TDE(G@@&_;\R2/TWO.W/D@[?6!VZ?9ZG9C2%B M?C1O,\/W/QX?['1LK;J9<9+JQUT90,TFIZ*3:5JJUAW+])W?OM[Z[GSU(Y6E M5&RX0PP4A;D\O%2HK5];YCJ*^J5YO]5VSAOOZI!/Z)#?JS,^$8[YF8'CO+W_ MDV:[W2ZX83`2C(285;Q&/K=DO?G-]85ZF7&E")=GU&ZFN\.WOF11[5_0XMUP MR]K3\NZ?-M';^DI3#LUVH^V8*):N0O0`'Q@#=\4HUP>I9>P&0WZO[PO&;AUV M#M-'?+=E%MW'>YU`%>?%8Q#'P)Y?;4NYE6BMQM3KQ&L@(A*4X_K,5_*:W-P2 MY[0/%>-%[523=J$13"Q/5D)%W^?PW&'<-;B?Z4!)(I@0E#2L%"?+$4;!W3S( MA_*",GSU\`/,E]]M/I.-3"3I>+(TFV)1*_JY?"N>O3S9>/#C'%KET)N*L;#] M2I/VHZ[/@W(@/V&#;L'J&6%>PB-OH"&"KPFI')RK3"[$=/W3/%@*I/R+F.C" M)TT]J/4]1%V!U5*TU'!_AP<5,>'*GT0T_LLT*,>\<7HJEJKJ33^&_']@#W%. MCO@3="(Z7>;L#1` MUJ.`,NQX5S(IN2"U-)YCYZBM#3>_/5 M_[059;>LG:46M<\:(Z=YAW0YS)[KO2"5)M^EU M@HQX*9`>020.F63+RHL\'._#S`F&LKHL.2O=(_8+++5XH62^\`>1(]?BTF5R;R]H>7!H96XO42]:+T@O9R]S96UI8V]L M;VXO='=O+T(O:R]B+W1H7 MJ^(*!E2\XM9Z=U<%UG6MUTK;G=%VZ+R'?LQV$[O=F[WMQ MS-<'PW%\UJYM.T*WA2W9*TN5*I=M54E29`G>\\4*EX3Y92)4U5BK>F)<@5Z7*%1"5-7"X6!Z>DB'=[ M)RC%NZ5*J4+M.7UG2BQ3BB5BE4*2*$V5*#X3RY/$H;(TN2HK72H._E@L24M< M(5>(99Y[RLQXI2Q1)E'(I,KEOP+"<$]ATS'LMQBV`,=6XM@Z#-N$85MXV%8< MVX%A.S%LCR^V#\/F>%+!>!B!+<.*<"%>CK_PB?$YSEO)T_F*?--\OR5RB!?\ ME?P>/](OV^^)?YS_YP$I8H&GD`BR\;_?Y)4BD>AJVX,;=RBWHEUFE)@E3.Q` ML8Q*VINDR64$<"-K@'O3@]\&7RZZGC/])-KN&B(X*V8((&DW=^P3>@X7?@1FB87X%HN1V5@!E MMFXXUPU5W3J7D'O41(Y-"";FB28+^>2HSN]"T3%S,F4P)ECR&31C,BQ[1XYE M?T&@CBOQNPYK=>7$HBUQ4A1.9\0Y.JM*ZF^"CH5U9IMM/Z6SZ(IRF$;S7L__K+RN M)TZE*1Y6SF;D. M2J*XH=PW,`S[O^D)68D$2]`+%(MFVV!^"_,ST.F3<+S#"U3\/3E&CL*" MB9FBT^9V2Q*EST\PJ1@T97+C_W&L+K^(,IW].%5GLU7U,Y<@G#`WUUC^1D/T M51`\9,DQ6((^/!S+H,-\V/*IJ*K$Z>J@P:=#$HR"4*!M4VZ>W:'QOJI#/3'? MA8]P'&]BBR=$%*;C-UC[B](H>5QP@8Y!!]!WA)F_C?O$.-157B-(?LFIU:(7KV"=`AH;]-&+5Z, M4N:E'ZJ_Q`B>&WHXM@GO>`:*YSSX_@=1PL'H^)UT6.K`Z+?W(`1FUS>:<]CL MG,(,2E6K;VUMKF_K5)Q?AQ8AQB,_#P4^4=P:_^MP5RLCR+T4>8Z;V0('ZNHU MPMKGL&/$5$MFPKJ3HC#;U;JOOH$4\#UKBU6AWRQ&NY>RY`FX]%`4)=&H-'2^ ML:S6!=.YC]RPB367$F1FI"'2%&GVS_:[4EQF5E%ZD\(H9^+0:JN5:"XR=>_Q M[!WZ"&U'2R*:MCYA2?7YH3KPN?\.WVU,+E*I*'6YXE3WK;-WW%[(`6Y6"][Y M'+2W>;`42D4O3]X=O4RW'M&JC6;//XR7L*!<)(K?)Y&%TY*(EKN-I8VE36Q; M"0%K6[Y^_(CJ3SD:Z:']`&U`\T.[-HZ_^>JUJY(1;$`)3=RC+M`VXVCA"/?[ M1[P3G%CTBK]ZAP-)5EBST[U'_E\U,,.:N=,XFF84 M*FURKL]$KX^;&71[8OE'R'FAAABATOUJNH'-L-<[*\C_;*UCR+2SA M1KQD]R+R(GXA.VW+4*/W)QO4E+Q$UG_]U+G1"\PO(4:[A-`[7/R83";;N3A/ M=-%)BL\TM%5OKV7)Q(Y_@LU-G58=C5F_`K'!T9[H;H+4"Q$9;@C/#\_WS+]\ MQ)"C_@3EIB""'>;WP=QJ]YE[_F3B4,^-9^?H!J<^BR7;$X*114FEV5//7#YQ MYLYY1M#5I(:QM]MN)58)!S@>^05,G]T'@34#?[GO3[;7EE\#7B=-?G$TYZ"; MKNRQ73RNJ%6%_A$%;#W$&C56^R!$>4U4'S#MRHTT>9;%7EGIJ*0[2W7Z@D)9 M?A+[!S1`"+H,3=S2%B'@#\Z,''.1;WM@@4B#5A,N?J6SY$A->Z^V@QX::P6< M?8H$+V]0@UT5S&R%] M.VP?$_`^]PLK21IJ>UM3.GOGMX0>#CR`O/?ZJP&P]Y<#][SX0!4[!J?RC9.) ME(2)&8*-AX*'AF]H6UYJ>GJ";X2%@HB&BX:,A0C5!D/[IP6'>WA.?!IMIX&? MO[*WV+X>?I(%:W)H7'<;@(:3E(Z+C8R.'^/WX07?!@Z`P%BZ]_Z9G7>H=Q*U MV?<]V1..$U;X8?<)%5]H;VAX&X"*EI":F+>1GQ_:][\%009D('5,6D$($XY7 M:4PM8!MVB*"8CA_F]_^(C043KEE_68)9A0A]![2>BVX?<#_[D%\:7YY\K^75 M]Q'W!<\>C@833G0Y=S=Y&GR-9KB]I:7FRAX.XHYV^#F8I'<2]QS2]SR^$[@3 M^*#X)Q75DHU[FS$(E5&8^S9#&GJ+?I2:G9_2S1X3N*RN]RGW1N<:L'.E:G=[ M?7P>5;669!I9._L+4E`>;&N$]QV%W6WW&!F@AHJ*@1N&6GV`0A\.XH#"5-CW MPM13PV:P$G#X;A.4^";W`Q5M<'=F=AMWA*2;AQ^%I&GW')T:B\_W#:@>$Z2A MDGJC&Z.5GIT?$Y2C=9=X5UQ..5<>@,(%XWE\BW4;:TES@G`?$XR/?`63JYF. ME!NFCWULE!^,AJW[&8(:^Q7F>=1MU?WE['Q.4@COQTCP=] MF?A6E?=>F0C[;HSX'EZ>WQ]?G^`@8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J; MG)V>GZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?( MR+CY.7FY^CIZNOL[>[O\/'R\_3U M]O?X^?K[_/W^_P(,`*WV?X$*#0IE;F1S=')E86T-96YD;V)J#3,Q(#`@;V)J M/#PO3&5N9W1H(#4R-R]&=6YC=&EO;E1Y<&4@,"]&:6QT97(O1FQA=&5$96-O M9&4O16YC;V1E6S`@,C4U72]":71S4&5R4V%M<&QE(#$V+T1O;6%I;ELP(#%= M+U-I>F5;,C4V72]286YG95LM,2`Q72]$96-O9&5;+3$@,5T^/G-T'B`B(B(D) MB8F*"HJ*BPN+BXP,C(R-#8V-C@Z.CH\/CX^0$)"0D1&1D9(2DI*3$Y.3E!24 ME)45E966%I:6EQ>7EY@8F)B9&9F9FAJ:FIL;FYN<')RGIZ?'Y^? MH""@H*$AH:&B(J*BHR.CHZ0DI*2E):6EIB:FIJH**BHJ2FIJ:HJJJJK M*ZNKK"RLK*TMK:VN+JZNKR^OK[`PL+"Q,;&QLC*RLK,SL[.T-+2TM36UM;8V MMK:W-[>WN#BXN+DYN;FZ.KJZNSN[N[P\O+R]/;V]OCZ^OK\_O[_`0,#`P4'! MP<)"PL+#0\/#Q$3$Q,5%Q<7&1L;&QT?'Q\A(R,C)29FYN;G9^?GZ&CHZ.EIZ>GJ:NKJZVOKZ^QL[.SM;>WM[F[N M[N]O[^_P?GY M^GKZ^OM[^_O\?/S\_7W]_?Y^_O[_?___`@P`YZP_$`H-"F5N9'-T'1'4W1A=&4O4T$@9F%L M7!E+U!A M9V5S+TMI9'-;,38@,"!273X^#65N9&]B:@TR(#`@;V)J/#PO4W5B='EP92]8 M34PO3&5N9W1H(#,T,#4O5'EP92]-971A9&%T83X^G)E4WI.5&-Z:V,Y9"(_ M/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K M/2(S+C$M-S`Q(CX*("`@/')D9CI21$8@>&UL;G,Z&UL;G,Z M<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@ M/'!D9CI07-T96T@."XQ,G4O5R!"151!/"]X M87`Z0W)E871O&UL.FQA;F<](G@M9&5F875L="(^=6YT:71L960\+W)D9CIL:3X*("`@("`@ M("`@("`@/"]R9&8Z06QT/@H@("`@("`@("`\+V1C.G1I=&QE/@H@("`@("`\ M+W)D9CI$97-C&UL;G,Z>&%P34T](FAT='`Z+R]N&%P+S$N,"]M;2\B/@H@("`@("`@("`\>&%P34TZ1&]C=6UE M;G1)1#YU=6ED.C@W86,P934Q+6,T.#@M-#,Q,"UB-F4W+3(S86(V,C5C8V8U M83PO>&%P34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AA<$U-.DEN#IX;7!M971A/@H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"CP_>'!A8VME="!E;F0](G EX-32.PDF 10 c14902exv32wpdf.pdf PDF SECTION 906 CERTIFICATION begin 644 c14902exv32wpdf.pdf M)5!$1BTQ+C(-)>+CS],-"C$T(#`@;V)J(#P\+TQI;F5AF4@,S0O4')E=B`R-#0X,R]2;V]T(#$U(#`@4B]);F9O(#$S(#`@4B]) M1%L\1C(Q-S=&,C4U.$8U,3$X0S0S-S$U,D0W,3!$,#1"0S,^/$8Y,#,V,#(W M,#-!,CE!-$4Y1D%&0T4U-#`Q-D4Y,41%/ET^/@T*"ZUDWB MJ%-SB;Y2#>,,B')>!H8X,R#-",2G`0(,`*L!"U,-"F5N9'-T7!E+T9O;G0^/@UE;F1O8FH-,3D@ M,"!O8FI;+U-E<&%R871I;VXO0FQA8VLO1&5V:6-E0TU92R`R,R`P(%)=#65N M9&]B:@TR,"`P(&]B:CP\+TQE;F=T:"`R.#,X/CYS=')E86T-"B]'4S(@9W,* M0E0*+T8Q(#$@5&8*,3`N,#`P-B`P(#`@,3`N,#`P-B`T.#`N,3,R,B`W,3`N M-#$X-R!4;0HO0W,X(&-S(#$@2DM,S(S+C$H4F5P;W)T*2TS,38N-"AO M9BDM,S$R+C$H6FEM;65R*2TS,C8N-BA(;VQD:6YG91<*2DM,S$U+CDH;VXI+3,P M.2XU*$9O2DT-RXX*"PI M+3,V-RXY*'!U&-H86YG92E=5$H*+3(N,#`Q,2`M M,2XQ.38Q(%1$"ELH06-T*2TS,C0N-BAO9BDM,S(S+C0H,3DS-#LI+3,Q."XS M*&%N9"E=5$H*,BXP,#$Q("TQ+C@P,C<@5$0*6RA<*#)<*2DM-3`P+C8H5&AE M*2TT-C@N-RAI;F9O2DM-#
&5C=71I=F4I+3,T M-RXU*$]F9BDQ.2XV*&EC97(I751*"B]&,B`Q(%1F"BTR,BXX,#`U("TR+C,Y M."!41`I;*$UA>2DM,S(Q+C$H-RDQ+C$H+"DM,S(R+C8H,C`P-RE=5$H*,C(N M.#`P-2`M,RXU.3DX(%1$"ELH+W,O*2TQ,#`U+C$H2F%M97,I+3,R,BXS*%0I M-C8N."@N*2TS,38N.2A#7!E(#`O1FEL=&5R+T9L M871E1&5C;V1E+T5N8V]D95LP(#(U-%TO0FETF5;,C4U72]286YG95LP(#$@,"`Q(#`@,2`P(#%=+T1E8V]D M95LP(#$@,"`Q(#`@,2`P(#%=/CYS=')E86T-"DB)',,#D!`(``#`RZ[/QG^V M[?ILV[:-R;9MV[9MV[9=.^W,!@3\%C&,*:QC&T]K&O_>SO``Z MRYQK_O<[P$/>LC#'O&HQSSN"4]ZRM.>\:SG/.\%+WK) MRU[QJM>\[@UO>LO;WO&N][SO`Q_ZR,<^\:G/?.X+7_K*U[[QK>]\[P<_^LG/ M?O&KW_SN#W_ZR]]_!!@`O<)_`@H-"F5N9'-T7!E+U1Y<&4Q0R],96YG=&@@,S,S,"]&:6QT97(O1FQA=&5$ M96-O9&4^/G-TL8##Q2#FKAJ MXIHE9319W>3KR9M*;0_9VK+>J^^/K^I]O^/]/AQSD&$XCJNBPZ,B5R[S7*/3 M:TUSEAK3DNQ==U&-BY,=Q&D3IZ!`9/BM\+=W%=.,N`ODO0'MD\Y-<_E:AI,F MS)!HY-.-?$*F-LE;HPE.2]/$V">8-#%:DY;/EKKC9#0ZDR9!D\DG)&GU"7RJ MQIBLB=`9C)EYZ5I-\'N:!$/27".OT4GO3%D?F'1)N@1>IS5YOR8$PZ6#NUN.!>#8,@P+P[&U&+8!PZ9+CF`.&(F]@\5@ M)NRR9,1:?$#F+-/+0*Z5GW$(9#[YS%'K^(-3H%/+ M!-\)#1-^<8YS[G#^<6*!S5Y/BC^*?2?&F,LIT4-8`HYX+Y3+X1@`O-@&LR3PVW@Z;#M M*\NRV9RRCU.2U>OSA\"=@SSRH1E4-P8_7XT\632`G&FT\3F:#I-!\RT$0"B4 MH(G@Z.:!5.ZHEE6:6ZQ>.3A$P2RY&-5"S]K>=H,3;^23J!;AB@QR=U=7?8.Z MQ[R9YVPT&5F1A!PMK$ET)I5F/VXK?4R),`/_!6 M``&X^>X!!KS0&]V1Z*UH-#,FAVTG'AVYLJM9_;)IIA%-0"YH*O)#P5RF.)]4 M;OM"O/E`!8?!(P@(:OBBN(]N:>R^-*RF'M_IW!SM$\#'%W+Y)#5\-P,F)2!7 MQG>](9Z-U#]?J$[59VZ-N&WX1A+H`DK0C&X9"3S`48][VWJ$>\S8LA.>:,)B MWP@#J]QQ62P!"A>=[LMAMMA/0P=Q$B@%&B7^C)Z/E-TMNZ%W/9-Y=D,4$Q"6 MI6,C8KY;H=Z2FVJ,N9YV#\)?@0S^]#SZZB:!"ST:N$,*@$NYBF$'H7%9R$(.1Q=$9]74FQB>R$"E&=_ MVN>(9MJJZ4!S1%1DX178T%EWWF)AZS_;8VE2#S;'4 M&'*RM=-W/N\XV,?>W'1M2P"38?:9%ZZ_/L(JZ[)A7U]&*_S>IFH%+TFM+W6J MHX@&*?ENL`;"&2E>W`5?%*I%B]>RU`,4!`[:X;V-ENI&ECK56-50VU@7AU8C MI[B9.8XP4ZRFOS9?O7RE,1)MR"R-JRA@=^Q,+RM0KRBX"Y+N+\T"!/6(?\G! M/[4&RJTA`AU?6="UZ5=D$ING&@G$V_KT0=MT:W>X\K!9('55\=5'F::FX^TC M+&01#:F'@M.9K7D[(\M8'NZ1M@KXF/X!RG]&Y0IEC5G@#\'006@]R`NJ5S`? M?"``L1!$&6`//*,/$E36M8HGA4U]K&AQ:+986D^KJ>P'^Z-# M9F0E((9#%IL3#:,$I8>4FEO/'S%`N'VQL(&M(JGN$[M!T0IR!GS0EII8%EWA MB?Z*$Y5AC"V7C$HMCRUEE5_F#EJ=.O%3$"+Z"7+K#/"BO?V#](O4:8&-(PE< M\E#ILTL,+.J!.>`!Q"/D-+^;%:`HG>"+MV>G9RP^Y:M&R6@Z\D&;T2I0(7_8 M!I/O7WUX9]P^OEM\U24)_%':R+_"4BJM80H,$U!;)V7`!R(8\/:!I:B311<) M:@]/]I3W5D8QMF(R.<<0P5)I4"G>H/?OW"D,J2&H&>E\T(ZW5R*'^.U[CW'C M%G;`Z2XXU#5NH1_XM0(A4#G4X28K1_]?:&1:14PI2^7PXC_(8Y"DD#[.,V)& MQFQU>&Y]+P=EY(O3>C2IGFN%[S.(0O1F7(:GQ1$*R9-[:\Z!^C:/W)HEQ1MM M7Q'*]5(@+KP&.$<`LH5Z03VT`PY4''\=D`>;0(94)U9=9V`;":JFI0&?<0)\ MSQ/;WBU_($B;65;A/M^MD4"&2*40$HH9P>@0\!_D3!*P4]N-0OT MND\^K+G$B+GDM;[JD]6L@,9XLK>B7X)$B:@4$LGK_56]]OY3GCQ1?K(RW$XE M.K5L78E$Y:E`KMN57'.9@7PH1?ED5'+Y.CO%,5*)VLR"E1!P4$A`(B'0:VH2 MJX?L0#<'+0-5TL"7/-E?,?`_;4GE:^UQ?DG^X;\5$U3_`3\JW:J"'-I`(,7& M6'_DJ0[-JAODQ#3R28?EEIW4OWFR;]P?ZH@]>_J*V!*62N?%4=(>DZQLJZ_D M:*^XK)?J:YH".0(17)?]MQ%&G"[%.%=<;>M1M(O?$H.[FD<^E::E\N2#TOJM MJQATOI)$/XE+%"B%)W8W5:PXSU%]-@,99BQ95<)*5N9V6J=VXMT0`K]"B%QT MM7K0H#F"EB./^:7H([0$+2F%C[X#CR.P'#1_RH:^M86RDN.(Q:I16+"P@6#<*XL(B`B6!D+TMX(1L($I80EA`R)+2HN*6,KC*;J MQ'*E:A2JQ4?J#DMCXPG-D]Y=J,#`I"R<:OW/A4YWPT6)="`];=$0J1JF!SSB MJ-I;8VVXK'E\.GD6OI^0B\'5G!B-]]4EA9;6(@ZU<$H^Z'SCA?<8U3!$8%K= M:@I#I[A:Y36%21B6'N"CRNDZ7[K)5_6YML<,;#E*8`?>ED.*(B"43H_Q!O5X M#H`_Y>'D#<=4+T2#F*V&O7N)P6@LW)^U[?@RC>HA;LK$#V*TYC"(7,+=V2._ ME7E>_R53;)R#4R0_5VT$^=@!+@O-'D6+O::UW7LV_0\-K+L)4Y^#?^2U=">' ML^_+5??#SQ@Z!IE;EX]=@G=O(%G=RDHL$R>Z_2?\0DO])OPTI7ZPF8X@KDLF M'G:K5]3HK<\842!#56^,;;A(Z5&80"L?'U7PJ)5[%&VPZ$W-+W;EN$#"]::5 M$N-]E'"&"SY_M_^?\!D\Z)?Y-OH6JS%'I_BMRI$>P^`U$FW"^90A'YJ!O)$[<[;IQ74&[I'; MG0V7Z]BW>VO+$P/=_BV^2)GO"ZF-3:?HY[NJ,YDR4[6 M_W_E\_Q)TTXF9T]<12F+,OR:1K-">7E+@;N9Z7+4#E$TSW5D@!>2:\H@&I^% MX&RR6&]:(SG*:VINAW*M3QE81R`6;K9U>^PNV_2`T*)N<>8@1`G^]X"#<)@M M<_I"U;T5KJIMS/C?#O+K%7G2N1]*O!I8\C,-A2H(7CF&9$WJKH/Y'#@PGD`\ M#JD[ZIM/GM.,U"*S`1>F;5D?5SS0Q06$F@4QZ(Y4>XC69H&3B5Y!G6CN!DQ4*I[ MJJ*Y(HG!\V1K/I]:1L^5$]4GF"#Z:&Q.[DX_UW?B>']?>D]R4D9J"DOS=LE= M^*=?&H<,KHDIZOFP7*>(FI>T/3Y)F7,)'Y(\BST<_#2_]P[UM7.Z!GE>:7YF MEF:'Y70+!X.O:-05H",/E@A!#C%S/`.60Q!$J,9$@Z`NMI?;RAIQ#AA"5*-C M$-3:*3BZ[-,%C*"WYQW5>4R1V;SB8[;0%?O(R;1TV@560)N>'*VJ*W/N@VGX M30@&8R1?O=VHU,-R@>1;,LQNINVG1ZY.UIOHS*LO5#H,M0653,'^JMQJ:80D MP.#R+6[&?(<"V@^-Y]I(49,8?QB2FI2891'U=1!HGL2VKSH8/#%E$G"3+5," M1'Z:[R/UOP(,`!__TVL*#0IE;F1S=')E86T-96YD;V)J#3(U(#`@;V)J/#PO M4W1E;58@,3,Y+T9O;G1.86UE+U!*3DU+0RM4:6UE%LM M,38X("TR,3@@,3`P,"`Y,S5=+T%S8V5N="`V.3DO0V%P2&5I9VAT(#8W-B]8 M2&5I9VAT(#0V,2]4>7!E+T9O;G1$97-C"]H+VDO8B]T+W1H"](+T(O:'EP:&5N+U@O3"]9*3X^#65N M9&]B:@TR-B`P(&]B:CP\+U-U8G1Y<&4O5'EP93%#+TQE;F=T:"`U-S8S+T9I M;'1E879F$&61'0=E MEIM=C7JG1$#44P3-;A1%Q1POG^C!`HN"P.+NPBY!Y(W"`BHJ(.I*>!RB(`]! M3C%E+**Y4_`9!#7QD3-(RI1U>&5Z-C^YNR%4)7<5ZZ_JJK]K^NNO^^_^!L@2-4EC[O<$.2ZX2@2W22[(#R7]N.='%])- MASE"NA,T.G>[31N4878X?MBZ0I>-_*\%P\6`3<,S1"9N!83,);(X=YH%A7ACF+<%\,>Q#>RQ0BL5B M6!R&F3#L`[$G&(&1F!]FP%JQ'NP%]F\\`-^+W[);9&>PZR<6$M'$2\E:2:'D M6_(CLHERHDIIC-Y%5]-#]F'V]1/<)E0XX`Y_#,Q8^*S20LG=3E2CJ'2 MV5*K5'#*<^J9O&/R`V:BU06W/FKO!9S+3I\%RA%N0;A:'RMR7 MJ8-XJ3(?L"6I,O!J9R*?H.DL4]UX].N^>]R3X$JC/GY/9'1+=GW9P>+B4K[X M0&EQB9R)+"LKR#&G_WF-1B$UP,8;>#L4$>UPE`V$HANT5)D%!'X7"`*8.S(,G[)V2NH(6L_W-^`JUGE-%^7GP0=J>[?)T8YYN MTS<%M3`?)OT#9L"T/Y[3G%0PS_HN_.7"5:XC^3O$!G@GH*G1?-4^LJ&J\^&0 MO+]EXV9/5;A7DE@LI*^[*02;9!7G(>\A8Q82()V=)01'4.C6:#"Y#IIIYJ_( M=Y!FS.`[0J.`FRS*HR`'ALD2L>FMPN>/,S"9JK\B.5(J:+M14X9 MN2_KY-&6I.P=EPR/ MP!OLWH+KBZS3D5<40??GG?`]9B_-:!`D%R'O.-X\#`>^)800FXI%!;EH.5J+ M(C@4._(^.,"J%ECP)7#+!J:'IF;&A_%6D+X&.:QJL$=1J)U]V_C[F8C3I M7CDD4FCKZ##92\%.VPQ29&.3-LAZ!OS[07AYYH:7LLCX?F,R+'RUM`LF56ZG7$/=*P0Q>/?VX\R4W ML+X/D8MF;YB]]'S<4[48Z+TZ*F$AQPP^%F:QW6<_>S!X;D/8@M!8K9[?4>/] M^4-.:DV%W`N"I`%O?`EYWQ/74U@H.PZS(01V1/7"? M?G:RM8LO*C`-DMC/)/XQIP^FFBD>] M=[FG016I6>'[PV(;]Y[]/VW8^:LV,%YM0OP[!4#`+5;8TB$L,N%5MM6$;:.5 MC2C-*-_U)2H1>J>9*!0SFFF.2/C0J'=-,W]RJB,3^=BXXMB>3,YNBH_/:J4_EX'3?=T;=>!GF5N%9J]DJ^]>(0`'.)!QW M@58*KC^"S>`*1K0`<)2G0#44<\),#^:79ZNYT2#:/S/]@WT\DP`APDWVE,5Z M"60]R9'=_)WUM4L76-?-2*!-3M$%G!QQI$[.\'H$3-4W_P:9F M88Q)^`Z6L3IJ=L261.0L1W,LQ1T***;!H_!)455&A:]K#>PQ4BNSL@UBG1Z@ MIYHK+-4\R"D@ZM.]JQ1UU'YXCQQMH)@6,WVCH#;?;XS;6':CCP>VW^$]^P?>G?3+W MJ/:);]5DI5>6FBH><*"C85;A@Z+:[/+%KN.C<;D+6JWX#R/0,T)87>",E5IV M,-O:QT$4]*!-M&I?RN(QB#-6>MPO!-'W*BH'#O%6=,9,]^V/A; MOTAA/%YJL%AM$BL.]`CQ7ZJK/"B*,XN+D^F/K+6Z1:=!NZUN$I.8J/%@D^#M MJD3!`_$`$1!O`;E$.89A9CB4$1P:ADM@@.%T@%$$.302$,$C&A*OB*"B(S%N M3*W6!C6^IKYQ=[]!*[M;W?]TU7O]?N^]W^][[RMUA`XCM5CHB-W],2T68$&M`5J M-]:Z`VU4J??SNZHMR[D(9;A"G9U0'"\D'JG6M'(F>#\3?`AS:M_&MCLME0[) MAE^08PO[4SC**N($291C/P75>ZC\P`+6.@7A4;&J15J2;Z(1+5)3,H?^U6!7#Y2T M$"@9O%8SX$%.&R<(`25V)5J931Y7;(^5.`0^QD[@(32\@V4?_0Q[00&R@:$A MD,W%"KSW(QGP6OQ79H:XKBZ@45GDTYE28@^C"F'Z"]C+ M_E^,=W$\B<%/?[*/;]L@=[D#CGN`Y0K+=!E%`GXR?)$9"15/%A02:@1"),3; M(`A$S80;+0UPPB8X`DE#!/=T>+*1V2[N+XTQX>V0/?YL/CA6`)CKT)R4<;K&[.0CJWV32>K*UQ%))Z=KHR'W>]6NX63/7 M8^J3GBV_^`@P^8OBD'6L]XYU\S#G"XYM"CZ:JL/!\@JJ.+^DG*]K#^GC8-*U M?SP48!O^J0RFL%?.FCM>]LR:4\)74R.*EYZUVI650\@0A)2_-UOR-3*NF8G& M:ZR4VX5@=$T\'ETN5%&IL%!NO4REXH7R*G+V5)B,,)KKLJ91B].B9]JH\#6R MM?ZT-&RT>S$$KT_+AFWC$:L4U(U#54IG%E>BN` M6S;1W+6)AIP+?=JB)"*F[]$:,E7(."G0@=<]'HK0RQ)#?^[(`752>G#2+D]Z M*)-N@ANS)$:Q`CMQ.)^2W*3?Y09K)8K#B^1'J:N%!3_`)`ZB**N']7>Y2KJ, MJLA*-?:GY`N@C87Y50Z-CY8]@$\&Z)?0#..8\+3$,!6O30G3Q'"[(\QM@HCJ MCYR'J1T\S,"!3$J2)CF6B]#5U@JP$7VK^R?^E*>?8OL`MQT)!9'FH\:*"._5-]ZN)0K-F>TMPIC MDX])8[Z#V8;3<0[7+1#WB!X@.]MMYD)63^DQ[N\-'T[W2,!RC/:Y%9X07!.8 MW2_W=L#J2^#R^-4Z0/C/BWS61J?RZ=!-:44Y;?57^JG]-?8)*",[7Y?-G=;% MA@LDVQ\E>:U==;],^@!F,KXAN[I`- MZUD;UDTC6'/_P(IGHMH]X45;.?S.-(RP$]X*D^*:>AL;3:6"Z$EEINMR%\YC;`E\E"M!#@5.26^=GW#S\ M%T^\&G_0-X=L)Q]>A(GF?`'?@VG,H^(F4S=W-]_=/X?<*G0&:?(QV%9C]]PB M@RN2#X/'@3W5J._LYMOT?VOERBH+:^NWF-9C=QW^:KTP)_0^ODHM5*9XI/$J M*#2@&>+AHY=9N`ICT5@<<0$^[ML6"U.K84^3OL:AYD;$@_G?@F^_J8;N=:9/ M.3^;Q=25EIL;>?+9EERA^S7-OC>]/3V0]5F^!;_+$PM,!36;!;IW:Y?DQEQM MJFP8+,9L9(QV\?(%43_?Y>G[SG#S#-.T$"7$B[FQQ-#9L",F-YA;--4?CUE; MO_E2E$#?*G>9K],HV!*,Z4HS)E;;;C<1UO>GW+0MX6N@!*<'` M;,I+UM]BP1\U'X8Q>-P:O]!-P6_HF/F6CH$C+<[\H\764+0D^:#W05*T,`/R MTROT_2RDHF]:F@RU7'?%3G!Q1[KCX/TAASM#7UKH MEV3?2390R[*T)60\`SJ4N5'AJ]BHG*!"8F&A6,05&P]["5B%%BA35Z?Q]/@K MTFNR$BJ*0AOJ*BIJ:V(JPX-5H0K>EM%L`RPM(AG=M]#].8Z@,5!Q&?(]8DQN M"PL>9.#Q>)6\0)F7+.'-\>_!GXC*\UR<$!N!K=.Q(]D^ MXT7V"FD.\7R^#'#RU?`06AE0OJF5&(1 M:4!1HGQ+3D9=!5F*4*_ZQ:3YGFOVQ_*M26&M*SCO[:&!7L)M=)"`'=BL#%`% M:.R52,S-?].052,$,ETH38`L>;$`;,]7%QUER:6P\ M:2ZKXRZ5!GD*>!=:%*7=;;/829B2E6AH8R$>P3@WTV:O7<&;_T-YE08W547A M5DA>58R01[1];WQ/1W'#!>JH,(Z*6!PZ:I%%*-THM(6FI=`U39O7)3';R]*D MV9J7-FV:M*2QI4`HI=)A*Q9*&=0RB,H@'1AQ0=R=.8^Y_/"&&?WOG_OKS/>= M>\\YWW=/#G/Y+MW7";J"NW0.WW]TVJB8'DT>N`'"C3G`BX4*1"W'"^6#B+[Q M!"C@N1E@?X5%SU]'#[-==[(4:%XMO/?E7Q/'IW\XAL/FH\=7EV2S,E01A+6# M8DI`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`(S&[#8$.JJ^W+6)G`BB;(WHL/89`Q;Z, MGQ$7>3^EL--N\M`N3WB/CX6%\&7DM*MS;UMB^7&IX(0*W@@DAVZ_/$?\'.-S M1,388ZJA6@R5K=7,4E3]&I1)N+C!%Z0&^MJ&G!A_"T>,&'WZ_4BR!.6FYL/" M#X`>"_KO4:MDAV#7NVFW MPQOO9(&!7P/[G=Z0*RU`8)F`F`K[3'*7N&T.3%Q4.(P=+1RETIEV)H0L/T`T MVBIM)9-H(62G7H5Y;G\L-FI+"Z!TCNBRA"TJJM6@RWJ)40]LFPI2H3Y[$"=4 MQ!%#M@[K2-9/Z(E4)$7+R_.;^$IS&@>+,)[*&N19GQ!J]S"7X4$)=N_95_\0 MQP-R0=Q*[A=W)YZ\4RW'27'%#`PK<@;6?K&1 M(?]NQ0O3W$[-5FISZ:Z<#>J(C_'O]>ZENKA(6=7NAAWKI@HOWQJ;GCY5-91Y MBK'C>?QSQ;6/#D]_1IW>=C+W((,>`8FD.J3[N(<*=Q\YPY!_)7W2RS6P>B57 M3C5Y=AT8[HS$)K/B[ZY\I^35U8=*)_(9'K>CN&*9=]/:MRB0_:Z8`!(E?;!% M6;4]+V?L0`FK"E7WCU#C\6",D5T75T$22@*3M5X^&B\&]L?$08Z0J^%%O,3, M2ZK0+L_,H)9--H?[A@*C!W=XJ_1&B\7,6$QF"T_K]4Y/=^?8^4,LN1)JNO]' M_%UF$V9.DL>`+8[_F#C(#63H4W$5AHEYOSU_@;JZUE];7<85%NW3]KN<-EL; M8W.TV>RTRV74J34%F5M9T@P&]?^(ES4)MY\5D,H+-58I!-QW.!O1)(@;O5`@ MI*!=-K'&#?.M]T;OF[U?-"^$VXI_!!@`&&L:<`H-"F5N9'-TU!39QK&SR&<`%[BRC%6SG'. MB>/6RWJOZX6M=@>5:55$J[*@@!`@2"P02$(2"(%`0DB("0206[B+RRV**QA0 M\8I;Z]U=%5C7M5XK;7=&VZ'S'OHQVTWL=F[[OQ3%?'PS' M\5F[MH7O"`M=LE>:)E$LVZH4ITH3O>>+.1KGWO-EGNV/F^;#S9TV&VU$:3^: M?O0CYLJF3@?##.B>>6;NE/Y`S`?'*YHVRS*RY=*#*4K1HL3%HE7!Z]O%(4DR1(DHCW9"J4D32':FIXHDV?(Y&*E)&FY2!22FBK:[9V@$.V6 M*"1RE>?TG2F15"$2BY1R<9(D32S_3"1+%H5)TV7*[`R)*.1CD3@]:85,+I)Z M[BFR$A32)*E8+I4HEO\*",,]A4W'L-]BV`(<6XECZS!L$X9MX6%;<6P'ANW$ ML#V^V#X,F^-)!>-A!+8,*\8#\0K\A4^LSW'>2I[65^B;[OLMD4N\X*_D]_B1 M?CE^3_SC_3\/2!4)/(6$D(/__2:O#`F%5]L?W+A#N>4=4H/8)&;B!DJD5/+> M9'4>(X`;V0/ZX)P+ MJEU:9R#WJ)D)CIA1*;T@T%S!HQF1XSHY<\_["("U7 MZG<=UFHKB$5;XB4H@LZ,MW=5ES;\,;+.%\%IQPO6>_UEYW4".3@1Y MK9BT_(O%;99D*MN85JQ[YR-[>YXERA"DA3*GG]0FMO525?9J1PMS'11$26.O M99"N=YGC5":E6DNQNHO4]!"5%@A%AFL@N9 MA##[#0S#_F]Z0E@P'[9\*JPN=3@[:?#I%(>@8!1DW927;[.KO:]J5TW,=^(C',>; MV.()$85K^8V6_N)T2A8?4JAET`'T'6'B;^,^,0QUEUYT!#E1D=9OR&@W-:$9 M3R?KYS3RN0`.$4<&2P$<8=T`MSZ4- M18[RKM?PM;V:-=H)LB_<:#87Q!$6?KOYT+%X&@6A96@G6IAN_^`-2PYLS4*0&FVX*4M)Y5@S3[N/]SR\QI!]DU,KA:]>008$=+1KHA?/^#,/%@3,)..CQM8/3;>Q`*LQN:3+EL3FY1)J6L MT[6UM32T=\G/KT.+$..1GX>"GLAOC?]UN+N-$>1=BCK'S6R%`_4-ZL"ZY[!C MQ%A'9L&ZD\)PZ]7ZK[Z!5/`]:XU3HM\L1KN7LN0)N/10&"U6*]5T@:&\S@G3 MN8_/8.?82V MHR61S5N?L*3J_%`]^-Q_A^\VI!0KE92J0G[*=>OL';<7$G[)H>^PF;H<=:U('0]\C^#U).NCD)!`BC)8I4-6TPE%>S M9$[S8Z@\0=V*+<]:]3Y:OB^5L=A@"K?=F[8\,O]/A9%%_EJ_8X<)5TE%7CZ5 MJ]VM%S-HSJ2%&.:[(+#NRL!=__:F+X$X3SMK"G)8TIT7C'HSJ8P:3?=M]_6+ M/9XT]&6UK(O8-AL(\C) M).-ZK<3B$;U285*QL@WH<`R5;8T[.]1_Y?-3##FK@S,*IV$M.:Y#"J4F):4U MI\WE[&KRRKBY<:<'MF^4O`<:F"$,VZ^2R>E<:ZVCJN+/MDJ6?`M+N!$OV;W( M_,A?R$Y;,U7H_.9?/J+/57V" M\E(1P0[S^V!NC?O,/7\R::CGQK-S=*-#E\V2'8DAR*R@TFUI9RZ?.'/G/"/H M;E;!V-MMMY*J`P@FZ[JL5X\ M+J]3AOT1!6P]Q!K4%ML@1'M-U!PP[LJ+,GJ6Q5959:^BN\JTNL(B:4$R^P32<]--8&./L4"5[> MH`:[*UN8_P)2`JW]$_C,HU%2D!^;!I_W'P5]!H.&A8%Z;7><7ALA?3ML'Q/P M/O<+*TD::GM;4SI[Y[>$'@X\@+SW^JL!L/>7`_>\^$`5.P:G\HV3B92$B1F" MC8>"AX9O:%M>:GIZ@F^$A8*(AHN&C(4(U09#^Z<%AWMX3GP:;:>!G[^RM]B^ M'GZ2!6MR:%QW&X"&DY2.BXV,CA_C]^$%WP8.@,!8NO?^F9UWJ'<2M=GW/=D3 MCA-6^&'W"15?:&]H>!N`BI:0FIBWD9\?VO>_!4$&9"!U3%I!"!..5VE,+6`; M=HB@F(X?YO?_B(T%$ZY9?UF"684(?0>TGHMN'W`_^Y!?&E^>?*_EU?<1]P7/ M'HX&$TYT.71I\C6:XO:6EYLH>#N*.=O@YF*1W$O<YLQ")51F/LV0QIZBWZ4FIV?TLT>$[BLKOWU\'E6U MEF0:63O["U)0'FQKA/<=A=UM]Q@9H(:*BH$;AEI]@$(?#N*`PE38]\+44\-F ML!)P^&X3E/@F]P,5;7!W9G8;=X2DFX%=<3CE7'H#"!>-Y?(MU&VM)AL35'EYGG4;=7]Y>Q\3E'.;>*RJEY:>G!ZML+7! MN\VI^PP85IB:?:@;HJB+]P;2'PYYG?DAG/N&F/=_D@;WH([\=(\'?9GX5I7W M7ID(^VZ,^'.3]Q"+"=<+^(@4]_D5`@P`&!\C%PH-"F5N9'-T7V!A8F-D969G:&EJ:VQM;F]P<7)S M='5V=WAY>GM\?7Y_@(&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@ MH:*CI*6FIZBIJJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;'R,G*R\S- MSL_0T=+3U-76U]C9VMOKK[.WN[_#Q\O/T]?;W^/GZ M^_S]_O\"#`"M]G^!"@T*96YD7!E(#`O1FEL=&5R+T9L871E1&5C;V1E+T5N M8V]D95LP(#(U-5TO0FET'AX@(B(B)"8F)B@J* MBHL+BXN,#(R,C0V-C8X.CHZ/#X^/D!"0D)$1D9&2$I*2DQ.3DY04E)25%965 MEA:6EI<7EY>8&)B8F1F9F9H:FIJ;&YN;G!R'IZ>GQ^?GZ`@H*"A M(:&AHB*BHJ,CHZ.D)*2DI26EI:8FIJ:G)Z>GJ"BHJ*DIJ:FJ*JJJJRNKJZPL MK*RM+:VMKBZNKJ\OKZ^P,+"PL3&QL;(RLK*S,[.SM#2TM+4UM;6V-K:VMS>W MM[@XN+BY.;FYNCJZNKL[N[N\/+R\O3V]O;X^OKZ_/[^_P$#`P,%!P<'"0L+" MPT/#P\1$Q,3%1<7%QD;&QL='Q\?(2,C(R4G)R)BXN+C8^/CY&3D MY.5EY>7F9N;FYV?GY^AHZ.CI:>GIZFKJZNMKZ^OL;.SL[6WM[>YN[N[O;^_O M\'#P\/%Q\?'R/CX^7GY^?IZ^OK[ M>_O[_'S\_/U]_?W^?O[^_W___P(,`.>L/Q`*#0IE;F1S=')E86T-96YD;V)J M#3,R(#`@;V)J/#PO0D<@,S`@,"!2+U12+TED96YT:71Y+TA4+T1E9F%U;'0O M3U`@=')U92]50U(@,S$@,"!2+U1Y<&4O17AT1U-T871E+U-!(&9A;'-E+U-- M(#`N,#(^/@UE;F1O8FH-,2`P(&]B:CP\+T-O=6YT(#$O5'EP92]086=EFMC.60B/SX*/'@Z M>&UP;65T82!X;6QN#IX;7!T:STB,RXQ M+3&UP;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\ M/WAP86-K970@96YD/2)W(C\^#0IE;F1S=')E86T-96YD;V)J#3,@,"!O8FH\ M/"]!6S$R(#`@4ETO5B`Q+C$O0VY;-"`P(%)=/CX-96YD;V)J#30@,"!O8FH\ M/"]$6S<@,"!272]4>7!E+TIO8E1I8VME=$-O;G1E;G1S+TU3(#4@,"!2/CX- M96YD;V)J#34@,"!O8FH\/"]-92`V(#`@4CX^#65N9&]B:@TV(#`@;V)J/#PO M1&U;-C$R+C`@-SDR+C`@-C$R+C`@-SDR+C!=/CX-96YD;V)J#3<@,"!O8FH\ M/"]06S$P(#`@4ETO1FE;."`P(%)=/CX-96YD;V)J#3@@,"!O8FH\/"]#4"A$ M:7-T:6QL97(I+T9I(#D@,"!2/CX-96YD;V)J#3D@,"!O8FHO5&AI')E9@T*,"`Q-`T*,#`P,#`P,#`P,"`V-34S-2!F#0HP,#`P,#(P,S$P M(#`P,#`P(&X-"C`P,#`P,C`S-C$@,#`P,#`@;@T*,#`P,#`R,S@T,B`P,#`P M,"!N#0HP,#`P,#(S.#@W(#`P,#`P(&X-"C`P,#`P,C,Y-#<@,#`P,#`@;@T* M,#`P,#`R,SDW-2`P,#`P,"!N#0HP,#`P,#(T,#(R(#`P,#`P(&X-"C`P,#`P M,C0P-C$@,#`P,#`@;@T*,#`P,#`R-#$P,R`P,#`P,"!N#0HP,#`P,#(T,3(S M(#`P,#`P(&X-"C`P,#`P,C0Q.#D@,#`P,#`@;@T*,#`P,#`R-#(R-"`P,#`P M,"!N#0HP,#`P,#(T,C@P(#`P,#`P(&X-"G1R86EL97(-"CP\+U-I>F4@,30^ :/@T* GRAPHIC 11 c14902c1490200.gif GRAPHIC begin 644 c14902c1490200.gif M1TE&.#EA<`!/`,0``$&GQX#$VO#X^^#Q]J#3XS&?PM#I\2&8O6&UT!&0N9#, MWG&]U;#:Z%&NS,#B[`&)M/___P`````````````````````````````````` M`````````````````````````"'Y!```````+`````!P`$\```7_("2.9&F> M:)H*3FNH<"S/=*T*3``<`!#\"$`!@%"\;,BDTB8@-`H+AT!E4#P7@Z5VNQ0$ M"H&LC=!S<,]HE+=`V`Z"Q[1\ZP"G'8#%=,ZW+0!B<@H%<7V&:G:&!@!MAXXD M!@4,CP)LCX\&!PPMG)V>GZ"AG):7?94&`0^JJZRMJD*NL;&,I7.5DZFRJP<+ M#'L`NL$(M[5I12*YL@!F)`[!P5D"!X'%2PP`(\FM!Q#: MJP$HSN"N">@0"PKE2O0DZ@F-)]_OK.Q(G+-G8\"!$MH2%"I!X%^K>"8(!"0X M`P$_9*PNFCC@$""*`O(HKCB(<)V*AAU5_T$\(5%D#`7U2CXH`(-CR@8H8@.WG`P0W$A#5:(*!.*41<^9[D#0;4:,J:&(M M@?3$EZA390`(B57L3ZU.;X)5$:#;6`A-?W:%,$#JS4DR",!5*B`O0A4(B!J& MX6#BV,8H`)\80/2!71@#&MP5`5GG4<4V%BOM3,-`Y:!9A"$%+)CQ( ME(0BF+;*8CN)F"%;ZOQC8`D&0-@?6=;I1D"#E*7%DHTWCA")BR,L0T)B--5!$`Y(K9H`@@&2(@F1)8`P20GRM-,?#.:IYYY\]K!`)@.ZB$"#BAP0*)W#..*`H6C",`A\9WPQ M9Z/-%#"8&WE0.H,`;N*&Q!J>:HH"4T8J$28IHMHPW`$*0*J3$ZBFFD033Q3A MP'8.Y"#$G[*F88!$>RY0UZ2]%FOLL<@FJ^RRIHK2R0`#@#(%"YZ(,8#_1$9` MH@!X\ACPR3@_^#("#@%DRU(#!R"(Q3B?H-/"5JL4\&8K65#8"C-#L3*-EZHT MP$)^^XP[)@$$`$P`IZU@-P)3JM1C[P,!U=@*`08\G`!@N2C(KRK`(:=*-^$` M>4`!#Z\22(PDN\(+D,3UM -----END PRIVACY-ENHANCED MESSAGE-----